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Abstract 
The genome of the eukaryotic parasite Trypanosoma brucei is both dynamic and 
unconventional in several aspects. In comparison with other eukaryotic genomes, 
where the majority of protein coding genes are associated with their own 
transcriptional promoters, T. brucei transcribes almost all protein-coding genes 
polycistronically. Transcription initiates from broad regions that lack defined 
promoter sequences and RNA Polymerase II then traverses up to hundreds of genes, 
generating a pre-mRNA that then requires trans-splicing and polyadenylation to 
generate mature mRNAs. Termination of transcription, via virtually unknown 
processes, occurs where two multigene transcription units converges or, in some 
cases, adjacent to a downstream transcription initiation site. RNA Polymerase II 
transcribes the majority of protein-coding genes in this manner, negating any 
differential gene expression via transcriptional control.  A further unusual aspect of 
the genome is the dedication of as much as a third of the coding capacity to 
elements of antigenic variation.  When infecting the mammalian host, parasites 
express a dense protein coat of variant surface glycoprotein (VSG). In order to 
evade host immune elements, T. brucei switches expression to antigenically distinct 
VSGs, employing a repertoire of ~2,000 genes. Both transcriptional and 
recombination-based strategies enable the parasite to either switch transcription 
between ~15 expression sites, each housing a distinct VSG, or relocate VSG 
sequence from silent gene arrays into an active VSG expression site. Although 
multiple factors have been found to regulate these processes, the events which 
trigger a VSG switch by either pathway are unclear.  
R-loops are three stranded structures containing an RNA-DNA hybrid and displaced 
single-stranded DNA. Although potentially deleterious to genome integrity, R-loops 
have been linked to transcription initiation and termination, DNA replication and 
recombination events. In this study, the potential for R-loop involvement in these 
fundamental genome functions of T. brucei was investigated. Firstly, Ribonuclease 
(RNase) H enzymes, which resolve the RNA-DNA hybrid portion of R-loops, were 
characterised, revealing T. brucei expresses potentially three distinct catalytic 
enzymes, two functioning in the nuclear genome and one in the kinetoplast 
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(mitochondrial) genome. Nuclear RNase H activity was depleted by null mutation or 
RNAi mediated knockdown of the nuclear RNase H enzymes, showing that while one 
RNase H, TbRH1, is non-essential, loss of the other, TbRH2, caused several growth 
and genome integrity defects. As it was hypothesised to increased levels of RNA-
DNA hybrids of the genome, RNA-DNA hybrids were mapped in wild type parasites 
and those lacking RNases H using a specific antiserum, S9.6. This mapping identified 
the conserved formation of R-loops at centromeres, retrotransposon-associated 
genes, rRNA and tRNA genes. R-loop enrichment was also uncovered at RNA 
Polymerase II transcription start sites, as documented in mammalian genomes. DNA 
damage was specifically increased at these sites after TbRH2 depletion, indicating 
efficient resolution of these transcription initiation-associated R-loops is critical for 
genome maintenance. In contrast, R-loops were not associated with DNA replication 
or transcription termination suggesting RNA-DNA hybrids are not involved in these 
processes in T. brucei. The most abundant sites of R-loop enrichment were found to 
be at the nucleosome depleted regions located between the coding regions of 
polycistronically transcribed genes and are associated with polyadenylation and 
trans-splicing, highlighting a novel correlation of R-loops with pre-mRNA processing. 
Lastly, R-loops were mapped to VSG expression sites where their abundance 
increased after ablation of RNase H activity, an effect that was associated with 
both increased DNA damage and VSG switching, uncovering an R-loop-driven 
mechanism of antigenic variation. 
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D-loop displacement-loop 
DRIP DNA-RNA hybrid immunoprecipitation 
DSB double-stranded DNA break 
E-value expected-value 
EcRHI E. coli RNase HI 
ESC embryonic stem cell 
ESAG expression site associated gene 
FA formaldehyde 
FACT factilitates chromatin transcription complex 
FLC floral repressor gene 
G4 G-quadruplex 
GO gene ontology 
GPI glycosylphosphatidylinositol 
gRNA guide RNA 
HA hemaglutinin 
HAT human African trypanosomiasis 
HBD hybrid binding domain 
HP1g heterochromatin protein 1g 
HR homologous recombination 
HYG hygromycin 
Ig immunoglobulin 
IP immunoprecipitation 
K kinetoplast 
 15 
kDNA kinetoplast DNA 
KO knockout 
LOH loss-of-heterozygosity 
MRE11 meiotic recombination 11 
mtDNA mitochondrial DNA 
MTS mitochondrial targeting sequence 
mVSG metacyclic variant surface glycoprotein 
N nucleus 
ncRNA noncoding RNA 
NEO neomycin 
NER nucleotide excision repair 
NUP-1 nucleoporin-1 
ORC origin recognition complex 
ORF open reading frame 
ORI origin of replication 
PAF1 RNA Polymerase II associated factor 1 
PAS polyadenylation site 
PBS phosphate buffered saline 
PCF procyclic form 
PCR polymerase chain reaction 
PCR2 polycomb repressive complex 2 
PI propidium iodide 
PIC protease inhibitor cocktail 
PCNA proliferating cell nuclear antigen  
Pol  polymerase 
poly(Y) polypyrimidine 
pre-mRNA precursor-messenger RNA 
PTU polycistronically transcribed unit 
qPCR quantitative-polymerase chain reaction 
RED ribonucleotide excision defective 
RER ribonucleotide excision repair 
RHS retrotransposon hotspot 
RLFS R-loop forming sequence 
RMI1 RecQ mediated genome instability 1 
RNAi RNA interference 
RNAP RNA polymerase 
RNase H ribonuclease H 
RPA replication protein A 
RpD (5')-RNA-DNA(3')/DNA 
SAS splice acceptor site 
Sen1 senataxin 
seq next-generation sequencing 
SETX senataxin 
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SIF stumpy inducible factor 
siRNA small-interfering RNA 
SL  splice leader 
ssDNA single-stranded DNA 
SSR strand switch region 
TbRH1 T. brucei ribonuclease H1 
TbRH2 T. brucei ribonuclease H2 
TbRH3 T. brucei ribonuclease H3 
TERRA telomeric repeat-containing RNA 
tet tetracycline 
TOPO3a topoisomerase 3a 
TSS transcriptional start site 
TTS transcription termination site 
U2AF1 U2 snRNA auxiliary factor 1 
UMS universal minicircle sequence 
UMSBP universal minicircle sequence binding protein 
VIM vimentin 
VSG Variant Surface Glycoprotein 
WHO World Health Organisation 
WT wild type 
XPF exoderma pigmentosum type F 
XPG exoderma pigmentosum type G 
yH2A Thr130 phophorylated H2A 
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1 Introduction  
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1.1 Trypanosoma brucei 
The eukaryotic parasite Trypanosoma brucei is a member of the protozoan 
Trypanosomatidae family within the Kinetoplastida order and is further divided into 
three subspecies: T. brucei gambiense, T. brucei rhodesiense and T. brucei brucei. 
Commonly referred to as kinetoplastids, members of the Kinetoplastida order are 
distinguished by possession of the kinetoplast, a specialised disk-like network of 
concatenated circular DNA (kDNA), comprising the mitochondrial genome (Lukes et 
al., 2002).  The Trypanosomatida are further identified as having only a single 
flagellum. In T. brucei the flagellum protrudes from the flagella pocket as an 
extension of the basal body (a cylindrical structure made up of microtubules), to 
which the kinetoplast is connected (Robinson and Gull, 1991).  All T. brucei 
subspecies cause mammalian disease across sub-Saharan Africa where they are 
found within the limited geographical location of the tsetse fly vector which they 
also infect (Figure 1.1). Yet, each subspecies’ epidemiology, virulence and 
pathogenicity vary considerably.  
Human African trypanosomiasis (HAT) is classed as a neglected tropical disease by 
the World Health Organisation (WHO) and exists in two documented forms.  The 
slow progressing form found in Western and Central Africa is caused by T. b. 
gambiense, whereas T. b. rhodesiense causes a much faster progressing disease in 
Eastern and Southern Africa (Simarro et al., 2010) (Figure 1.1).  In complete 
contrast, T. b. brucei is unable to infect humans, due to sensitivity to the 
trypanosome lytic factors 1 and 2 found in human serum, but can cause the animal 
trypanosomiasis disease, Nagana (Vanhollebeke and Pays, 2010).  Although HAT is 
now a rare disease (only 2,804 cases recorded in 2015), cases are still reported in 
over 20 African countries, where it causes substantial morbidity in some rural 
communities (Büscher et al., 2017).  As only a limited arsenal of treatments and 
control tools are currently available, infection in these populations still causes 
suffering and poses the significant threat of epidemic outbreak (Franco et al., 
2014). Nagana, however, remains endemic to 40 African countries and causes a still 
greater economic burden; the high mortality rate caused by infection accounts for 
massive losses in milk and meat production across the continent (Swallow, 1999).  
 19 
All T. brucei subspecies contribute in a minor capacity to Nagana in cattle along 
with other Trypanosomatida, most predominately T. brucei’s close relatives T. 
congolense and T. vivax (Abebe, Gute and Simon, 2017).  Due to the ease with 
which T. b. brucei can be cultured in a laboratory environment and the range of 
genetic tools available for its manipulation, this subspecies lends itself to molecular 
research as an ideal model in which to study trypanosome biology. 
 
Figure 1.1 Geographical distribution of human African trypanosomiasis cases reported between 
2010 and 2014.  
The number of infections by T. b. gambiense and T. b. rhodesiense per km2 per year are plotted as 
density in red and blue respectively, along with the predicted distribution of the tsetse fly in yellow. 
Plotted data was reported in the WHO atlas of HAT (Simarro et al., 2010). Image source Büscher et al. 
(2017), license number 4410690838783. 
1.1.1 The T. brucei life cycle 
All T. brucei subspecies are transmitted between mammalian hosts and the blood 
sucking tsetse fly vector of the Glossina genus, although T. b. gambiense can 
additionally be transmitted congenitally (Rocha et al., 2004; De Kyvon et al., 2016). 
During the life cycle, the parasites undergo metabolic and morphological changes to 
allow specialisation of each distinct form to the disparate environments of the 
mammal and tsetse fly, with infective and proliferative forms of the parasite found 
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in at least three stages in the life cycle (Figure 1.2).  Within infected tsetse fly 
salivary glands reside metacyclic form trypanosomes. These parasites are 
preadapted for mammalian infection, such as by expressing a Variant Surface 
Glycoprotein (VSG) coat (see below), and remain arrested in the cell cycle until 
injected into the mammalian host skin when the fly takes a blood-meal (Matthews 
and Gull, 1997).  In the mammal, metacyclic forms differentiate into ‘long-slender’ 
bloodstream form (BSF) cells, which proliferate locally for several days before 
rapidly spreading via the blood and lymph circulatory systems. 
 
Figure 1.2 The T. brucei parasitic life cycle.  
Scanning electron micrograph images of each life cycle stage are shown to scale. Hosts and 
environments within the tsetse fly host are labelled. Circular red arrows indicate replicative parasites 
while straight arrows show direction of cycle progression. Image source Barry and McCulloch (2001), 
license number 4410691284150. 
As parasitaemia increases, quorum sensing of the elusive molecule(s) termed the 
Stumpy Inducible Factor (SIF) triggers transformation of long-slender BSF cells into 
‘short-stumpy’ BSF parasites (Reuner et al., 1997; Vassella et al., 1997; Rico et al., 
2013). These cell cycle-arrested parasites must be ingested from either the blood or 
skin (Caljon et al., 2016; Capewell et al., 2016) by the insect vector if they are to 
survive (Turner, Aslam and Dye, 1995).  If successfully transmitted, short-stumpy 
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BSF cells pass into the midgut of the tsetse fly where they differentiate into 
replicative procyclic form (PCF) trypanosomes (Fenn and Matthews, 2007).  A 
portion of the PCF parasites can transform into proventricular mesocyclic forms, 
which migrate to the salivary glands of the fly (Van Den Abbeele et al., 1999).  
Here, transformation into replicative epimastigotes takes place before 
differentiation into mammalian infective metacyclic cells completes the life cycle 
(Van Den Abbeele et al., 1999). 
As T. brucei is strictly extracellular, the parasite has evolved a sophisticated 
mechanism of antigenic variation in order to evade the adaptive immune defences 
of the mammal.  Metacyclic parasites are coated in metacyclic VSG (mVSG) dimers, 
which provide initial protection from the mammalian immune system upon 
transmission (Tetley et al., 1987; Turner et al., 1988). Once differentiated into 
long-slender BSFs the mVSG coat is replaced by BSF VSG, here referred to simply as 
VSG. VSG dimers are highly immunological and, although they shield underlying 
invariant membrane proteins from innate immune attack (Bartossek et al., 2017), 
the dense coat elicits a specific antibody response (Guirnalda et al., 2007). 
However, a huge repertoire of antigenically distinct VSGs is available to the BSF 
parasites, which switch between the proteins to prevent the accumulation of 
effective immunological memory in the host immune system.  The details of this 
complex process are discussed in detail in section 1.3. 
1.1.2  T. brucei cell structure and cell cycle 
T. brucei BSF cells are highly polarised, with microtubules running under the 
membrane from the anterior to the posterior of the cell body to form the 
cytoskeleton structure (Figure 1.3; reviewed in Matthews 2005).  The microtubules 
open at the posterior end to form the flagella pocket, from which the flagellum 
extends and attaches laterally along the side of the cell body with only the distal 
end free (Wheeler et al. 2013).  Many of the cell organelles and structures, 
including the flagellum, flagella pocket, kinetoplast and nucleus, are single copy 
and specifically positioned within the organised cell body (Figure 1.3).   
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Figure 1.3 The cellular structure of bloodstream form T. brucei.  
A simplified diagram of BSF parasite morphology. The microtubule cytoskeleton (10) that is found 
beneath the cell membrane is presented in the anterior end. Image source (Matthews, 2005). 
Commencing synthesis of a new flagellum by duplication of the basal body, marks 
the initiation of the cell cycle (Woodward and Gull, 1990; Wheeler et al., 2013).  
This event is immediately followed by duplication of the Golgi complex (Ho et al., 
2006). Two coordinated, temporally overlapping S phase events then take place 
(Figure 1.4). kDNA replication initiates first, before nuclear DNA replication 
commences as the kDNA comes to the end of S phase and enters the G2 stage 
(Figure 1.4; Benz et al., 2017).  The newly formed kinetoplast network is 
segregated from the old as the duplicated basal bodies are separated via 
microtubule movement, during which nuclear G2 phase takes place (Liu et al., 
2005; Jensen and Englund, 2012). At this stage cells possess one nucleus (1N) and 
two kinetoplasts (2K), before mitosis divides the duplicated nuclear genome, 
resulting in cells with two nuclei and two kinetoplasts (2N2K) (Ogbadoyi et al., 
2000). After nuclear mitosis, cytokinesis commences as a cleavage furrow forms 
from the anterior to the posterior between the old and new flagella that develops 
continuously during the previous stages (Wheeler et al., 2013). Finally, abscission 
and remodelling of the new cells’ posteriors completes the cell cycle (Figure 1.4). 
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Figure 1.4 Model of the T. brucei cell cycle.  
Events of the T. brucei cell cycle are shown as a simplified schematic above the relative timing of 
coordinated nuclear DNA and kDNA duplication. The nuclei (large blue circles), kinetoplasts (small 
blue circles), basal bodies (small green circles) and flagella (black) are shown. In the G1 phases of 
both the nuclear and kinetoplast cycles, the cells possess 1 nucleus and 1 kinetoplast (1N1K), before 
kDNA synthesis and kinetoplast division generates 1N1eK (elongated kinetoplast) then 1N2K cells. 
Before the end of Sk/G2, synthesis of the nuclear genome ensues and continues while the kinetoplast 
divides. Nuclear G2 follows before mitosis and cytokinesis complete the cycle. G1 – gap phase 1, Sk – 
kDNA synthesis, SN – nuclear DNA synthesis, G2 – gap phase 2, M – mitosis, D – kinetoplast division, 
C – cytokinesis, A – after kinetoplast division.  Recreated from (Benz et al., 2017), under the Creative 
Commons Attribution 4.0 International License.  
1.1.3 Human African trypanosomiasis  
The clinical features of HAT depend greatly on whether disease is caused by T. b. 
gambiense or T. b. rhodesiense infection, host response, disease stage and 
subspecies strain (Beckers et al., 1981; MacLean et al., 2010). Infection of either 
subspecies is nearly always fatal if untreated, though instances of healthy carriers 
or self-cure have been documented in the case of T. b. gambiense HAT (Jamonneau 
et al., 2012).  With either subspecies disease progresses in two stages: the first, 
hemo-lymphatic stage (blood and lymph infection) is followed by a second, 
meningo-encephalitic stage where parasites cross the blood-brain barrier and 
invade the central nervous system. Symptoms of the first stage predominantly 
consist of a long-lasting intermittent fever, headaches, itching and 
lymphadenopathy (abnormal lymph nodes).  Neuopsychiatric symptoms, including 
the characteristic sleeping disorder that elicited the name sleeping sickness, add to 
these when the second stage is reached.  The slowly progressing form of HAT 
caused by T. b. gambiense tends to be chronic with a mean duration of around 3 
years (Checchi et al., 2008). However, acute infection by T. b. rhodesiense 
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progresses from the initial stage within a few weeks and leads to death within 6 
months (Odiit, Kansiime and Enyaru, 1997). 
Treatment options depend on the causative subspecies and stage of disease: 
pentamidine and suramin are available for first stage treatment, and melarsoprol, 
eflornithine and nifurtimox for the second (Keating et al., 2015).  As first stage 
drugs are unlikely to effectively treat a second stage infection, and those for the 
later stage are too toxic to justify use in the first, the stage must first be 
determined by lumbar puncture to examine parasite load in the cerebral-spinal 
fluid.  Several rapid diagnostic tests have been developed for T. b. rhodesiense 
infection as the characteristic high levels of parasitaemia allow identification by 
microscopy examination of lymph or concentrated blood samples, but no field-
applicable tests are yet available for T. b. gambiense  HAT (reviewed by the WHO in 
Büscher et al. 2017). 
Pentamidine remains the first-line treatment for T. b. gambiense HAT, and an 
alternative for T. b. rhodesiense HAT for which suramin is the first choice.  T. b. 
gambiense infection has been effectively treated with pentamidine for decades (95-
98% effective) and is well tolerated. Suramin is effective against both subspecies 
but is more complex to administer and can cause some adverse reactions (Simarro 
et al., 2012).  Second stage treatment induces more adverse reactions (abdominal 
pain, vomiting and headache) than either first stage drug, but treatment against T. 
b. gambiense HAT with nifurtimox-eflornithine combination therapy is better 
tolerated and has higher cure rates (95-98%) than monotherapy with melarsoprol or 
eflornithine (Priotto et al., 2009; Franco et al., 2012).  Use of melarsoprol is 
restricted to treatment of second stage T. b. rhodesiense HAT due to the high 
frequency of severe and life-threatening adverse reactions, the most severe of 
which is encephalopathic syndrome that occurs in 5-18% of treated patients and is 
fatal in 10-70% of cases (Lutje, Seixas and Kennedy, 2010; Büscher et al., 2017). 
Cases of drug resistance to melarsoprol and pentamidine have been documented 
(Graf et al., 2013; Munday et al., 2014; Fairlamb and Horn, 2018), but the 
introduction of nifurtimox-eflornithine combination therapy has decreased the 
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probability of resistance emergence (Büscher et al., 2017). Additionally, two new 
drugs are under clinical development: fexinidazole (Torreele et al., 2010) and 
benzoxaborole (Robert T Jacobs et al., 2011). Importantly, both are easily 
administered orally, target both T. b. gambiense and T. b. rhodesiense and are 
intended against both stages of HAT (Torreele et al., 2010; Robert T. Jacobs et al., 
2011).  
1.1.4 Animal African trypanosomiasis/Nagana 
Cases of Nagana have been documented in a vast range of domesticated and wild 
animals including pigs, sheep, goats, horses, ruminants, lions and leopards, 
nonhuman primates and some rodents.  Cattle infections remain problematic as the 
high mortality rates due to the associated wasting lead to an estimated loss in 
productivity of up to 20% across a range of factors, including meat and milk 
production (Swallow, 1999). Nagana is somewhat controlled via selective bush 
clearing to remove vegetation relied upon by the vector, employing insecticide use 
and in some cases breeding of naturally resistant cattle (reviewed in, Meyer et al. 
2016). However, meaningful and standardised evalution of these control operations 
is required in order to inform the implementation of future control programmes 
(Meyer et al., 2016).  
Particularly in areas outside of vector control operations, a handful of trypanocides 
are widely employed in cattle, with diminazene aceturate and isometamidium used 
most heavily. Threateningly, resistance to these drugs has been increasing, with 
between 35 and 70 million doses of trypanocides used across sub-Saharan Africa 
annually (Holmes, 2013; Giordani et al., 2016).  Despite high demand, there has 
been a lack of interest from pharmaceutical companies due to their anticipation of 
low profits, and so novel licensed compounds are unlikely to be available for 
several years (Giordani et al., 2016). However, recent investment from the Bill and 
Melinda Gates Foundation and the UK Department for International Development 
(via the Global Alliance for Livestock Veterinary Medicines, GALVmed), hopes to aid 
the development of new anti-trypanosome therapies, which will be essential if the 
burden of Nagana is to be tackled. 
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1.2 The unconventional genome of T. brucei 
1.2.1 Genome composition 
The ~26 Mb T. brucei genome consists of 11 megabase-sized chromosomes, ranging 
from ~1-5.2 Mb, an unspecific number of mini and intermediate-sized chromosomes 
(30-700 kb) and a circular kDNA mitochondrial genome (Melville et al., 1998; 
Wickstead, Ersfeld and Gull, 2004; Berriman, 2005).  
The kDNA genome is composed of interlocking circles of two types: a few dozen 
maxicircles, which encode typical mitochondria genes, and thousands of 
minicircles, which encode guide RNAs (gRNAs) (Lukes et al., 2002). The gRNAs store 
information needed to restore a viable coding sequence to the maxicircle 
transcripts, which require uridine insertion or deletion before being translated 
(Hajduk and Ochsenreiter, 2010; Aphasizhev and Aphasizheva, 2011). Maxicircles 
range in size from 20 to 40 kb, whereas minicircles are only 0.5 to 10 kb in length, 
encoding 50-60 nt long gRNAs. Although all kinetoplastids have minicircles and 
maxicircles, the dense, inter-locked, disk-like structure that the kDNA forms in T. 
brucei appears unique to trypanosomatids (Marande, Lukes and Burger, 2005). 
There are also several unusual characteristics of the T. brucei nuclear genome 
compared to other eukaryotic genomes.  The most striking of these distinct features 
is the organisation of nearly all protein-coding genes into polycistronically 
transcribed units (PTUs), in which tens to hundreds of genes are transcribed from 
the same strand in the same direction (see review, Campbell et al. 2003). 
Maturation of mRNA requires co-transcriptional processing of the pre-mRNA into 5’ 
capped and 3’ polyadenylated mRNA molecules through coupled trans-splicing and 
polyadenylation (see below).  Although genes within each PTU can be differentially 
regulated, all are transcribed from shared transcriptional start sites (TSSs), 
explicitly limiting any means of transcriptional control via the activation or 
repression of transcription (Clayton, 2014, 2016).  Another unusual feature is the 
presence of a modified DNA base, termed base J (ß-D-glucosyl-
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hydroxymethyluracil), which is associated with the ends of PTUs and repetitive DNA 
regions such as telomeric sequences (Maree and Patterton, 2014).  
PTUs make up the actively transcribed core of the Mb chromosomes and are distinct 
from the highly variable subtelomeric regions that consist of mainly 
transcriptionally silent gene arrays (Berriman, 2005). Where the cores of the 11 Mb 
chromosomes are conserved and diploid, the subtelomeres can differ considerably 
in composition between chromosome homologues and so could be considered 
aneuploid (Berriman, 2005).   
1.2.2 Transcription 
As stated above, transcription of the core T. brucei genome occurs almost 
exclusively in a polycistronic manner (Johnson, Kooter and Borst, 1987; Berriman, 
2005). This transcription is largely carried out by RNA Polymerase (Pol) II, whereas 
RNA Pol I and RNA Pol III transcribe specific loci, although transcription by these 
Pols is also often polycistronic, such as in the case of the RNA Pol I transcribed VSG 
expression sites (see below). Multiple protein-coding genes are transcribed as a PTU 
and the resulting pre-mRNA transcripts are processed in trans by the addition of a 
splice leader (SL) RNA 5’ cap, and polyadenylation of the 3’ end to generate mature 
mRNA (detailed in section 1.2.2.3; Figure 1.5).  Adjacent PTUs meet at regions 
termed strand switch regions (SSRs), where the units either converge (transcription 
termination sites; TTSs) or diverge (TSSs). At several sites over the Mb chromosomes 
transcription can terminate and re-initiate on the same strand (Siegel et al., 2009; 
Wright, Siegel and Cross, 2010). Although no true strand switch takes place, these 
regions are termed head-to-tail SSRs for continuity. Short PTUs have also been 
identified in nematodes (Spieth et al., 1993), and a few cases of dicistronic units 
have been observed in Drosophila (Brogna and Ashburner, 1997) and humans (Lee, 
1991). However, the near universal use of polycistronic transcription appears to be 
unique to the kinetoplastids (Jackson et al., 2016) and raises several questions 
concerning the control of gene expression in T. brucei and its relatives. 
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Figure 1.5 Polycistronic transcription and mRNA maturation in T. brucei.  
Transcription by RNA Pol II takes place on either the sense (+) or anti-sense (-) strand, here starting at 
divergent SSRs. Transcription in opposite directions converges to terminate at convergent SSRs. 
Trans-splicing and polyadenylation dissect pre-mRNA transcripts and generates mature mRNA. Image 
source Siegel et al. (2011), license number 4410700809096. 
1.2.2.1 RNA Polymerase II transcription initiation 
Nuclear run-on assays performed in Leishmania major, a tryapnosomatid parasite 
and close relative of T. brucei, first inspired the proposal that RNA Pol II 
transcription initiates at divergent SSRs and continued until termination at 
convergent SSRs (Martínez-Calvillo et al., 2003, 2004).  Later, genome-wide analysis 
via Chromatin-Immunoprecipitation coupled to next-generation DNA sequencing 
(ChIP-seq) revealed the enrichment of multiple histone modifications and histone 
variants at SSRs (Siegel et al., 2009; Wright, Siegel and Cross, 2010).  H4K10ac 
(histone 4 lysine 10 acetylation) and H3K4me3 (histone 3 lysine 4 trimethylation), 
along with histone variants H2A.Z and H2B.V, were found to be enriched up to 300-
fold at divergent SSRs, indicating their association with transcription initiation in T. 
brucei (Siegel et al., 2009; Wright, Siegel and Cross, 2010). These factors were also 
found to be enriched within some PTUs, suggesting the presence of head-to-tail 
SSRs at these sites (Siegel et al., 2009; Wright, Siegel and Cross, 2010). These, 
along with divergent SSRs, were experimentally confirmed as TSSs using a 
sequencing technique that enriches for RNA possessing a 5’ triphosphate, which 
only newly transcribed RNA possesses before the addition of a 5’ cap (Kolev et al., 
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2010). Mapping of histone H3 acetylation in Leishmania major revealed acetylation 
of the histone at divergent SSRs as well as towards the chromosome ends and within 
PTUs, highlighting that the core genome polycistronic structure is conserved 
between Trypanosoma and Leishmania parasites (Thomas et al., 2009). 
Although these studies have successfully identified broad TSS regions, the 
mechanisms governing transcription initiation by RNA Pol II are still largely unclear. 
With the exception of the SL RNA promoter (Günzl et al., 1997), no classical 
promoter sequences, which in other eukaryotes provide a platform for transcription 
machinery binding, have been identified in T. brucei. However, GT-rich motifs have 
been found to promote deposition of histone variant H2A.Z to the boundaries of the 
nucleosome depleted regions found across T. brucei divergent (and head-to-tail) 
SSRs, presumably ensuring a region of relaxed chromatin upstream of the broad TSS 
(Wedel et al., 2017). This GT-rich motif-directed deposition of H2A.Z is sufficient 
for transcription initiation in T. brucei (Wedel et al., 2017). These RNA Pol II 
promoters hence appear similar to “dispersed” promoters observed in other 
eukaryotic genomes that lack both typical motifs, such TATA boxes, and defined 
TSSs (Juven-Gershon et al., 2008; Lenhard, Sandelin and Carninci, 2012). Instead, 
they most commonly contain CpG islands, house a broad region where transcription 
may start, and are associated with constitutively expressed house-keeping genes 
(Juven-Gershon et al., 2008; Lenhard, Sandelin and Carninci, 2012). In common 
with divergent SSRs and the initiating portion of head-to-tails SSRs, nucleosomes 
are well positioned downstream of, and depleted upstream of, the TSSs associated 
with dispersed promoters in metazoan genomes (Rach et al., 2011; Wedel et al., 
2017).  Histone variant H2A.Z is also deposited at the flanking sites of nucleosome 
depleted regions across TSSs of dispersed promoters in metazoans (Rach et al., 
2011), as observed at T. brucei TSSs (Wedel et al., 2017).  These characteristics are 
in contrast to differentially regulated “focused” promoters, which contain typical 
motifs, a defined site of initiation and are associated with less organised chromatin 
(Rach et al., 2011).  Hence, RNA Pol II initiation sites in T. brucei may be 
mechanistically similar to dispersed promoter regions (Wedel et al., 2017), in 
keeping with a lack of transcriptional control over gene expression in the parasite.  
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1.2.2.2 Transcription termination 
Histone variants H3.V and H4.V have been shown to be enriched at TTSs in T. brucei 
(Siegel et al., 2009), as has base J, which flanks PTUs (Cliffe et al., 2010).  
Depletion of base J leads to transcriptional read through at sites of termination in 
the Leishmania genome (van Luenen et al., 2012; Reynolds et al., 2014). 
Contrastingly, depletion of base J in T. brucei does not lead to complete read 
through, although specific sites proximal to normal base J deposition do display 
minor read through (Reynolds et al., 2014).  A combination of base J depletion and 
H3.V deletion does, however, cause antisense transcription of genes downstream of 
the TTSs in T. brucei (Schulz et al., 2016).  Interestingly, H3.V has been shown to 
promote transcriptional termination prior to the end of a PTU to regulate the 
transcription of specific genes, in particular small-interfering RNA (siRNA) producing 
loci, suggesting some genes are preferentially located to the ends of PTUs (Reynolds 
et al., 2016).  
1.2.2.3 Trans-splicing and polyadenylation 
Maturation of the pre-mRNA transcripts is achieved first by trans-splicing, which 
adds a 39 nt SL sequence of heavily modified RNA. The SL RNA substrate is first 
transcribed independently by RNA Pol II at a locus separate from the primary 
transcript before 8 methylation events occur across the first 4 nts, generating a 
“cap 4” structure, which includes the conserved 7-methylguanylate cap (m7G) 
(Perry, Watkins and Agabian, 1987). nt 28 of the SL RNA is additionally 
pseudouridylated (y28) (Liang, Xu and Michaeli, 2002), although this modification is 
not required for trans-splicing (Sturm, Fleischmann and Campbell, 1998; 
Mandelboim et al., 2002).  Only two T. brucei genes, encoding a putative poly(A) 
polymerase (Tb927.3.3160) and an ATP-dependent DEAD/H RNA helicase 
(Tb927.8.1510), have been found to undergo cis-splicing (the process of removing 
an internal fragment from a transcript that is fundamental to gene regulation in 
mammals) (Mair et al., 2000; Berriman, 2005; Siegel et al., 2010). Therefore, the 
vast majority of T. brucei protein-coding genes do not have a conventional 
intron/exon structure. Multiple parallels do, however, exist between cis-splicing 
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and trans-splicing: the requirement for a polypyrimidine (poly(Y)) tract (Huang and 
Van, 1991), an AG dinucleotide 3’ splice acceptor site (SAS) where the SL sequence 
is fused, and formation of intermediate Y structures (Murphy, Watkins and Agabian, 
1986).   
SASs have been mapped in T. brucei by retrieving RNA sequencing reads which span 
the SAS-coding region junction and removing the SL sequence before aligning the 
remaining sequence to the genome (Kolev et al., 2010; Nilsson et al., 2010; Siegel 
et al., 2010). Combined efforts have now mapped >32,000 unique SASs in >8,900 
genes in PCF and BSF T. brucei (Kolev et al., 2010; Siegel et al., 2010).  Most T. 
brucei genes have between 1 and 3 available SASs, and the alternative use of these 
has been observed in 676 genes when comparing long-slender BSF, short-stumpy BSF 
and PCF cells (Nilsson et al., 2010). 
Polyadenylation is strictly dependent on the downstream trans-splicing events 
(López-Estraño, Tschudi and Ullu, 1998). In fact, the same poly(Y) motif influences 
the efficiency of polyadenylation of one gene and splicing of the immediately 
downstream gene (Matthews, Tschudi and Ullu, 1994).  An average of 10 
polyadenylation sites (PASs) have been mapped per gene in T. brucei (Nilsson et al., 
2010; Siegel et al., 2010). Binding of poly(A)-binding proteins (PABPs) to poly(A) 
tails stabilises mRNA transcripts by preventing the deadenylation-dependent mRNA 
decay pathway, which is initiated by removal of the poly(A) tail and leads to rapid 
cleavage of the 5’ cap (Wilusz, Wormington and Peltz, 2001).  
1.2.3 DNA replication 
Like other eukaryotes, initiation of DNA replication in T. brucei depends upon the 
assembly of the origin recognition complex (ORC) at discrete sites in the genome, 
termed origins or ORIs. In humans, ORC is made up of five ATPase subunits, ORC1-5, 
and a sixth unrelated protein, ORC6 (Duncker, Chesnokov and McConkey, 2009).  
Five subunits of the divergent T. brucei ORC have been identified to date; one 
ORC1-like factor named ORC1B, a highly divergent ORC4-like protein, two even less 
homologous proteins, Tb7980 and Tb3120, and OCR1/CDC6, a factor which appears 
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homologous to both ORC1 and CDC6 (Godoy et al., 2009; Dang and Li, 2011; 
Tiengwe et al., 2012).   Indeed, OCR1/CDC6, ORC4 and MCM3 (a DNA replicative 
helicase) have been found to form part of a high-molecular-weight complex (~530-
1011 kDa), implying T. brucei does possess a functional ORC (Marques et al., 2016). 
ORC binding licenses ORIs in the G1 phase through Cdc6-mediated recruitment of 
MCM, but only some of these primed ORIs are activated upon entering S phase. In T. 
brucei, ORC1B is only found in the nucleus of S phase cells, perhaps indicating a 
diverged strategy for ORI licensing or activation.(Marques et al., 2016). 
1.2.3.1 Origins of replication 
In most eukaryotic genomes multiple ORIs initiate replication, although not all ORIs 
that are licensed for replication are activated when the cells enter S phase. 
Although the role of ORC appears well conserved among eukaryotes the means by 
which the complex recognises ORIs is not.  For example, ORC binds S. cerevisiae 
ORIs in a sequence-specific manor (Marahrens and Stillman, 1992), and via non-
specific AT-rich sequences in both S. pombe and Drosophila (Kong and DePamphilis, 
2001; Vashee et al., 2003).  In the human genome the most efficiently activated 
ORIs are associated with CpG island promoters (Lombraña et al., 2015).  The 
molecular details of this close relationship between replication and transcription 
initiation are still uncertain, but analysis revealed most human and mouse ORIs 
contain G-rich repeat elements with the potential to form G-quadruplex (G4) 
structures (Besnard et al 2012; Cayrou et al 2012).  Interestingly, human ORC1 has 
been shown to efficiently bind G4 structures present in either RNA or single-
stranded DNA (ssDNA), both of which are present as transcription takes place, in 
vitro (Hoshina et al 2013).  
Replication and transcription processes are also closely link in the T. brucei 
genome, as the ORC subunit ORC1/CDC6 was found to bind to potentially all SSRs, a 
subset of which were found to be activated as ORIs in the S phase of wild type (WT) 
cells (Tiengwe et al., 2012).  Of these ORIs, 19 were located at divergent SSRs, 3 at 
convergent SSRs and 18 at head-to-tail SSRs.  In all cases replication appears to 
occur in both directions, with an equal rate of movement in both directions at 
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convergent and divergent SSRs.  At head-to-tail region ORIs, however, replication 
appears to be faster when occurring in the same direction as transcription.  Thus, it 
can be hypothesised that the T. brucei genome has evolved to minimise head-on 
collisions between the replication and transcription machineries.  Further 
supporting the mechanistic links between replication and transcription, RNAi-
mediated depletion of ORC1/CDC6 causes changes in mRNA abundance proximal to 
SSRs (Tiengwe et al., 2012). In addition, the single actively transcribed VSG 
expression site (see below) has been shown to be replicated earlier in S phase than 
all other transcriptionally silent sites, each of which are replicated very late (Devlin 
et al, 2016). 
1.3 Antigenic variation in T. brucei  
The selective forces placed on pathogens by the complex, adaptive mammalian 
immune system has led to the independent evolution of antigenic variation in many 
species.  All aim to evade the defences of the immunocompetent host and often 
share common features: monoallelic expression of a single antigen, an archive of 
silent antigen genes of the same ‘family’, and antigen expression switching 
strategies which occur above background levels of recombination or mutation. For 
example, Borrelia sp possess a specialised vls locus, which contains an active vls 
surface antigen expression site, vlsE, as well as a silent array of vls cassettes, and 
relies on recombination events to move diverse silent vls genes into the vlsE 
(Norris, 2014). Neisseria gonorrhoeae and N. meningitidis also rely on 
recombination to relocate silent pilin genes into the expression loci, pilE (Hagblom 
et al., 1985). Plasmodium falciparum similarly employs antigenic variation and is 
able to recombine ~60 var genes during meiosis. However, antigenic variation 
amongst var genes is controlled by epigenetic transcription-driven switching, where 
the promoter of the active var gene is silenced and an alternative var gene 
promoter is activated (Kyes, Kraemer and Smith, 2007).  T. brucei antigenic 
variation is impressively complex and employs transcriptional switching as well as 
various recombination strategies.  
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BSF T. brucei parasites are coated in ~5 x 106 VSG antigen dimers, which comprise 
5-20% of each cell’s total protein (Cross, 1975).  Each protein is approximately 60 
kDa in size and is attached to the cellular membrane via a conserved 
glycosylphosphatidylinositol (GPI) anchor (Ferguson et al., 1988).  The resulting 
dense ‘coat’ is believed to act as a physical barrier, blocking immune elements 
from binding other surface proteins (Schwede et al., 2011). However, this 
understanding has been challenged as some proteins have been shown to protrude 
above the VSG coat (Higgins et al., 2013). Each BSF parasite expresses a single VSG 
at a time from one of approximately 15 specialised RNA Pol I-transcribed 
bloodstream expression site (BES) (Hertz-Fowler et al., 2008). Expression of the VSG 
antigen is detected by the mammalian host defences and a specific immune attack 
to be mounted against the parasites (Guirnalda et al., 2007).  Antigenic variation 
ensues as the parasites switch expression to that of a different, antigenically 
distinct VSG, thus avoiding complete elimination of the infecting population.   
1.3.1 Genomic elements associated with VSG switching 
The ~15 BESs present in the genome are split between the subtelomeres of the 11 
Mb chromosomes and the intermediate chromosomes (Figure 1.6).  BESs have a 
generic structure consisting of a RNA Pol I promoter and a string of up to 13 
expression site associated genes (ESAGs), separated from the telomere proximal 
VSG by a series of DNA sequence repeats termed the 70-bp repeats (Figure 1.6) 
(Hertz-Fowler et al., 2008).  Although RNA Pol I typically transcribes rRNA genes, 
BES promoters show limited homology to the rRNA promoter (Zomerdijk et al., 
1990), as well as the promoter associated with the procyclin genes, which encode 
the surface proteins of PCF T. brucei and are also transcribed by RNA Pol I (Günzl et 
al., 2003). Each of these RNA Pol I promoters binds slightly divergent RNA Pol I 
associated transcription factors (Brandenburg et al., 2007), and display different 
subnuclear localisations: whereas BES transcription occurs in a discrete site known 
as the expression site body (ESB) (Chaves et al., 1998; Navarro and Gull, 2001), 
rRNA and procyclin transcription occurs in the nucleolus (Landeira and Navarro, 
2007).  Similar telomeric mVSG expression sites (ESs) are activated in metacyclic 
trypanosomes to express mVSGs.  Although the promoter sequence here is again 
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divergent (Ginger et al., 2002), the promoter is recognised by the same general 
transcription factors employed at BES promoters (Kolev, Günzl and Tschudi, 2017). 
However, mVSG ESs differ from BESs in lacking ESAGs, and thus are monocistrons 
that contain only VSGs.  
 
Figure 1.6 The VSG archive of T. brucei.  
Pulsed field gel electrophoresis separated whole T. brucei chromosomes are shown to the left. 
Elements of the VSG archive are shown in line with the chromosomes on which they occur, including 
the BES found in the telomeric regions of Mb and intermediate chromosomes. Here, the RNA Pol I 
promoter (flag), ESAG coding regions (black boxes), 177-bp repeats (narrow lined box), 70-bp repeats 
(wide lined box) and the telomere (vertical line) positions are indicated.  Peach boxes indicate pseudo 
VSGs (ψ) found in the arrays within the subtelomeres of the Mb chromosomes. Mini-chromosomes 
appear to house only intact VSG that are immediately adjacent to the telomere. Image source 
(McCulloch, Morrison and Hall, 2015).  
Sequencing of different T. brucei strains has led to the number of genes in the VSG 
archive being estimated as between ~1,000 and ~2,500, which accounts for as much 
as 20% of the coding capacity of the genome (Berriman, 2005; Marcello and Barry, 
2007; Cross, Kim and Wickstead, 2014). This bank of VSGs is spread between Mb 
chromosome subtelomeres, where they are found as arrays (Berriman et al 2005), 
telomere adjacent regions of the mini-chromosomes (Wickstead, Ersfeld and Gull, 
2004) (Figure 1.6), and within telomere proximal BESs and MESs.  90% of VSGs, in all 
locations, are flanked by 70-bp repeats, although typically the number of repeats is 
highest within the BESs (Marcello and Barry, 2007).  Interestingly, only ~5% of silent 
VSGs are predicted to be functionally intact, and most of the array VSGs are 
pseudogenes (Berriman, 2005; Marcello and Barry, 2007). Of these pseudogenes, 
 36 
~65% appear to have frameshift mutations or premature stop codons in their 
sequence, 20% of the coding sequences are truncated, and ~10% are classed as 
atypical in that their predicted folding patterns or post-translation modifications 
differ to that of characterised VSGs (Marcello and Barry, 2007).  The location of the 
VSGs in the subtelomeres appears to promote diversification of the repertoire, as 
Mb chromosome sizes differ considerably between isolates and most of this change 
is due to variation in the size of VSG arrays (Melville, Gerrard and Blackwell, 1999; 
Callejas et al., 2006).  In fact, differences in chromosome length extends to 
chromosomes homologues within a single cell (Melville, Gerrard and Blackwell, 
1999), indicating the arrays are sites of considerable rearrangement.   
1.3.2 Monoallelic VSG expression and in situ switching 
Multiple BESs requires a layer of transcriptional control over VSG variant expression: 
only one BES is actively transcribed at a time, with all others largely silent. 
However, transcription of the active BES can be silenced, and another activated in 
an apparently co-ordinated reaction: so-called ‘in situ’ VSG switching.  As no 
change in the DNA sequence is needed, in situ VSG switching represents a case of 
transcriptionally controlled gene expression regulation not seen in the 
polycistronically transcribed core of the T. brucei genome.  Although transcription 
of the BESs is dynamic, strict monoallelic expression of a single VSG is evident, 
since artificially forced selection for WT cells expressing two or more BESs results in 
inviable parasites, with any such expression being unstable (Chaves et al., 1999; 
Ulbert, Chaves and Borst, 2002). Both transcription initiation and elongation have 
been suggested to be supressed in the silent BES (Vanhamme et al., 2000; Nguyen 
et al., 2014), reducing silent VSG transcript abundance to 10,000–fold below that of 
the active VSG (Yang et al., 2009). 
As well as transcriptional control, the environmental context of the BESs is critically 
important for monoallelic regulation of VSG expression and, potentially, in situ 
switching.  Expression of the active VSG takes place in the ESB, which is 
geographically separated from the nucleolus (Navarro and Gull, 2001), though both 
subnuclear structures recruit RNA Pol I for transcription (Landeira and Navarro, 
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2007). Insertion of the distinct rRNA RNA Pol I promoter into a BES results in the 
divergent promoter adopting the transcriptional status of the BES in question (Horn 
and Cross, 1995; Rudenko et al., 1995), consistent with features of the ESB 
exercising control over monoallelic BES expression. The ESB is present in all cell 
cycle stages of the long-slender BSF trypanosomes, but is lost upon differentiation 
to the short-stumpy stage, during which the active BES relocates to the nuclear 
periphery (Landeira and Navarro, 2007).  Faithful duplication and segregation of the 
ESB during mitosis is also required to maintain monoallelic expression of the active 
BES, as knockdown of cohesin, which is required for accurate chromosome 
segregation, leads to transcriptional switching (Landeira et al., 2009).  
As well as maintenance of active BES expression in the ESB, the inactive BESs must 
be maintained in a silent state in order to prevent expression of more than one VSG 
per parasite. The nuclear lamina in mammals is a dense network of lamina 
filaments that controls nuclear organisation and so influences transcriptional 
processes (Kind and van Steensel, 2010).  In the T. brucei nucleus the divergent 
repetitive protein nucleoporin-1 (NUP-1) performs the role of the lamina, most 
likely as a nuclear envelope fibre component (Rout and Field, 2001; DuBois et al., 
2012).  Interestingly, knockdown of NUP-1 leads to derepression of silent BESs, 
suggesting the inactive BESs are organised into heterochromatin regions regulated 
by NUP-1 (DuBois et al., 2012). 
Studies of chromatin remodelling factors, histone chaperones and the histones 
themselves, further support the importance of chromatin structure in the 
transcriptional control of the BESs.  Depletion of either the core histone H3 (Alsford 
and Horn, 2012), or ‘linker’ histone H1 (Povelones et al., 2012) causes activation of 
silent BESs. Similar phenotypes are observed when targeting histone chaperones 
NLP (Narayanan et al., 2011), FACT (Denninger et al., 2010; Denninger and 
Rudenko, 2014), ASF1A or CAF-1b (Alsford and Horn, 2012). Depletion of the 
chromatin remodeller ISWI also derepresses the silent BES promoters, though the 
increase in resulting VSG expression remains significantly lower than that observed 
from the active VSG (Stanne et al., 2011).  Additionally, histone methyltransferase 
DOT1B, which generates the H379me3 modification, exhibits some influence over 
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BES repression, as depletion of the protein causes partial expression of previously 
inactive VSGs as well as slowing in situ switching rates (Janzen et al., 2006; 
Figueiredo, Janzen and Cross, 2008). Lastly, the active BES is specifically depleted 
of nucleosomes (Figueiredo and Cross, 2010; Stanne and Rudenko, 2010), an effect 
regulated by the architectural chromatin protein TDP1 (Narayanan and Rudenko, 
2013).  
Although these findings appear to implicate typical epigenetic factors in the control 
of chromatin dynamics involved in VSG expression regulation, Glover et al. (2016) 
took steps towards better understanding if trypanosome-specific mechanisms are 
involved, through the discovery of VSG exclusion 1 (VEX1).  VEX1 locates to the 
active BES where it is required for monoallelic expression, since RNAi leads to 
increased silent VSG expression (Glover et al., 2016). Indeed, when VEX1 is 
overexpressed surplus protein binds to other BESs, which also results in expression 
of more than one VSG. Hence, VEX1 is required for VSG expression and its 
sequestration to the active BES is critical for monoallelic expression (Glover et al., 
2016). 
The above discussion demonstrates the clear importance of chromatin structure and 
subnuclear localisation in the monoallelic expression of VSGs, although no studies to 
date have demonstrated how in situ switching is initiated, or if a clearly defined 
trigger does in fact exist.  The ‘winner-takes-all’ mechanism proposed by Glover et 
al. (2016) implicates VEX1 as a key protein in the silencing of inactive BESs, but 
whether the protein actively takes part in an in situ switching pathway remains to 
be investigated. 
1.3.3 VSG switching via recombination 
In order for T. brucei to access the full repertoire of VSG genes and pseudogenes 
available, the parasite employs DNA recombination to translocate sequences into 
the active BES.  Three recombinational VSG switching strategies have been 
described: VSG gene conversion, segmental gene conversion and, to a lesser extent, 
reciprocal VSG recombination (Figure 1.7). The latter process involves the exchange 
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of VSGs and associated chromosome ends between two BESs or between a BES and 
mini-chromosome, so that crossover occurs without sequence loss (Pays et al., 
1985), and the reaction is limited to telomere located VSGs. Gene conversion 
involves the copying of the whole VSG open reading frame (ORF), as well as some 
up and downstream sequence, into the BES, displacing the resident VSG.  The 
upstream 70-bp repeats provide homology for recombination (Liu et al., 1983), but 
the region of copied DNA has been shown to extend beyond the repeats to include 
some of the ESAGs (Pays et al., 1983; McCulloch, Rudenko and Borst, 1997) and 
even the promoter (Hertz-Fowler et al., 2008). The region of 3’ DNA copied during 
conversion can terminate in the coding or non-coding sequence of the VSG 
(Bernards et al., 1981), or as far as the chromosome end in the case of telomeric 
VSGs (De Lange et al., 1983; Kim and Cross, 2010).  Segmental gene conversion is 
distinct from the other mechanisms, as it instead pieces together segments of VSG 
sequence to form ‘mosaic’ VSGs with functional and novel sequences (Roth et al., 
1989; Thon, Baltz and Eisen, 1989; Thon et al., 1990). This means the parasite is 
able to make use of the predicted non-functional VSG pseudogenes, exploiting 
inter-sequence homology between VSG ORFs, as well as hugely amplifying the 
number of antigenically distinct VSGs available for expression. 
 
Figure 1.7 The various mechanism of VSG switching in T. brucei.  
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a) Gene conversion involves copying the complete sequence of a VSG found elsewhere in the archive 
into the active BES. b) Segmental gene conversion instead recombines sequences from several VSGs 
to generate a mosaic VSG gene in the active BES. c) Telomeric exchange occurs when cross-over of 
chromosome ends, including the telomeres, takes place. d) Transcriptional in situ switching does not 
reply on recombination and instead a switch of active transcription from one BES to another takes 
place. Black flags indicate promoter positions, blue horizontal arrows indicate active transcription of the 
site and black arrows show movement of VSG sequence. Dashed lines indicate region of cross-over. 
Image source Vink, Rudenko and Seifert (2012), license number 4410710021799. 
1.3.3.1 The role of homologous recombination in VSG switching 
Homologous recombination (HR) facilitates the repair of double-stranded DNA 
breaks (DSBs) using a related stretch of DNA sequence located elsewhere in the 
genome, as a template for repair (Figure 1.8).  DNA synthesis during the repair 
process results in the exchange of template DNA sequence from one location to 
another, and is hypothesised to do so during VSG switching events (McCulloch, 
Morrison and Hall, 2015). A key HR factor, RAD51, coats 3’ ssDNA (generated by 5’-
3’resection of DNA strands at the DSB site), forming a nucleoprotein filament that 
invades the DNA duplex of homologous template DNA, resulting in the formation of 
a displacement (D)-loop.  Once RAD51, facilitated by other proteins including 
BRCA2 and Rad51 paralogues, has catalysed this strand invasion, break-pair can 
commence.  Break-pair can proceed via several routes, although this occurs most 
commonly via gene conversion, during which both 3’ ssDNA tails can participate in 
strand invasion (Chen et al., 2007). Firstly, the ssDNA strands of the resulting D-
loop are extended via DNA synthesis, having been primed by base hybridisation to 
the template DNA during strand invasion, and the ssDNA tails pair. Ligation then 
joins the paired tails to form two Holliday junction structures. Random cleavage of 
the Holliday junctions by resolvase enzymes results in either crossover, where 
recombinant chromosomes are formed, or non-crossover events (Chen et al., 2007).  
During a non-crossover event, retention of the short stretch of DNA synthesised 
during D-loop extension results in the uni-directional exchange of sequence from 
the template strand into the chromosome where the DSB occurred (Figure 1.8).  
Alternatively, dissolution of Holliday junctions by convergent migration can also 
lead to non-crossover events and gene conversion (Chen et al., 2007). 
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Figure 1.8 Model of double-stranded break repair pathways.  
The steps of double-stranded break (DSB) repair by Holliday junction resolution and dissolution are 
depicted along with discussed factors involved in each step. The 5’ ends of a DSB are first resected by 
the action of the MRE11 complex (MRE11, RAD50 and Xrs2/NBS1) to generate 3’ ssDNA tails. Strand 
invasion is then facilitated by RAD51, RAD51 paralogues and BRCA2 to form a displacement (D)-loop, 
which is extended by DNA synthesis. End-pairing of the ssDNA tails and ligation then form two Holliday 
junction structures. The RTR complex (RecQ/Sgs1-Top3/TOPO3a-Rmi1/BLAP75/18) enables 
dissolution of the Holliday junctions by facilitating convergent branch migration (black arrows), resulting 
in non-crossover events. Alternatively, resolution of the junctions is performed by a resolvase enzyme 
leading to either crossover (cut with green arrows at both junctions) or non-crossover (cut with green 
arrows at one junction and black at the other) events.  Hence, resolution can lead to either recombinant 
chromosomes or gene conversion, whereas dissolution by the RTR complex causes gene conversion 
exclusively. Recreated from (Chen et al., 2007), license number 4413841438071.  
Null mutation of RAD51 in T. brucei results in a 10-fold reduction in VSG switching 
rate, including via gene conversion, indicating HR does have a role in VSG switching 
(McCulloch and Barry, 1999).  In a similar manner, mutation of the T. brucei 
homologue of BRCA2 also leads to a reduction in VSG switching, to a similar extent 
to that seen after loss of RAD51 (Hartley and McCulloch, 2008).  Perplexingly, in 
both cases VSG switching is not abolished and the relative use of recombination and 
 42 
in situ switching is not changed, suggesting two things: some recombination-based 
switching must occur via a route independent of RAD51 and BRCA2 activity, and 
transcriptional switching may also be suppressed in the absence of these HR 
factors. Four Rad51 paralogues exist in T. brucei and all function in DNA 
recombination and repair, but mutation of just one, RAD51-3, has been found to 
cause significant impairment of VSG switching (Proudfoot and McCulloch, 2005; 
Dobson et al., 2011). 
In contrast to the impaired VSG switching seen in the above mutants, mutation of 
likely components of the RTR complex (RecQ/Sgs1-Top3/TOPO3a-Rmi1/BLAP75/18) 
in T. brucei results in increased rates of VSG switching (Kim and Cross, 2010, 2011; 
Devlin et al., 2016).  The RTR complex mediates dissolution of Holliday junctions 
(Figure 1.8) and is known to suppress the occurrence of recombinant chromosomes, 
as dissolution exclusively results in non-crossover, gene conversion events during 
DSB break-repair (Wu and Hickson, 2003).  Mutation of the RecQ helicase (which 
pushes the two Holliday junctions towards one another) curiously results in 
increased levels of VSG switching via gene conversion (Devlin et al., 2016), as does 
mutation of either Topo3a, the DNA decatenase that resolves the linked DNA 
strands (Kim and Cross, 2010), or the stabilising protein RMI1 (Kim and Cross, 2011).  
These findings are somewhat surprising considering that mutation of these factors 
would be hypothesised to suppress gene conversion events, as their function is to 
promote non-crossover resolution.  It is plausible, however, that mutation of the 
RTR complex results in less stable Holliday junctions and increased gene conversion 
via resolution, or an as yet un-investigated pathway.  
Mutation of MRE11, another HR factor that acts as part of a complex (MRE11, RAD50 
and Xrs2/NBS1) involved in DSB processing, again leads to unexpected findings; T. 
brucei MRE11 mutants display no changes in VSG expression despite high levels of 
chromosome arrangements due to loss of array VSGs (Robinson et al., 2002; Tan, 
Leal and Cross, 2002).  The MRE11 complex detects DSBs and can act as the initiator 
for break-repair via HR by performing resection of the DNA strands to generate 3’ 
ssDNA tails, or by recruiting other long-range nucleases to do so (Paull and 
Deshpande, 2014). Hence, if it is assumed that DSBs act to initiate VSG switching, it 
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might have been hypothesised that mutation of MRE11 would result in reduced 
recombination and a lower rate of VSG switching (Robinson et al., 2002; Tan, Leal 
and Cross, 2002). Though the effects of MRE11 mutation cannot rule out a role for 
DSBs, execution of VSG switching can clearly occur independently of this complex, 
or other factors can readily assume its roles. Although a clear link between HR and 
VSG switching has been demonstrated, mutation of any one HR-associated factor 
results in only modest changes in switching rates (McCulloch, Morrison and Hall, 
2015). How VSG switching may occur independently of RAD51-catalysed HR remains 
unclear, but one possibility is that at least some of the switching that is observed in 
HR mutants is through segmental gene conversion, a reaction that has not been 
dissected genetically.  Additionally, microhomology mediated end-joining (MMEJ) 
has been shown to repair DSBs in T. brucei and can occur without the action of 
RAD51 resulting in deletions at the break site (Conway et al., 2002; Glover, 
McCulloch and Horn, 2008; Glover, Jun and Horn, 2011). During this process 5’ DNA 
stand resection occurs via the MRE11 complex as in HR, however, as little as 5 – 20 
bp of homology is required for the exposed 3’ DNA ends to anneal and ligation to 
take place (Glover, Jun and Horn, 2011). Indeed, MMEJ events were found to 
contribute to gene conversion events, although, this was only documented to occur 
at one end of a duplicated sequence and RAD51-dependent HR was required at the 
other (Glover, Jun and Horn, 2011). 
1.3.3.2 70-bp repeats 
As noted above, the vast majority of VSGs (~90%) are associated with 70-bp repeats 
(Marcello and Barry, 2007), although with considerable size variation (Shah et al., 
1987).  Analysis of the 70-bp repeats located in the BESs revealed the repeat 
sequence is an average of 76 bp in length and largely AT-rich (78%), although two 
GC-rich regions were found to be conserved within the repeat sequences (Hovel-
Miner et al., 2016).  Interestingly, the AT-rich triplet repeat element of the 70-bp 
repeats has been found to have the potential to become non-H bonded (Ohshima et 
al., 1996), and may promote recombination, as documented in bacterial plasmids 
(Pan et al., 2010).  Artificial induction of DSBs adjacent to the 70-bp repeats of the 
active BES can induce VSG switching, an effect not seen after DSB induction when 
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the 70-bp repeats have been deleted from the BES, suggesting they may act in 
triggering recombination (Boothroyd et al., 2009). However, VSG switching has 
been documented in cells lines were the 70-bp repeats have been deleted from the 
BES, albeit at low levels (McCulloch, Rudenko and Borst, 1997), and the same 70-
bp-independent VSG switching was reported in the absence of DSB induction by 
Boothroyd et al, 2009. More recently, deletion of the 70-bp repeats in the active 
BES was shown to increase VSG switching before and after artificial DSB induction 
(Hovel-Miner et al, 2016), despite the previous findings that 70-bp repeat deletion 
represses switching induced by artificial DSBs (Boothroyd et al., 2009). These data 
perhaps suggest the role of the 70-bp repeats in VSG switching cannot be over 
simplified, and most likely extends beyond simply providing homology for VSG 
recombination (Liu et al., 1983). As discussed above, the boundaries of 
recombination are frequently seen upstream of the 70-bp repeats (Pays et al., 
1983; Proudfoot and McCulloch, 2005) and even encompassing the BES promoter 
(Hertz-Fowler et al., 2008).     
1.3.3.3 Telomeres and VSG switching 
Telomere length has also been proposed as the determining factor for VSG 
switching events (Dreesen, Li and Cross, 2007; Hovel-Miner et al., 2012). T. brucei 
cells with critically short telomeres, revealed by mutation of telomerase, have been 
shown to have an increased rate of VSG switching compared to those with longer 
telomeres (Hovel-Miner et al., 2012), supporting this notion. How recombination is 
promoted in parasites with critically short telomeres remains unclear, however, as 
ISceI-mediated removal of telomeric repeats failed to increase switching rate 
(Glover, Alsford and Horn, 2013). Interestingly, after loss of telomere length in 
telomerase deficient cells, re-expression of the enzyme results in the telomere 
adjacent to the active BES extending at a higher rate than those associated with 
silent BES, indicating active transcription influences telomere maintenance, 
perhaps by enhancing recombination events (Dreesen and Cross, 2006).  More 
recently, depletion of T. brucei RAP1, which is known to be critical for telomere 
stability in mammals (Martinez et al., 2010), has been shown to results in increased 
levels of telomeric repeat-containing RNA (TERRA), telomeric RNA-DNA hybrids, 
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DSBs and VSG switching (Nanavaty et al., 2017). Hence, it is likely that telomere 
instability can cause VSG switching via recombination, but whether this is able to 
drive antigenic variation in unperturbed WT parasites remains untested.  
1.4 R-loops 
R-loops are three stranded nucleic acid structures formed of a double-stranded 
RNA-DNA hybrid and displaced ssDNA.  The sequence specific, DNA-binding 
capabilities of RNA were first demonstrated by detection of radiolabelled rRNA 
hybridised to extrachromosomal single-stranded rDNA in Xenopus oocytes using 
autoradiography (Gall and Pardue, 1969).  rRNA hybridisation to denatured, double-
stranded rDNA of both Drosophila melanogaster and S. cerevisiae was later imaged 
with electron microscopy, and the triple-stranded structures were termed R-loops 
(Thomas, White and Davis, 1976; White and Hogness, 1977).  A large expansion of 
research into in vivo R-loops has now revealed their frequent occurrence outside of 
the rDNA loci, as well as their central role in several physiological processes, 
including telomere maintenance, immunoglobulin (Ig) class switching and 
mitochondrial DNA (mtDNA) replication (Yu et al., 2003; Skourti-Stathaki and 
Proudfoot, 2014; Santos-Pereira and Aguilera, 2015a).  More recently, increasingly 
diverse roles have been attributed to R-loops, including transcription initiation and 
termination, DNA replication initiation, and chromatin remodelling (Skourti-Stathaki 
and Proudfoot, 2014; Lombraña et al., 2015; Santos-Pereira and Aguilera, 2015b).  
Despite their seemingly diverse functionality, R-loops can also create obstacles for 
replication forks, have been shown to cause genomic instability and hyper-
recombination (Chan, Hieter and Stirling, 2014; Hamperl and Cimprich, 2014; Pan 
et al., 2014; Sollier and Cimprich, 2015), and have been linked to various 
neurological diseases and cancers (Groh and Gromak, 2014; Richard and Manley, 
2017).  Several R-loop capture techniques have now been developed (discussed in 
more detail in chapter 4) that allow detailed mapping of the transient structures; 
however, separating functional R-loops from those which are aberrant and 
deleterious to genome integrity remains challenging. 
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1.4.1 Programmed R-loops and their physiological functions 
1.4.1.1 R-loops form at gene promoters 
Genome-wide mapping of RNA-DNA hybrids across the human genome has revealed 
strong enrichment for R-loops at the promotor regions of 1,972 unique genes (Ginno 
et al., 2012). Interestingly, 84% of these were CpG island (CGI) promoters and the 
majority had areas of particularly strong GC skew downstream of the TSS (65%), 
whilst the remainder presented more minor GC skew (19%) (Ginno et al., 2012). R-
loop formation was also shown to directly protect sequences from transcriptionally 
repressive de novo DNA methylation (Ginno et al., 2012).  Hence, R-loop formation 
is hypothesised to protect CGI promoters from methylation to allow active 
transcription, an idea supported by the fact that methylation status can be 
predicted by the level of GC skew, and thus the R-loop forming potential, of CGI 
promoters (Ginno et al., 2012).  Using GC skew levels and the prevalence of CGIs, 
promoters were classed into four groups (Ginno et al., 2013). The first are CGI 
promoters with high levels of GC skew, which were largely associated with 
consistently transcribed “house-keeping” genes. The second contains shorter CGIs, 
lower levels of GC skew and are less strongly associated with house-keeping 
functions. These two classes can be considered “dispersed” promoters (section 
1.2.2.1) and are associated with R-loop formation. The third class are promoters 
with low levels of CGI that do not show strong GC skew or R-loop formation. These 
genes are associated with more tissue-specific functions. Lastly, a fourth class of 
promoter is defined as those with apparent CGIs but strong negative GC skew found 
upstream of the TSS. Genes with this final class of promoters were clearly enriched 
for transcription regulation, cell fate and morphogenesis functions (Ginno et al., 
2013). Considering that high levels of GC skew were associated with R-loop 
formation over GCI promoters, and these are associated with lower levels of DNA 
methylation (Ginno et al., 2012), it is hence plausible that R-loop formation 
maintains active transcription of class I, and to a lesser extent class II, promoters 
(which fall into the dispersed category) to allow continued expression of house-
keeping genes (Ginno et al., 2013).  
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Strand-specific analysis of genome-wide R-loops in human cells also identified R-
loops over promoter regions, again most prominently at CGI promoters (Sanz et al., 
2016). R-loops over these promoter regions were associated with increased 
chromatin accessibility, high RNA Pol II occupancy, and several epigenetic markers 
characteristic of open chromatin (Sanz et al., 2016; Chen et al., 2017) (Figure 1.9). 
These include, Histone 3 lysine 4 di- and tri-methylation (H3K4me2/3), H3K9 
acetylation (H3K9ac), and H3K27ac, which are all markers of active transcription 
and show marked enrichment in R-loop forming promoters, peaking over the TSS 
(Sanz et al., 2016; Chen et al., 2017).  H3K9me1 is also enriched, but directly over 
the R-loop peaks that are positioned 1 – 2 kb downstream of the TSS (Sanz et al., 
2016; Chen et al., 2017). Histone variant H3.3, which is associated with 
transcriptionally active chromatin, is also slightly enriched around the TSS of R-loop 
forming promoters (Sanz et al., 2016). Lastly, the transcription elongation marker 
H3K36me3 is significantly enriched over the gene body, also downstream of the TSS 
(Sanz et al., 2016).  In addition to the increased levels of open chromatin markers, 
a decrease in heterochromatin markers H3K9me3 (Sanz et al., 2016) and H3K27me3 
(Chen et al., 2017) is evident over the TSS of such promoters, as well as protection 
from hyper DNA methylation (Sanz et al., 2016). Hence, R-loop forming promoters 
are heavily protected from epigenetic silencing in the human genome (Sanz et al., 
2016; Chen et al., 2017), and mostly likely contribute to continued transcription of 
house-keeping genes associated with dispersed promoters (Ginno et al., 2013).   
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Figure 1.9 Chromatin features associated with R-loop forming promoter regions of the human 
genome.  
Several epigenetic markers have been associated with R-loop formation at CpG island promoters, 
either located directly at the transcriptional start site (TSS anchored) or at the R-loop formation peak, 
typically found 1 – 2 kb downstream of the TSS (R-loop anchored). Mostly, these promoters display 
higher GC skew and GC content, as well as increased DNase I sensitivity. Enrichment of several 
epigenetic markers characteristic of active transcription have been documented at such promoters as 
well as protection from repressive H3K9 tri-methylation and DNA methylation. R-loop formation has 
also been correlated with RNA Pol (RNAP) pausing downstream of the TSS, as well as the increased 
presence of transcription and elongation markers H3K4me1 and H3K36 methylation. Hypothesised to 
link R-loops and chromatin patterning is the action of chromatin-modifying enzymes, perhaps recruited 
via interaction with the C-terminal domain (CTD) of paused RNAP, recruitment to the R-loop structure 
itself, or repression of nucleosome association. Findings and hypothesis depicted are sourced from 
Sanz et al. (2016), Chen et al. (2017) and Chédin, (2016). Image source Chédin, (2016), license 
number 4410710157988.  
R-loops which form around human promoter regions have been shown to form co-
transcriptionally and to initiate at the TSS, which forms the 5’ R-loop boundary 
(Dumelie and Jaffrey, 2017). The 3’ R-loop boundary has been mapped to the first 
exon/intron junction of intron containing genes, whereas when introns were lacking 
the 3’ boundary varied from gene to gene (Dumelie and Jaffrey, 2017). Despite this 
fine mapping of R-loops and the clear association with constitutively active 
promoters, how R-loops may form part of a promoter driven transcription initiation 
pathway genome-wide is less clear.  
Some studies have investigated the function of promoter-associated R-loops at 
specific loci.  In the Arabidopsis genome, for example, R-loops have been 
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associated with both promoter regions and gene bodies, as well as noncoding RNA 
(ncRNA) (Xu et al., 2017). Detailed investigation of R-loop formation at the floral 
repressor gene (FLC) locus revealed a direct role for R-loops in transcription 
regulation (Sun et al., 2013). In response to prolonged cold, antisense transcription 
of the FLC locus generates antisense transcripts termed COOLAIR, which are able to 
induce epigenetic silencing of sense FLC transcription via various pathways.  The 
COOLAIR promoter was found to be GC rich, depleted of nucleosomes, and have the 
potential to form R-loops (Sun et al., 2013). R-loops originating from the COOLAIR 
promoters can be additionally stabilised via binding of the homeodoman-containing 
protein, AtNDX, repressing transcription of COOLAIR (Sun et al., 2013). Therefore,  
negative regulation of the COOLAIR transcripts via R-loop formation has the 
potential to positively regulate transcription of FLC to regulate flowering (Sun et 
al., 2013). Sense and anti-sense transcription is also observed at the CGI promoter 
of a human gene, vimentin (VIM) (Boque-Sastre et al., 2015).  Anti-sense 
transcription of VIM favours formation of an R-loop structure on the negative 
strand, reduced nucleosome occupancy and increased transcription factor binding 
to the displaced ssDNA strand, all allowing active sense transcription of VIM (Boque-
Sastre et al., 2015). Hence, in both cases R-loop formation on the antisense strand 
is associated with active sense strand transcription. Whether this model holds true 
across all R-loop-associated promoters is unlikely, however, as most promoter-
associated R-loops form on the sense strand in the human genome (Sanz et al., 
2016).  
Genome-wide mapping of R-loops in mouse embryonic stem cells again revealed R-
loop enrichment at promoter regions, largely in highly expressed genes (P. B. Chen 
et al., 2015). Interestingly, these R-loops enhance binding of the Tip60-p400 
chromatin remodelling complex and, contrastingly, inhibit binding of polycomb 
repressive complex 2 (PRC2) as well as histone H3 lysine 27 methylation (H3K27me) 
(P. B. Chen et al., 2015). The Tip60-p400 complex is made up of the Tip60 protein 
lysine acetyltransferase, which acetylates histone H4 and H3A lysine residues, and 
the p400 ATPase that incorporates the histone variant H2A.Z. Curiously, the 
complex is able to simultaneously repress differentiation genes and activate 
proliferation genes. Since dispersed, CGI promoters display H2A.Z deposition at the 
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boundaries of the nucleosome depleted region (Rach et al., 2011), it may be 
possible that associated R-loops enhance binding of the Tip60-p400 complex, 
facilitating deposition of the histone variant to positively regulate transcription. 
PCR2 is an H3K27 methyltransferase that is important for gene silencing during 
development.  Disruption of promoter-proximal R-loops increased PRC2 binding and 
impaired embryonic stem cell (ESC) differentiation (P. B. Chen et al., 2015). 
Therefore R-loops are able to bind some protein complexes whilst preventing 
binding of others.  How the two activities are distinguished, however, remains 
unclear.  
In light of these experiments, it is clear that promoter proximal R-loops have a role 
in transcription regulation, which impacts upon important biological processes, such 
as cell differentiation (P. B. Chen et al., 2015) and flowering (Sun et al., 2013). 
However, it is probable that R-loops are implicated in many different pathways 
which influence transcription, potentially both positively and negatively, and that 
no one model is likely to be conserved uniformly across all species, or even 
between different genes within the same species.  
1.4.1.2 R-loops and transcription termination 
R-loop mapping across the human genome also found enrichment to the 3’ end of a 
subset of genes, the majority of which harboured GC skew (Ginno et al., 2013). 
Interestingly, these highly GC skewed TTSs were somewhat protected from DNA 
methylation in a similar manner, although less significantly so, to the protection 
observed over R-loop forming promoter regions (Ginno et al., 2013). Detailed 
analysis of the human β-actin gene loci revealed R-loop formation over regions of 
RNA Pol II pausing at the 3’ end of the gene, immediately downstream of the PAS 
(Skourti-Stathaki, Proudfoot and Gromak, 2011; Skourti-Stathaki, Kamieniarz-Gdula 
and Proudfoot, 2014). R-loop resolution by senataxin, an RNA-DNA targeting 
helicase, in these regions is necessary to allow Xrn2 exonuclease access to the 3’ 
cleavage-associated PAS  (Skourti-Stathaki, Proudfoot and Gromak, 2011). Hence, 
R-loop resolution appears to be required before correct mRNA maturation can take 
place. The terminal RNA Pol II pause regions were also found to be sites of RNAi 
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activity and epigenetic silencing (Skourti-Stathaki, Kamieniarz-Gdula and Proudfoot, 
2014). Antisense transcription and binding of the RNAi factors AGO1 and DICER were 
detected over the R-loop forming TTS, and were diminished by R-loop degradation 
(Skourti-Stathaki, Kamieniarz-Gdula and Proudfoot, 2014). R-loop formation also 
initiated G9a histone lysine methyltransferase recruitment, H3K9me2 enrichment 
and chromodomain protein HP1γ binding, to promote transcriptional silencing of β-
actin (Skourti-Stathaki, Kamieniarz-Gdula and Proudfoot, 2014). Therefore, R-loop 
formation is required for correct termination of β-actin transcription, yet the R-
loop must be subsequently resolved to allow maturation of the transcripts.  
Genome-wide comparison of human R-loop forming TTSs and non-R-loop forming 
genes, however, found no overall enrichment of H3K9me2/3 over R-loop positive 
termination regions (Sanz et al., 2016).  This finding indicates R-loop driven 
recruitment of G9a lysine methyltransferase at the β-actin locus is not conserved 
elsewhere.  Broadly, global enrichment was observed for binding of the RNAP-
interacting complex, PAF1, which has been shown to interact with cleavage and 
polyadenylation specific factors (Tomson and Arndt, 2013), further linking terminal 
R-loops to terminal mRNA maturation (Sanz et al., 2016). R-loop positioning around 
the PAS was also found to correlate with the site of termination; early R-loop peaks 
corresponded to transcription termination occurring ~7 kb downstream of the PAS, 
whereas late forming R-loop genes terminated ~17 kb downstream (Sanz et al., 
2016). Notably, terminal R-loops were only found in those transcripts undergoing 
PAS-dependant cleavage and polyadenylation and their formation does not 
correlate with GC skew in this study, indicating factors which influence R-loop 
formation are likely to differ in promoter and terminator regions (Sanz et al., 
2016).   
Evidence of R-loop involvement in termination processes is also found in the S. 
cerevisiae genome, where mapping of RNA-DNA hybrids found >60% form at highly 
transcribed genes with long 3’ homopolymeric dA:dT tracts (Wahba et al., 2016). 
The likelihood of R-loop formation over the poly(A) tracts was found to be 
dependent on the length of the tract, where ~92% of poly(A) tracts of ≥ 21 bp were 
prone to hybrid formation (Wahba et al., 2016). These studies in the yeast and 
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human genomes reveal a clear link between 3’ R-loop formation in a subset of 
genes, although these may be related to cleavage and polyadenylation rather than 
termination. Exactly how R-loops participate in any of these processes, or whether 
R-loops simply form as a consequence of RNA Pol pausing, remains unclear.  
1.4.1.3 R-loops and DNA replication 
R-loops were first linked to DNA replication when found to initiate replication of 
the E. coli plasmid ColEI; a persistent RNA-DNA hybrid forms within specific origins 
(Dasgupta, Masukata and Tomizawa, 1987; Masukata and Tomizawa, 1990) and is 
cleaved by the RNA-DNA hybrid-targeting endonuclease Ribonuclease (RNase) H, 
allowing it to serve as the primer for DNA synthesis (Itoh and Tomizawa, 1980). 
RNA-DNA hybrids have also been found to form at the well conserved mtDNA ORI, 
dependant on the presence of a GC-rich cluster (Chang and Clayton, 1985; Chang, 
Hauswirth and Clayton, 1985). The RNA strand of the initiation R-loop acts as the 
primer for elongation by mtDNA polymerase, much like E. coli plasmid replication 
(Xu and Clayton, 1996). Similarly, R-loop formation over a specific DNA unwinding 
element initiates DNA replication of bacteriophage T4 by providing a primer for 
leading-strand synthesis, generated by either RNA polymerase or RNase H (Carles-
Kinch and Kreuzer, 1997). Alternatively, T4 primase synthesises a primer on the 
non-template ssDNA strand of the R-loop (Belanger and Kreuzer, 1998).  
DNA replication can also be initiated by R-loop formation in the E. coli chromosome 
of RNase H-deficient cells (Asai and Kogoma, 1994) or WT cells under stress 
conditions (Hong, Cadwell and Kogoma, 1996; Camps and Loeb, 2005; Wimberly et 
al., 2013). During this alternative route of replication, R-loops form by transcript 
invasion rather than co-transcriptionally (Asai and Kogoma, 1994), initiating 
replication at multiple sites that are separate from the single origin and resulting in 
global changes to replication fork migration patterns and frequent converging forks 
(Maduike et al., 2014).  
R-loops have more recently also been linked to DNA replication in the human 
genome. As discussed above, R-loops frequently locate to CGI promoters; these are 
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also the sites of the most efficiently activated and conserved ORIs in mice and 
humans (Sequeira-Mendes et al., 2009; Cayrou et al., 2011; Besnard et al., 2012; 
Picard et al., 2014).  Hence, like in T. brucei, DNA replication is heavily linked to 
transcription in mammalian genomes and, importantly, R-loops may provide a 
functional link (Lombraña et al., 2015).  How co-transcriptional R-loops may initiate 
DNA replication in these more complex genomes is, however, unclear.  One 
plausible hypothesis involves the formation of G4 structures (Lombraña et al., 
2015), which are present in most mammalian genome ORIs (Cayrou et al., 2011; 
Besnard et al., 2012). Interestingly, in vitro assays have demonstrated that ORC1 is 
able to bind G4 DNA (Hoshina et al., 2013).  Binding affinity of ORC1 to G4 DNA is 
also dramatically increased by G4 structures from with ssDNA, rather than a DNA 
duplex (Hoshina et al., 2013), and the ssDNA element of R-loops have the potential 
to form G4 DNA.  In support of this hypothesis, 30% of stringently selected ORIs 
found at CGI promoters that display R-loop enrichment (Ginno et al., 2012, 2013) 
also display OCR1 binding upstream of the TSS and G4 formation (Lombraña et al., 
2015) (Figure 1.10). 
 
Figure 1.10 Association of R-loops, G4 motifs and GC skew at sites of ORC binding.  
The distribution of ORC1-binding (orange), DNA-RNA hybrid enrichment (blue), GC skew regions 
(green) and G4 motifs (red) at CGI promoters that also function as ORIs. In each case hits per bp are 
mapped over 6 kb centres at the TSSs of 485 CGI promoters. Predicted G4 motifs were identified with 
algorthym Quadparser (Huppert and Balasubramanian, 2005) and GC-skew regions were sourced 
from (Ginno et al., 2012). Data, analysis and image source Lombraña et al. (2015). 
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1.4.1.4 R-loops as regulators of chromatin dynamics 
As discussed above (sections 1.4.1.1 and 1.4.1.2), R-loop formation has been linked 
to several epigenetic markers, both of open (Sanz et al., 2016; Chen et al., 2017) 
and compact (Skourti-Stathaki, Kamieniarz-Gdula and Proudfoot, 2014) chromatin, 
at promoter and terminator regions, respectively.  DNase I hypersensitivity is 
associated with R-loop formation irrespective of genic position, highlighting the 
possibility that R-loops influence nucleosome positioning genome-wide (Sanz et al., 
2016; Chen et al., 2017).  In support of this, R-loops were found to correlate with 
lower nucleosome occupancy and chromatin opening over the Snord116 allele 
(Powell et al., 2013), and conversely, directed R-loop disruption leads to chromatin 
condensation at the VIM loci (Boque-Sastre et al., 2015).  Additionally, incorrect 
transcription-coupled nucleosome positioning may increase R-loop formation, as 
deletion of the FACT histone chaperone complex in yeast leads to R-loop 
accumulation (Herrera-Moyano et al., 2014). Interestingly, these observations are 
consistent with the finding that the presence of RNA within the DNA double helix 
prevents binding of the core histones (H2A, H2B, H3 and H4) to plasmids in vitro 
(Dunn and Griffith, 1980).  
1.4.1.5 Telomeric R-loops 
Telomeric repeats undergo transcription by RNA Pol II to generate TERRA, which 
harbours telomeric repeat sequence as well as elements from the subtelomere 
(Luke et al., 2008). TERRA is able to form RNA-DNA hybrids at telomeres, which 
have been proposed to have physiologically relevant functions (Balk et al., 2013; 
Arora and Azzalin, 2015; Rippe and Luke, 2015). Cancer cell lines which employ 
alternative telomere lengthening (ATL) strategies exhibit high levels of TERRA and 
telomeric RNA-DNA hybrids (Arora et al., 2014; Yu, Kao and Lin, 2014). Additionally, 
RNA-DNA hybrids are elevated in telomerase-null yeast whose telomeres undergo 
homology directed repair (Balk et al., 2013). Hence, TERRA is thought to form co-
transcriptional R-loops in critically short telomeres to promote telomere 
lengthening and avoid premature cellular senescence (Balk et al., 2013; Rippe and 
Luke, 2015; Graf et al., 2017). In fact, increased levels of R-loops in critically short 
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telomeres may promote recombination via clashes with replication machinery, 
which are known to induce DNA damage and recombination (Aguilera and Gómez-
González, 2008; Hamperl and Cimprich, 2016), since telomeric R-loops are cell 
cycle regulated (Graf et al., 2017) and short telomeres are replicated earlier in S 
phase (Bianchi and Shore, 2007).  
1.4.1.6 R-loops and centromeres 
ncRNAs transcribed from centromeric repeats are capable of forming R-loops. In a 
similar RNAi-dependent mechanism to that observed at the R-loop forming β-actin 
terminator region (Skourti-Stathaki, Kamieniarz-Gdula and Proudfoot, 2014), 
centromeric R-loops mediate heterochromatin formation in yeast (Nakama et al., 
2012). Moreover, centromeric R-loops have been found to direct histone H3 serine 
10 phosphorylation (H3S10P), a known marker of chromatin condensation, to 
maintain genome stability (Castellano-Pozo et al., 2013). More recently, ATR (a 
master check-point kinase) has been shown to locate to centromeres, where the 
protein is activated via R-loops and the mitotic regulator kinase, Aurora A (Kabeche 
et al., 2018). Here, ATR is able to promote Aurora B activation, which is critical for 
correct chromosome alignment during metaphase (Shuda et al., 2009), and faithful 
chromosome segregation (Kabeche et al., 2018).  How R-loops contribute to ATR 
binding and activation in this scenario remains unclear, although is it possible that 
ATR binds to replication protein A (RPA)-coated ssDNA, generated by R-loop 
formation (Kabeche et al., 2018).  Indeed, RPA has been shown to locate to R-loops 
and become phosphorylated by the action of ATR in human cells (Leong et al., 
2017).  Therefore, R-loops appear to have a role in maintaining heterochromatin at 
centromeric repeat regions, as well as aiding correct chromosome segregation 
during mitosis by the activation of Aurora B kinase via ATR (Shuda et al., 2009; 
Kabeche et al., 2018). 
1.4.2 R-loops and genomic instability 
As well as performing physiological functions in genomes of all types, R-loops pose 
significant risks to genome integrity.  Aberrant R-loop formation, either in terms of 
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the hybrid’s location or timing, leads to DNA damage that undermines the genome 
and can lead to mutation at the DNA base or chromosome level. In particular, RNA 
biogenesis mutants are associated with increased levels of R-loops (section 1.4.2.2). 
How deleterious R-loop formation is converted into DNA damage is debated, as 
various studies have led to different conclusions being drawn, although generally it 
is accepted that R-loop formation alone is insufficient, and a secondary event is 
required. For example, the exposed ssDNA portion of an R-loop is vulnerable to the 
actions of nucleases and is prone to breakage. R-loops also present potential 
obstacles to replication forks, which when stalled often collapse, leading to the 
occurrence of DSBs. For these reasons, all organisms studied thus far express R-loop 
resolving enzymes (section 1.4.2.3).   
1.4.2.1 DNA sequence composition influences R-loop formation 
Several aspects of DNA sequence composition have been documented to correlate 
with or determine R-loop formation. Clustering of three or more guanine residues 
has been shown to be important for the initiation of R-loop formation, and guanine-
rich regions were found to allow elongation of the R-loop (Roy and Lieber, 2009). In 
silico analysis of the human genome searching for regions meeting these criteria 
revealed ~250,000 putative R-loop forming sequences (Wongsurawat et al., 2012; 
Jenjaroenpun et al., 2015).  GC skew, irrespective of clustering, correlates with R-
loop formation over CGI promoters and 3’ terminator regions of human genes 
(Ginno et al., 2013). Both positive GC skew and AT skew have also been shown to 
correlate with R-loop formation in the Arabidopsis thaliana genome (Xu et al., 
2017). Lastly, poly(A) tracts consisting of >21 bp are sufficient for R-loop formation 
in S. cerevisiae (Wahba et al., 2016).  
1.4.2.2 RNA biogenesis mutants accumulate R-loops 
To date, mutants of >50 proteins have been shown to cause increased levels of R-
loop formation, most of them in yeast (Santos-Pereira and Aguilera, 2015a; Al-Hadid 
and Yang, 2016) (Figure 1.11b). These include proteins involved in transcription 
elongation (Huertas and Aguilera, 2003) and termination (Wahba et al., 2011), 
mRNA spicing, polyadenylation, mRNA export and degradation (Santos-Pereira and 
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Aguilera, 2015a; Al-Hadid and Yang, 2016). Other mutations in proteins that affect 
mitosis regulation, DNA topology, nucleosome organisation and the DNA damage 
response also display increased levels of R-loops (Santos-Pereira and Aguilera, 
2015b; Al-Hadid and Yang, 2016).  In general terms, these studies highlight the 
importance of efficient RNA maturation and turn over in order to avoid the 
formation of deleterious RNA-DNA hybrids.  
In keeping with the observation that the presence of introns appears to protect 
genes from R-loop formation in complex genomes (section 1.4.1.1), splicing factor 
mutants accumulate R-loops (Li and Manley, 2005; Wahba et al., 2011; Stirling et 
al., 2012; Nguyen et al., 2017). Depletion of the ASF/SF2 splicing factor in chicken 
B-cells leads to extensive DNA rearrangements due to the accumulation of R-loops 
(Li and Manley, 2005). Human cells expressing a mutant form of splicing factor 
U2AF1 (U2 snRNA auxiliary factor 1) similarly display increased R-loop formation as 
well as DNA damage, as does the pharmacological inhibition of mRNA splicing 
(Nguyen et al., 2017). Screening of yeast mRNA splicing and polyadenylation factors 
further linked these processes and the prevention of R-loops, as several mutants 
were shown to possess higher levels of both DNA damage and R-loops (Wahba et al., 
2011; Stirling et al., 2012).   
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Figure 1.11 Proteins which remove and prevent R-loops are found across species.  
a) Removal of R-loops can be achieved by different proteins, including endonuclease RNase H 
enzymes and the helicases Sen1/SETX. Other proteins that may be involved include the helicase 
aquarius (AQR). b) Other proteins prevent R-loop formation. These include topoiserase I (TOP1), 
which resolves negative supercoiling, and proteins invloved in RNA biogenesis and RNA surveillance. 
Image source Santos-Pereira and Aguilera, (2015b), license number 4410710530425. 
1.4.2.3 R-loop resolving enzymes 
As well as actively preventing aberrant R-loop formation, cells also express proteins 
that resolve R-loops (Figure 1.11a). These proteins include type 1 and type 2 RNase 
H enzymes that cleave the RNA strand within RNA-DNA hybrids (Cerritelli and 
Crouch, 2009).  Most organisms express one type 1 protein and a type 2 RNase H; in 
bacteria both classes are is monomeric, but in eukaryotes type 2 RNase H functions 
as a trimeric complex (Cerritelli and Crouch, 2009). In mammals, both RNase H1 
and H2 proteins are essential for development, as RNase H1 is essential for mtDNA 
replication (Cerritelli et al., 2003) and RNase H2 is critical for maintaining nuclear 
genome stability (Hiller et al., 2012). However, both types of RNase H are 
dispensable for cell viability in yeast, although their deletion does lead to 
detectable levels of mutation and chromosome rearrangement (Wahba et al., 2011; 
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O’Connell, Jinks-Robertson and Petes, 2015).  Type 2 RNase H in eukaryotes has an 
additional function as the protein is able to initiate the ribonucleotide excision 
repair (RER) pathway (Sparks et al., 2012; Williams, Gehle and Kunkel, 2017). The 
enzyme complex cleaves 5’ of ribonucleotides that have been mistakenly embedded 
into newly synthesised DNA by replicative polymerases, allowing them to be 
removed by the activity of flap endonucleases, polymerase δ and DNA ligase (Sparks 
et al., 2012).  RNase H enzymes are discussed in greater detail in Chapter 3.  
RNA-DNA hybrid helicase enzymes of the Sen1 family are also able to resolve R-
loops. Mutation in the helicase domain of yeast Sen1 results in the accumulation of 
DNA damage (Mischo et al., 2011). Interestingly, Sen1 is associated with replication 
forks across actively transcribed genes, and so may be involved in resolving 
replication and transcription machinery clashes associated with R-loops (see section 
1.4.2.4) (Alzu et al., 2012). The mammalian homolog for Sen1, senataxin (SETX), 
resolves R-loops particularly arising at G-rich transcription termination pause sites 
(Skourti-Stathaki, Proudfoot and Gromak, 2011). SETX has a prominent role in 
responding to R-loop associated DNA damage, significantly during male meiosis 
(Becherel et al., 2013), and mutations of the gene are associated with 
neurodegenerative disorders (Chen et al., 2004; Arning et al., 2013).  
RPA binds to ssDNA and has been shown to interact with RNase H1 at R-loops to 
stimulate binding and catalytic activity of the enzyme (Nguyen et al., 2017).  R-
loops resulting from mutations of splicing machinery in malignant cell lines are also 
associated with RPA and in this case RPA has been found to be phosphorylated by 
ATR (Leong et al., 2017). As discussed in section 1.4.1.6, ATR binds RPA-coated 
centromeric R-loops, where is it activated and stimulates Aurora B allowing correct 
chromosome segregation (Kabeche et al., 2018) (section 1.4.1.6). These studies 
highlight signalling pathways initiated by R-loop formation.  
1.4.2.4 Transcription-replication clashes 
R-loops present significant barriers to the DNA replication machinery, meaning 
deregulated co-transcriptional R-loops are a significant source of genome instability 
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as they prevent proper DNA replication and can lead to collapse of the replication 
fork (Aguilera and García-Muse, 2012; Wahba and Koshland, 2013; Hamperl et al., 
2017; Lang et al., 2017).  Whether such clashes occur co-directionally or as a result 
of a head-on clash between the replisome and RNA Pol machinery has consequences 
for the outcome (Hamperl et al., 2017; Lang et al., 2017) (Figure 1.12). Head-on 
clashes promote R-loops in sequences prone to their formation and result in the 
activation of the ATR-dependant DNA damage signally pathway, implying the 
exposure of ssDNA either within the stalled replication fork or the R-loop itself 
(Hamperl et al., 2017). The head-on collision further stalls the transcribing RNA 
Pol, which presumably increases the likelihood of R-loop formation, as well as the 
replication machinery resulting in incomplete DNA replication (Hamperl et al., 
2017). In contrast, co-directional clashes that occur due to R-loop-induced stalling 
of transcription machinery result in decreased R-loop levels. In this case ATM is 
activated, implying the presence of DSBs (Hamperl et al., 2017). Hence, the 
direction of transcription-replication clashes greatly influences R-loop and DNA 
damage levels, and may explain the bias towards co-directional activity of 
transcription and replication in the human genome (Hamperl et al., 2017).  
Head-on collisions between replication and transcription machinery also increases 
R-loop formation in bacterial pathogen Bacillus subtilis (Lang et al., 2017). Here, R-
loops completely blocked replication and resulted in high levels of mutation in 
genes where head-on collisions occurred, as well as changes in gene expression 
(Lang et al., 2017).  
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Figure 1.12 Head-on vs co-directional replicaition-transcription conflicts associated with R-
loops.  
Replication forks progress in both directions from ORIs and can collide with transcribing polymerases 
(RNAP) either head-on or co-directionally. Head-on collision result in stalled replication forks and an 
increase in R-loop formation behind the blocked transcription bubble. This type of collision is 
associated with ATR signalling via check point kinase 1 (Chk1). Co-direction clashes allow the 
replication fork to continue resolving the R-loop behind RNAP. This results in resolution of the R-loop 
and ATM-Chk2 signalling.  Image source Hamperl et al. (2017) 
1.5 Aims and objectives 
The gathering wealth of R-loop research is highlighting the diverse roles of these 
structures, as well as the risks they pose to genome stability.  The primary aim of 
this thesis was therefore to investigate the role of R-loops in the T. brucei genome.  
Several processes that R-loops have been implicated in, namely transcription 
initiation, termination and DNA replication, are not fully understood in T. brucei 
and so it was hypothesised that the structures may have conserved roles in one or 
more of these processes, revealing functional overlap with other eukaryotes, or 
divergence of T. brucei in each case.  As R-loops are also well-known inducers of 
DNA damage and recombination events, it was hypothesised that the structures 
could trigger VSG switching events in BSF T. brucei, shedding light on the 
mechanism(s) of antigenic variation.   
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To address the above questions, a number of approaches were taken. First, the 
mode of action of T. brucei RNase H enzymes were determined by gene knockout or 
RNAi-mediated knockdown, and localisation of the predicted RNases H examined. 
Second, R-loops were mapped across the T. brucei genome to determine regions of 
accumulation.  This mapping was undertaken in WT parasites as well as those 
lacking or depleted of RNase H activity. As RNase H enzymes resolve R-loops, 
reducing their activity might be predicted to increase the persistence of R-loops in 
the genome, validating that the precipitation approach adopted captures R-loops. 
Third, the effects of RNase H loss or depletion on expression of the VSG coat, as 
well as on R-loop accumulation in the BES and on DNA damage levels were 
evaluated.
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2 Materials and Methods
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2.1 T. brucei in vitro culture 
2.1.1 T. brucei strains 
The monomorphic Lister 427 strain of long-slender BSF T. b. brucei was used as the 
wild type (WT) cell line (Rudenko et al., 1996; McCulloch, Rudenko and Borst, 
1997). Gene deletion mutants and endogenously tagged cell lines were generated 
using this strain as the parental cell line. Inducible RNAi lines were generated using 
a genetically modified strain derived from Lister 427, named 2T1 (Alsford et al., 
2005). 
2.1.2 In vitro culture of BSF parasites 
Lister 427 WT and 2T1 lines, as well as mutant lines originating from each, were 
maintained in HMI-9 (HMI-9 (Gibco), 20% v/v FCS (Gibco), Pen/Strep (Sigma) 
(penicillin 20 U/ml, streptomycin 20 µg/ml)), and HMI-11 media (HMI-9 (Gibco), 10% 
v/v FCS (Gibco), Pen/Strep (Sigma) (penicillin 20 U/ml, streptomycin 20 µg/ml)), 
respectively.  Cells were cultured at 37˚C, 5% CO2, in vented flasks (Hirumi and 
Hirumi, 1989).  For routine culture parasites were maintained in 5 ml at a density 
below ~2 x 106 cells/ml.  2T1 cells lines were maintained in the presence of 0.2 
µg/ml Puromycin (InvitroGen) and 5 µg/ml phleomycin (InvitroGen).  Once 
transfected with a target gene construct, 2T1 parasites were instead cultured with 
5 µg/ml phleomycin (Invitrogen) and 5 µg/ml hygromycin B (Calbiochem) to 
maintain the RNAi construct.  RNAi was always induced with 1 µg/ml tet.  
Name Concentration 
Hygromycin 5 µg/ml 
Neomycin 2.5 µg/ml 
Blasticidin 10 µg/ml 
Phleomycin 5 µg/ml 
Puromycin 0.2 µg/ml 
Table 2.1 Selective drug concentrations for T. brucei culture. The final concentration of each 
selective drug. 
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For EdU incorporation experiments (section 2.5.4) the RNAi cell line was cultured in 
a thymidine-free version of HMI-11 media (Iscove’s MDM media (Gibco), 10% v/v FCS 
(Gibco), 1 mM Hypoxanthine, 0.05 mM Bathocuproine disulphic acid, 1 mM sodium 
pyruvate, 1.5 mM L-cystiene).  
Population density was determined by loading 10 µl of resuspended culture into a 
Neubauer improved haemocytometer (Marienfeld-Superior) and counting at least 2 
of the 1 mm square corner regions, taking the average of these.  This number was 
then multiplied by 10,000 to give the number of parasites per ml of culture. 
2.1.3 Stable transfection of BSF parasites 
A 33 ml culture of cells was grown to ~1 x 106 cells/ml, allowing collection of 3 x 
107 cells by centrifugation at 432g for 10 min.  The majority of the media was 
poured off before the pelleted parasites were resuspended in the residual media 
and transferred to a 1.5 ml microcentifuge tube.  Cells were then centrifuged at 
664 g for 3 min before the media was completely removed.  Cells were resuspended 
in 100 µl of Amaxa Human T Cell Nucleofactor kit solution (Lonza) and transferred 
to an electroporation cuvette.  10 µg of linearised construct DNA was added to the 
cuvette and cells were electroporated using Nucleofector™ 2b Device (Lonaz), 
programme X-001.  Once electroporated, cells were immediately transferred into 
30 ml of the appropriate media (free of selective drugs) and the tube was inverted 
several times.  Two serial dilutions of the culture were then made by transferring 3 
ml of the first into another 27 ml of fresh media, inverting the culture several times 
and repeating the process once more to generate 1:10 and 1:100 dilutions.  This 
resulted in three cultures at cell densities of approximately 1 x 106 cells/ml, 1 x 105 
cells/ml and finally 1 x 104 cells/ml.  Each cell dilution was then aliquoted as 1 ml 
cultures into 24 well plates (Corning).  24 hr later, the appropriate selective drug 
(Table 2.1) was added to the parasites in a further 1 ml of media (containing double 
the final drug concentration) per well.  Parasites were cultured for 5 - 7 days 
before 1 ml of each surviving clone was added to 4 ml of fresh drug-containing 
media in 6 well plates (Corning).  The following day, protein (section 2.4.1) or 
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genomic DNA (section 2.2.1) samples were prepared and either western blot 
(section 2.4.3) or PCR (section 2.2.2) analysis was performed to confirm the correct 
generation of modified cell lines.  
2.1.4 Stabilate preparation and retrieval 
Parasites were grown to ~1 x 106 cells/ml before stabilates were prepared.  800 µl 
of culture was added to 200 µl of 50% glycerol (diluted in the appropriate drug-free 
media) in 1.8 ml cryovials. Stabilates were stored in a box containing cotton wool 
and placed at -80°C to allow slow cooling.  Parasites were kept at -80 °C for short 
term storage and transferred to liquid nitrogen for longer storage. To retrieve cells, 
stabilates were defrosted at room temperature and added to 9 ml of appropriate 
drug-free media.  After 24 hr cells were passaged as a 1:1,000 dilution into media 
containing any required selective drugs as normal.  
2.1.5 Growth curves 
To begin each growth curve cultures at a density of 5-9 x 105 cells/ml were used to 
ensure parasites were in log phase.  In the case of the RH2ARNAi cell line, cultures 
were diluted to 1 x 105 cells/ml in 1.2 ml in 12 well plates and tet was added to 
final concentration of 1 µg/ml to induce RNAi.  Every 24 hours, un-induced samples 
were diluted to a density of 1 x 105 cells/ml to prevent parasites reaching 
stationary phase and final numbers were corrected according to this dilution to 
generate cumulative growth curves.  For all other cell lines growth curves began at 
1 x 104 cells/ml in 1.2 ml and no dilutions were performed.  
2.2 Basic molecular techniques 
2.2.1 Genomic DNA extraction 
Genomic DNA (gDNA) extracts were made from approximately 4 x 106 BSF cells 
harvested by centrifugation at 432g for 10 min.  Pelleted parasites were 
resuspended in 1 ml 1X Phosphate Buffered Saline (PBS) to wash away residual 
media and transferred into a 1.5 ml microcentrifuge tube before centrifuging at 664 
g for 3 min to collect cells.  The supernatant was removed and parasites were 
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resuspended in 200 µl fresh 1X PBS.  The DNeasy Blood and Tissue DNA extraction 
kit (Qiagen) was then used following the manufacture’s protocol to extract DNA.  
Samples were eluted in 50 µl of either Buffer AE or ddH2O and stored at 4 ˚C. 
2.2.2 Polymerase chain reaction (PCR) 
The following standard 50 µl PCR master mix was used to amplify gene fragments 
for cloning into endogenous tagging and gene deletion constructs: 1X Phusion® HF 
Buffer (New England Biolabs; NEB), 2.5 µl forward primer (10 pmol/ml stock) and 
2.5 µl reverse primer (10 pmol/ml stock), 1 µl 10 mM dNTP mix (Promega) 4 µl gDNA 
(prepared as in section 2.2.1), 0.5 µl Phusion® High-Fidelity DNA Polymerase (NEB) 
and ddH2O to a total volume of 50 µl.  PCR was carried out with the following 
thermocycler sequence: 98˚C for 3 min, 30 cycles of 98˚C for 30 seconds, 54-65˚C 
for 45 seconds and 72˚C for 1 min per kb (1 min minimum), ending with 10 min at 
72˚C.  Amplification of gene fragments to be used in Gateway® cloning to generate 
RNAi constructs was done using the following reaction: 10 µl 5X Phusion® HF Buffer 
(NEB), 2.5 µl forward primer (10 pmol/ml stock) and 2.5 µl reverse primer (10 
pmol/ml stock), 1 µl 10 mM dNTP mix (Promega), 2 µl gDNA, 0.5 µl Phusion® High-
Fidelity DNA Polymerase (NEB), 32 µl ddH2O.  PCR was then performed with the 
following thermocycling conditions: 98˚C for 3 min, 30 cycles of 98˚C for 30 
seconds, 60˚C for 30 seconds and 72˚C for 30 seconds, ending with 10 min at 72˚C.  
Where PCR was used to confirm the correct integration of a construct into a mutant 
cell line or presence/loss of an ORF, Taq Polymerase (NEB) was used as appose to 
Phusion Polymerase, as was Thermo Buffer (NEB), and the extension temperature 
was reduced to 68 ˚C.  All other reagents and parameters were as described above.
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No. Target Gene Sense Sequence (5’-3’) Cloning sites Purpose 
1 TbRH1 Fwd CGACGAAGCTTCTGCGGATGACGGTAATG HindIII Myc epitope tagging 2 Rev CGACGTCTAGAGCCAAAGGGCGATTCACA XbaI 
3 TbRH1 Fwd CCTGTTTTGGTGGGTGTAA N/A Correct tag integration  
4 pNATx12M Rev GACAGAAGGACGAAGGAG N/A Correct tag integration  
5 TbRH2A Fwd CGACGAAGCTTGAACACGCTTAGCCATCAAAC HindIII HA epitope tagging 6 Rev CGACGTCTAGAAGGGACTTCCCGCGACAAA XbaI 
7 TbRH2A Fwd GAGGAAAAGCGTTGTTAGC N/A Correct tag integration  
8 TbRH3 Fwd CGACGAAGCTTCCACACTTACATTGACACGG HindIII Myc epitope tagging 9 Rev CGACGTCTAGATGAGTGGCTATCTTTCATTTTG XbaI 
10 TbRH3 Fwd CCGATGAGGAGTTTCAGAT N/A Correct tag integration  
11 
TbRH1 
Fwd CGACGGGATCCTTGCCTTACCCGTGTTTT BamHI 
5' UTR amplification 
12 Rev CGACGTCTAGACCTTTTCTTTCCCATGGAC XbaI 
13 TbRH1 Rwd CGACGCCCGGGAGGTGTGTATGGGAATGA SmaI 3' UTR amplification  14 Rev CGACGCTCGAGGCACCACCCAGTATAGAAA XhoI 
15 NEO Fwd GGATTCATCGACTGTGGC N/A Correct 3' NEO integration 
16 TbRH1 Rev GGGCAAAAAAGTCCACCA N/A Correct 3' NEO/BSD integration 
17 BSD Fwd TTTTCTCGTCTTGGTGTG N/A Correct 3' BSD integration 
18 TbRH1 Fwd GTGGAGGAAGCGGTCTTT N/A Correct 5' NEO/BSD integration 
19 NEO Rev GCGTGCAATCCATCTTGTTC N/A Correct 5' NEO integration 
20 BSD Rev AAGCGGTCTTTCATATGG N/A Correct 5' BSD integration 
21 TbRH1 Fwd GAGCCCGTTTTAAGTCTT N/A TbRH1 ORF 22 Rev CTGATTGGTCTGGGGTTC N/A 
25 TbRH2A Fwd CGACGGCGGCCGCGGATCCCTTGAGTGGGCATAGTTA BamHI + NotI 5' UTR amplification 26 Rev CGACGAAGCTTTTACTACTGGAAGACCGA  HindIII 
27 TbRH2A Fwd CGACGATCGATTCCCTTAGACACCCCTGA  ClaI 3' UTR amplification  28 Rev CGACGGCGGCCGCCTCGAGGGACTGAGATGATGCATAA XhoI + NotI 
29 TbRH2A Fwd GTTTCGTTCTTTCGTTCC N/A Correct 3' NEO/BSD integration 
30 TbRH2A Fwd CACGCTTAGCCATCAAAC N/A TbRH2A ORF 31 Rev CCATCACCAGAACATTTG N/A 
32 TbRH2A Fwd GGGGACAAGTTTGTACAAAAAAGCAGGCTCCGCAGCTATGACAGGTGTA AttB TbRH2A RNAi fragment amplification 33 Rev GGGGACCACTTTGTACAAGAAAGCTGGGTCTCGAAGACGATAGGGATGC AttB 
Table 2.2 Primers used for cloning and mutant cell line confirmation.  
Sequences of primers used for construct generation and confirmation of mutant T. brucei cell lines are shown along with their targets. Restriction digest and 
attB cloning site sequences are underlined. All sequences are shown 5’-3’. 
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2.2.3 Agarose gel electrophoresis 
DNA fragments were separated with 1% (w/v) UltraPure™ Agarose (Life 
Technologies) in gels made with 1X TAE buffer (40 mM Tris base, 19 mM acetic acid, 
1mM EDTA) and SYBR® Safe DNA Gel Stain (Life Technologies), added at a 1:20,000 
dilution. Loading dye was added to DNA samples before loading alongside 8 µl 1 Kb 
Plus ladder (Invitrogen™, Life Technologies).  Gels were run for 30-60 min in 1X TAE 
buffer at 100-120 v. 
2.2.4 Restriction digest 
All enzymatic restriction digest reactions were set up as multiples of the following 
30 µl reaction according to the amount of DNA which required digestion:  3 µl 10X 
appropriate buffer, 1-6 µl of eluted DNA, 0.5 µl restriction enzyme(s), ddH2O up to 
30 µl.  Reactions were incubated at the appropriate temperature for the enzymes 
used, usually 37 °C, for 1-12 hr.  Products were resolved by agarose gel 
electrophoresis (section 2.2.3) and the target fragments were purified (section 
2.2.5).    
2.2.5 DNA extraction from agarose gel  
DNA bands were visualised on a UV light box, cut from agarose gel with a sterile 
razor blade and transferred into 1.5 ml microcentrifuge tubes.  The DNA was then 
purified using the QIAquick® Gel Extraction Kit (Qiagen) as per the manufactures 
protocol.  DNA samples were eluted in 30-50 µl of Buffer EB or ddH2O. 
2.2.6 DNA ligation 
Ligation reactions between digested DNA fragments and construct backbones were 
set up as follows: 1 µl 10X T4 DNA Ligation Buffer (NEB), 0.5 µl T4 DNA Ligase (NEB), 
6.5 µl plasmid backbone and 2 µl purified insert fragment.  Reactions were 
incubated at 16 ˚C overnight.  3 µl of ligation reaction was used to transform 50 µl 
of E. coli MAX Efficiency® DH5-α™ competent cells (Life Technologies) as described 
in section 2.2.8. 
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2.2.7 Gateway® cloning to generate RNAi constructs 
A derivation of Gateway® cloning technology was used to produce tet-inducible 
RNAi constructs (Jones et al., 2014).  PCR to generate gene fragments was 
performed as described in section 2.2.2 using gene specific primers designed to 
include attB sites (Table 2.2).  Products were resolved on 1% (w/v) agarose gel and 
extracted, as described in sections 2.2.3 and 2.2.5 respectively.  The Gateway® BP 
Clonase® II Enzyme mix kit (Life Technologies) was used to perform a BP reaction 
between the PCR product and pGL2084 vector as follows:  5 µl PCR product, 1 µl 
pGL2084, 3.75 µl TE buffer (10 mM Tris, 1mM EDTA) and 0.25 µl BP Clonase® II 
(Jones et al., 2014).  Reactions were incubated at room temperature before being 
stopped by the addition of 1 µl Proteinase K solution (2 µg/µl) and incubation at 37 
°C for 10 minutes.  3 µl of the reaction mix was then used to transform 50 µl of E. 
coli MAX Efficiency® DH5-α™ competent cells (Life Technologies) as described in 
section 2.2.8.  
2.2.8 E. coli transformation and plasmid purification 
E. coli MAX Efficiency® DH5-α™ competent cells (Life Technologies) were incubated 
on ice for 30 minutes with the construct of interest.  Cells were then heat shocked 
at 42 ˚C for 45 seconds and returned to ice for 5 min.  1 ml of S.O.C buffer (2% 
tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4, 
and 20 mM glucose) was added to the cells which were incubated at 37˚C for 1 hr 
with agitation.  Cells were then pelleted by centrifuging at 700 g for 1 min.  Most of 
the supernatant was removed leaving ~50 µl in which cells were gently resuspended 
and transferred to a selective agar plate containing 100 µg/ml Ampicillin (Amp).  
Plates were incubated over night at 37 ˚C.  Once established, colonies were picked 
using a pipette tip and added to 5 ml L-Broth containing 100 µg/ml Amp, then 
incubated at 37 ˚C overnight in a shaking incubator.  Transformed E. coli DH5-α 
cultures were pelleted by centrifuging at 25,000 g for 10 minutes and the 
supernatant was removed.   QIAprep Spin Miniprep Kit (Qiagen) was then used 
according to the manufactures protocol to purify plasmid DNA from the pelleted 
bacteria. 
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2.2.9 DNA sequencing  
For Sanger sequencing to confirm the generation of correct DNA constructs, 2 µl of 
sequencing oligos (10 pmol/ml) listed in Table 2.3 were added to 15 µl plasmid DNA 
(prepared as in section 2.2.8) in Mix2Seq bar-coded tubes.  DNA sequencing was 
carried out by Eurofins Genomics (Ebersber, Germany) and the resulting sequence 
was aligned to the appropriate reference construct using CLC Genomics Workbench. 
For next-generation sequencing applications, libraries were prepared by Craig 
Lapsley (section 2.6.4) and sequenced with the Illumina NextSeq 500 platform by 
Glasgow Polyomics. 
No. Target Sense Sequence (5’-3’) 
78 pNATx12M contruct Fwd CGTTGGCCGATTCATTAATGC  
79 Rev TAATGACGAACGGGAAATGC  
80 KO constructs Fwd AGGGTTTTCCCAGTCACGACGTT  
81 Rev GAGCGGATAACAATTTCACACAGG  
Table 2.3 Primer sequences used for Sanger sequencing.  
Primers used for Sanger sequencing (Eurofins Genomics) are shown 5’-3’ along with their target 
constructs.  
2.3 RNA analysis 
2.3.1 RNA extraction  
1 x 107 cells were collected by centrifugation at 432g for 10 min, media was 
removed, and the cells were washed in 1 ml 1X PBS.  Cells were then pelleted at 
664 g for 3 min.  Pelleted cells were either stored at -80 ˚C or used immediately for 
total RNA extraction.   RNeasy Mini Kit (Qiagen®) was used following the provided 
protocol “Purification of Total RNA from Animal Cells Using Spin Technology", 
starting by adding 600 µl RLT Buffer to each sample and pipetting up and down 
several times to ensure the cells were homogenized.  On-column DNase I (RNase-
Free DNase Set, Qiagen®) treatment was performed after step 5 of this protocol 
where the column was incubated for 15 minutes with DNase I.  RNA was eluted in 30 
µl RNase-free water and stored at -80 ˚C.    
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2.3.2 First-strand cDNA synthesis 
The SuperScript™ First-Strand Synthesis System for RT-PCR (Invitrogen, Life 
Technologies) was used with 1 µg of total RNA to generate complementary DNA 
(cDNA). The manufactures protocol was followed using random hexamer primers 
and SuperScript™ II Reverse Transcriptase.  Synthesis was followed with RNase H 
treatment as per the protocol to remove the resultant cDNA-RNA hybrids.  All cDNA 
samples were stored at -20 ˚C.  
2.3.3 Quantitative real-time PCR (qPCR) 
Primers, designed using Primer Express version 3.0 software (Bio Rad), were first 
assessed for efficiency by analysing calibration curves and melting profiles.  Those 
which achieved efficiency of approximately 100% (within a 15% interval) were 
deemed suitable for use (Table 2.4).  For every primer pair, each cDNA sample was 
run in triplicate using Precision™ qPCR MasterMix with SYBR Green.  Samples were 
set up as follows in MicroAmp® Optical 96-well Reaction Plates  (Applied 
Biosystems®, Life Technologies):  12.5 µl 2X Master Mix, 2µl forward primer (3.3 
pmol stock), 2 µl reverse primer (3.3 pmol stock), 5 µl of cDNA (prepared as 
described in section 2.3.2 and diluted 1:10) and 5.5 µl RNase-free water (Qiagen).  
Plates were sealed using MicroAmp® clear adhesive film (Applied Biosystems®, Life 
Technologies) and run using a 7500 Real Time PCR system (Applied Biosystems®) as 
follows: 10 min at 95 ˚C, 40 cycles of 95 ˚C for 15 sec and 60 ˚C for 1 min.  
Fluorescence intensity data was collected at the extension step (60 ˚C for 1 min).  
Amplification curves were analysed using the 7500 software version 2.3 (Applied 
Biosystems®) and results exported as an Excel (Microsoft Office) spreadsheet.  For 
normalisation between samples, primers targeting the Tb927.10.12970 gene (C1) 
(Kabani et al 2009) were used as the reference gene.  The 2-ΔΔCt method (Livak and 
Schmittgen, 2001) allowed analysis by normalising sample CT to C1 CT values and 
calculating the fold-change of induced samples relative to uninduced. 
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No. Target Gene Sense Sequence 
23 TbRH1 Fwd ACGAACCCCAGACCAATCAG 24 Rev CGCGCAAGACATGGATGA 
34 TbRH2A Fwd CCGAGCGGTGCCAAGA 35 Rev TGCATAAATTCGGAAACATCG 
36 rRNA promoter Fwd GTCAATACAACACACAATAGG  37 Rev CTTAACTGAGGAAGTGTCATA  
38 rRNA 5.8S Fwd GGATGACTTGGCTTCCTAT  39 Rev ATTGATACCACTTATCGCACT 
40 rRNA 28Sβ Fwd GTAAGTTCGCAAGAAGCAT  41 Rev  ACCAGAAGGAGGTTAGTAGATA  
42 NEK22 Fwd TTACTCCTCGCCTCTCATT  43 Rev TGTTCTGGACGTAGGAACTA 
44 HDAC3 Fwd CGA CAG CGT GAG GAA TAA G 45 Rev CAC GGG AGA CCT TTC ATT C 
46 ATR Fwd TCTAGTATCGCCGGCAGCTT 47 Rev TTGGCTGTATGGCCTGATCTC 
48 GPI-8 Fwd TCTGAACGCGCGCACTTC 49 Rev CCACTCACGGACTGCGTTT 
50 ORC1B Fwd ACGTCAACTGTGCGGATATG 51 Rev TCCAAGCGAACCTGTGAAC 
52 Actin Fwd CGGACGAGGAACAAACTGC 53 Rev TTTCCATGTCATCCCAATTGG 
54 tRNA Glycine Fwd CGGACTGCGCAGACTTTTC 55 Rev CGGCGGTAGACTATTATCGTTTG 
56 tRNA Lycine Fwd CCCCAGCGGCATGTTC 57 Rev TTTGTGTGGAGAATGTTGGATCTAG 
58 snRNA 1 Fwd GGGAGGTGTGAACGCAAGA 59 Rev AAGGAGTACCGGATATAGTATTGCACTAG 
60 snRNA U1 Fwd TCCACGGGCCCTGTTG 61 Rev AAAATCAGAGCCCCCAAACAC 
62 ESAG6 Fwd TGGGAGGGATGGATGTAATTT 63 Rev CCGACCCCCCTTCCAAT 
64 ESAG8 Fwd CGGATGCGTCGTGGAA 65 Rev CCTCCGATACGCCGTTGA 
66 VSG221 Fwd AGC AGC CAA GAG GTA ACA GC 67 Rev CAA CTG CAG CTT GCA AGG AA 
68 VSG121 Fwd AGGAAGGCAAATACGACCAG 69 Rev  TTGGGGTAAAAGTCCTTG 
70 VSG800 Fwd ACAGACCGCCGACAGTATC 71 Rev GTATCTTTGTAGGCCGCTGC 
72 VSG T3 Fwd CAGCGCAAGTCCAGGACG 73 Rev TGCTTCGTCGTCGCTTAC 
74 VSG13 Fwd ATAACGCATGGCCATCTTGCA 75 Rev GTCGTTGCTGTGGATTGCTC 
76 VSG224 Fwd GACGCAGCAGAATCAACAC 77 Rev GCTTATTTTGTGTCTGTCGC 
Table 2.4 Primers used for qPCR analysis. 
All primers used for qPCR analysis are listed with the target genes.  
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2.3.4 RNA-seq library preparation and sequencing 
Total RNA samples prepared as in 2.3.1 were used to prepare libraries for Illumina 
sequencing. All RNA library preparation was performed by Craig Lapsley using the 
TruSeq Stranded mRNA kit (Illumina). mRNA strands were poly(A) selected and 
Illumina adapters ligated to give a final fragment size of approximately 300 bp.  
Sequencing was performed with the NextSeq 500 platform giving paired-end reads 
of 75 bp in length (Glasgow Polyomics). 
2.4 Protein analysis 
2.4.1 Whole cell protein extraction 
2.5 x 106 cells per sample were harvested by centrifuged at 432g for 10 min.  Cells 
were washed in 1 ml 1X PBS before being resuspended in 10 µl Loading Buffer (1X 
NuPAGE® LDS Sample Buffer (Life Technologies), 0.1% β-mecaptoletanol, 1X PBS) 
per 2.5 x 106 cells.  Samples were then boiled for 10 min before being analysed 
immediately or stored at - 20 ˚C.  
2.4.2 Sodium-dodecyl-sulphate-polyacrylamide gel electrophoresis 
(SDS-PAGE)  
If previously frozen, protein extracts were boiled again for 10 min.  4-10 µl of 
sample (1-2.5 x 106 cells) was loaded per well of NuPAGE® Novex® 10-12% Bis-Tris 
Protein Gels 1.0 mm (Life Technologies), alongside 10 µl Novex® Sharp Protein 
Standard ladder.  Gels were run in 1X NuPAGE® MOPS SDS Running Buffer at 200 v 
for 50 min.  
2.4.3 Western blotting 
SDS-PAGE separated protein was transferred to PVDF Transfer Membrane 
(ThermoFisher) in 1X Transfer Buffer (25 mM Tris, pH 8.3, 192 mM Glycine, 20% 
(v/v) methanol) at 100 v for 70 min.  Ponceau S solution (Sigma Aldrich) was used to 
confirm the transfer of protein to the PVDF membrane.  Membranes were 
subsequently washed twice in 1X TBST (1X PBS pH 7.2, 0.01% Tween-20) for 5 min 
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on a rocker.  A Blocking Solution of 5% dried milk in 1X TBST was used to incubate 
the membrane for 1 hr at room temperature or overnight at 4 ˚C.  Membranes were 
then incubated with the primary and then secondary antisera in Blocking Solution 
(see Table 2.5 for dilution factors) for 1 hr each, separated by three 10 min washing 
steps in 1X TBST.  The membrane was washed again three times in 1X TSBT for 10 
min, incubated for 2 min with SuperSignal West Pico Chemi-luminescent Substrate 
(Thermo Scientific) and finally exposed to X-ray film (Kodak).   
Antibody Serotype Concentration Source 
α-Myc  mouse 1:7,000 Millipore 
α-HA mouse 1:10,000 Sigma Aldrich 
α-EF-1α (elongation factor-1 alpha) mouse 1:25,000 Millipore 
α-yH2A rabbit 1:1,000 R. McCulloch 
α-mouse HRP conjugate goat (Ig H+L) 1:1,000 Thermo Scientific 
α-rabbit HRP conjugate goat (Ig H+L) 1:5,000 Thermo Scientific 
Table 2.5 Antisera used for western blot analysis. 
All antibodies used for western blot analysis are listed along with dilutions used and manufacturers. 
HRP – horseradish peroxidase.  
2.5 Immunofluorescent analysis and imaging  
2.5.1 DAPI staining and cell cycle analysis 
Parasites were maintained under 1 x 106 cells/ml to ensure cultures were in log 
phase, diluting cultures with appropriate media and selective drugs where 
necessary between time points. Per sample, 1 - 2 x 106 cells were centrifuged at 
432g for 10 min.  Centrifuged cells were washed in 500 µl 1X PBS and pelleted by 
centrifugation 664 g for 3 min.  Most of the supernatant was remove, leaving ~30 µl 
which the pellet was resuspended in and transferred to the well of a 12 well glass 
slide (Thermo Scientific), spread with Poly-L-Lysine (Sigma Aldrich).  Cells were 
allowed to settle for 5 min before fixing with 25 µl 4% FA for 4 min.  Cells were 
washed twice in 50 µl 1 X PBS for 5 min before 5 µl of Fluoromount G with DAPI 
(Cambridge Bioscience, Southern Biotech) was added and incubated in the dark for 
4 min.  A glass coverslip was applied, and the slide was sealed with nail varnish.    
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2.5.2 Standard immunofluorescent analysis of BSF T. brucei 
For standard immunofluorescence to localise epitope-tagged proteins and 
phosphorylated histone variant, gH2A, 1 - 2 x 106 cells were collected by 
centrifugation at 432 g, resuspended in 500 µl 1X PBS and pelleted at 664 g for 3 
min.  All but ~ 30 µl of supernatant was removed and cells were resuspended in the 
remaining 1X PBS.  Cells were transferred to wells of a 12 well slide (Thermo 
scientific) spread with Poly-L-Lysine (Sigma Aldrich), before being incubated for 5 
min allowing cells to settle and adhere. 1X PBS was removed and replaced by 25 µl 
4% FA in 1X PBS for 5 min.  0.01% Triton X-100 (Promega) in 1X PBS was added for 5 
min to permeabilise the cells before quenching with 25 µl 100 mM glycine twice for 
10 min.  Cells were then incubated in 50 µl Blocking Solution (3% Bovine Serum 
Albium (BSA), Sigma Aldrich, 0.002% Tween-20, Sigma Aldrich, 1X PBS) for 1 hr in a 
humidity chamber. Blocking Solution was then replaced with primary antibody 
diluted in Blocking Solution to the concentration stated in Table 2.6 and incubated 
for a further 1 hr.  Wells were then washed twice in 50µl 1X PSB for 5 min, before 
incubation with secondary Alexa Fluor antibodies for 1 hr. Finally, wells were 
washed three times in 1X PBS for 5 min and Fluoromount G with DAPI (Cambridge 
Bioscience, Southern Biotech) was added and incubated for 4 min, before a glass 
coverslip was applied and sealed with nail varnish. 
Antibody Serotype Concentration Source 
α-Myc Alexa Fluor® 488 conjugated mouse 1:5,000 Millipore 
α-HA mouse 1:1,000 Sigma Aldrich 
α-yH2A rabbit 1:1,000 R. McCulloch 
α-VSG 221 rabbit 1:10,000 R. McCulloch 
α-VSG 221 rat 1:10,000 Gift, L. Glover 
α-VSG 121 rabbit 1:10,000 Gift, L. Glover 
α-mouse Alexa Fluor® 594 Goat goat (Ig H+L) 1:1,000 Molecular Probes® 
α-rabbit Alexa Fluor® 594 Goat goat (Ig H+L) 1:1,000 Molecular Probes® 
α-mouse Alexa Fluor® 488 Goat goat (Ig H+L) 1:1,000 Molecular Probes® 
Table 2.6 Antisera used for immunofluorescent analysis. 
All antisera used for immunofluorescent detection are listed with dilutions and source. R. McCulloch 
antisera were produced by previous member of the McCulloch lab.  
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2.5.3 VSG immunofluorescent analysis 
VSG immunofluorescent analysis was performed as previously described (Glover et 
al. 2016). Cells were centrifuged at 432g for 10 mins, resuspended in 1X PBS to 
wash cells before centrifuging again at 664 g for 3 min to re-pellet cells. 1% FA was 
used to fix cells in suspension at room temp for 15 min before adhering to a slide 
coated in Poly-L-Lysine solution (Sigma Aldrich).  Cells were then blocked in 50% 
FBS serum for 15 min before incubation with primary, α-VSG221 and α-VSG121, and 
secondary, Alexa Fluor 594 goat α-rabbit (Molecular Probes) antibody and Alexa 
Fluor 488 goat anti-rat (Molecular Probes), antibodies were carried out at room 
temp for 45 min in both cases.  Cells were then mounted in Fluoromount G with 
DAPI (Cambridge Bioscience, Southern Biotech).   
2.5.4 Assay of EdU incorporation 
For 5-ethynyl-2’-deoxyuridine (EdU) incorporation assays, parasites were culture in 
thymidine-free HMI-11 media (section 2.1.2) and were maintained in log phase (1 x 
105 - 1 x 106 cells/ml) during time course experiments. 4 hr prior to each time 
point, 4 ml of culture was transferred to a 6-well plate and incubated with 150 µM 
EdU (Life Technologies). After 4 hr, cells were collected by centrifugation at 432 g 
for 10 min. The media was removed, and cells were washed in 1 ml 1X PBS before 
centrifuging again at 664 g for 3 min. The majority of the supernatant was then 
removed leaving ~ 30 µl. Parasites were resuspended and transferred to wells of a 
12 well glass slide (Thermo Scientific) spread with Poly-L-lysine (Sigma Aldrich), 
where they were left to settle for 5 min. Supernatant was then removed and 
parasites were incubated in 20 µl 3.7% FA for 5 min at RT.  FA was removed, and 
cells were washed in 25 µl 3% BSA for 5 min, twice. After removing 3% BSA, 20 µl 
0.2% Triton X-100 (Promega) was added and cells were incubated for 10 min at RT 
to permeabilise. Cells were then washed twice with 3% BSA for 5 min.  Click-iTâ 
(Life Technologies) reaction mix was prepared as multiples of the following for each 
sample: 21.5 µl 1X Reaction Buffer, 1 µl CuSO4, 0.25 µl Alexa Fluor 555 Azide and 
2.5 µl 1X Additive Buffer. BSA was removed and parasites were incubated for 1 hr at 
RT in 25 µl of the Click-iTâ reaction mix, in a dark chamber. After incubation, cells 
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were washed 6 times in 3% BSA. For dual staining with gH2A antiserum, samples 
were then incubated with primary gH2A antiserum in 3% BSA for 1 hr, washed 3 
times in 3% BSA and then incubated in anti-rabbit Alexa Fluor 594 (Table 2.6) for 1 
hr. Finally, parasites were washed 3 times in 1X PBS before 5 µl Flouromount G with 
DAPI (Cambridge Bioscience, Southern Biotech) was added and coverslips were seals 
to slides with nail varnish. 
2.5.5 Fluorescent imaging and analysis 
For counting purposes, parasites were imaged using an Axioscope 2 fluorescence 
microscope (Zeiss) and a Zeiss PlanApochromat 63x/1.40 oil objective. DAPI staining 
was visualised with 440 nm filter, Alexa Fluor 488 staining with a 520 nm filter and 
Alexa Fluor 594 staining with a 620 nm filter. Background fluorescence was 
subtracted from images using Fiji software rolling ball background subtraction 
plugin (http://imagej.net/Rolling_Ball_Background_Subtraction). Counting was 
performed with Fiji software (Schneider, Rasband and Eliceiri, 2012). For increased 
resolution, an Olympus IX71 DeltaVision Core System microscope (Applied Precision) 
was used, running a SoftWoRx Suite v2.0 (Applied Precision) software. Either an 
Olympus PlanApo 60x/1.42 or an UplanSApo 100x/1.40 oil objectives were used. Z-
stacks of 5-6 µm thickness were acquired in 25 sections, and then deconvolved with 
the ‘conservative’ method and high noise filtering. Fiji software was then used to 
generate maximum projection images. 
2.5.6 Super-resolution structured illumination microscopy (SR-SIM) 
SR-SIM was performed with imaging specialist Dr Leandro Lemgruber Soares, who 
also performed image processing. Imaging was performed with an ELYRA PS.1 
Microscope (Zeiss), using a Plan-Apochromat 63x/1.40 Oil DIC objective and 405, 
488 and 594 nm lasers. Z-stack sections were ~0.15 µm in thickness and totalled ~10 
µm. Image reconstruction was performed with ZEN Black software (Ziess) and 3D 
rendering with Imaris software (Bitplane) to produce 3D models.  
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2.6 Chromatin-immunoprecipitation (ChIP) 
2.6.1 Fixing and Shearing Chromatin 
The ChIP-IT® Express Enzymatic (Active Motif) kit was used to perform ChIP 
reactions.  Approximately 1 x 108 BSF cells were pelleted by centrifugation at 1,200 
g at 4 °C for 10 mins.  The media was removed, and pellets were resuspended in 10 
ml Fixing Solution (10 % FA, 1X HMI-9, Gibco) and incubated shaking at room 
temperature for 5 min.  10 ml 2X Glycine-Stop Solution (2 ml 10X Glycine Buffer, 8 
ml 1X PBS) was added to fixed cells and briefly mixed by pipetting.  Cells were 
pelleted by spinning at 1200 g at 4°C for 10 min and the supernatant was removed.  
The cells were then washed in 1X Glycine-Stop Solution (1 ml 10X Glycine Buffer, 9 
ml 1X PBS) and pelleted as before.  Glycine-Stop Solution was removed, and the 
pellet was resuspended in 500 µl Lysis Buffer (supplemented with 2.5 µl 100 mM 
PMSF and 2.5 µl Protease Inhibitor Cocktail (PIC)) and incubated on ice for 30 
minutes. The suspension was transferred to an ice-cold dounce homogenizer and 
repetitively dounced until all nuclei were realised.  Cells were transferred to 
microcentrifuge tubes and the nuclei were pelleted by centrifuging at 2,400 g at 
4°C for 10 min.  The supernatant was discarded, and the nuclei pellet was 
resuspended in 350 µl Digestion Buffer (supplemented with 1.75 µl 100 mM PMSF 
and 1.75 µl PIC). This was incubated at 37°C for 5 min before 17 µl Enzymatic 
Shearing Cocktail (200 U/ml, 50% glycerol) was added and chromatin was incubated 
for a further 5 min at 37°C.  The digest reaction was stopped with the addition of 7 
µl ice-cold 0.5 M EDTA and incubated on ice for 10 minutes.  Lastly, sheared 
chromatin was centrifuged at 18,000 g at 4°C for ten min and the supernatant was 
collected in fresh microcentrifuge tubes.  Samples were stored at -80°C until use.  
A 50µl aliquot of each chromatin sample was reverse crosslinked and cleaned 
according to the DNA Clean Up protocol of the ChIP-IT® Express Enzymatic kit.  The 
concentration of dsDNA in each sample was determined using the Qubit 3.0 
Fluorometer (Thermo Fisher Scientific).    
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2.6.2 Chromatin-immunoprecipitation (ChIP) 
Sheared chromatin was thawed on ice and used in 200 µl IP reactions according to 
the ChIP-IT® Express Enzymatic kit (Active Motif) instructions.  Each reaction 
contained 1-2 µg chromatin, 25 µl Protein G magnetic beads, 20 µl ChIP Buffer 1, 2 
µl PIC, antibody (4.5 ng S9.6, Kerafast or 10.7 µl a-gH2A, R. McCulloch) and ddH2O 
to 200 µl in total. Reactions were incubated at 4°C overnight on an end-to-end 
rotator. The following morning the microcentrifuge tubes were placed on a 
magnetic rack to collect the beads.  Supernatant was removed, and beads were 
washed once in 800 µl ChIP Buffer 1 and twice in 800 µl ChIP Buffer 2. At this point 
ChIP samples using the S9.6 antibody (DRIP) were used to perform an on-bead 
RNase H control (see section 2.6.3). To elute DNA the beads were resuspended in 50 
µl elution Buffer AM2 and incubated at room temperature on an end-to-end rotator 
for 15 min. 50 µl Reverse Cross-Linking Buffer was added and mixed by pipetting.  
The beads were pelleted using the magnetic stand and supernatant containing the 
eluted chromatin was transferred to fresh microcentrifuge tubes.  At this point 10 
µl of Input sheared chromatin (200 - 300 ng) was thawed on ice.  78 µl of ChIP 
Buffer 2 and 2 µl 5M NaCl was added to make a total volume of 100 µl.  Both eluted 
ChIP and Input samples were then incubated at 65°C for 3 hr.  To degrade protein 
in the samples, 2 µl Proteinase K was added to each ChIP and input sample and 
incubated at 37°C for 1 hr.  Lastly 2 µl of Proteinase K Stop Solution was added to 
each sample and DNA was stored at -20 °C.  
2.6.3 RNase H treatment of S9.6 DRIP samples 
In the case of S9.6 ChIP samples (DRIP), each IP reaction was set up in duplicate as 
described in section 2.6.3.  After washing ChIP samples, beads were resuspended in 
300 µl RNase H Buffer (50 mM Tris-HCl, 75mM KCl, 3 mM MgCl2, 10 mM DTT, 4% 
glycerol and 20 µg/ml BSA).  15 µl of E. coli RNase H (30 Units, Invitrogen) or 
RNase-free ddH2O was added to samples which were then incubated at 37°C with 
shaking at 1,000 rpm for 3 hr.  Beads were then washed as before; once with 800 µl 
ChIP Buffer 1 and twice with 800 µl ChIP Buffer 2.  DNA was then eluted for each 
sample as described in section 2.6.2.  
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2.6.4 DNA library preparation 
The TrueSeq ChIP Library Preparation Kit (Illumina) was used to prepare all gH2A 
ChIP and DRIP DNA samples for next-generation sequencing with the exception of 
WT and Tbrh1-/- gH2A ChIP samples where the NEBNextâ ChIP-sep Library 
Preperation kit was used. In all cases 300 bp fragments (including adaptor 
sequences) were selected for with Agencourt AMPure XP beads (Beckman Coulter). 
Preparation of all samples was carried out by Craig Lapsley.  
2.6.5 ChIP-qPCR 
qPCR was performed using DRIP/ChIP input and eluted (IP) DNA samples diluted 
1:100 and 1:10 respectively. 1 µl of DNA and 400 nM of primers (Table 2.4) were 
added to SYBR Select Master Mix (Life Technologies) to a total of 21 µl per reaction.  
All samples were run using a 7500 Real Time PCR system (Applied Biosystems) using 
the following conditions: 50 °C for 2 min and 95 °c for 2 min, followed by 40 cycles 
of 95 °C for 15 sec, 59 °C for 15 sec and 72 °C for 1 min.  Fluorescence intensity 
was measured at the end of extensions step, 72 °C for 1 min.  CT values were 
adjusted according to the dilution factor of each samples (minus log2(dilution)) and 
the percentage of input DNA from in the IP DNA of each sample was calculated. The 
calculation methodology is described by Thermo Fisher Scientific 
(https://tinyurl.com/y7uuzvay).   
2.7 Flow cytometry  
2.7.1 Cell cycle analysis by flow cytometry 
For each sample, 3 x 106 cells were harvested by centrifugation at 432 g for 10 min.  
Media was removed, and pellet was resuspended in 800 µl 1X PBS.  Cells were 
centrifuged again at 664 g for 3 minutes and the supernatant was removed.  Cells 
were then suspended in 200 µl 1% FA and incubated at RT for 10 min.  Fixed cells 
were pelleted by centrifuging at 6,000 g for 3 min, supernatant was removed, and 
parasites were resuspended in 1X PBS for storage at 4 °C.  Once collected, all 
samples were centrifuged again at 6,000 g for 10 min.  PBS was removed, and cells 
  
82 
were resuspended in 0.01% Triton X-100 (Promega) in 1X PBS before incubating on 
ice for 30 min.  Cells were pelleted again by centrifugation at 6,000 g for 10 min 
and supernatant was completely removed.  Cells were then resuspended in 1ml of 
100 µg/ml RNase A (Sigma Aldrich), 15 µg/ml propidium iodide, 1 X PBS and 
incubated at 37 °C for 30 min before analysing with the BD FACSCalibur™ (BD 
Biosciences).  Data was analysed on FlowJo_V10™ software (FlowJo, LLC). 
2.8 Bioinformatics 
2.8.1 Sequence retrieval 
DNA and amino acid sequences of interest were downloaded in FASTA format from 
either TriTrypDB (Aslett et al., 2010) or GenBank® 
(http://www.ncbi.nlm.nih.gov/genbank/) databases. For construct assembly and 
mutagenesis, the latest gene sequences were retrieved from the T. brucei Lister427 
v4 assembly. For DRIP-seq, ChIP-seq and RNA-seq analysis (targeting the whole 
transcriptome) a hybrid genome containing the 11 Mb chromosome assemblies of 
the T. brucei TREU927 v5.1 genome, 14 BES contigs and 5 mVSG ES contigs 
(Hutchinson, Glover and Horn, 2016) was used for alignments. For RNA-seq analysis 
of VSG transcripts specifically, reads were aligned to a collection of 2470 VSG 
coding regions of the T. brucei Lister427 strain (Cross, Kim and Wickstead, 2014). 
2.8.2 Primer and construct design 
The CLC Genomics Workbench V7 (CLC Bio, Qiagen®) was used to design primers for 
the amplification of gene fragments to be used in endogenous tagging and gene 
deletion constructs.  CLC was also used to generate construct maps, align 
sequencing data and identify restriction digest sites.  Primers to be used in the 
generation of RNAi constructs were generated using the TrypanoFAN:RNAit target 
selection script (http://trypanofan.bioc.cam.ac.uk/software/RNAit.html).  This 
online service uses MIT Primer3 and NCBI Blast to identify suitable primers to 
amplify a targeting gene fragment.  The ORF of targeted genes was uploaded and 
primers were generated using default parameters. attB sites were then added to 
the 5’ end to give the final primers.  
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2.8.3 Protein sequence alignment  
Amino acid alignments were completed using the multiple sequencing alignment 
(MSA) tool Kalign from EMBL-EBI (http://www.ebi.ac.uk/Tools/msa/kalign/).  
Kalign is a MSA tool with equal accuracy to other popular methods but is up to ten 
times faster and concentrates on local regions (Lassmann and Sonnhammer).  FASTA 
sequences were uploaded to the online form and output was given in a ClustalW 
format using default settings.  Annotations were made manually using annotation 
information obtained from NCBI databases (http://www.ncbi.nlm.nih.gov/protein).  
2.8.4 DRIP/ChIP-seq analysis 
2.8.4.1 Read mapping and filtering 
Sequencing read quality was first checked using FastGC, before reads were trimmed 
using TrimGalore (https://github.com/FelixKrueger/TrimGalore) under default 
settings to remove Illumina adaptor sequences and bases with quality scores < 20.  
Remaining reads were then mapped to the hybrid reference genome (see above) 
using Bowtie2 v2.2.9 (Langmead and Salzberg 2012) in "very-sensitive" mode.  Reads 
with a MapQ value <1 were removed using SAMtools (Li et al. 2009) leaving at least 
30 million aligned reads per sample (Hutchinson, Glover and Horn, 2016).  Quality 
control read mapping and filtering was carried out by Dr. Kathryn Crouch.  
2.8.4.2 Calculating DRIP/ChIP-seq signal enrichment 
The fold-change between the read depths of input and IP DNA was found for each 
sample in 50 bp bins using the DeepTools bamCompare tool (library size was 
normalised by the SES method and fold-change was expressed as a ratio) (Ramirez 
et al., 2014) and visualised as tracks with IGV (Robinson et al. 2011). In the case of 
gH2A ChIP-seq mapping in RH2ARNAi parasites, fold-change was calculated in the 
same manner using DeepTools bamCompare in tet-induced data relative to un-
induced.  
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2.8.4.3 Defining and classifying DRIP enriched regions 
To identify regions enriched of RNA-DNA hybrids, the 50 bp bins with a fold-change 
over 1.2 were extracted as a list of chromosomal start and end coordinates.  
Custom Python script, DRIP_Enriched_Regions.py (Figure 8.1), was used to find the 
start and end coordinates of adjacent 50 bp bins, without allowing gaps, to collate 
a list of RNA-DNA hybrid signal enriched regions.  
Bedtools (v2.26.0) Intersect (Quinlan and Hall, 2010) was used to ask if each DRIP 
enriched region overlapped with genome annotations of SSRs, CIR, VSG arrays, RHS, 
snRNA, tRNA, rRNA, procyclin, mVSG and VSG expression sites, all inferred from the 
reference genome annotation and supplied as lists of coordinates in BED files.  
Results were exported to Excel (Microsoft) and the number of enriched regions 
overlapping the features within each group was calculated. The remaining DRIP 
enriched regions were assumed to be located within Pol II transcribed PTUs.  These 
were further classified as being associated with the 5’ UTR, 3’UTR or CDS, this time 
asking only where the middle base of each enriched region located.  The remaining 
enriched regions were assumed to be associated with the regions between UTRs (or 
within unannotated UTRs) and were classified as intergenic.  
2.8.4.4 Plotting DRIP/ChIP-seq signal profiles and heatmaps  
Normalised ratio files (described in section 2.8.4.2) were used to generate plots and 
perform K means clustering analysis using the deepTools tools, computeMatrix, 
plotProfile and plotHeatmap (Ramirez et al. 2014).  The computeMatrix function 
calculates scores (in this case based on the fold-change ratio) per genome regions, 
supplied as chromosome coordinates in BED format. Matrices of the scores for all 
regions listed in the BED files were generated and either exported and plotted using 
GraphPad Prism or used as an intermediate file for plotProfile and plotHeatmap 
functions.   
2.8.4.5 GC/AT skew analysis 
GC and AT skew were calculated using the custom script GC/ATskew.py (Figure 8.2) 
which used the following formulas: GC skew = (#G - #C)/(#G + #C), AT skew = (#A - 
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#T)/(#A + #T). The skew was calculated in 20 bp bins across a list of regions given 
as coordinates in a BED file. The average GC and AT skew value for each bin in all 
regions listed in BED was exported and plotted using GraphPad Prism. 
2.8.4.6 Comparing DRIP-seq data with gene expression  
Rate of mRNA decay has previously been analysed by Fadda et al., (2014). Genes 
analysed were ordered according to the rate of mRNA decay in BSF parasites, 
excluding those for which no data is available. The 690 genes with the fastest rates 
of mRNA decay were taken as a group of low expression genes and 690 with the 
slowest rates of decay were classified as high expression genes. 690 genes taken 
from the centre of the list were taken as an intermediate expression sample.  DRIP-
seq signal profiles were generated for each group as described in section 2.8.4.4. 
2.8.4.7 Predicting R-loop forming regions 
R-loop predications were made using the QmRLFS-finder algorithm (Jenjaroenpun et 
al., 2015) that is based upon the findings by (Roy and Lieber, 2009), where an R-
loop forming sequencing (RLFS) was defined as containing three parts: an initiation 
zone containing G-clustering, a G-rich elongation zone where the R-loop can 
extend, and a linking sequence between 0 and 50 bp of any composition.  To 
predict RLFS in the T. brucei genome, G-clustering was defined as three clusters 
containing ≥ 3 G residues, or two clusters of ≥ 4 G residues.  In both cases clusters 
were separated by 1 - 10 bp. Elongation zones were defined as comprising ≥ 40% G 
residues and 100 - 2000 bp in length. 
2.8.5 RNA-seq analysis 
Read mapping, filtering, count analysis and differential expression analysis was 
carried out by Kathryn Crouch.  
2.8.5.1 Read mapping and filtering 
As for DRIP-seq data, sequencing reads were first quality checked with FastQC 
before trimming with Trim Galore to remove Illumina adaptor sequences and base 
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with quality scores < 20. Any resulting reads < 20 bp in length were discarded along 
with the associated paired read. Reads were then mapped with HiSat2 v2.0.5 using 
default parameters with the exception of not permitting splice alignments (--no-
splice-alignment), to either the hybrid genome or VSG collection (section 2.8.1). 
Mapped reads were then filtered to remove reads with MAPQ scores <1 (Hutchinson, 
Glover and Horn, 2016).  
2.8.5.2 Read count analysis 
Mapped reads were counted using HTseq-count software, using default parameters. 
Here only uniquely mapping reads were considered and those mapping to rRNA 
genes were masked.  For alignments to the hybrid reference genome, strand 
information was considered when carrying out read count analysis. However, strand 
information was ignored (--stranded no) when analysing alignment to the VSG 
collection (Cross, Kim and Wickstead, 2014), as no strand information was available 
for these coding regions. 
2.8.5.3 Differential expression analysis 
Normalisation and differential expression between data sets was carried out using 
DESeq2 v1.18.1 (Love, Huber and Anders, 2014). Data from the 24 hr TbRH2A RNAi 
samples were considered separately from data generated at 36 hr. In each case 
HTSeq counts data were used from each duplicate sample, to compare counts for 
each gene between tet-induced un-induced samples. Those with an adjusted p 
value < 0.05 were considered significantly differentially expressed.  
2.8.5.4 RPKM calculations 
In order to compare read alignment to VSG coding regions in WT and Tbrh1-/- 
samples the number of reads per kb of transcript per million mapped reads (RKPM) 
was calculated manually for each VSG (Cross, Kim and Wickstead, 2014) using 
counts data generated with HTseq (section 2.8.5.2) and the following formulas:  
RPK = read counts/gene length (kb) 
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RPKM = RPK/(total RPK/1,000,000) 
Fold-change in RPKM for each VSG was then calculated for Tbrh1-/- relative to WT. 
2.8.5.5 Gene ontology (GO) term analysis 
For GO term enrichment analysis of genes which have R-loops associated with their 
coding regions (CDS), TriTrypDB (Aslett et al., 2010) biological processes GO term 
analysis was performed in the T. brucei TRUE927 background and a significance 
cutoff of p < 0.05. For analysis of genes found to be differentially expressed in RNA-
seq experiments, GO term analysis was performed using Cytoscape v3.6.1 (Shannon 
et al., 2003) plugin BiNGO (Maere, Heymans and Kuiper, 2005). BiNGO analysis was 
performed with hypergeometric statistical testing of significance, and multiple 
testing was corrected for with the Benjamini and Hochberg False Discovery Rate 
(FDR) correction. FDR adjusted P values < 0.01 were deemed significantly enriched 
terms. Networks were mapped also using Cytoscape v3.6.1.
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3 Characterisation of T. brucei RNase H Enzymes
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3.1 Introduction 
RNase H enzymes are endonucleases characterised by the capacity to hydrolyse the 
RNA strand of RNA-DNA hybrids, frequently those which form as R-loop structures 
within the DNA helix.  Of those studied, most organisms possess at least one RNase 
H, though most commonly two distinct catalytic proteins are found.  Eukaryotic 
RNases H are larger and more complex than their prokaryotic counterparts, though 
similarities in structure and function exist.  Since their discovery in calf thymus 
extracts (Stein and Hausen, 1969) and, later, in E. coli (Itaya, 1990), standard 
nomenclature to describe these enzymes has been adopted for clarity: Arabic 
numerals were assigned to eukaryotic RNase Hs, RNase H1 and RNase H2; and 
Roman equivalents to the prokaryotic proteins, RNase HI and RNase HII.  
3.1.1 RNase H1 
Eukaryotic RNase H1 consists of highly conserved N-and C-termini, connected by an 
internal variable sequence.  The N-terminal Hybrid Binding Domain (HBD) binds RNA 
duplexes with a 25-fold increased affinity for RNA-DNA hybrids over RNA-RNA 
equivalents, as demonstrated with human RNase H1 (Nowotny et al., 2008).  The 
HBD domain binds two consecutive 2’-OH groups of the RNA strand in a non-
sequence specific manner (Nowotny et al., 2008).  Hydrolysis is accomplished by 
the C-terminal RNase H domain, which requires a substrate containing at least four 
consecutive ribonucleotides (Ohtani et al., 1999) and contains four highly conserved 
carboxylic acid residues (Nowotny et al., 2008). The RNA strand of an RNA-DNA 
duplex sits in one shallow groove of the RNase H domain, attracted via the minimal 
four 2’-OH groups, and the DNA strand in another (Nowotny et al., 2005), meaning 
both the HBD and RNase H domains of type 1 RNases H are involved in binding RNA-
DNA hybrid substrates. The Connecting Domain, bridging the HBD and RNase H 
domain, is highly variable in both length and sequence, and so has been suggested 
to allow flexible movement of the two domains around substrates (Cerritelli and 
Crouch, 2009). The RNase H domain of eukaryotic type 1 RNase H is highly similar to 
that of the E. coli RNase H domain, yet few bacterial RNases HI additionally have 
HBDs, and in these cases, the RNase H domain and HBD are connected by relatively 
short a Connecting Domain (Kochiwa, Tomita and Kanai, 2007). Evolution of the 
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HBD appears to have improved activity of eukaryotic RNase H1, as deletion of the 
domain in human and mouse RNase H1 results in defective RNase H activity; full-
length mammalian RNase H1 proteins resolve long RNA-DNA hybrids processively, 
meaning long stretches of the hybrid are catalysed per interaction event, whereas 
enzymes lacking the HBD cleave the hybrid substrate in a disrupted manner, much 
like E. coli RNase H1 (Gaidamakov et al., 2005; Nowotny et al., 2005).  
Mammalian RNase H1 enzymes contain two in-frame methionine start codons, 
causing the translation of RNase H1 protein with and without a mitochondrial 
targeting sequence (MTS) (Cerritelli and Crouch, 2009).  Knockout mutation of 
mouse Rnaseh1 is embryonically lethal due to failure to replicate mtDNA (Cerritelli 
et al., 2003).  However, the model organisms S. cerevisiae and C. elegans have no 
MTS associated with their respective HBD-containing RNase H1 proteins.  S. 
cerevisiae mtDNA is vastly different to that of mammals, being significantly larger 
and linear in conformation, and so its replication is likely to occur via a different 
mechanism, independent of essential RNase H1 activity (Cerritelli and Crouch, 
2009).  C. elegans mtDNA is similar to that of mammals, but C. elegans expresses a 
second type 1 RNase H-like protein (RNase H1.1) which contains an MTS domain and 
two alternative start codons (Arudchandran et al., 2002).  Though unessential, 
deletion of RNase H1 in S. cerevisiae leads to detectable levels of genome 
instability and modest sensitivity to DNA damaging agents (Wahba et al., 2011; 
O’Connell, Jinks-Robertson and Petes, 2015). No human disease has been linked to 
mutation of RNase H1, although this may be due to the protein’s essential role in 
mtDNA amplification during embryo development (Cerritelli et al., 2003). Taken 
together, these findings indicate RNase H1 is essential for typical eukaryotic mtDNA 
replication and has a non-essential role in nuclear genome maintenance.  
3.1.2 RNase H2   
Type 2 RNase H differs from RNase H1 in several aspects.  Most obviously, 
eukaryotic RNase H2 functions as a complex of three subunits (Jeong et al., 2004), 
where RNase H2A is the catalytic component and RNase H2B and RNase H2C are 
believed to be largely structural (Chon et al., 2009).  However, RNaseH2B does 
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contain a PCNA (proliferating cell nuclear antigen)-interacting peptide, which 
directs an interaction between RNase H2 and PCNA (Chon et al., 2009), and 
accordingly, the complex’s localisation to replication forks (Bubeck et al., 2011), 
pointing to a role of type 2 RNase H in replication-associated repair processes.     
Prokaryotic homologues of the catalytic RNaseH2A subunit, termed RNase HII, exist 
and function as a monomer (Itaya, 1990). In addition, and in contrast to RNase HI, 
which requires a stretch of at least four hybridised ribonucleotides, bacterial RNase 
HII enzymes are specialized to detect (5’)-RNA-DNA-(3’)/DNA (RpD) junctions 
(Tadokoro and Kanaya, 2009).  This specificity allows RNase HII to remove single 
ribonucleotides embedded in a DNA duplex, which are often aberrantly 
incorporated by replicative DNA polymerases (Schroeder et al., 2015).  Despite the 
structural elaboration eukaryotic RNase H2 has undergone during evolution, the 
enzyme complex is still able to detect RpD junctions, as well as RNA-DNA hybrids 
formed either as tracks of embedded ribonucleotides or R-loops.  Hence in 
eukaryotes, both type 1 and type 2 RNase H are able to resolve R-loops, yet the 
latter additionally detects single ribonucleotides embedded in the genome 
(Cerritelli and Crouch, 2009).  RNase H2 detects the reactive 2’-OH group of 
embedded ribonucleotides and proceeds to cleave 5’ of the ribonucleotide, 
initiating the RER pathway (Sparks et al., 2012; Williams, Gehle and Kunkel, 2017). 
DNA polymerase δ subsequently performs PCNA-dependent nick translation, causing 
strand displacement of the ribonucleotide that is then removed from the DNA by 
the action of flap endonuclease FEN1, before DNA ligase repairs the lesion (Sparks 
et al., 2012).  
In further contrast to type 1 RNase H, human RNase H2 has a critical role in the 
nuclear genome, since mutation in any of the three subunits causes neurological 
defects and other symptoms associated with Aicardi-Goutières Syndrome (AGS) 
(Crow et al., 2006).  Additionally, full knockout of either mouse RNase H2B or 
RNase H2C is embryonically lethal (Hiller et al., 2012; Reijns et al., 2012).  
Fibroblasts harvested from RNase H2B-null embryos show impaired proliferation and 
accumulation in the G2/M phase (Hiller et al., 2012).  However, like yeast RNase 
H1, S. cervesiae RNase H201 (the yeast RNase H2 catalytic subunit) is dispensable 
  
92 
for growth, though its loss causes low levels of genome instability (O’Connell, Jinks-
Robertson and Petes, 2015).  
The critical role of RNase H2 in the mammalian genome may be attributed to the 
secondary function of the complex in RER, as embedded ribonucleotides 
accumulate, along with DNA damage, in the genome of RNase H2-null mouse cells 
(Reijns et al., 2012).  Various studies have been undertaken to try and elucidate 
the RNase H2 function (RNA-DNA hybrid resolution or RER) whose loss causes 
extensive DNA instability, with findings leading to contrasting views (Conover et al., 
2015; O’Connell, Jinks-Robertson and Petes, 2015). Investigations have been aided 
by the use of a yeast mutant line termed rnh201-RED (Ribonucleotide Excision 
Defective), which expresses an RNase H2 complex capable of resolving RNA-DNA 
hybrids but not of excising singularly embedded ribonucleotides (Chon et al., 2013).  
rnh201-RED yeast display mildly elevated levels of genome instability compared to 
WT, although this does not match levels seen in the rnh201-null yeast (Epshtein, 
Potenski and Klein, 2016; Zimmer and Koshland, 2016; Cornelio et al., 2017). These 
studies have led to the general conclusion that both functions contribute to 
instability observed in rnh201-null S. cerevisiae, perhaps to different extents in 
different regions of the genome (Cornelio et al., 2017).  However, it is worth noting 
RNase H2 is not essential in yeast but is essential in mammalian embryo 
development, and so these studies do not fully clarify the critical function of 
mammalian RNase H2. 
Despite the complexity of the above findings, the available data from yeast and 
mammals highlight the overlapping yet distinct functions of eukaryotic RNase H1 
and H2, as well as the possibility that each are specialized for different RNA-DNA 
hybrids in the nuclear genome.  Although each has a unique function (mtDNA 
amplification in the case of RNase H1, and RER initiation by RNase H2), the 
conservation of the catalytic R-loop resolving function in both enzymes perhaps 
indicates each has specific RNA-DNA hybrid substrates it is most effectively able to 
target in the nuclear genome. Indeed, the presence of the PCNA-interacting domain 
in RNase H2B led Chon et al (2009) to suggest a role for RNase H2 in resolving R-
loops that cause DNA damage associated with DNA replication. 
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3.1.3 RNase H enzymes in kinetoplastids 
RNase H proteins of either type are relatively unstudied in kinetoplastids, with few 
investigations described to date.  Hesslein and Campbell (1997) successfully cloned 
the RNase H1 gene from T. brucei, Tbrh1, and discovered the conservation of three 
predicted catalytic carboxylic acids and other active site residues present in the 
RNase H domain (Hesslein and Campbell, 1997).  The authors were also able to 
express and purify recombinant TbRH1 fused to a histidine tag and demonstrate the 
catalytic breakdown of RNA-DNA hybrids in vitro by the fusion protein (Hesslein and 
Campbell, 1997).  The N-terminal 47 amino acids of TbRH1, fused to GST, have also 
been expressed and assessed for RNA binding capabilities via RNA dot plot assays, 
demonstrating this region is crucial for WT levels of RNA binding, yet dispensable 
for enzyme activity (Kobil and Campbell, 2000).  The connecting sequence that 
joins the N- and C-termini was, however, found to be essential for TbRH1 function 
(Kobil, 2000; Kobil and Campbell, 2000).  The N-terminal RNA binding motif was 
also found to direct nuclear localisation of TbRH1 by fusion of the 47 amino acid 
sequence to GFP and immunofluorescence imaging (Kobil and Campbell, 2000).   
In 2005, Misra et al identified four putative RNase H-encoding genes in Leishmania, 
one highly homologous to Tbrh1 identified by Campbell and colleagues, and three 
others assumed to be the subunits of RNase H2 (Misra et al., 2005).  LmjF36.0330, 
assigned as LmRNaseH2C, was found to have a MTS within the N-terminal 40 amino 
acid residues and was enriched in mitochondrial fractions of the cell (Misra et al., 
2005). The authors additionally found that expression of LmjF36.0330 is able to 
restore growth of E. coli lacking RNase HI and HII activity, which is only able to 
form colonies at 30°C, at 42°C (Misra et al., 2005). Given these findings, the 
identification of this protein as the RNase H2C subunit is doubtful, since in all 
characterised eukaryotes this subunit is not catalytic and lacks a MTS. No evidence 
is available regarding whether or not the putative RNase H2C protein forms a 
complex or co-localises with the putative LmRNaseH2A and LmRNase2B proteins 
identified. The authors also noted homologs to three of the four RNase H proteins in 
T. brucei and T. cruzi, documenting the apparent absence of RNase H2A subunits in 
the two Trypanosoma species (Misra et al., 2005).  
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3.1.4 Chapter aims 
As the RNase H enzymes of T. brucei have been relatively unstudied and the most 
recent characterisation of each protein (Misra et al., 2005) presents many 
inconsistences with what is known about RNases H in other systems, the first 
undertaking of this chapter was to identify and characterise the complement of 
RNase H proteins encoded in the parasite.  Each putative catalytic protein was then 
epitope tagged and localised via indirect immunofluorescence.  Mutant cell lines 
were also generated to facilitate initial characterisation of the T. brucei repertoire 
of RNase H enzymes.   
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3.2 BLASTp identification of RNase H proteins  
To confirm the previously identified RNase H proteins of T. brucei, as well as to 
investigate the apparent absence of the RNase H2A subunit (Misra et al., 2005), 
Basic Local Alignment Search Tool (BLAST) searches were carried out using the 
amino acid sequences of RNase H proteins well characterised in other species 
(section 2.8.3).  This was executed using TriTryDB’s BLASTp function, using 
sequences of all known RNase H proteins from Homo sapiens, M. musculus, S. 
cerevisiae, E. coli and L. major (Table 3.1).   
Query 
protein  Query species Query ID Hit ID E-value 
Identity 
Score 
RNase HI E. coli YP_006780767.1 Tb427.07.4930 4.00E-10 55.5 
RNase H1 
L. major LmjF.06.0290  Tb427.07.4930 1.00E-21 90.9 
S. cerevisiae NP_013961.1 Tb427.07.4930 7.00E-09 55.1 
M. musculus NP_035405.2 Tb427.07.4930 4.00E-31 118 
H. sapiens NP_002927.2 Tb427.07.4930 2.00E-31 119 
RNase HII E. coli YP_006780795.1 Tb427.10.4730 1.00E-16 76.6 
Tb427.10.5070 6.00E-05 41.6 
RNase H2A 
L. major LmjF.13.0050  Tb427.10.4730 1.00E-08 53.9 
S. cerevisiae NP_014327.1 
Tb427.10.5070 2.00E-40 145 
Tb427.10.4730 9.70E-02 32.7 
M. musculus  NP_081463.1 
Tb427.10.5070 5.00E-42 148 
Tb427.10.4730 1.00E-05 45.1 
H. sapiens NP_006388.2 
Tb427.10.5070 8.00E-40 142 
Tb427.10.4730 1.00E-06 47.8 
RNase H2B 
L. major LmjF.36.0640  
Tb427.10.5070  8.00E-113 332 
Tb427.10.4730 1.10E-02 35.8 
S. cerevisiae NP_010565.3 Tb427.07.3160 2.10E-01 32.3 
M. musculus NP_080277.1 
Tb427.01.4220 3.00E-08 53.1 
Tb427.08.4240 3.00E-01 31.6 
H. sapiens NP_078846.2 
Tb427.01.4220 2.00E-08 53.5 
Tb427.08.4240 2.50E-01 31.6 
RNase H2C 
L. major LmjF.36.0330 
Tb427.10.4730 0.00E+00 526 
Tb427.10.5070 5.40E-02 34.3 
S. cerevisiae NP_013255.1 Tb427.02.5040 1.00E+00 26.9 
M. musculus NP_080892.1 Tb427.01.4730 2.40E-01 29.6 
H. sapiens NP_115569.2 Tb427.01.4730 8.20E-02 31.2 
Table 3.1 BLASTp identification of putative T. brucei RNase H proteins.  
Query protein sequences from E. coli, L. major, S. cerevisiae, M. musculus and H. sapiens were used 
with NCBI-BLAST via TriTrypDB v2.48. Expected (E)-value describes probability of achieving hit by 
chance. Identity score describes the extent to which the query and hit protein sequences align where 
higher score equates to better agreement.  
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As previously identified, Tb427.07.4930 encodes a predicted protein that showed 
good sequence identity with both prokaryotic and eukaryotic type 1 (RNase H1, HI) 
proteins, and from here will be referred to as TbRH1.  The identification of the 
catalytic RNase H2 subunit proved interesting as two proteins, encoded by 
Tb427.10.5070 and Tb427.10.4730, showed good homology to E. coli RNase HII and 
the eukaryotic RNase H2A subunit. The exception to this finding was that 
Tb427.10.5070 did not show homology to the L. major RNase H2A subunit proposed 
by Misra et al. (2005) and encoded by LmjF.13.0050.  In fact, Tb427.10.5070 
showed far greater identity scores with the H. sapiens, M. musculus and S. 
cerevisiae RNase H2A subunits (142, 148 and 145 respectively) compared to 
Tb427.10.4730 (47.8, 45.1 and 32.7), which showed greater homology to the E. coli 
RNase HII protein (76.6 vs 41.6).  T. brucei proteins Tb427.01.4220 and 
Tb427.01.4730 showed limited homology to mammalian RNase H2B (53.1 and 53.5) 
and H2C (29.6 and 31.2) subunits, respectively, but both contain RNase H subunit-
like domains, as revealed by InterPro protein analysis (Figure 3.1). These proteins 
were therefore assumed to be the most likely candidates for the non-catalytic 
RNase H2 subunits but were not investigated further.  
Query 
ID Hit Species Hit Annotation Accession number E-value 
Identity 
score 
Tb
42
7.
10
.5
07
0  
 
Trypanosoma congolense putative RNH CCC93661.1 0.00E+00 539 
Trypanosoma cruzi RNH XP_806655.1 1.49E-175 502 
Leishmania major putative RNH XP_001686636.1 2.80E-115 348 
Leishmania mexicana putative RNH XP_003874409.1 1.72E-110 336 
Angomonas deanei RNH2A EPY38111.1 2.33E-106 325 
Ricinus communis predicted RH2A isoform X1 XP_002515756.1 2.69E-48 175 
Callorhinchus milii predicted RH2A XP_007905341.1 6.54E-48 174 
Populus euphratica predicted RH2A XP_011032867.1 2.14E-46 170 
Chinchilla lanigera predicted RH2A XP_005381086.1 2.21E-46 170 
Ricinus communis predicted RH2A isoform X2 XP_015572727.1 2.37E-46 168 
Tb
42
7.
10
.4
73
0 
Trypanosoma congolense putative RHII CCC93631.1 0.00E+00 786 
Trypanosoma vivax putative RHII CCC51426.1 0.00E+00 677 
Trypanosoma cruzi RHII XP_805682.1 0.00E+00 669 
Trypanosoma cruzi RHII XP_809747.1 0.00E+00 668 
Leptomonas pyrrhocoris putative RHII XP_015658298.1 0.00E+00 557 
Angomonas deanei RHII EPY42595.1 0.00E+00 538 
Angomonas deanei RHII EPY34030.1 0.00E+00 535 
Leishmania major putative RHII XP_001686603.1 0.00E+00 529 
Leishmania mexicana putative RHII XP_003874375.1 0.00E+00 528 
Psychrobacter RHII WP_057760473.1 2.36E-20 1.01E+02 
Candidatus Stoquefichus 
massiliensis RHII WP_044600096.1 4.90E-18 9.28E+01 
Roseburia sp. CAG:100 RHII CDF47048.1 1.55E-17 9.24E+01 
Clostridium sordellii RHII WP_057536894.1 3.65E-17 9.13E+01 
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Table 3.2 BLASTp identification of Tb427.10.5070 and Tb427.10.4730 homologues. 
Protein sequences were used as a query for NCBI-BLASTp search of the non-redundant protein 
sequence database. Expected (E)-value describes probability of achieving hit by chance. Identity score 
describes the extent to which the query and hit protein sequences align where higher score equates to 
better agreement. 
To clarify whether Tb427.10.5070 or Tb427.10.4730 may be the true RNase H2A 
catalytic subunit, each was used as a query for BLASTp searches using NIH’s 
Standard Protein BLAST search of the non-redundant protein sequence database.  
The results in Table 3.2 show Tb427.10.5070 had many high-confidence hits to 
predicted eukaryotic RNase H2A subunits, whereas the top hits for Tb427.10.4730 
consisted of other trypanosomatids and then weaker hits to predicted RNase HII 
proteins in bacterial species.  These data indicate the latter protein may be 
kinetoplastid-specific and shares more in common with monomeric prokaryotic 
RNase HII than the eukaryotic RNase H2A catalytic subunit.  As a result, 
Tb427.10.5070 was considered the most likely candidate for the catalytic A subunit, 
and from here is termed TbRH2A, and Tb427.10.4730 is termed TbRH3 for the 
purpose of this thesis.  
Protein domain predictions of TbRH1, TbRH3 and the three putative subunits of 
TbRH2 were next made using the InterPro protein analysis tool and are depicted in 
Figure 3.1, along with amino acid alignments for TbRH1, TbRH3 and TbRH2A with 
selected RNase H proteins and subunits.  In the case of TbRH3, the protein was 
aligned with its orthologues from T. cruzi and L. major, as well as RNase HII from E. 
coli and Thermotoga maritina, since eukaryotic RNase H proteins showed limited 
homology. The InterPro predictions indicated that all three T. brucei RNase H 
proteins have the conserved domains expected for RNase H enzymes. TbRH1 is 
predicted to contain both HBD and RNase H domains and, notably, the predicted 
domains of the three putative TbRH2 subunits follow domain organisation of H. 
sapiens RH2A, RH2B and RH2C. However, unlike HsRH1, no MTS domain was 
detected in TbRH1 or TbRH2A, but instead this sequence was found at the N-
terminus of TbRH3. Beyond the domain predictions, sequence alignments revealed 
that all catalytic and active site residues that have been characterised in RNase H 
enzymes of other species are present in TbRH1, TbRH2A and TbRH3 (Figure 3.1). 
These data strongly support the possibility that T. brucei, and perhaps all 
trypanosomatids, encode a third catalytic RNase H protein, TbRH3, which is 
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predicted to be mitochondrial. It should be noted that the putative RNase H-domain 
of TbRH3 is split and separated by non-conserved sequence, but whether this 
insertion renders the protein non-functional is unclear (Figure 3.1). Nonetheless, 
these data may indicate that the mitochondrion of T. brucei has necessitated the 
evolution of a dedicated organellar RNase H. 
 
Figure 3.1 Protein analysis of putative T. brucei RNase H enzymes.  
A) Amino acid sequence alignments of TbRH1, TbRH2A and TbRH3 to appropriate homologs. Hybrid-
binding domain (HBD) sequence is highlighted in green, RNase H domain (H-Domain) in blue and 
mitochondrial targeting sequence (MTS) in red. Conserved active site residues are highlighted in aqua, 
and catalytic residues are indicated by red dots below alignments. B). Protein domain models of the T. 
brucei RNase H repertoire as resolved via InterPro analysis (https://www.ebi.ac.uk/interpro/). H. 
sapiens RNase H proteins are shown for reference. HBD is shown in green, H-domains in blue and 
MTS in orange. Conserved active site residues are highlighted by white boxes above the models and 
catalytic residues by red diamonds. 
HsRH1
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TbRH1
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3.3 Cellular localisation of T. brucei RNase H enzymes 
Each putatively catalytic T. brucei RNase H protein (TbRH1, TbRH2A and TbRH3) 
was C-terminally epitope tagged at one endogenous allele in order to detect the 
proteins’ cellular localisation via immunofluorescence. This was achieved with the 
pNATx12M vector developed by Alsford and Horn (2008) (Figure 3.2).  ~600 bp of each 
3’ ORF, minus the stop codon, was amplified via PCR for each gene.  Restriction 
sites at the ends of the primers used (Table 2.2) allowed insertion into the tagging 
plasmids via restriction digest and ligation as detailed in methods sections 2.2.4 and 
2.2.6.  Sanger sequencing was used to confirm correct generation of constructs 
(section 2.2.9). The resulting tagging constructs were then linearized using a 
restriction site within each cloned T. brucei ORF sequence (Figure 3.2A), providing 
two gene fragments as targeting sequences at the ends of the linear plasmids 
(Figure 3.2B). The linearised plasmids were separately transfected into WT BSF 
parasites (section 2.1.3), allowing them to undergo single cross-over recombination 
to integrate at the 3’ end of one endogenous allele of the target gene (Figure 
3.2B).  Resultant drug resistant clones were checked by PCR (using primers 
indicated in red in Figure 3.2B, Table 2.2, section  2.2.2) and western blot (section 
2.4.3), testing for the correct insertion of the plasmid and expression of the tagged 
RNase H protein, respectively. 
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Figure 3.2 C-terminal epitope tagging strategy.  
A) Plasmid map of pNATx12M epitope tagging construct (Alsford and Horn, 2008). B) Scheme of single 
crossover recombination, which results in 3’ epitope tagging of the gene of interest. Blue striped areas 
indicate regions of homology; the full linearised construct is not depicted for simplicity (indicated by 
dashed gap). Red arrows indicate approximate binding sites of primers used to confirm integration of 
construct. Diagram not to scale. 
 
3.3.1 TbRH1 is a nuclear protein 
TbRH1 was endogenously tagged with 12 copies of the Myc epitope, as confirmed by 
PCR (Figure 3.3B) and western blot (Figure 3.3A) with anti-Myc antibody, verifying 
expression of a Myc-tagged protein of the expected size (~57 kDa).  Growth of three 
tagged clones, TbRH112Myc cl1-3, was also analysed, indicating that addition of the 
Myc epitope did not result in impaired growth (Figure 3.3C). 
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Figure 3.3 Confirmation of TbRH1 C-terminal epitope tagging.  
A) Western blot of whole cell extracts from three putative TbRH112Myc expressing transformants and 
untransformed wild type (WT) cells. B) PCR amplification of Tbrh1 fragment plus the fused Myc tag 
sequence from genomic DNA of three putative TbRH112Myc transformants and WT cells; a control PCR 
using only water as substrate is also shown. C) Growth curve of three TbRH112Myc clonal transformants 
relative to WT. Error bars indicate SD from the mean of three independent experiments.  
 
Indirect immunofluorescence using anti-Myc antibody (section 2.5.2, Table 2.6) 
revealed signal that co-localised exclusively with DAPI stained nuclear signal, 
suggesting that TbRH1 is localised to the nucleus of the parasite (Figure 3.4A).  
Analysis of anti-Myc pixel intensity, as a proxy for TbRH112Myc protein levels, 
indicates that TbRH1 is expressed at higher levels in cell cycle stages 1N1eK and 
1N2K, which are undergoing nuclear S phase, compared to 1N1K cells (Figure 3.4B). 
Super-resolution imaging (section 2.5.6) reveals that, although nuclear expression 
levels change, TbRH112Myc does not display any discrete localisation within the 
nuclei at any point during the cell cycle, at least in the BSF life cycle stage (Figure 
3.4C). 
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Figure 3.4 Cellular localisation and expression of TbRH1. 
A) Immunofluorescent imaging of TbRH112Myc in WT and tagged BSF T. brucei using anti-Myc 
antiserum and DAPI staining. Error bar, 5 µm. B) Mean pixel intensity analysis of immunofluorescent 
imaging, corresponding to expression of the TbRH112Myc fusion protein. Mean fluorescence plots for 
DAPI (cyan) and anti-Myc (magenta) signal in cells displaying different nuclear (N) and kinetoplastid 
(K) configurations. Significance was determined by Kruskal-Wallis non-parametric test: (*) p-value 
<0.05; (**) p-value < 0.01; (***) p-value < 0.001; (****) p-value <0.0001. C) Super-resolution imaging of 
DAPI (cyan) and anti-Myc (magenta) is shown, as well as merged images of the two channels.  Graphs 
shown pixel intensity of each channel (y-axis) across the nucleus (x-axis). Error bar, 5 µm. 
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3.3.2 TbRH2A is a nuclear protein 
TbRH2A was tagged using a modified version of same pNATx12M plasmid, which 
contains 6 copies of the hemagglutinin (HA) tag sequence rather than 12 copies of 
Myc.  Correct construct integration was confirmed by PCR (Figure 3.5B) using 
primers No. 7 and No. 4, and expression of the HA-tagged protein (expected size, 
43 kDa) was confirmed via western blot using an anti-HA antibody (Figure 3.5A). 
Growth of three TbRH2A6HA clonal cell lines was no different to that of WT cells 
(Figure 3.5C).   
Figure 3.5 Confirmation of TbRH2A epitope tagging.  
A) Western blot confirmation of TbRH2A6HA expression. B) Amplification of Tbrh2a fragment plus HA 
tag sequence. C) Growth curve of three TbRH2A6HA clonal cell lines. Error bars indicate SD from the 
mean of three independent experiments. 
Fluorescent imaging of the TbRH2A6HA cells using anti-HA antiserum showed that 
TbRH2A displays a very similar localisation to that of TbRH1; the tagged protein was 
only detected in the nucleus (Figure 3.6A) and showed no significant sub-nuclear 
localisation throughout the cell cycle (Figure 3.6C).  Also in common with TbRH1, 
expression of TbRH2A peaks during S phase, as indicated by measuring anti-HA 
mean fluorescence levels (Figure 3.6B). 
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Figure 3.6 Cellular localisation and expression of TbRH2A6HA.  
A) Immunofluorescent imaging of TbRH2A6HA in BSF T. brucei. B) Mean pixel intensity analysis of 
immunofluorescent imaging, corresponding to expression of the TbRH2A6HA fusion protein. Mean 
fluorescence of each nuclei is shown for DAPI (cyan) and TbRH2A6HA (magenta) signal. Significance 
was determined by Kruskal-Wallis non-parametric test: (*) p-value <0.05; (**) p-value < 0.01; (***) p-
value < 0.001; (****) p-value <0.0001. C) Super-resolution imaging of DAPI (cyan) and TbRH2A 
(magenta) is shown, as well as merged images of the two channels.  Graphs shown pixel intensity of 
each channel (y-axis) across the nucleus (x-axis). 
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3.3.3 TbRH3 localises to the kDNA 
Lastly, TbRH3 was tagged with 12 copies of the Myc epitope. Integration of the 
plasmid was determined with PCR (Figure 3.7B), and expression of Myc-tagged 
protein (expected size, 71 kDa) was determined via western blot with an anti-Myc 
antibody (Figure 3.7A). In contrast with the cells expressing epitope tagged TbRH1 
or TbRH2A, growth of three TbRH312Myc clones appeared somewhat reduced relative 
to WT cells, perhaps indicating a slight impairment in cell fitness when TbRH3 is C-
terminally tagged (Figure 3.7C).   
 
Figure 3.7 Confirmation of TbRH3 C-terminal epitope tagging.  
A) Western blot confirmation of TbRH312Myc expression. B) Amplification of Tbrh3 fragment plus Myc 
tag sequence. C) Growth curve of three TbRH312Myc clonal cell lines. Error bars indicate SD from the 
mean of three independent experiments. 
Imaging of TbRH312Myc cells indicated that TbRH3 shows a greatly different 
localisation to that of TbRH1 and TbRH2A, as the majority of anti-Myc 
immunofluorescent signal was detected in co-localisation with kDNA, rather than 
nuclear DNA (Figure 3.8).  Moreover, super-resolution imaging showed the protein 
localisation changes during the cell cycle; in 1N1K cells anti-Myc signal either co-
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localised with the DAPI-stained kDNA, or was seen as a focus beside the kDNA, 
whereas the signal migrated to form two foci around at opposite poles of the kDNA 
in 1N2K and 2N2K cells (Figure 3.8B).  Some signal could also be observed in the 
body of the parasite cell (Figure 3.8).  
  
Figure 3.8 Cellular localisation of TbRH312MYC.  
A) Immunofluorescent imaging of TbRH312Myc in BSF T. brucei. B) Super-resolution imaging of DAPI 
(cyan) and TbRH2A (magenta) is shown, as well as merged images of the two channels.  Graphs 
shown pixel intensity of each channel (y-axis) across the area indicated by the white box (x-axis). 
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These localisation experiments confirmed the initial conclusion that Tb427.10.5070 
is a much more likely candidate for the TbRH2A subunit than Tb427.10.4730, as the 
latter protein lacks nuclear localisation. 
3.4 TbRH1 is non-essential for BSF T. brucei 
Heterozygous, Tbrh1+/-, then homozygous, Tbrh1-/-, BSF knockout cells were next 
generated using the method described by McCulloch and Barry (1999). Two 
constructs were generated, each containing a drug resistance cassette for neomycin 
(NEO) or blasticidin (BSD), flanked by Tbrh1 5’ and 3’ UTR sequences (Figure 3.9). 
389 bp of the 5’ UTR and 435 bp of the 3’ UTR were amplified using primers No. 11 
and No. 12, No. 13 and No. 14, respectively (Table 2.2).  Inclusion of restriction 
digest sites in these primer sequences, allowed two-step, directional cloning of the 
UTR sequences into the two plasmids (sections 2.2.4 and 2.2.6).  The two resulting 
constructs were then linearised using BamHI and XhoI restriction digestion, giving 
linear DNA for each that, when transformed into T. brucei, allows homologous 
recombination on the UTRs to insert the drug resistance cassette into the genome, 
replacing the TbRH1 ORF (Figure 3.9A).  
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Figure 3.9 Gene deletion strategy.  
A) Scheme of homologous recombination, which results in deletion of the gene of interest. Dashed 
lines indicate regions of homology on the UTRs surrounding the ORF. Diagram not to scale. B) Maps 
of NEO- and (C) BSD-containing knockout constructs for TbRH1 (Devlin et al., 2016). 
The NEO-containing linearised TbRH1 KO construct was first transfected into WT 
BSF cells, as described in section 2.1.3. Generation of Tbrh1+/-NEO clones was tested 
by PCR, using primers which bound within the NEO resistance gene and within the 
3’ UTR (Table 2.2), downstream of the flanking sequence used to generate 
homology regions (Figure 3.10A). The second TbRH1 KO construct, containing the 
BSD resistance cassette, was then transfected into one Tbrh1+/-NEO cell line and 
integration was tested in 11 transformants via PCR (Figure 3.10A). Though all 11 
clones had integrated the BSD construct as expected, loss of the Tbrh1 ORF, 
consistent with the generation of a double knockout, was detected in only two of 
the clones using PCR (Figure 3.10A, B). The nine aberrant, non-null mutants were 
not examined further, but the two putative successfully generated Tbrh1-/- clones 
were checked for correct integration of the drug resistance cassettes at the 5’ end 
of the TbRH1 gene using PCR (Figure 3.10B). Finally, loss of detectable Tbrh1 RNA 
expression in one of the null mutant clones was determined via RT-qPCR (Figure 
3.10C), with the Tbrh1+/-NEO cell showing 50% less RNA than WT, consistent with 
loss of one allele.  
A 
B C 
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Figure 3.10 Confirmation of Tbrh1-/+ and Tbrh1-/- mutant cell lines.  
A) An agarose gel is shown of PCRs to check 3’ integration of NEO (primers No. 15 and No. 16) and 
BSD (primers No. 16 and No. 17) resistance cassettes, and the presence or absence of the Tbrh1 
ORF (primers No. 21 and No. 21), in WT cells, in the single selected TbRH1+/- cell and in 11 putative 
TbRH1 null (Tbrh1-/-) clones. B) PCR to check 5’ integration of NEO (primers No. 18 and No. 19) and 
BSD (primers No. 18 and No. 20) resistance cassettes in two Tbrh1-/- cells. C) RT-qPCR to determine 
TbRH1 RNA expression (primers No. 23 and No. 24) after gene deletion in Tbrh1+/-Neo and Tbrh1-/- cl1 
relative to WT (set as 100%); error bars show SD from two experiments.  
Growth of both the heterozygous and homozygous knockout clone cells was found to 
be virtually identical to that of the WT progenitor (Figure 3.11A), indicating loss of 
TbRH1 has no deleterious effect on BSF T. brucei in culture. The cell cycle profiles 
of WT and Tbrh1-/- populations, analysed via DAPI staining, also appeared 
identical, since the proportion of cells in each detectable stage (1N1K, 1N2K and 
2N2K, or other) showed no difference (Figure 3.11B). Hence, deletion of TbRH1 
causes no discernible effect on the growth or cell cycle progression in BSF T. brucei 
parasites in culture. 
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Figure 3.11 Loss of TbRH1 does not affect growth or cell cycle progression of BSF parasites in 
culture.  
A) Growth curve of WT. Tbrh1+/- and Tbrh1-/- cell densities over 72 hr. B) Cell cycle profile of each 
population presented of the proportion of cells in each cell cycle stage determined by DAPI staining of 
nuclear (N) and kinetoplast (K) DNA: 1N1K, 1N2K, 2N2K or other (meaning aberrant) cells. Error bars 
show standard deviation from the mean of three independent repeats counting at least 200 cells.   
3.5 TbRH2A is an essential protein 
Given the success of generating TbRH1 mutants, the same strategy was also 
attempted to generate knockout mutants lacking TbRH2A in BSF parasites. This was 
conducted as described in section 3.4, but using primers No. 25 and No. 26, and No. 
27 and No. 28 to generate BSD and NEO constructs targeting TbRH2A (Table 2.2).  
Heterozygous cells containing either a NEO- or BSD-cassette integrated at the 
TbRH2 locus were successfully generated, as confirmed by PCR (Figure 3.12). 
However, transfection of the alternate construct in either cell line resulted in no 
antibiotic resistant clones when the transformant cells were subject to selection 
with both NEO (2.5 µg/ml) and BSD (10 µg/ml) to select for null mutant cells.  
When transfections were repeated, but only the antibiotic of the secondarily 
introduced construct was used for selection, multiple clones could be recovered.  
However, when the clones were checked by PCR, in all cases these cells had lost 
the previously integrated construct (presumably via homologous recombination 
targeting the modified allele) and so still possessed a copy of the TbRH2A ORF 
(Figure 3.12). 
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Figure 3.12 Failure to generate a full TbRH2A knockout cell line.  
PCRs to check 3’ integration of Neo- and BDS-containing constructs to delete one allele of TbRH2A in 
heterozygous cell lines Tbrh2a+/- Neo and Tbrh2a+/-BSD, respectively. Transformant clones 1-12 
recovered after transfection of the BSD-containing construct in Tbrh2a+/- Neo were checked for 
integration of each construct (NEO; primers No. 15 and No. 29, BSD; primers No. 17 and No. 29). In all 
cases the TbRH2A ORF was also targeted to check for presence of the gene (primers No. 30 and No. 
31).   
3.5.1 RNAi depletion of TbRH2A 
Though not definitive, the above data suggest that TbRH2A, unlike TbRH1, may be 
essential. To test this and explore the function of TbRH2A further, an RNAi 
approach was employed to deplete TbRH2A mRNA. The pGL2084 vector produced by 
Jones et al. (2014), modified from the pRPaISL vector (Alsford and Horn, 2008), 
allows integration of two, inverted copies of the target gene sequence into an rRNA 
spacer locus where they are expressed via a rRNA promoter under the control of a 
tetracycline (tet) operator, generating long-hairpin RNA. Gateway cloning was used 
to produce a tet-inducible RNAi construct targeting TbRH2A derived from the 
pGL2084 construct. PCR was used to amplify 432 bp of the TbRH2A ORF and add 
AttB flanking sites (primers No. 32 and No. 33), which facilitated BP cloning of the 
PCR product as a head-tail duplication into the pGL2084 vector, which contains AttP 
sites (Figure 3.13A and C). The resulting construct (Figure 3.13B) was then 
linearised by digestion with AscI and transfected into the BSF 2T1 T. brucei cell line 
generated by Alsford and Horn (2008). An rRNA spacer locus of the 2T1 parasites 
houses an incomplete hygromycin (HYG) resistance gene, which is completed by 
successful integration of an RNAi construct that contains the remaining HYG-
resistance gene sequence.  Hence, the targeted integration of the Tbrh2a RNAi 
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construct into the rRNA spacer was selected for with 5 µg/ml HYG after 
transfection.  RNAi could then be induced by the addition of tet to the resulting 
clones to trigger RNAi-mediated ablation of TbRH2A transcripts.  
  
Figure 3.13 RNAi cloning strategy.  
A) Plasmid map of the pGL2084 construct, which acts as the backbone for integration of RNAi 
targeting fragments. B) Plasmid map of the Gateway-generated RNAi construct containing two head-
tail TbRH2A gene fragments. C) Diagram of the BP recombination event that allows cloning of the PCR 
amplified gene fragment into plasmid pGL2084 via Att recombination sites in the sense and antisense 
direction.  
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To evaluate the specificity of TbRH2A targeting in the RNAi clones, levels of 
TbRH2A RNA were measured by RT-qPCR 24 hrs after tet induction and found to be 
reduced to ~3% of that seen in WT 2T1 T. brucei BSF cells (Figure 3.14A). In fact, 
un-induced TbRH2ARNAi cells were also found to have slightly lower levels (~75 %) of 
TbRH2A RNA compared with the parental 2T1 cell line, indicating the RNAi system is 
“leaky”, causing some knockdown of TbRH2A expression in the absence of tet 
(Figure 3.14A).  Growth of the TbRH2ARNAi cells was then analysed with and without 
the addition of tet (Figure 3.14B). After 24 hr of growth, a small decrease in density 
of tet-induced cultures was seen relative to cultures free from tet and, from that 
point on, no further increase in density of the RNAi induced cells was seen, whereas 
un-induced cells continued to grow unperturbed.  These data indicate that TbRH2A 
RNAi causes a cell growth stall from 24 hrs, a phenotype that could be explained by 
increased cell death after RNAi or a halt in cell replication. 
 
Figure 3.14 Depletion of TbRH2A leads to stalled growth.  
A) Levels of TbRH2A transcripts in tetracycline induced (+) and un-induced (-) cells after 24 hr of 
culture, relative to 2T1 cells (levels set at 100%), determined by RT-qPCR (primers No. 34 and No. 
35). Error bars show standard deviation of two independent repeats. B) Cumulative growth curved of 
tet + and tet- TbRH2ARNAi cultures, showing cell densities over 72 hr. Error bars show standard 
deviation from the mean of three independent repeats.  
To understand the growth stall after RNAi, the cell cycle profile with and without 
tet induction was analysed via DAPI staining and counting the N and K configuration 
of individual cells (Figure 3.15). 24 hr post induction, at the time of the stall, there 
was a large increase in the amount of 1N2K cells (~40.5 % in tet +, ~9.8 % in tet-), 
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concomitant with a reduction in 1N1K (~42 % in tet +, ~76.2 % in tet-) and 2N2K 
(~2.8 % in tet +, ~9.2 % in tet-) cells, indicating a stall at the G2/M phase check 
point (Figure 3.15A). After 30 hr of RNAi induction, the proportion of 1N1K cells 
reduced further, an effect that was not due to further increases in 1N2K cells, but  
mainly due to the appearance of cells (~20%) with 1 nucleus and >2 kDNA foci 
(1NXK), indicating that kDNA replication and division is unperturbed (Figure 3.15A 
and B). Coincident with the appearance of these cells, accumulation of cells with 
abnormal nuclei was seen, including cells with increased nuclear staining or with 
less clearly defined nuclei, and with >2 kDNA foci (YNXK) (Figure 3.15A and B). The 
relative percentages of all these cell cycle forms did not clearly change from 30 – 
72 hrs, consistent with cell growth having stalled and not with increasing 
accumulation of aberrant cells. 
 
Figure 3.15 TbRH2A depletion causes a stall in the cell cycle and appearance of abberant cells.  
A) Bar graph should the percentage of tet-induced cells at multiple time points in the  population that 
correspond to the following cell cycle stage, as defined by DAPI staning of the nucleus (N) and 
kinetoplast (K); 1N1K, 1N2K, 2N2K 1NxK (>2 K foci), YNXK (>2 K foci and abberant N number or 
morphology), and other. tet– shows the average of uninduced samples from all time-points. Error bars 
show strandard deveation from the mean of three independent replicates. B) Example images of (tet +) 
induced and un-induced (tet-) cells after 30 hr of growth. Scale bar = 5 µm. 
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The cell cycle distribution and nuclear content was further investigated using flow 
cytometry of propidium iodide stained cells (section 2.7). As soon as 12 hr post tet-
induction there was a reduction in the proportion of 2N (G1) cells, which appeared 
to be accompanied by a modest increase in 4N (G2/M) cells (Figure 3.16). However, 
from 12-36 hr of induction the most notable change was an increase (to 50% at 36 
hrs) in cells with DNA content above that of a 2N2K cell (>4N) (Figure 3.16), and 
with loss of 2N-4N cells.  Hence, though DAPI staining suggested RNAi knockdown of 
TbRH2A causes a stall in growth at the G2/M stage, this is partial and continued 
accumulation of nuclear DNA content is seen from 24 hrs onwards.  
 
Figure 3.16 Flow cytometry analysis of TbRH2A depleted cells.  
Profiles of propidium iodide (PI) stained uninduced (tet –, pink) and RNAi induced (tet +, blue) 
populations after 6, 12, 24 and 36 hr growth are shown. y-axes show cells count and x-axes PI-area 
fluorescence. The graph above shows the percentage of cells in each cell cycle stage, G1, S and G2-
M or cells with genome content >4N, based on measuring proportion of the population with 2N, 2N-4N, 
4N and >4N content; tet- shows the average of all tet- time points. Error bars shown the standard 
deviation from the mean of three independent replicates.  
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3.5.2 Depletion of TbRH2A cause the accumulation of DNA damage 
To understand if loss of TbRH2A has wider consequences for nuclear genome 
integrity, levels of DNA damage were next investigated using the TbRH2ARNAi cell 
line. Phosphorylation of histone H2A on Thr130 (γH2A), generating the T. brucei 
equivalent of the variant histone γ-H2AX (Kinner et al., 2008), occurs in response to 
increased levels of lesions, including double stranded DNA breaks (Glover and Horn, 
2012).  Expression of γH2A was assessed using western blotting and indirect 
immunofluorescence with anti-γH2A antiserum over 36 hr of culture with and 
without tet-induction (Figure 3.17). The number of cells in the populations that 
displayed nuclear γH2A staining increased dramatically with time, rising from ~17% 
of un-induced cells to ~50% and ~73% of cells after 24 and 36 hr RNAi induction, 
respectively (Figure 3.17A and B). High-resolution imaging showed that yH2A 
staining after RNAi induction was often diffuse throughout the nuclei, although in 
some cells more discrete foci were apparent (Figure 3.17A).  Western blot analysis 
of whole protein extracts using anti-γH2A antiserum confirmed the dramatic 
increases in modified histone marker 24 and 36hr post tet-induction (Figure 3.17C).  
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Figure 3.17 Depletion of TbRH2A causes increased nuclear DNA damage  
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A) High-resolution imaging of DAPI (blue) and γH2A (green) immunofluorescence with (tet +) and 
without (tet-) RNAi induction, at various time points. Images to the right show increased magnification 
of the boxed nuclear DNA. B) Bar graphs showing the percentage of tet + and tet- populations 
positively staining for γH2A after 12, 24 and 36 hrs growth; error bars show standard deviation from the 
mean of three independent repeats. C) Western blot detection of γH2A in whole protein extracts after 
12, 24 and 36 hrs growth of tet + and tet- cells. EF1α staining is shown for each sample as a loading 
control.  
3.5.3 TbRH2A depleted cells continue to synthesise DNA 
To ask if loss of TbRH2 after RNAi was accompanied by impaired DNA replication, 
incorporation of the thymidine analogue EdU was measured via immunofluorescence 
using Click-ITâ chemistry (section 2.5.4). TbRH2ARNAi cells were cultured with and 
without tet and, for the last 4 hr of each time point, with the addition of EdU to a 
final concentration of 150 µM.  Cells were then fixed and stained for both EdU and 
γH2A (using antiserum) to assess whether any change in nuclear DNA replication 
was associated with changes in DNA damage, given the increase in γH2A (Figure 
3.17), and content, as seen by flow cytometry analysis (Figure 3.16). No significant 
decrease in the number of cells staining for EdU incorporation was seen, as even 
after 36 hr of tet-induction the number of positive cells reduced to only ~96% of the 
population (Figure 3.18), with many cells showing both EdU and γH2A signals. 
Super-resolution imaging of cultures with and without tet after 36 hr of growth 
revealed co-localisation of EdU and γH2A signals (Figure 3.19). In the absence of 
RNAi induction most cells showed a single focus of γH2A signal, whereas RNAi 
induced cells either showed a few foci or signal throughout the nuclei. However, in 
both cases the signals overlapped with incorporated EdU. These data indicate that 
TbRH2A-depleted cells contain significantly increased amounts of nuclear DNA 
damage, which does not halt DNA synthesis.  
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Figure 3.18 TbRH2A-depleted T. brucei cells continue to synthesis DNA.  
A) Immunofluorescence imaging of DAPI (cyan), EdU (yellow) and γH2A (magenta) staining with (tet +) 
and without (tet-) induction of RNAi. Scale bar = 5 µm. B) Bar graph showing the percentage of tet + 
and tet- populations positively staining for EdU incorporation after 12, 24 and 36 hrs of growth.  
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Figure 3.19 Super-resolution imaging of EdU incorporation and γH2A.  
Super-resolution images of DAPI, γH2A and EdU are shown along with 3D reconstructions of staining 
demonstrating coloalisation of the signal. The TbRH2ARNAi line was cultured in the presence (tet +) or 
absence of tet (tet -) for 36 hr before samples were analysed. Scale bar = 1 µm. Imaging and 
processing was carried out by Dr. Leandro Lemgruber.  
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3.6 Discussion 
In this chapter, homology searches were used to clarify the number of putative 
RNase H enzymes encoded by T. brucei, and genetic approaches were used to 
localise the proteins and examine their importance in BSF cells. BLASTp and protein 
sequence analysis allowed the identification of three putatively catalytic RNase H 
proteins, one being the previous identified TbRH1 (Hesslein and Campbell, 1997).  
The two remaining RNase H domain-containing proteins appear to belong to the 
Type 2 RNase H family, with TbRH2A (Tb427.10.5070) showing greater homology 
with eukaryotic RNase H2A species and TbRH3 (Tb427.10.4730) with bacterial RNase 
HII proteins. In addition to these factors, which all appear to retain catalytic 
residues, two likely TbRNase H2 structural subunits (Tb427.01.4220 and 
Tb427.01.4730) were identified. These have a domain organisation consistent with 
encoding T. brucei homologues of eukaryotic RNase H2B and H2C proteins, but this 
was not tested. 
3.6.1 TbRH1 is non-essential in cultured BSF T. brucei 
Immunofluorescence detection of a 12-Myc tagged variant reveals TbRH1 to show 
nuclear localisation (as previously suggested by Kobil & Campbell 2000), with 
increased expression during S phase cell cycle stages, possibly indicating a greater 
requirement for the RNA-DNA hybrid resolution during DNA replication. 
Additionally, the protein shows no distinct subnuclear localisation and instead 
remains distributed across the nucleus throughout the BSF cell cycle. Interestingly, 
TbRH1 lacks a predicted MTS and does not shown additional mtDNA localisation, in 
contrast to mammalian RNase H1, which is essential for mtDNA amplification 
(Cerritelli et al., 2003). Hence, TbRH1 appears not to have a role in kDNA 
replication or maintenance in T. brucei.  
Analysis of Tbrh1-/- parasites shows loss of the protein has no deleterious effect on 
BSF growth or cell cycle progression, supporting the hypothesis that RNase H1 is not 
essential for eukaryotic nuclear genome viability under normal conditions, as 
demonstrated in yeast (Wahba et al., 2011; O’Connell, Jinks-Robertson and Petes, 
2015). Yeast lacking RNase H1 show only minor increased levels of chromosome 
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instability, though these effects are mostly seen when combined with loss of RNase 
H2, elevating instability to levels above those caused by RNase H2 null mutation 
alone (Wahba et al., 2011; O’Connell, Jinks-Robertson and Petes, 2015). 
Interestingly, genomic instability documented in yeast strains lacking various mRNA 
biogenesis factors that display greater levels of RNA-DNA hybrid formation, is 
consistently reduced when RNase H1 is over expressed (Wahba et al., 2011). Hence, 
RNase H1 has a role in resolving nuclear R-loops formed under stress conditions, 
such as perturbed transcription or RNA processing.  
TbRH1 is likely to share a similar nuclear role with other eukaryotic RNase H1 
proteins, which are not essential for nuclear genome viability. Indeed, TbRH1 may 
play a critical role in genome stability during stress conditions where R-loop 
formation may be more likely. Another possibility is that TbRH1 resolves R-loops 
that are isolated to specific genomic loci. In either case, RNase H2 is likely to be 
functionally redundant and so assume the role of R-loop resolution in the absence 
of TbRH1. Although structural genome changes resulting from a loss of TbRH1 have 
not been directly investigated, DNA damage and changes to gene expression in 
Tbrh1-/- parasites are explored in Chapter 6. 
3.6.2 TbRH2A is essential for BSF T. brucei 
Immunofluorescent detection of HA-tagged TbRH2A showed highly similar nuclear 
localisation to that of TbRH1, again with increased expression in S-phase cell cycle 
stages and diffuse localisation across the nucleus throughout the cell cycle. In 
contrast to TbRH1, however, TbRH2A was found to be essential, a finding that 
correlates with the essential nature of RNase H2 in mouse embryo development 
(Hiller et al., 2012; Reijns et al., 2012) and AGS-causing RNase H2 mutations in 
humans (Crow et al., 2006), but contrasts with the non-essentiality of RNase H2 in 
yeast (Conover et al., 2015; O’Connell, Jinks-Robertson and Petes, 2015). Mouse 
fibroblast cells lacking the RNase H2B subunit stall in the G2/M stage of the cell 
cycle and display increased DNA damage (Hiller et al., 2012), both of which are also 
observed in T. brucei after TbRH2A depletion. However, further investigation by 
flow cytometry and EdU incorporation shows that, despite the high levels of γH2A 
  
123 
that accumulate after TbRH2 RNAi, the parasites continue to synthesise DNA, 
resulting in cells with >4N DNA content that fail to undergo faithful nuclear mitosis. 
RNaseH2B-null mouse fibroblasts also fail to undergo mitosis yet do not continue to 
synthesise DNA, as flow cytometry analysis showed accumulation in the G2/M phase 
(Hiller et al., 2012). Hence, in both cases the G2/M check point appears to be 
activated, yet in T. brucei DNA replication continues.  
Although tet-induced TbRH2ARNAi cells undergo ~4 rounds of the cell cycle before 
stalling, TbRH2A mRNA transcripts are likely to persist initially, and so the rapid 
nature of the phenotype observed after TbRH2A loss in T. brucei differs slightly to 
that of RNaseH2B-null mice that develop into embryos (Hiller et al., 2012). 
Therefore, while RNase H2 appears essential for both T. brucei and mammals, the 
importance of the complex may be more immediate for the parasite. Interestingly, 
TbRH2A has conserved all the critical binding sites and catalytic residues predicted 
to be necessary for both R-loop resolution and initiation of RER. Hence, it is 
plausible that accumulation of either incorporated ribonucleotides or R-loops (or 
both) leads to the vast amounts of DNA damage observed in parasites depleted of 
TbRH2A. Accumulation of DNA damage in RNase H2B-null mouse cells has been 
attributed to the incorporation of overwhelming amounts of ribonucleotides in the 
DNA (Hiller et al., 2012; Reijns et al., 2012), although R-loop accumulation was not 
assessed. This may also be the case in T. brucei, yet the rapid onset of stalling 
implies that rather than a build-up of mutagenic ribonucleotides during each round 
of the cell cycle leading to accumulation of DNA damage and stalling at the G2/M 
stage, TbRH2A is completely essential for an aspect of basic genome biology and T. 
brucei is unable to complete the cell cycle without it. For example, TbRH2A may be 
required for unperturbed replication of the genome, chromosome segregation or 
transcription of vital genes.  Whether TbRH2A acts to remove unresolved R-loops or 
embedded ribonucleotides that prevent the execution of one or more of these 
functions is explored further in chapter 5. 
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3.6.3 T. brucei encodes a third putatively catalytic RNase H 
As in other eukaryotes, with the known exception of S. cerevisiae, an RNase H 
domain-containing protein is required for mtDNA replication (Cerritelli and Crouch, 
2009). Given this precedent, is it possible that T. brucei kDNA replication also 
requires such an activity, which is normally assumed by a type 1 RNase H. However, 
the data provided here indicate that TbRH1 shows no kDNA localisation. In contrast, 
TbRH3 has a predicted MTS and immonflourescence of Myc-tagged protein indicates 
localisation to the kDNA. In fact, TbRH3 localises in discrete foci at the poles of 
duplicated kDNA, which is a pattern shared with other proteins, including a kDNA 
replication polymerase, Pol β (Saxowsky et al., 2003), supporting a functional role 
for TbRH3. However, as TbRH3 has higher sequence identity with bacterial RNase 
HII proteins than eukaryotic RNase H1, and the RNase H domain is somewhat larger 
than is found in other type 2 RNase H proteins, its activity may be diverged or 
specialised when compared to typical RNase H1 functions in RNA-DNA hybrid 
resolution during mtDNA amplification (Cerritelli et al., 2003). As the protein 
follows a localisation pattern similar to that of Pol β, perhaps it functions in the 
initiation of DNA replication, as reported in E. coli plasmid (Itoh and Tomizawa, 
1980) and mtDNA replication (Xu and Clayton, 1996). Whatever its role, TbRH3 is 
likely to be an essential protein in T. brucei since efforts to generate even a 
heterozygous TbRH3 knockout mutant in BSF parasites were unsuccessful (no data 
shown), although this was not experimentally confirmed by RNAi. Nonetheless, 
TbRH3 is conserved in at least Leishmania and T. cruzi, suggesting kinetoplastids 
have evolved a third class of RNase H that acts in facets of kDNA function, perhaps 
reflecting the unique structure of this organellar genome (Jensen and Englund, 
2012). 
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4 RNA-DNA Hybrid Mapping in the T. brucei Genome
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4.1 Introduction 
A variety of techniques have been used to map R-loops genome-wide; most are 
variants of immunoprecipitation (IP) using the DNA-RNA hybrid-binding antibody 
S9.6 (DRIP) followed by quantitative PCR (DRIP-qPCR), next-generation sequencing 
(DRIP-seq) or hybridisation of isolated DNA to tilling arrays (DRIP-chip) (Halász et 
al., 2017).  Alternatively, catalytically inactive RNase H1 can be used in an affinity 
pull-down assay to isolate the hybrids the protein binds to, in a protocol termed 
DRIVE-seq (DNA-RNA in vitro enrichment followed by next-generation sequencing of 
the DNA) (Ginno et al., 2012). Similarly, the “R-ChIP” protocol uses catalytically 
inactive RNase H1 expressed in human cells to capture R-loops in vivo via ChIP-seq 
by targeting the mutant RNase H, which in theory binds to but does not resolve R-
loops, for pull-down (Chen et al., 2017).  Both DRIP-seq using native chromatin 
samples (i.e. not treated with a fixative such as formaldehyde) and DRIVE-seq 
identified R-loops highly correlated with positively GC-skewed, CGI promoters in 
the human genome (Ginno et al., 2012, 2013).  Though there was a strong overlap 
in DRIP-seq and DRIVE-seq signal over promoter regions, in total, DRIP-seq 
identified 20,862 enrichment peaks, whereas DRIVE-seq only revealed 1,224 peaks 
(Ginno et al., 2012).  R-ChIP in human cells identified an intermediate number 
(12,521) of significantly enriched peaks (Chen et al., 2017). DRIP-chip and DRIP-seq 
using formaldehyde fixed chromatin (also referred to as S9.6 ChIP-seq) have been 
effectively used to map R-loops in the S. cerevisiae (El Hage et al., 2010; Wahba, 
Gore and Koshland, 2013; Chan et al., 2014) and S. pombe (Ohle et al., 2016) 
genomes.   
More recently, variations on the DRIP-seq protocol have been developed: RNA-DNA 
immunoprecipitation (RDIP), where several changes were made to the DRIP protocol 
including switching from enzymatic digestion of the chromatin to sonication and 
pre-treatment with RNase I to remove single stranded RNA (Nadel et al., 2015); S1-
DRIP-seq, where chromatin is pre-treated with S1 nuclease before sonication 
(Wahba et al., 2016); bis-DRIP-seq, where bisulfite converts cytosine residues to 
uracil in ssDNA before S9.6 antibody capture of hybrids, allowing identification of 
ssDNA associated with DNA-RNA hybrids and increasing mapping resolution of R-
  
127 
loops (Dumelie and Jaffrey, 2017); complementary DRIP (DRIPc-seq) where 
recovered RNA is reverse transcribed and cDNA is sequenced to reveal strand 
information (Sanz et al., 2016); and, finally, single-stranded DRIP (ssDRIP-seq) using 
fixed chromatin to  reveal strand information via initial adapter ligation to only the 
3’ ends of DNA fragments during library preparation (Xu et al., 2017). DRIP-seq 
using native chromatin has also been referred to as DIP-seq (Skourti-Stathaki, 
Proudfoot and Gromak, 2011), although there are no notable differences between 
these protocols. In all cases, pre-treatment of native or fixed chromatin, or “on-
bead” treatment of the IP reaction, with E. coli RNase H can be used to verify S9.6 
binding specificity to R-loops, as a reduction in IP recovered DNA or RNA should be 
observed in treated samples (El Hage et al., 2014; Halász et al., 2017). 
Additionally, mapping can be carried out in RNase H mutants as a further control, 
as DNA-RNA hybrid signal is expected to increase when RNase H activity is reduced. 
4.1.1 Chapter aims 
As R-loops have been linked to various biological processes (see section 1.4.1), as 
well genomic instabilities (see section 1.4.2), R-loop mapping was undertaken in WT 
and Tbrh1-/- BSF T. brucei cells. Several of the predicted R-loop associated 
processes are not entirely mechanistically understood in T. brucei, including DNA 
replication, transcription termination and transcription initiation, and so identifying 
regions of R-loop enrichment in the genome was hypothesised to either implicate or 
rule out the involvement of RNA-DNA hybrids in these fundamental processes. The 
DRIP-seq approach was taken using the S9.6 antibody and fixed chromatin samples, 
as performed in S. cerevisiae (El Hage et al., 2014) and S. pombe (Ohle et al., 
2016), since T. brucei is also a single celled eukaryote and has a similar sized 
genome.  In this chapter R-loop localisation across the core genome of T. brucei is 
compared in the presence and absence of TbRH1, thus identifying sites of R-loop 
localisation and inferring likely functions. The mapping revealed conserved sites of 
R-loop localisation, an association with RNA Pol II transcription initiation, 
correlation with nucleosome depletion, and a potentially novel role for R-loops in 
trans-splicing and polyadenylation. R-loop localisation in genomic regions 
associated with VSG switching is discussed in chapter 6. 
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4.2 Identifying RNA-DNA hybrid forming regions in the T. 
brucei genome 
DRIP-seq was employed using formaldehyde fixed chromatin samples taken from ~2 
x 108 BSF Lister 427 T. brucei cells per sample (section 2.6). Briefly, chromatin was 
extracted and sheared using enzymatic digestion, before incubation with the S9.6 
antibody to perform IP of the RNA-DNA hybrids (Figure 4.1).  The eluted chromatin 
was reverse cross-linked, and proteins digested. DNA libraries were prepared using 
Illumina’s TrueSeq ChIP kit and 300 bp fragments including adaptor sequences were 
selected (carried out by Craig Lapsley) for sequencing with the Illumina Nextseq 500 
platform (performed by Glasgow Polyomics). Sequence reads were aligned to a 
“hybrid” reference genome (Hutchinson, Glover and Horn, 2016) consisting of the 
T. brucei TREU927 v5.1 Mb-sized chromosomes and Lister 427 BES and mVSG ES 
contig assemblies (carried out by Dr Kathryn Crouch), since the TREU927 genome is, 
so far, better annotated than the T. brucei Lister427 equivalent, allowing for more 
in-depth downstream analysis (section 2.8.4). DNA isolated from both the DRIP 
reactions, as well as from samples of ‘input’ chromatin DNA from each (i.e. a 
sample of chromatin used for the IP reaction), were sequenced and aligned in this 
manner.  This allowed DRIP-seq signal enrichment to be calculated as ratio of read 
coverage fold-change for each IP relative to the corresponding input sample 
(section 2.8.4.3). Hence, enrichment of DRIP-seq signal >1 corresponds to RNA-DNA 
hybrid formation in the population. 
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Figure 4.1 DNA-RNA hybrid immunoprecipitation (DRIP)-seq scheme.  
Parasites were fixed with formaldehyde before the chromatin was extracted and enzymatically 
digested. A sample of chromatin was incubated with the S9.6 antibody, which binds RNA(pink)-
DNA(blue) hybrids. The antibody was adhered to magnetic beads, allowing capture of the hybrids. 
Chromatin was then eluted and reverse cross-linked, and the proteins digested. The remaining DNA 
was then prepared as libraries and sequenced. See section 2.6 for detailed methods, and section 2.8.4 
for analysis. 
Numerous attempts were made to call peaks of DRIP-seq signal enrichment using 
existing peak-calling software packages SICER (Zang et al., 2009), MACS2 (Zhang et 
al., 2008) and HOMER (Heinz et al., 2010). However, none were able to call DRIP-
seq peaks with satisfactory accuracy, despite several attempts at optimisation (data 
not shown). Sanz et al. (2016) overcame the same problem using a custom hidden 
Markov Model that involved the manual annotation of DRIP peaks and then the 
development of a peak-calling pipeline based upon the manually defined model 
peaks. As this pipeline was developed for use with human DRIP-seq data (where 
enrichment is several fold higher and in fewer regions than seen in the T. brucei 
DRIP-seq signal, see below), and developing a model requires a larger number of 
data sets than presented in this study, DRIP-seq peaks were annotated manually.  A 
“peak” was defined as a region where IP signal was enriched ≥ 1.2-fold above the 
input signal. Enrichment was calculated using non-sliding 50 bp windows, and the 
  
    
  
  
  
Library 
preparation 
and 
sequencing 
  
  
    
  
  
  
  
  
  
  
  
  
    
  
    
  
  
  
    
  
  
  
  
  
    
  
  
    
    
      
Crosslink DNA:RNA 
hybrids in parasites 
with formaldehyde  
Extract nuclei and 
enzymatically shear 
chromatin 
Bind hybrids to S9.6 
antibody 
Capture hybrids with 
magnetic beads 
Elute chromatin, 
reverse cross-link and 
digest proteins 
-     
      
  
130 
coordinates of each window with sufficient enrichment were extracted (section 
2.8.4.3). Coordinates of adjacent enriched 50 bp windows were then combined 
using a custom script (Figure 8.1) to generate final coordinates of DRIP-seq 
“peaks”, which from here on are referred to as DRIP enriched regions.  
4.2.1 R-loops are highly abundant in the T. brucei genome 
Visual analysis of DRIP-seq signal across the 11 Mb  chromosomes showed extensive 
coverage in both the WT and Tbrh1-/- samples, with good overlap in signal 
localisation between them (Figure 4.2). Broadly, DRIP-seq signal enrichment of both 
WT and Tbrh1-/- samples showed some correlation with the locations of tandem 
array sequences predicted with a tandem repeat finder algorithm that requires no 
prior knowledge of repeat composition,  repeat length or number of repeat copies 
(lower track; Benson, 1999), as previously reported for many triplet repeats 
implicated in human genetic disease (reviewed in Freudenreich 2018). Curiously, 
this enrichment also seemed to be found within the subtelomeres that contain, 
among other gene types, the VSG tandem arrays, despite these regions being 
transcriptionally silent. This was particularly evident in the Tbrh1-/- sample.
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Figure 4.2 DRIP-seq signal across the 11 Mb-sized chromosomes of T. brucei.  
DRIP-seq signal for WT (pink) and Tbrh1-/- (green) cells is plotted as fold-change relative to input 
coverage (scale: 1-4 fold-change). Upper track shows transcripts on sense (black) and antisense (red) 
strands. Known centromeres are shown as peach circles. Lowest track shows tandem repeat 
sequences.  
A total of 37,527 and 34,207 DRIP enriched regions were identified in WT and 
Tbrh1-/- samples, respectively. These enriched regions amount to ~22.3% 
(7,461,359 bp) of the genome in the WT sample population, and ~32.2% (10,795,714 
bp) of the Tbrh1-/- cells (Figure 4.3A). Hence, the increased R-loop coverage in the 
Tbrh1-/- sample indicated that although ~8.6% less R-loop forming regions were 
identified, R-loops lengthened upon loss of TbRH1 (Figure 4.3B).  
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Figure 4.3 DRIP-seq signal is more widespread after TbRH1 null mutation. 
A) Bar graph of the number of bp occupied by a DRIP enriched region in WT and Tbrh1-/- samples. B) 
Histogram of DRIP enriched region lengths in WT and Tbrh1-/- samples.  
Localisation analysis revealed the majority of R-loops located to the RNA Pol II 
transcribed PTUs, with ~94.1% of the WT enriched regions and ~87.2% in the Tbrh1-
/- population locating here (Figure 4.4). Though the number of PTU-associated DRIP 
enriched regions did not increase when TbRH1 was ablated, there was an increase 
in R-loops in other areas of the genome, including the largely non-transcribed VSG 
arrays, RHS-associated genes and across genes transcribed by RNA Pol I (Figure 4.4). 
R-loop localisation at each of these regions is explored in more detail below.  
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Figure 4.4 Location analysis of DRIP enriched regions.  
The composition of the T. brucei genome (upper), based on the TREU927 plus Lister 427 expression 
sites hybrid genome assembly (section 2.8.4.3), and the distribution of DRIP enriched regions of WT 
and Tbrh1-/- samples across the genome elements (lower). 
4.2.2 Many more R-loops form than are predicted 
QmRLFS-finder is an algorithm developed with the aim of predicting likely R-loop 
forming sequences (Jenjaroenpun et al., 2015).  This algorithm is based upon 
findings from (Roy and Lieber, 2009), which indicate G clustering is important for 
initiating R-loop formation and, downstream of this, G-rich sequences are sufficient 
for elongation of the RNA-DNA hybrid. When the QmRLFS-finder algorithm was 
applied to the T. brucei TRU927 v5.1 genome sequence (section 2.8.4.7) only 565 R-
loop forming sequences were predicted (Figure 4.5).  Of these regions, 227 
overlapped with DRIP enriched regions in the WT sample and 305 in the Tbrh1-/- 
sample, meaning the vast majority of R-loops found in the T. brucei genome, both 
with and without the presence of TbRH1, were not predicted by the algorithm. 
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Some predicted regions did, however, show good correspondence to DRIP enriched 
regions, including those within the locus housing histone H3 coding genes (Figure 
4.5B).  
 
Figure 4.5 QmRLFS-finder R-loop predictions.  
A) Table showing the number of DRIP enriched regions that were correctly predicted by the QmRLFS-
finder algorithm. B) Screenshot of WT DRIP-seq signal (pink) over the locus in chromosome 1 that 
encodes histone H3 genes. Manually annotated DRIP enriched regions (blue) and QmRLFS-finder 
prediction (orange) are shown (Jenjaroenpun et al., 2015). The scale in the DRIP track shows fold 
enrichment in the DRIP sample relative to input. 
4.3 R-loops form at T. brucei centromeres 
R-loops have previously been found to form over the centromeric repeats of S. 
cerevisiae, C. elegans and human cells, suggesting their conservation across 
eukaryotes (Castellano-Pozo et al., 2013; Kabeche et al., 2018). Supporting this, 
weak DRIP-seq signal enrichment was apparent across the annotated centromeric 
repeats of T. brucei chromosomes 1-8 (Echeverry et al., 2012) in the WT sample. 
Furthermore, the signal was substantially increased in the Tbrh1-/- sample, 
implying TbRH1 targets centromeric R-loops (Figure 4.6).  
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Figure 4.6 TbRH1-targeted R-loops form at the centromeric repeat of T. brucei.  
A) Metaplot of average DRIP-seq signal of WT (pink) and Tbrh1-/- (green) samples over scaled 
centromeric repeats and 1 kb of up and downstream flanking sequence. Standard error is shown as 
shaded area. B) Screenshots of each annotated centromere DRIP-seq signal for WT (pink) and Tbrh1-
/- (green) sample. Scale, 1-5 fold-change relative to input. Centromeric repeats are shown in red, CDS 
in thick black and UTR sequences in thin black lines.  
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4.4 R-loops at RNA pol I transcribed genes 
In common with other eukaryotes, T. brucei rRNA genes are transcribed by RNA Pol 
I, as arrays. Such rRNA arrays have previously been shown to form R-loops in yeast 
(Chan et al., 2014; El Hage et al., 2014). Here, minor DRIP-seq signal enrichment 
was seen across loci encoding the rRNA subunits in WT parasites. However, this 
signal increased dramatically when TbRH1 activity is lost (Figure 4.7A, C).  DRIP-
qPCR was performed with two independently generated DRIP samples targeting 
three regions of the rRNA loci; the rRNA Pol I promoter, the 5.8S coding region and 
28.S coding region (Figure 4.7B). For both WT and Tbrh1-/- samples of each 
replicated, IP reactions were set up in duplicate and one was on-bead treated with 
E. coli RNase HI (EcRHI) (section 2.6.3) to ensure RNA-DNA hybrids were being 
detected. In each case the percentage of input sequence detected in IP samples 
was higher in Tbrh1-/- samples compared to WT, in agreement with DRIP-seq 
mapping. EcRHI treatment reduced signal in both WT and Tbrh1-/- samples, 
confirming detection of RNA-DNA hybrids (Figure 4.7B).   
Protein-coding genes are also transcribed by RNA pol I in T. brucei, including 
procyclin and associated genes (PAGs) (Günzl et al., 2003), VSGs and associated 
ESAGs (Günzl et al., 2003), and the monocistronically transcribed mVSGs (Alarcon 
et al., 1994; Graham and Barry, 1995). The number of DRIP enriched regions 
increased in the VSG BESs in response to loss of TbRH1 (Figure 4.7), a phenomenon 
discussed further in Chapter 6. R-loop localisation was also seen in the procyclin 
loci and in mVSG expression sites, which is somewhat contradictory, since both 
these loci should be transcriptionally silent in BSF T. brucei. In principle, this 
appears to rule out these R-loops forming in cis during transcription, but where 
they may be generated and then form in trans is unclear. Since the mVSG 
expression sites are immediately downstream of telomeres, which are prominent 
sites of R-loop formation in human cells (Rippe and Luke, 2015), as well as  in T. 
brucei (Nanavaty et al., 2017), the predominant DRIP signal located towards the 
telomeric repeats may suggest much of the mVSG R-loop detection derives from the 
telomere. However, some signal can also be observed upstream of the mVSG genes 
in some cases (Figure 4.7D, Figure 8.3), and its source is less clear.  
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Figure 4.7 R-loops form at sites of RNA Pol I transcription in T. brucei.  
A) Bar graph showing the number of enriched regions found per kb in each type of RNA pol I 
transcribed sites in WT and Tbrh1-/- cells. B) Graph showing DRIP-qPCR targeting the rRNA promoter, 
the 5.8S coding region and 28S coding region of the rRNA locus. Percentage of input sequence 
detected in IP samples is shown for WT (pink) and Tbrh1-/- (green) samples. In both cases dash lined 
bars shown IP reactions treated with EcRHI. Error bars shown SEM of two independent replicates. C-
E) Screenshots of DRIP-seq signal for WT (pink) and Tbrh1-/- (green) samples over the rRNA array of 
chromosome 8 (C), procyclin expression site (D) and two representative mVSG expression sites (E). 
4.5 R-loops form over T. brucei RNA Pol III transcribed 
genes 
In yeast, R-loops were found to form over RNA Pol III transcribed tRNA and snRNA 
genes, the abundance of which increased with double null-mutation of RNase H1 
and RNase H2 (El Hage et al., 2014).  In this study DRIP-seq signal was enriched over 
both snRNA and tRNA T. brucei genes (Figure 4.8) but, paradoxically, a loss of DRIP-
seq signal was seen in the absence of TbRH1. DRIP-qPCR however, reveals increased 
detection of input sequence in Tbrh1-/- IP samples compared to WT over both tRNA 
and snRNA genes (Figure 4.8B). Signal is reduced by treatment with EcRHI, hence 
RNA-DNA hybrids have been detected. Although DRIP-seq peaks are still observed in 
the null mutant line, it is possible that scaling during normalisation of the 
sequencing data (section 2.8.4) has masked any increase in signal between WT and 
Tbrh1-/- DRIP-seq mapping at these loci.  
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Figure 4.8 R-loops form over RNA Pol III transcribed snRNA and tRNA gene.  
A) Bar graph showing the number WT and Tbrh1-/- DRIP enriched regions per kb found over tRNA and 
snRNA genes. B) Graph showing DRIP-qPCR targeting two tRNA and two snRNA genes. Percentage 
of input sequence detected in IP samples is shown for WT (pink) and Tbrh1-/- (green) samples. In both 
cases dash lined bars shown IP reactions treated with EcRHI/ Error bars shown SEM of two 
independent replicates. C) Screenshot of region on chromosome 10 where both an snRNA and tRNA 
are located. WT (pink) and Tbrh1-/- (green) DRIP-seq signal is shown.  
4.6 RHS-associated genes are prominent sites of R-loop 
formation 
RHS-associated genes and pseudogenes are a highly abundant and variable family in 
T. brucei that are expressed from subtelomeric arrays (Bringaud et al., 2002). Little 
enrichment was found over the RHS genes in the DRIP-seq signal of WT cells, but 
signal was substantially increased with loss of TbRH1 (Figure 4.9).  
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Figure 4.9 TbRH1-sensitive R-loops form over RHS loci.  
A) Bar graph showing the number of DRIP enriched regions per kb found over the RHS regions in WT 
(black) and Tbrh1-/- (grey, striped) cells. B) Screenshot of DRIP-seq signal enrichment over a section 
of RHS gene array found in chromosome 7.  WT DRIP-seq signal is shown in pink and Tbrh1-/- in 
green. 
4.7 R-loops at RNA pol II transcribed PTUs 
In order to explore the most abundant localisation of R-loops within the RNA Pol II 
transcribed PTUs, those DRIP enriched regions that were located within the PTUs 
were further classified according the regions they overlapped most extensively 
with: CDS, 5’ UTR, 3’ UTR or intergenic sequences. Most R-loops were found to 
associate with intergenic or UTR sequences, with only ~34% and ~39% of enriched 
regions locating to CDS regions in WT and Tbrh1-/- cells, respectively, despite this 
feature constituting 53% of the PTUs (Figure 4.10A). Inspection of DRIP-seq signal 
across the RNA Pol II PTUs confirmed this, as DRIP-seq signal was found to be most 
clear and of greater enrichment levels in the regions flanking CDSs, with good 
correspondence between WT and Tbrh1-/- sample profiles (Figure 4.10B). Indeed, 
the proportion of DRIP enriched regions that located to each PTU feature did not 
drastically change upon loss of TbRH1 (Figure 4.10).   
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Figure 4.10 Distribution of DRIP-seq signal and enriched regions over the PTU genomic 
elements.  
A) The composition of RNA Pol II transcribed PTUs (left) shows the proportion of CDS and UTR 
sequences.  The amount of DRIP enriched regions associated with each element is shown for both WT 
(centre) and Tbrh1-/- (right) samples. B) Screenshots of RNA Pol II transcribed protein-coding genes in 
two areas of chromosomes 2 and 7. WT DRIP-seq signal is shown in pink and Tbrh1-/- in green; scale 
bars show enrichment in DRIP relative to input, as in previous figures. 
DRIP-qPCR, however, revealed increased detection of RNA-DNA hybrids within the 
coding regions of six RNA Pol II transcribed genes (Figure 4.11). In all cases, greater 
input sequence was detected in the Tbrh1-/- IP samples compared to WT, and these 
were diminished by EcRHI treatment. Hence, a global increase in RNA-DNA hybrid 
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levels across the PTUs may occur in Tbrh1-/-, which is masked by normalisation of 
DRIP-seq samples.   
 
Figure 4.11 DRIP-qPCR targeting RNA Pol II transcribed coding regions.  
Graph showing DRIP-qPCR targeting six RNA Pol II transcribed coding regions; NEK22 
(Tb927.2.2120), HDAC3 (Tb927.2.2190), ATR (Tb927.11.14680), GPI-8 (Tb927.10.13860), ORC1B 
(Tb927.9.2030) and actin. Percentage of input sequence detected in IP samples is shown for WT 
(pink) and Tbrh1-/- (green) samples. In both cases dashed bars shown IP reactions treated with 
EcRHI/ Error bars shown SEM of two independent replicates. 
Meta-analysis of the DRIP-seq signal over every RNA Pol II transcribed protein-
coding gene revealed a striking pattern of signal enrichment over the flanking 
regions of each CDS, with enrichment peaking in close proximity to both the start 
and end of the CDS (Figure 4.12). This distribution of signal was both conserved and 
accentuated in the Tbrh1-/- cells. 
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Figure 4.12 DRIP-seq signal is enriched over the 5’ and 3’ flanking sequences of each RNA Pol 
II transcribed CDS.  
Heatmaps of DRIP-seq signal, for WT and Tbrh1-/- samples, over each RNA Pol II transcribed protein-
coding CDS plus and minus 1 kb of flanking sequence. Metaplot profile summaries of the data are also 
shown above. 
4.7.1 R-loops at sites of trans-splicing and polyadenylation 
Motif analysis using the MEME algorithm (Bailey and Elkan, 1994) was used to 
analyse the DNA sequences of regions defined as DRIP-enriched within the PTUs. 
Three motifs were revealed; two poly(Y) sequences, and one poly(A) tract (Figure 
4.13). This finding suggests a relationship between R-loop formation and mRNA 
maturation, as poly(Y) tracts are critical for both trans-splicing and polyadenylation 
of transcripts (Liang et al., 2003).  
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Figure 4.13 Three motifs are associated with DRIP-seq enriched regions in the PTUs.  
Three motifs found in WT DRIP-seq intra-PTU enriched region sequences are shown. E- values are 
shown to the right of each motif. 
 
As >50,000 PASs have been mapped for >8,000 T. brucei genes (Nilsson et al., 2010; 
Siegel et al., 2010), and an average of 2.8 SASs have been mapped per gene (Siegel 
et al., 2011), the correlation between these processing sites and DRIP-seq signal 
was investigated. Inspection of WT DRIP-seq signal across the PTUs in comparison 
with SASs (Kolev et al., 2010; Nilsson et al., 2010; Jensen et al., 2014) and PASs 
(Kolev et al., 2010; Siegel et al., 2010) locations revealed an apparent 
correspondence between DRIP-seq signal enrichment and PAS location, as higher 
DRIP-seq peaks were evident over areas more densely populated with PASs (Figure 
4.14A). Any correlation with SASs was less clear. To test the significance of this 
putative relationship, the numbers of PASs and DRIP enriched regions were plotted 
per gene, per bp, across 5 kb of flanking sequence up and downstream of each RNA 
Pol II transcribed CDS (Figure 4.14B). This analysis revealed that DRIP-seq 
enrichment regions correlated strikingly well with PAS location in both WT (r = 
0.985, p < 0.0001) and Tbrh1-/- (r = 0.978, p < 0.0001) data sets (Figure 4.14B).   
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Figure 4.14 DRIP-seq signal correlates with PASs within the PTUs.  
A) Screenshot of WT DRIP-seq signal (pink) over a region of chromosome 5. PAS (blue) and SAS 
(orange) locations are shown below. B) Metaplots of the number of identified DRIP enriched regions 
per bp per gene (pink, left axis) and the number of PAS per bp per gene (blue, right axis) over 5 kb of 
CDS flanking sequences. 
4.7.2 Intra-PTU R-loops form at nucleosome depleted regions 
Recently, nucleosome occupancy mapping across the RNA Pol II PTUs of T. brucei, 
via histone H3-targetting MNase-ChIP-seq, revealed that nucleosome density is 
decreased immediately upstream of ATG translational start sites and increases 
downstream, across the CDSs (Wedel et al., 2017). As R-loops have been implicated 
in chromatin dynamics and organisation in other genomes (Al-Hadid and Yang, 
2016), MNase-ChIP-seq data from Wedel et al (2017) was plotted alongside the WT 
DRIP-seq data generated here to assess potential correlation. Average signal was 
plotted from each data set over the 1 kb regions surrounding each RNA Pol II 
transcribed gene’s ATG start site.  The first gene of each PTU (n, 110) was 
separated from all other genes within the PTUs (n, 8,278), allowing comparison of 
signal found proximal to the sites of transcription initiation, and signal which is 
found at sites of trans-splicing and polyadenylation. A significant inverse-
correlation could be seen between increased DRIP-seq signal and reduced 
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nucleosome occupancy at the intra-PTU genes (r = -0.8406, p <0.0001) (Figure 
4.15A). Though the same pattern was seen at the first predicted genes of the PTUs, 
it was less clear (r = -0.1779, p = 0.0916). However, when comparing DRIP-seq 
signal between WT and Tbrh1-/- cells over the same sets of genes, a much greater 
increase was seen in the absence of TbRH1 at the start of the PTUs, indicating RNA-
DNA hybrids do form around these genes as well as between genes within the PTU 
(Figure 4.15B). 
 
Figure 4.15 DRIP-seq signal increase over nucleosome depleted regions upstream of ATG start 
sites. 
 A) WT DRIP-seq signal is plotted (blue, left axis) along with histone H3 MNase-ChIP-seq average 
signal (red, right axis) over the 1 kb regions surrounding the ATG start sites of lead PTU genes (left, n 
= 110) and PTU-internal genes (right, n = 8,278). H3 MNase-ChIP-seq was previously published by 
Wedel et al 2017 and is plotted at counts per billion reads. B) WT (purple) and Tbrh1-/- (green) 
average DRIP-seq signal over the same sites. Standard error is shown as shading in each case.  
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4.7.3 DRIP-seq signal correlates with AT and GC negative skew 
Positive GC skew has been shown to correlate with R-loop formation over some CGI 
promoters in the human genome (Ginno et al., 2013), as has both positive GC and 
AT skew over coding regions of genes in the A. thaliana genome (Xu et al., 2017).  
Unexpectedly, both negative GC and AT skew were found to correlate with intra-
PTU DRIP-seq signal surrounding the ATG start sites of both internal (GC: r=-0.2695, 
p=0.0067; AT: r=-0.472, p<0.0001) and leading (GC: r=-0.5487, p<0.0001; AT: r=-
0.8923, p<0.0001) protein-coding genes (Figure 4.16). 
 
Figure 4.16 DRIP-seq signal correlates with negative GC and AT skew over ATG start sites.  
A) DRIP-seq average signal is plotted over the ATG of the first genes of each PTU (left, n = 110) and 
internal genes (right, n = 9977) in purple (left axis), alongside GC skew in blue (right axis). B) As in A, 
however AT skew is shown.  
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4.7.4 Intra-CDS R-loops 
As a significant proportion of RNA Pol II PTU-associated DRIP enriched regions 
showed some overlap with some CDS (Figure 4.10), R-loop formation over these 
genes was explored further. Intra-CDS DRIP enriched regions were found in 3,224 
and 3,179 genes in WT and Tbrh1-/- samples, respectively. Of these, 2,254 genes 
were found in both data sets. Various attributes of intra-CDS R-loop positive genes 
were compared to those of CDS that do not possess intra-CDS R-loops in any data 
set (n, 3,071).  The WT DRIP-seq signal profile was not significantly different 
between these gene sets (Figure 4.17A): although DRIP-seq signal was slightly 
higher over the CDS of R-loop positive genes, as expected, this enrichment was far 
below the level of enrichment found at the flanking sites in both sets (Figure 
4.17A). GC and AT skew were also compared between the two sets, but no 
difference could be detected between those that possess intra-CDS R-loops and 
those that do not (Figure 4.17B). 
 
Figure 4.17 DRIP-seq profile and GC/AT skew do not differ over genes which contain an intra-
CDS R-loop and those that do not.  
A) WT DRIP-seq average signal is plotted for genes which contain an intra-CDS DRIP-enriched region 
(solid purple line) and a random set of genes which do not (dashed purple line). B) GC (red, left axis) 
and AT (blue, right axis) skew over the CDS +/- 500 bp over genes which contain intra-CDS DRIP 
enriched regions solid lines) and those which do not (dashed lines).  
Gene function was also investigated via gene ontology (GO) term analysis. 
Unexpectedly, enrichment in ‘binding’ function terms (including ATP, nucleotide, 
protein and ion binding) was observed in genes that were found to form intra-CDS 
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R-loops in the WT sample (Table 4.1). However, the fold-enrichment between the 
number of genes in the data set relative to the number expected by chance 
averaged only 1.3 fold, with a standard deviation of 0.15. CDS length, mRNA half-
file (Fadda et al., 2014), 5’ and 3’ UTR length were all compared between genes 
found to contain an intra-CDS DRIP enriched region in both WT and Tbrh1-/- data 
sets, and genes which did not (Figure 4.18). In all cases no significant difference 
could be found.
  150 
ID Name Result count 
Fold 
enrichment P-value Benjamini 
GO:0005488 binding 1509 1.13 7.88E-08 3.94E-06 
GO:0032559 adenyl ribonucleotide binding 397 1.32 3.16E-06 4.84E-05 
GO:0030554 adenyl nucleotide binding 401 1.32 3.28E-06 4.84E-05 
GO:0005524 ATP binding 395 1.32 3.87E-06 4.84E-05 
GO:0032555 purine ribonucleotide binding 453 1.27 1.42E-05 6.55E-05 
GO:0032549 ribonucleoside binding 452 1.26 1.55E-05 6.55E-05 
GO:0001882 nucleoside binding 452 1.26 1.55E-05 6.55E-05 
GO:0032550 purine ribonucleoside binding 452 1.26 1.55E-05 6.55E-05 
GO:0001883 purine nucleoside binding 452 1.26 1.55E-05 6.55E-05 
GO:0017076 purine nucleotide binding 457 1.26 1.59E-05 6.55E-05 
GO:0097367 carbohydrate derivative binding 459 1.26 1.60E-05 6.55E-05 
GO:0032553 ribonucleotide binding 459 1.26 1.60E-05 6.55E-05 
GO:0035639 purine ribonucleoside triphosphate binding 451 1.26 1.70E-05 6.55E-05 
GO:0003674 molecular function 2075 1.07 3.08E-05 0.000109916 
GO:0000166 nucleotide binding 490 1.23 6.03E-05 0.00018835 
GO:1901265 nucleoside phosphate binding 490 1.23 6.03E-05 0.00018835 
GO:0036094 small molecule binding 494 1.23 6.59E-05 0.000193732 
GO:0043168 anion binding 480 1.23 7.04E-05 0.000195516 
GO:0005515 protein binding 636 1.18 0.000103838 0.000273259 
GO:0097159 organic cyclic compound binding 842 1.14 0.000176392 0.000419981 
GO:1901363 heterocyclic compound binding 842 1.14 0.000176392 0.000419981 
GO:0043167 ion binding 678 1.16 0.000262957 0.000597629 
GO:0016887 ATPase activity 112 1.44 0.001624295 0.003531077 
GO:0042623 ATPase activity, coupled 87 1.49 0.002549561 0.005311585 
GO:0016462 pyrophosphatase activity 200 1.26 0.004109398 0.007902688 
GO:0016818 hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides 200 1.26 0.004109398 0.007902688 
GO:0017111 nucleoside-triphosphatase activity 195 1.27 0.004382276 0.008115326 
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GO:0016817 hydrolase activity, acting on acid anhydrides 201 1.26 0.004966523 0.008868791 
GO:0008026 ATP-dependent helicase activity 43 1.66 0.008623755 0.014372925 
GO:0070035 purine NTP-dependent helicase activity 43 1.66 0.008623755 0.014372925 
GO:0016787 hydrolase activity 421 1.14 0.009754508 0.015733077 
GO:0016773 phosphotransferase activity, alcohol group as acceptor 151 1.25 0.015078862 0.023560721 
GO:0004386 helicase activity 51 1.49 0.018276414 0.027235004 
GO:0004672 protein kinase activity 122 1.27 0.018519803 0.027235004 
GO:0016301 kinase activity 161 1.23 0.020322907 0.028621349 
GO:0004016 adenylate cyclase activity 41 1.56 0.020607371 0.028621349 
GO:0003729 mRNA binding 110 1.28 0.022840644 0.030393689 
GO:0003774 motor activity 59 1.42 0.023099204 0.030393689 
GO:0004674 protein serine/threonine kinase activity 75 1.35 0.024219967 0.030838196 
GO:0009975 cyclase activity 41 1.53 0.024670556 0.030838196 
GO:0003723 RNA binding 249 1.16 0.027699753 0.032811201 
GO:0044822 poly(A) RNA binding 110 1.27 0.027812196 0.032811201 
GO:0022804 active transmembrane transporter activity 69 1.36 0.028217632 0.032811201 
GO:0008094 DNA-dependent ATPase activity 21 1.82 0.031811929 0.035760812 
GO:0003777 microtubule motor activity 55 1.4 0.032184731 0.035760812 
GO:0003676 nucleic acid binding 436 1.11 0.033776143 0.036562734 
GO:0016772 transferase activity, transferring phosphorus-containing groups 228 1.16 0.03436897 0.036562734 
GO:0005215 transporter activity 138 1.21 0.036986137 0.038527226 
GO:0008017 microtubule binding 44 1.42 0.044181551 0.045083215 
GO:0003824 catalytic activity 1000 1.06 0.048957109 0.048957109 
 
Table 4.1 Genes with intra-CDS R-loops may be associated with binding activities.  
Table shows results of molecular function GO term analysis. All hit GO terms with a P value > 0.05 are shown with number of genes found (result count), 
enrichment above the number of genes expected by change (fold-change) P value and Benjamini value. 
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Figure 4.18 Intra-CDS R-loop formation does not correlate with CDS length, mRNA half-life or 
UTR length.  
CDS length, mRNA half-life (Fadda et al., 2014), 5’ UTR length, and 3’ UTR length (from left to right) 
are compared between genes which were found to have an intra-CDS DRIP enriched region in WT 
(pink) and Tbrh1-/- (green) data sets, and those genes which did not in any data set (grey).  
4.8 R-loops are not associated with DNA replication origins 
As discussed in detail above (section 1.4.1.3), R-loops are known to partake in the 
initiating steps of DNA replication of bacteria plasmids (Gowrishankar, Leela and 
Anupama, 2013), the E. coli chromosome (Asai and Kogoma, 1994) and mtDNA (Lee 
and Clayton, 1998). Additionally, R-loop formation is enriched over CGI promoters 
that also act as ORIs in the human genome (Ginno et al., 2012; Lombraña et al., 
2015).  Hence, any potential relationship between ORIs and R-loops in the T. brucei 
genome was investigated. Virtually all SSRs have been shown to have OCR1/CDC6 
binding potential in T. brucei, yet only a proportion of these ORC-bound sites were 
found to be active ORIs in early S phase (Tiengwe et al., 2012).  SSRs were 
therefore divided according to whether they were found to be active ORIs or not, 
and average DRIP-seq signal was plotted over each class of SSR (Figure 4.19).  
Notably, in both cases DRIP-seq signal was reduced across the SSR body but 
increased in the flanking regions, where the immediately upstream and downstream 
genes are located. This pattern of R-loop formation was not significantly different 
between the ORI and non ORI SSRs; in addition, DRIP-seq signal increase after 
deletion of TbRH1 was seen to similar extents in both cases (Figure 4.19).  
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Figure 4.19 R-loops are not associated with ORIs in T. brucei.  
WT (pink) and Tbrh1-/- (green) DRIP-seq average signal is plotted across SSRs which are also ORIs 
(upper left) and those which are not (lower left). Standard error is plotted as shaded regions. 
Screenshots of DRIP signal across two example SSRs; upper is an ORI and lower is not.  
4.9 R-loops are associated with RNA Pol II transcription 
initiation 
R-loop formation has also been associated with sites of transcriptional initiation and 
termination (see sections 1.4.1.1 and 1.4.1.2 ). Hence, DRIP-seq signal was re-
plotted over SSRs, in this case by classifying the SSRs into three groups according to 
their transcriptional, rather than replicative, status: (i) divergent SSRs where 
transcription initiates in both sense and antisense directions; (ii) convergent SSRs 
where transcription from both directions terminates; and (iii) head-to-tail SSRs 
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where transcription terminates then re-initiates on the same strand. A clear 
association was evident between DRIP-seq signal enrichment and transcription 
initiation sites, at both divergent SSRs and in the initiation region of head-to-tail 
SSRs (Figure 4.20).  Conversely, DRIP-seq signal was not consistently enriched at 
sites of transcription termination, either in convergent or head-to-tail SSRs (Figure 
4.20). Average DRIP-seq signal did display two peaks of signal within the convergent 
SSR group, but this was due to the presence of tRNA and snRNA genes, which are 
known sites of R-loop formation in yeast (El Hage et al. 2014) and where DRIP-seq 
enrichment was seen in T. brucei (see section 4.5). Similar spikes in signal due to 
RNA-coding genes were also seen in the head-to-tail region average DRIP-seq 
profile. Besides these signal peaks, DRIP-seq signal remained relatively flat across 
the convergent SSRs and the termination portion of head-to-tail regions.  DRIP-seq 
signal increased when TbRH1 is lost, but this appeared to be uniform across each 
class of SSRs, implying R-loops cannot be linked to termination processes in this 
study.  
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Figure 4.20 DRIP-seq signal enrichment is associated with sites of transcription initiation.  
Average DRIP-seq signal is plotted for WT (pink) and Tbrh1-/- (green) data sets over divergent (upper), 
head-to-tail (centre) and convergent (lower) SSRs. In all cases 5’ and 3’ denote SSR boundaries 
defined by flanking transcript coordinates. Transcription direction is shown by dashed arrows. Standard 
error is shown as shaded regions. A DRIP-seq signal screenshot example of each SSR class is shown 
to the right of each metaplot; CDS (thick black), UTR (thin black) and snRNA/tRNA genes (red) are 
shown below the DRIP-seq tracks. 
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4.9.1 DRIP-seq signal correlates with transcription initiation-
associated epigenetic markers 
To further investigate the association between R-loops and transcription initiation, 
DRIP-seq signal was again plotted around each class of SSR, this time extending 
analysis to 8 kb upstream and downstream of the SSR boundaries.  WT DRIP-seq 
signal over these regions was compared to previously published ChIP-seq data sets 
of four factors that are associated with transcription initiation: histone variants 
H2B.V and H2A.Z, histone H4 acetylation of lysine 10 (H4K10ac), and bromodomain 
factor BDF3 (Siegel et al., 2009). Comparison of DRIP-seq signal showed strong 
correlation with three of the epigenetic markers, H2A.Z, H2B.V and H4K10ac 
(Figure 4.21). Both DRIP-seq signal and the ChIP-seq signal for all three of these 
factors peaked slightly downstream of divergent SSR 5’ and 3’ boundaries, although 
ChIP-seq signal of each factor diminished further upstream than that of the DRIP-
seq signal.  This effect is presumably due to inter-PTU R-loop formation across the 
RNA Pol II transcribed units, maintaining DRIP-seq signal.  BDF3 ChIP-seq signal 
instead peaked directly at the boundaries of the divergent SSRs, and so did not 
correlate as well with DRIP-seq signal, which peaked slightly downstream of the 
highest point of BDF3 signal. In all three cases, similarly correlated enrichment was 
also apparent at the transcription initiation portion of head-to-tail SSRs.  Within 
convergent SSRs, as well as at the termination portion of heat-to-tail regions, ChIP-
seq signal of all four epigenetic factors was diminished. Although DRIP-seq signal 
was also lower in these termination regions compared to initiation sites, it did not 
reduce completely, again presumably due to the presence of inter-PTU R-loops 
(Figure 4.21).
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Figure 4.21 R-loop formation correlates with epigenetic factors associated with transcription initiation.  
WT DRIP-seq signal average (blue) is plotted over each class of SSRs, divergent (left), head-to-tail (centre) and convergent (right). Average ChIP-seq 
signal for histone H2A.Z, H4K10ac, histone H2B.V and bromodomain protein BDF3 are plotted for comparison in red (Siegel et al., 2009). In all cases 
standard error is plotted as shaded regions around the mean.
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4.9.2 DRIP-seq signal does not associate with transcription 
termination epigenetic markers 
Two other histone variants, H3.V and H4.V, have previously been associated with 
transcription termination (Siegel et al., 2009).  Published H3.V and H4.V ChIP-seq 
signal was therefore plotted alongside WT DRIP-seq signal, as above, to allow 
comparison.  In this case no correlation could be observed between the DRIP-seq 
signal and ChIP-seq signal of either histone variant (Figure 4.22).  ChIP-seq signal of 
each histone variant was significantly greater than that of DRIP-seq at both 
convergent SSRs and the terminal portions of head-to-tail-regions, whereas DRIP-
seq signal exceeded both at sites of transcription initiation (Figure 4.22). 
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Figure 4.22 R-loop formation does not correlate with histone variants associated with transcription termination. 
WT DRIP-seq signal average (blue) is plotted over each class of SSRs, divergent (left), head-to-tail (centre) and convergent (right). Average ChIP-seq 
signal for histone variants H3.V and H4.V are plotted for comparison (red). In all cases standard error is plotted as shaded regions around the mean.
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4.10 Discussion 
R-loop mapping has been carried out in a range of species, revealing widespread 
roles in DNA replication, transcription initiation and termination, telomere 
maintenance and recombination events (see section 1.4.1). Although few cases 
have demonstrated direct mechanistic links (Skourti-Stathaki, Kamieniarz-Gdula and 
Proudfoot, 2014; Boque-Sastre et al., 2015), several studies have correlated R-loop 
formation to various epigenetic markers and nucleosome positioning dynamics 
(Santos-Pereira and Aguilera, 2015b; Al-Hadid and Yang, 2016; Sanz et al., 2016).  
In this chapter, R-loops have been mapped in the unconventional genome of T. 
brucei to find sites of conserved R-loop formation, and reveal evidence linking R-
loops to transcription initiation, trans-splicing and polyadenylation, but not to 
transcription termination or DNA replication. 
4.10.1 Conserved sites of R-loop formation 
4.10.1.1 Centromeres 
Repeat sequences are well-established sites of R-loop formation, many of which 
appear conserved in the T. brucei genome. Centromeric repeats are prominent sites 
of R-loop formation in T. brucei WT parasites and even more so in cells lacking 
TbRH1; hence, TbRH1 acts to resolve these R-loops. In other systems, binding of 
ncRNAs generates functional RNA-DNA hybrids at centromeres (see section 1.4.1.6, 
Nakama et al., 2012). In T. brucei, siRNAs may act as the RNA component of the R-
loops in the three CIR147 bp repeat-containing centromeres at which siRNAs have 
been detected (Tschudi et al., 2012). These siRNAs are known to function in the 
RNAi pathway (Patrick et al., 2009) and may therefore act to induce chromatin 
condensation at these centromeres via a similar ncRNA-dependent pathway to that 
documented in yeast (Nakama et al., 2012; Castellano-Pozo et al., 2013). However, 
CIR147 bp repeats are not present in the remaining identified centromeres in T. 
brucei, yet these different repeats all display enriched DRIP-seq signal. It seems 
plausible, therefore, that R-loop formation in centromeres is a conserved function 
of centromere-associated repeats across species, perhaps ensuring condensed 
chromatin (Castellano-Pozo et al., 2013) to direct correct chromosome segregation 
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(Kabeche et al., 2018). Nonetheless, how this putative conservation in centromere 
activity correlates with the pronounced divergence in the kinetoplastid kinetochore 
is unclear (Akiyoshi and Gull, 2014; D’Archivio and Wickstead, 2017). In addition, 
centromere-associated repeats have not been described at sites of kinetochore 
factor KKT1 enrichment in Leishmania (Garcia-Silva et al., 2017); mapping R-loops 
may clarify if these loci are true centromeres, since no such activity has been 
demonstrated to date. 
4.10.1.2 rRNA loci 
R-loops are also strongly apparent over the T. brucei rRNA loci, as has been 
reported for both eukaryotes (Gall and Pardue, 1969; Thomas, White and Davis, 
1976; White and Hogness, 1977; El Hage et al., 2010; Arana et al., 2012) and 
bacteria (Hraiky, Raymond and Drolet, 2000).  In yeast, antisense transcription 
generates ncRNAs, which form RNA-DNA hybrids at the rRNA RNA Pol I promoter to 
induce transcriptional silencing of the rRNA via DNA methylation and repressive 
histone marks (Mayer et al., 2006; Bierhoff et al., 2010; Schmitz et al., 2010). 
Indeed, small RNAs have been detected from the rRNA loci in T. brucei (Zheng et 
al., 2013) and DRIP-seq signal enrichment is evident over the RNA Pol I transcribed 
rRNA arrays. These findings highlight the intriguing possibility that R-loops may 
negatively regulate rRNA transcription in T. brucei. However, whether T. brucei 
rRNA-associated R-loops form co-transcriptionally or via antisense small RNAs 
cannot be extrapolated from this study.  
4.10.1.3 tRNA and snRNA 
Nascent tRNAs have been shown to engage in R-loop formation in yeast, as well as 
the snRNAs that are also transcribed by RNA Pol III (Chan et al., 2014; El Hage et 
al., 2014). DRIP-seq enrichment is observed at tRNA and snRNA genes in WT T. 
brucei parasites, although this signal appears slightly diminished in Tbrh1-/- 
mapping. DRIP-qPCR, however, revealed increased detection of RNA-DNA hybrids 
after loss of TbRH1, despite this not being reflected in DRIP-seq mapping of the 
hybrids. As tRNA and snRNA R-loops have previously been demonstrated to be 
targeted by RNase H enzymes in yeast (El Hage et al., 2014), it is hypothesised that 
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TbRH1 is also able to target such R-loops, as predicted by DRIP-qPCR. Indeed, it is 
possible that scaling of input and IP DNA libraries to remove bias introduced by 
amplification steps of library preparation and sequencing (section 2.8.4), has 
resulted in the reduction of signal enrichment at tRNA and snRNA genes in the 
Tbrh1-/- sample. In order to confidently compare signal between WT and Tbrh1-/- 
mapping, DRIP-seq would require repeating with the addition of spike-in controls to 
allow scaling to an exogenous factor (K. Chen et al., 2015).  
4.10.1.4 RHS-associated genes 
DRIP enrichment is also apparent at RHS-associated genes, and dramatically more 
so after loss of TbRH1. These genes are highly abundant, variable, are largely 
expressed in the nucleus and are targets for transposable elements (Bringaud et al., 
2002), although their exact function(s) is uncertain. Whether the R-loops detected 
in the RHS arrays form co-transcriptionally or via binding of siRNAs, which have 
been detected at RHS-associated sequences (Tschudi et al., 2012), is not clear. 
RNA-DNA hybrids are associated with retrotransposable elements in the yeast 
genome, where they most often form with cDNAs produced by reverse 
transcription, rather than chromosomal genes (El Hage et al., 2014). Transposable 
elements in A. thaliana genes are also sites of R-loop formation, where they have 
been associated with the heterochromatin markers, H3K27me1 and H3K9me2 (Xu et 
al., 2017). Although R-loop formation over the T. brucei RHS genes may relate to 
those observed at transposable elements in yeast (El Hage et al., 2014) and plants 
(Xu et al., 2017), the unique clustering nature of these genes in subtelomeric arrays 
may indicate a kinetoplastid-specific function of R-loops here.  
4.10.1.5 Telomeres 
As discussed in section 1.4.1.5, RNA-DNA hybrids that form in telomeres via the 
binding of TERRA RNA have been implicating in ATL (Arora et al., 2014; Yu, Kao and 
Lin, 2014). Examination of mVSG ESs, where mVSGs are located directly upstream 
of the telomeric repeats, shows formation of R-loops in both WT and Tbrh1-/- data 
sets. Moreover, chapter 6 describes R-loops at the telomeres of BESs. It is plausible 
that telomeric R-loops may play a role in telomere lengthening in T. brucei if 
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replication of these intrinsically difficult to replicate repeats fails (Özer and 
Hickson, 2018), and it has also been suggested that they are involved in VSG 
switching (Nanavaty et al., 2017). Indeed, clashes between the replication 
machinery and telomeric R-loops are hypothesised to trigger homology-directed 
repair via recombination in ATL (Graf et al., 2017), a proposal which could be 
extrapolated as a model for inducing recombination-based VSG switching (Nanavaty 
et al., 2017). This possibility is discussed in the context of DRIP-seq mapping to the 
BESs in detail in Chapter 6.  
4.10.2 R-loops are associated with regions of trans-splicing and 
polyadenylation 
The most prominent site of R-loop formation in both WT and Tbrh1-/- parasites is 
within the RNA Pol II transcribed PTUs. Here, R-loops were most extensively linked 
to the intergenic and UTR sequences in virtually all genes. Although several DRIP 
enriched regions were also found to associate with CDS regions, the enrichment 
here is minor compared to that of the intra-CDS signal and is not associated with AT 
or GC skew, UTR length, CDS length, mRNA half-life or gene function. This contrasts 
with the A. thaliana genome, where R-loops are enriched across the coding regions 
of a subset of genes and are associated with both AT and GC positive skew (Xu et 
al., 2017). Intra-CDS R-loops have also been documented in the S. cerevisiae 
genome, where they are most strongly associated with highly expressed genes 
(Wahba et al., 2016). As transcription rate is thought to be largely uniform across 
the RNA Pol II transcribed genes in T. brucei, due to the nature of multigenic 
transcription, it is unlikely that transcription rates are linked to levels of R-loop 
formation at different genes.  
The formation of R-loops predominantly in the intra-CDS regions does, however, 
suggest a strong association between these structures and coupled trans-splicing 
and polyadenylation events, reflecting the nature of gene expression organisation in 
the T. brucei genome.  Indeed, meta-analysis of DRIP enriched region and PAS 
occurrence across the CDS flanking sequences, reveals a significant relationship 
between the two: the density of PAS is positively correlated with R-loop formation 
in these regions. How R-loops may act in the process of polyadenylation remains 
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unclear, however. It is possible that increased RNA Pol II pausing may be evident at 
sites with many PASs, increasing the likelihood of R-loop formation. It is also 
plausible that the increased number of A bases in 3’ UTRs with multiple PASs 
increases the rate of R-loop formation, or stability of the structure, by influencing 
the DNA sequence composition.  
Motif analysis supports the relationship between R-loops and mRNA processing in T. 
brucei, since R-loop forming sequences are enriched for two poly(Y) tract motifs, 
which are vital for both splicing and polyadenylation (Matthews, Tschudi and Ullu, 
1994). Although, it should be noted that predominant R-loop formation over intra-
CDS regions necessitates enrichment of RNA processing-associated poly(Y) tracts 
and does not necessarily indicate these motifs are directly causal of R-loop 
formation. However, a third, poly(A) motif is also enriched in R-loop-forming 
sequences within the PTUs. Poly(A) tracts >21 bp are associated with R-loop 
formation in the genome of yeast mutants lacking both RNase H1 and H2 activity, 
along with positive AT skew (Wahba et al., 2016). In this setting the poly(A) tracts 
have been directly linked to R-loop formation, since deletion of the tracts led to a 
decrease in R-loops, often to background levels (Wahba et al., 2016). In the T. 
brucei genome poly(A) tracts, but not positive AT skew, are linked to DRIP 
enrichment, suggesting the possibility that poly(A) tracts themselves are sufficient 
for R-loop formation, independent of total base skew. However, to date no 
functional analysis of poly(A) tracts in T. brucei has been reported. 
DRIP enrichment in the intra-CDS regions is also significantly associated with 
nucleosome depletion and, thus, with relaxed chromatin. Similar R-loop enrichment 
in nucleosome depleted regions has been noted in the human genome irrespective 
of genic location (Sanz et al., 2016; Chen et al., 2017). R-loops are also heavily 
associated with euchromatin epigenetic markers, particularly at promoters (Sanz et 
al., 2016; Chen et al., 2017), where they have been shown to directly protect 
against DNA methylation, a known marker of heterochromatin (Ginno et al., 2012), 
and chromatin condensation (Boque-Sastre et al., 2015).  These findings highlight a 
potential role of R-loops in regulating nucleosome positioning between coding 
regions within the T. brucei PTUs.  However, RNA Pol II is likely to pause at sites of 
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nucleosome occupancy (Wedel et al., 2017), which may allow more opportunity for 
RNA to bind the DNA template. Hence, R-loop enrichment may reflect transcription 
dynamics in T. brucei as RNA Pol II pauses at organised nucleosomes positioned over 
the ATG translational start sites, potentially allowing R-loop formation upstream.  
In either case, positioning of nucleosomes 5’ of exons has been suggested to 
promote co-transcriptional cis-splicing in eukaryotes by slowing the transcribing 
polymerase (Schwartz and Ast, 2010). Cis- and trans-splicing share many 
mechanistic similarities (Michaeli, 2011) and so it has been suggested that 
nucleosome positioning also plays a role in trans-splicing via a similar mechanism in 
the T. brucei genome, where each CDS is effectively an exon (Wedel et al., 2017). 
Therefore, R-loops may act to slow the transcribing polymerase, rather than paused 
polymerases allowing R-loop formation. However, R-loops have so far shown poor 
correspondence with sites of cis-splicing. In yeast, introns have been found to 
protect genes from R-loop formation (Bonnet et al., 2017), an effect that also 
seems to be the case in the intron-rich mammalian genomes (Bonnet et al., 2017), 
where the first exon-intron junction acts as the 3’ boundary for promoter-
associated R-loops (Dumelie and Jaffrey, 2017). In these genomes, the action of the 
mRNA cleavage and polyadenylation machinery (Stirling et al., 2012), or 
spliceosome recruitment alone (Bonnet et al., 2017), appears to protect against R-
loop formation. DRIP-seq has shown this is not the case in T. brucei, where sites 
associated with the action of such factors show increased R-loop formation, rather 
than decreased.  Hence, the high levels of intra-CDS R-loops observed in the T. 
brucei genome may indicate a novel role for R-loops in pre-mRNA processing during 
polycistronic transcription, perhaps via maintaining open chromatin to allow 
efficient binding of splicing and polyadenylation factors. It is also clear that these 
R-loops are sensitive to RNase H activity as they showed increased enrichment in 
Tbrh1-/- parasites. Hence, RNase H detection and/or processing of intra-CDS R-
loops may also have a role in such processes. 
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4.10.3 R-loops are associated with transcription initiation 
As discussed above, R-loops are heavily associated with active transcription at 
promoters in mammals (Ginno et al., 2012; Boque-Sastre et al., 2015; P. B. Chen et 
al., 2015; Sanz et al., 2016), A. thaliana (Xu et al., 2017), and (less clearly) in 
yeast (Chan et al., 2014; El Hage et al., 2014).  Mapping of RNA-DNA hybrids to the 
SSRs in T. brucei shows R-loops are also associated with transcription initiation in 
this organism. In metazoan genomes two broad classes of transcriptional promoter 
have been described: “focused”, where transcription initiates from a discreet TSS 
and is associated with a well-defined promoter sequence (e.g. a TATAA box);  and 
“dispersed” promoters, which initiate transcription from multiple TSSs in a broad 
region of ~50-100 bp (Lenhard, Sandelin and Carninci, 2012). RNA Pol II 
transcription initiation in T. brucei lacks discreet TSSs and typical promoter 
sequences, so are likely to be mechanistically more similar to the dispersed 
promoter class (Kolev et al., 2010). This class lacks defined DNA sequences motifs, 
which in focused promoters provide sites for the binding of proteins such as 
transcription factors to allow transcriptional regulation of gene expression 
(Lenhard, Sandelin and Carninci, 2012). In dispersed promoters open chromatin 
alone is thought to facilitate transcription initiation of these broadly expressed 
genes and so negate the need for DNA motifs (Lenhard, Sandelin and Carninci, 
2012). As gene expression of RNA Pol II transcribed genes is independent of 
transcriptional regulation in T. brucei, the action of dispersed promoters to simply 
provide an environment for transcription initiation is in keeping with the nature of 
the kinetoplastid’s genome. Interestingly, dispersed promoters often display high 
GC content and overlap with CGI promoters, which are prominent sites of R-loop 
formation (Ginno et al., 2012). At these sites R-loops protect from DNA methylation 
(Ginno et al., 2012) and are associated with several epigenetic markers and histone 
variants associated with open chromatin (Sanz et al., 2016; Chen et al., 2017).  
Therefore, it is hypothesised that R-loops have a similar role in promoting an open 
chromatin environment favourable for active transcription in T. brucei. 
In T. brucei promoters, a GT-rich motif is capable of conferring RNA Pol II 
transcription initiation (Wedel et al., 2017).  This promoter element contributes in 
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some capacity to the deposition of histone variant H2A.Z, which is associated with 
transcription initiation sites (Siegel et al., 2009), to the boundaries of the 
nucleosome depleted region (Wedel et al., 2017). Supporting the hypothesised role 
of R-loops and the chromatin environment, DRIP signal is shown to correlate with 
H2A.Z ChIP-seq signal at the initiation sites, along with other activation markers 
(histone H2B.V, H4K10ac and, in a more minor sense, bromodomain factor BDF3). 
This association extends several kb into the PTUs and highlights a role for R-loops in 
the maintenance of active transcription rather than dynamic gene expression 
regulation via transcription, which T. brucei lacks.    
In contrast, no specific R-loop enrichment was associated with sites of transcription 
termination in either WT or Tbrh1-/- parasites, nor with termination associated 
histone variants H3.V and H4.V. Hence, R-loops were not associated with 
termination of RNA Pol II in this study, although it remains plausible that another 
factor, such as a helicase, targets termination associated R-loops in T. brucei.  
4.10.4 Perspectives 
Over the last decade, research into the physiological role of R-loops has expanded 
considerably leading to their implication in many processes, as well as human 
diseases (Groh and Gromak, 2014; Costantino and Koshland, 2015; Richard and 
Manley, 2017). Here, R-loop formation in the genome of T. brucei has added to 
understanding of R-loop biology and has linked them to functions in this 
kineotoplastid genome. DRIP enrichment is evident at rRNA, tRNA and snRNA genes, 
as well as telomeric and centromeric regions, highlighting the apparent 
conservation of R-loop formation at these sites. Whether R-loops have functional 
roles at these sites, and what these may be, remains an interesting avenue of 
investigation. However, it may be speculated that a functional role this is more 
probable at some regions (telomeres, centromeres and perhaps rRNA) than others 
(tRNA and sRNA).  
DRIP-seq enrichment analysis in T. brucei has additionally been able to tentatively 
rule out a eukaryotic-wide conserved role for R-loops in typical DNA replication and 
RNA pol II transcription termination. A lack of specific R-loop enrichment at ORIs in 
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WT and Tbrh1-/- parasites makes it unlikely that R-loop formation has a role in the 
initiation of DNA replication at ORIs, as suggested in mammals (Lombraña et al., 
2015). Although virtually all SSRs have been shown to bind ORC (Tiengwe et al., 
2012), a lack of DRIP signal across the bodies of the SSRs and enrichment at the 
flanks highlights transcription is much more closely linked to R-loop formation than 
DNA replication in T. brucei. Similarly, a lack of specific DRIP signal at sites of 
transcription termini undermines any potential role for R-loops in these regions. 
Analysis of R-loop mapping does, however, provide strong evidence linking R-loops 
to sites of mRNA processing in the PTUs. R-loop formation between coding regions 
has not been widely documented in other studies; in fact, introns appear to protect 
genes from R-loop formation in other eukaryotes. Whether R-loops result from 
transcriptional pausing or are actively involved in the mRNA maturation process, 
perhaps by signalling for machinery binding, remains to be investigated. It is also 
possible that R-loops regulate a chromatin environment permissible for such 
processes, as they are formed in nucleosome-depleted regions. A similar role in 
chromatin dynamics may be evident at transcription initiation sites, where DRIP 
signal correlates with prevalence of epigenetic factors associated with open 
chromatin. Hence, mapping in T. brucei supports a role for R-loops at dispersed 
promoters, also demonstrated at CGI promoters in mammals (Ginno et al., 2012, 
2013; P. B. Chen et al., 2015; Sanz et al., 2016), yet contradicts a role for these 
structures in gene expression regulation, as T. brucei lacks transcriptional control 
of polycistronically transcribed Pol II genes.
  
169 
5 Why is RNase H2A an Essential Protein for T. 
brucei Parasites?
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5.1 Introduction  
Data discussed in Chapter 3 of this thesis have revealed the requirement for 
functional TbRH2A, and by extension the RNase H2 complex, by T. brucei BSF 
parasites to maintain an intact genome and propagate in culture. RNAi-induced 
depletion of the complex’s catalytic subunit results in stalled growth of the 
parasites, which accumulate as G2/M stage and aberrant cells.  This stall is 
accompanied by a substantial accumulation of DNA damage; yet, the parasites 
continue to synthesise DNA, resulting in excess DNA content per cell. This 
phenotype differs greatly from the seemingly unperturbed Tbrh1-/- parasites but 
does have some common features with RNase H2 mutants of model eukaryotes (see 
below).  Also in common with other eukaryotes, the cause of DNA damage in T. 
brucei RNase H2 mutants cannot yet be confidently attributed to one, or both, of 
the complex’s two functions: R-loop resolution and activation of the RER pathway.  
Like T. brucei parasites depleted of TbRH2A, mouse cells that are null mutants of 
the structural B subunit (Rnaseh2b-/-) display impaired cell proliferation, arrest in 
the G2/M cell cycle stage and accumulate DNA damage (Hiller et al., 2012; Reijns 
et al., 2012). In contrast to T. brucei, however, where DNA synthesis appears to 
continue after TbRH2A depletion, the number of S phase epiblast cells taken from 
Rnaseh2b-/- mouse embryos is significantly decreased in comparison to WT cells 
(Reijns et al., 2012). Hence, loss of a functional RNase H2 complex in mice induces 
genuine cell cycle arrest, whereas in T. brucei DNA synthesis continues after the 
parasites fail to divide. Gene expression profiling of liver cells taken from 
Rnaseh2b-/- mice uncovered p53-induced up-regulation of several genes, including 
those involved in checkpoint activation, highlighting initiation of DNA damage 
response pathways (Hiller et al., 2012).  In an effort to identify the cause of DNA 
damage in Rnaseh2b-/- cells, Hiller et al (2012) assessed ribonucleotide load within 
the DNA genome by treating purified DNA with bacterial RNase HII in order to 
induce detectable DNA nicks at the sites of ribonucleotide inclusion. This technique 
enabled the authors to detect massive inclusion of ribonucleotides in the DNA of 
mutant cells, but not in WT equivalents (Hiller et al., 2012). Similarly, alkali-
treatment of Rnaseh2b-/- mouse DNA also revealed extensive accumulation of 
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alkali-sensitive ribonucleotides (Reijns et al., 2012). Hence, the role of RNase H2 in 
the RER pathway may underlie the essential need for RNase H2 in mice, although a 
role for RNA-DNA hybrids was not investigated in these studies and cannot be ruled 
out.  
Mutations in all of the RNase H2 subunits are known to cause the 
neuroinflammatory disease Aicardi-Goutières syndrome (AGS) in humans, as are 
mutations of the 3’ - 5’ endonuclease TREX1, dNTP-depleting enzyme SAMHD, 
adenosine deaminase ADAR1 and viral-DNA detecting helicase IFIH1. In all cases, 
AGS is believed to result from activation of the innate immune pathway due to 
accumulated nucleic acids (Crow et al., 2015). AGS-causing mutations of RNase H2 
can occur at more than 50 known sites across the three subunits and are normally 
found as heterozygous mutations (Crow et al., 2015).  To better model AGS in mice, 
Pokatayev et al (2016) generated G37S (glycine to serine) heterozygous and 
homozygous mouse mutants of the catalytic A subunit. RNA-seq carried out with the 
perinatal lethal homozygous mutant line, revealed an interferon-driven immune 
response, similar to that seen in AGS patients (Pokatayev et al., 2016).  
Importantly, the authors were able to elucidate that the immune response was 
triggered by the presence of cytosolic DNA, not RNA, in Rnaseh2aG37S/G37S mouse 
cells. Furthermore, this was deemed at least partially responsible for the lethal 
phenotype of the homozygous mutant mice (Pokatayev et al., 2016).  However, as 
the authors highlight, aberrant processing of either RNA-DNA hybrids or embedded 
ribonucleotides could result in the free nucleic acids activating the DNA sensing 
pathway (Pokatayev et al., 2016), and so which role, if not both, is the critical 
function of RNase H2 in mammals is still unclear. 
In complete contrast, yeast is able to tolerate null mutation of RNase H2, even in 
combination with RNase H1 deletion, although elevated recombination does occur 
(Conover et al., 2015; O’Connell, Jinks-Robertson and Petes, 2015). To elucidate if 
increased ribonucleotide load in the genome of RNH201-null yeast (where the 
catalytic subunit 201 is deleted) causes elevated instability, two studies expressed 
mutant DNA Polymerases that either incorporated greater or fewer ribonucleotides 
during replication in the RNH201-null line (Conover et al., 2015; O’Connell, Jinks-
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Robertson and Petes, 2015). M644G mutation of DNA Pol ε increases the frequency 
by which the polymerase incorporates ribonucleotides into the genome, and 
increases loss-of-heterozygosity (LOH) ~7 fold compared to S. cerevisiae expressing 
the WT Pol ε (Conover et al., 2015). When expressed in RNH201-null yeast LOH 
raised ~23-fold in comparison to RNH201-null yeast expressing WT Pol ε, indicating 
the cells inability to initiate RER causes wide spread instability (Conover et al., 
2015). However, the same change in LOH could not be observed when either Pol α 
or δ were manipulated to raise ribonucleotide incorporation in RNH201-null yeast 
(Conover et al., 2015). Both studies also aimed to see if recombination rates could 
be lower in RNH201-null cells by expressing a second mutant of Pol ε, M644L, which 
incorporated fewer ribonucleotides during replication (Conover et al., 2015; 
O’Connell, Jinks-Robertson and Petes, 2015). Conover et al observed a slight 
decrease in LOH rate in this line compared to the RNH201-null expressing WT Pol ε, 
though O’Connell et al detected no change in recombination. Additionally, 
O’Connell et al highlight that although null mutation of RNase H1 in yeast causes 
little effect on recombination, dual knock out of RNase H1 and RNH201 increases 
recombination ~50 % compared to RNH201-null mutation alone. Therefore, RNase 
H2 represses genome instability in yeast via both R-loop resolution and activation of 
RER to remove embedded ribonucleotides. Yet, loss of these functions is tolerated 
in yeast in ways mammalian cells are not able to.  
Together the above studies imply both RER and R-loop functions of eukaryotic 
RNase H2 are key for preventing genomic instability. Why the complex is essential 
in mammalian cells and not in yeast is most likely due to fundamental difference in 
the genome biology of each, and how RNase H2 fits into these genomic functions. 
The phenotype of T. brucei parasites depleted of TbRH2A has more in common with 
mammalian cells than yeast, and so events generating the respective DNA lesions 
may also be shared. The TbRH2A-tageting RNAi parasite line described in this thesis 
provides, firstly, a means to try and isolate the cause (or causes) of lethal DNA 
lesions in a eukaryote with dampened RNase H2 activity, and secondly, an 
opportunity to further investigate R-loop formation across the T. brucei genome.  
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5.1.1 Chapter aims 
In this chapter TbRH2A depleted parasites were investigated in more detail. Firstly, 
R-loops were mapped across the Mb chromosomes to ascertain if sites of RNA-DNA 
hybrid formation are conserved between samples and look for changes in hybrid 
location after the subunits depletion. Secondly, γH2A deposition was mapped via 
ChIP-seq analysis to locate sites of DNA damage after loss of RNase H2 activity. 
Finally, RNA-seq was carried out to profile gene expression in induced RNAi 
parasites in comparison to un-induced. Together these studies aim to investigate 
where DNA damage occurs most frequently in these parasites, if this damage relates 
to R-loop formation, and how the parasites respond to such damage.  
5.2 DRIP-seq mapping of R-loops in TbRH2A depleted cells 
To evaluate R-loop localisation before and after TbRH2A RNAi, DRIP-seq was 
performed as described in chapter 4, using the TbRH2ARNAi line described in chapter 
3. Parasites were cultured for 24 hr in the presence or absence of tet (1 µg/ml) 
before fixed chromatin samples were collected and subject to IP with the S9.6 RNA-
DNA hybrid targeting antibody (section 2.6). Mapping and analysis were then 
undertaken using the same methods employed to investigate R-loop formation in 
WT and Tbrh1-/- cells (section 2.8.4). 
5.2.1 R-loops form across the Mb chromosomes in TbRH2A RNAi 
parasites 
DRIP-seq data was mapped across the T. brucei Mb chromosomes and signal was 
expressed as the ratio of IP read coverage relative to input read coverage, in both 
induced and un-induced TbRH2ARNAi samples (Figure 5.1). As with WT and Tbrh1-/- 
mapping, R-loop formation was extensive across the Mb chromosomes in both un-
induced and induced samples, where the highest peaks again correlated with 
tandem repeat regions (Figure 5.1). In both samples, extensive DRIP signal was 
observed in the repetitive subtelomeric regions, housing VSG arrays.  
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Figure 5.1 DRIP-seq signal across the 11 Mb-sized chromosomes of TbRH2A RNAi parasites.  
DRIP-seq signal for un-induced (blue) and induced (orange) cells is plotted as fold-change relative to 
input coverage (scale: 1-4 fold-change). Upper track shows transcripts on sense (black) and antisense 
(red) strands. Known centromeres are shown as peach circles. Lowest track shows tandem repeat 
sequences. 
5.2.2 DRIP enriched region classification in TbRH2A depleted 
parasites 
Enriched regions of DRIP-seq signal (>1.2 fold-change) were identified as described 
for the analysis of WT and Tbrh1-/- DRIP data sets (section 4.2). Again the enriched 
regions, corresponding to sites of RNA-DNA hybrid formation, were classified 
according to their genomic location and compared to classification of WT DRIP 
enriched regions to allow consideration of leaky RNAi expression in the tet – 
parasites (Figure 5.2A).  The majority of DRIP enriched regions were located within 
the Pol II transcribed PTUs, with similar amounts of enriched regions (33,879 tet -, 
and 35,329 of tet + regions) compared with WT regions (35,320). The total number 
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of enriched regions between the tet – and tet + samples increased slightly from 
39,243 to 40,155, and both increased from the 37,527 WT regions. The location of 
these enriched regions did not notably differ between tet – and tet + samples. 
However, compared to classification of WT enriched regions the amount of DRIP 
enriched regions in the VSG array sites increased from 1,389 WT regions to 3,380 
and 2,800 regions in the un-induced and induced samples, respectively. The number 
of DRIP enriched regions forming in loci housing RNA Pol I transcribed genes also 
increased from 213 in the WT data to 1,153 tet – enriched regions and 1,102 tet + 
enriched regions. Lastly, RHS-associated DRIP enriched regions increased from 172 
in WT cells to 454 and 393 in tet – and tet + cells, respectively (Figure 5.2A).  
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Figure 5.2 Analysis of DRIP enriched region distribution before and after TbRH2A RNAi 
knockdown.  
A) The distribution of DRIP enriched regions in WT, TbRH2A RNAi un-induced (tet -) and induced (tet 
+) samples across the genome elements.  B) Bar graph of the number of bp occupied by a DRIP 
enriched region in WT, TbRH2A RNAi tet- and tet + samples. C) Histogram of DRIP enriched region 
lengths in tet – and tet + samples. 
The number of bp occupied by a DRIP enriched region slightly decreased, from 
11,324,282 bp to 10,230,755 bp, after tet induction of the RNAi cells (Figure 5.2B). 
Again, however, comparison with WT DRIP analysis revealed these values were both 
increased compared to 7,461,359 bp occupied by an RNA-DNA hybrid in the WT 
sample. The length of the enriched regions also revealed little difference between 
tet – and tet + DRIP enriched regions (Figure 5.2B), although this was again 
increased compared to WT enriched regions. 
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5.2.3 R-loops form in centromeric repeats after TbRH2A depletion 
As in Tbrh1-/- mutant parasites, in both tet – and tet + TbRH2ARNAi parasites DRIP-
seq signal peaks formed over the centromeric repeat regions compared to WT DRIP 
(Figure 5.3). In both cases DRIP signal was enriched over the repeat regions of all 
centromeres (Figure 5.3,Figure 8.4), above the level observed in WT DRIP mapping.  
 
Figure 5.3 TbRH2A-targeted R-loops form at the centromeric repeats of T. brucei.  
Left: Metaplot of average DRIP-seq signal of WT (pink), TbRH2ARNAi un-induced (tet -, blue) and 
induced (tet +, orange) samples over scaled centromeric repeats plus 1 kb of up and downstream 
flanking sequence. Standard error is shown as shaded area. Right: Screenshot example of DRIP-seq 
signal across the annotated centromeric repeats of chromosome 1. Colours are as for metaplot profile. 
Scale, 1-5 fold-change relative to input. Centromeric repeats are shown in red, CDS in thick black and 
UTR sequences in thin black lines. For DRIP-seq signal of all other centromeres see Figure 8.4.  
5.2.4 DRIP signal is enriched at RHS-associated genes in 
TbRH2ARNAi parasites.  
As witnessed at the centromeric loci, in both the tet – and tet + DRIP samples signal 
was enriched compared to WT DRIP mapping at RHS-associated genes (Figure 5.4). 
Correspondingly, the number of DRIP enriched regions overlapping RHS-associated 
gene coding regions increased from 167 WT DRIP enriched regions to 379 and 443 
enriched regions in un-induced and induced Tbrh2a RNAi samples, respectively 
(Figure 5.4, left). Notably, DRIP signal was seen to ‘dip’ over the coding regions of 
genes associated with RHSs (Figure 5.4, right).  
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Figure 5.4 R-loops form over RHS loci of both un-induced and induced TbRH2A RNAi parasites.   
A) Bar graph showing the number of DRIP-enriched regions found over the RHS regions in WT (black), 
TbRH2A RNAi un-induced (tet -, grey striped) and induced (tet +, white dotted) cells. B) Screenshot of 
DRIP-seq signal enrichment over a section of RHS gene array found in chromosome 7.  WT DRIP-seq 
signal is shown in pink, TbRH2A RNAi un-induced (tet -) in blue and induced (tet +) in orange. 
5.2.5 DRIP enriched regions increase at Pol I transcribed sites in 
TbRH2ARNAi cells relative to WT 
As seen after TbRH1 deletion, DRIP signal and DRIP enriched regions were both 
increased at RNA Pol I transcribed loci in the TbRH2ARNAi parasites, both induced 
and un-induced, compared to WT parasites (Figure 5.5A). This was most notable 
within the rRNA loci and BESs (Figure 5.5A and B). Again, the numbers of enriched 
regions identified in un-induced and induced DRIP samples did not notably differ in 
any Pol I transcribed loci. 
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Figure 5.5 R-loops form at sites of RNA Pol I transcription in TbRH2A RNAi parasites.  
A) Bar graph showing the number of enriched regions found in each type of RNA Pol I transcribed site 
in WT, TbRH2ARNAi un-induced (tet -, grey striped) and induced (tet +, white dotted) cells. B) 
Screenshot of DRIP-seq signal for WT (pink), TbRH2ARNAi un-induced (blue) and induced (orange) 
samples over the rRNA array of chromosome 8. C) Screen shot of WT (pink) TbRH2A RNAi un-
induced (blue) and induced (orange) DRIP-seq signal over the procyclin expression locus.  
5.2.6 DRIP enriched decrease at Pol III transcribed genes in 
TbRH2ARNAi cells relative to WT 
Interestingly, the number of DRIP enriched regions found at RNA Pol III transcribed 
loci decreased in the TbRH2ARNAi parasites cultured in the presence or absence of 
tet compared to WT DRIP enriched regions. This was true for both tRNA and snRNA 
genes, and was comparable with the mapping observed for Tbrh1-/- parasites.  
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Figure 5.6 Fewer R-loops form over RNA Pol III transcribed snRNA and tRNA genes in the 
TbRH2A RNAi line.  
A) Bar graph showing the number WT, TbRH2A RNAi un-induced (tet -, grey striped) and induced (tet 
+, white dotted) DRIP enriched regions found over tRNA and snRNA genes. B) Screenshot of region 
on chromosome 10 where both an snRNA and tRNA are located. WT (pink), TbRH2A RNAi un-induced 
(blue) and induced (orange) DRIP-seq signal is shown. 
5.2.7 RNA-DNA hybrids form at UTRs and intergenic sequences 
DRIP-seq mapping in WT and Tbrh1-/- parasites revealed a strong correlation 
between hybrid formation and non-CDS sequences. Analysis of DRIP enriched 
regions within the RNA Pol II transcribed PTUs found this correlation is conserved in 
the TbRH2ARNAi cells, both induced and un-induced: ~58.3% and ~60.1% of DRIP 
enriched regions overlapped most extensively with intergenic sequences in un-
induced and induced TbRH2ARNAi parasites, respectively. This was slightly increased 
from the 50.7% of intergenic sequence-associated DRIP enriched regions found in 
WT. The number of 5’ UTR, 3’ UTR and CDS-associated DRIP enriched regions all 
decreased in the un-induced sample compared to WT and decreased again in the 
RNAi-induced sample relative to un-induced. Visualisation of DRIP signal across the 
PTUs showed the pattern of association of DRIP signal peaks and non-CDS sequences 
is remarkably conserved between the WT, TbRH2ARNAi un-induced and induced 
samples (Figure 5.7).  
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Figure 5.7 Distribution of DRIP-seq enriched regions over the PTU genomic elements. 
 Above: The association of WT DRIP enriched regions found within the RNA Pol II transcribed PTUs is 
shown as the proportion mapping to  intergenic, CDS or UTR sequences in WT, TbRH2A RNAi un-
induced (tet -) and induced (tet +) samples. Below: Screen shot of RNA Pol II transcribed protein-
coding genes in an area of chromosome 2. WT DRIP-seq signal is shown in pink, TbRH2A RNAi un-
induced (tet -) in blue and induced (tet +) in orange; scale bars show enrichment in DRIP relative to 
input, as in previous figures. 
DRIP-seq signal was plotted as a heatmap and profile summary of all RNA Pol II 
transcribed protein-coding genes for both the tet – and tet + DRIP data (Figure 5.8). 
The WT heatmap and profile are also shown for comparison. In all three cases, 
distinctive peaks of read enrichment in the 5’ and 3’ regions flanking the CDS were 
conserved. In the WT metaplot profile, DRIP signal remained at a value of ~1 across 
the CDS, meaning hybrids are predominantly lacking across RNA Pol II transcribed 
CDS (i.e. no enrichment in S9.6 IP vs input). In both the tet- and tet + profiles, the 
signal dips below 1, indicating that CDS sequences comprise a smaller proportion of 
the tet – and tet + IP libraries compared to input after normalisation. It is notable 
that the distance between the signal peaks at CDS flanks and the trough of signal 
across the CDS is greater in the tet – and tet + profiles compared to WT. 
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Interestingly, this distance was less in the tet + sample compared to tet -.  As 
observed in section 4.7.1, DRIP enriched regions correlated strongly with PAS in the 
non-CDS sequences, for both tet – and tet + DRIP data sets (Figure 5.8B and C).  
 
Figure 5.8 DRIP-seq signal is enriched over the 5’ and 3’ flanking sequences of each RNA Pol II 
transcribed CDS.  
A) Heatmaps of DRIP-seq signal, for WT and TbRH2A RNAi induced (tet +) or uninduced (tet -) 
samples, over each RNA Pol II transcribed protein-coding CDS, plus and minus 1 kb of flanking 
sequence. Metaplot profile summaries of the data are also shown above. Metaplots of the number of 
identified DRIP enriched regions per bp per gene (pink, left axis) and the number of PAS per bp per 
gene (blue, right axis) over scaled CDS regions plus 5 kb of flanking sequences in tet- (B) and tet + (C) 
samples. 
5.2.8 DRIP-seq signal deceases after RN2A depletion at sites of 
transcription initiation  
Unlike the data discussed above, investigation of DRIP-seq signal around SSRs 
revealed differences in signal between the tet-induced and un-induced cells. DRIP-
seq signal was plotted over each class of SSR: divergent, representing sites of 
transcription initiation in both sense and anti-sense directions; convergent sites of 
transcription termination; and head-to-tail SSRs, where transcription both 
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terminates and initiates.  In each case, WT DRIP-seq signal was plotted as a 
comparison. In all cases, DRIP-seq signal was highly comparable between the 
TbRH2A un-induced and WT samples: signal was lacking across most of the SSR but 
increased to form a distinct peak at the boundary where transcription is predicted 
to initiate (Figure 5.9). In convergent SSRs, where transcription terminates and 
does not initiate, no such peaks appeared. Unexpectedly, upon RNAi depletion of 
TbRH2A, DRIP-seq signal was reduced relative to both the un-induced and WT signal 
at both divergent SSRs and the regions associated with transcription initiation in 
head-to-tail SSRs (Figure 5.9). Again, this decrease in the RNAi-induced cells was 
not apparent in convergent SSRs; instead, signal here was greater after TbRH2A 
RNAi relative to WT, and comparable with un-induced (as was seen in non-SSR 
mapping; see above).These patterns were observable in track images of DRIP-seq 
signal at individual SSRs; several enriched peaks that were apparent in the un-
induced sample at the TSSs, were not evident at the equivalent sites of the tet-
induced sample.  Hence, TSS-associated R-loops were not apparent after TbRH2A 
knockdown. It should be noted that DRIP-seq signal peaks observed within the 
divergent and head-to-tail SSRs correspond to RNA Pol III transcribed tRNA and 
snRNA genes (Figure 5.9, red).   
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Figure 5.9 RNA-DNA hybrids are depleted at RNA Pol II transcription initiation sites after 
knockdown of TbRH2A.  
Average DRIP-seq signal is plotted for WT (pink), TbRH2A RNAi un-induced (tet -, blue) and induced 
(tet +, orange) data sets over divergent (upper), head-to-tail (centre) and convergent (lower) SSRs. In 
all cases 5’ and 3’ denote SSR boundaries defined by flanking transcript coordinates. Transcription 
direction is shown above the plots by dashed arrows. Standard error is shown as shaded regions. 
DRIP-seq signal screenshot examples of individual SSRs in each class is also shown to the right of 
each metaplot; CDS (thick black), UTR (thin black snRNA/tRNA genes (red) are shown below the 
DRIP-seq tracks. 
Next, SSRs were re-grouped according to whether they have additionally been 
identified as ORIs or not (Tiengwe et al., 2012), and the average DRIP-seq signal 
was plotted across the two groups. DRIP signal was slightly reduced in the profile of 
RNAi induced cells of both groups, indicating that it is the transcriptional status, 
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not replicative status, of the SSRs that dictate this change in DRIP signal (Figure 
5.10). 
 
Figure 5.10 Loss of RNA-DNA hybrids after TbRH2A depletion is not dependent on ORI status 
of the SSRs.  
WT (pink), TbRH2A RNAi un-induced (tet -, blue) and induced (tet +, orange) DRIP-seq average signal 
is plotted across SSRs which are also ORIs (upper left) and those which are not (lower left). Standard 
error is plotted as shaded regions. Screenshots of DRIP signal across two example SSRs for one ORI 
(upper) and one non-ORI (lower) are also shown.  
5.3 DNA damage occurs at sites of transcription initiation 
when TbRH2A is depleted 
ChIP-seq targeting histone variant γH2A was next employed to map sites of DNA 
damage in both tet-induced and un-induced cells. In this case, the analysis was 
conducted 24 and 36 hr post-induction (Figure 5.11, Figure 5.12 and Figure 8.5), 
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since IFA (Chapter 3) showed that γH2A signal increased between these time points 
after TbRH2A depletion.  For each condition, ChIP-seq coverage was normalised to 
the related input sample and plotted across the 11 Mb chromosomes (Figure 8.5). 
Extensive γH2A signal was observed across the RNA Pol II transcribed PTUs in all 
cases (Figure 8.5), and little difference was evident between samples.  This signal 
is presumably due to specificity of the anti-γH2A serum, which is added in excess to 
the IP reaction, resulting in binding not simply to Thr130 phosphorylated H2A but 
also to unphosphorylated, canonical H2A histone. Hence, in order to focus analysis 
upon changes after knockdown of TbRH2A expression (where increased γH2A 
staining has been demonstrated via IFA and western blot, Figure 3.17), the fold-
change in signal between input-normalised, induced and un-induced ChIP-seq 
coverage was calculated as a ratio for each time point (Figure 5.11 and Figure 
5.12).  Therefore, in this analysis, a value of 1 indicates no difference in γH2A ChIP-
seq coverage between induced and un-induced samples, whereas values >1 indicate 
γH2A enrichment after loss of TbRH2A.  
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Figure 5.11 γH2A binding occurs at RNA Pol II transcription initiation sites across the 11 mb 
chromosomes after TbRH2A knockdown.  
γH2A ChIP-seq signal increase in induced relative to un-induced is plotted across the Mb 
chromosomes, for 24 hr (pink) and 36 hr (green) induction. (Scale 1-3 fold-change). Upper track shows 
transcripts on sense (black) and antisense (red) strands. Lowest track shows tandem repeat 
sequences. 
Plotting of the ChIP-seq signal enrichment across the Mb chromosomes revealed 
clear peaks at potentially all known RNA Pol II transcription initiation sites (Figure 
5.11 and Figure 5.12). Dense γH2A binding is also clear across the repetitive 
subtelomic regions that house the VSG arrays (Figure 5.11). To ask how γH2A ChIP-
seq signal correlated with the transcription boundaries, signal was analysed across 
the three classes of SSRs, in order to compare sites of R-loop and γH2A enrichment.  
24 hr post-induction, the ratio of induced signal relative to un-induced remained at 
a value of ~1, indicating there was no γH2A formation (Figure 5.12). However, 36 hr 
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post-induction, average γH2A ChIP-seq signal raised ~1.2 fold after TbRH2A 
knockdown at both the head-to-tail and divergent SSRs, but not at the convergent 
SSRs. Notably, the signal increase covered the entirety of the divergent SSRs (and 
extended into the transcribed flanks) but was only seen around the regions of 
transcription initiation, not termination, at head-to-tail SSRs. Notably, this pattern 
shows a clear correlation with pronounced R-loop formation around SSR 
transcription initiation regions, as well as the SSR regions that showed reduced R-
loop levels after TbRH2A RNAi (Figure 5.10). 
 
Figure 5.12 DNA damage is associated with sites of transcription initiation after TbRH2A 
knockdown.  
Increased γH2A ChIP-seq signal in TbRH2A RNAi induced samples relative to un-induced is plotted for 
both 24 hr (pink) and 36 hr of RNAi induction. Average signal is plotted across divergent (left), head-to-
tail (centre) and convergent (right) SSRs. In all cases 5’ and 3’ denote SSR boundaries defined by 
flanking transcript coordinates. Transcription direction is shown above the plots with dashed arrows. 
Standard error is shown as shaded regions. γH2A ChIP-seq signal increase in induced relative to un-
induced cells is also shown plotted across chromosome 8, after 24 hr (pink) and 36 hr (green) 
induction (scale 1-3 fold-change). Upper track shows transcripts on sense (black) and antisense (red) 
strands and arrows highlight transcription direction. Lowest track shows tandem repeat sequences. 
5.4 Depletion of TbRH2A causes up-regulation of VSGs and 
down-regulation of small molecule biosynthesis 
pathways 
Next, RNA-seq analysis was performed to assess if changes in gene expression in T. 
brucei parasites was detectable after RNAi depletion of TbRH2A.  Total RNA 
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extraction was performed, in duplicate, using parasites that had been cultured for 
24 and 36 hr, both with and without tet-induction (section 2.3.1). RNA-seq libraries 
were generated using poly(A) selection (performed by C. Lapsley, section 2.3.4) and 
the resulting reads were mapped to the T. brucei 927 reference genome (performed 
by Dr. K. Crouch, section 2.8.4.1).  DESeq2 software was then employed to analyse 
the duplicate data and identify statistically significant, differentially expressed 
RNAs in the tet + samples relative to tet – at the two time points (performed by K 
Crouch, sections 2.8.5.2 and 2.8.5.3). Genes that showed differential expression 
were deemed significant if the assigned adjusted p value was < 0.05 (Figure 5.13).  
 
Figure 5.13 Volcano plots displaying differential expression of genes after TbRH2A knockdown.  
Each data point represents a gene; red genes were deemed significantly differentially expressed 
(adjusted p value < 0.05) relative to uninduced levels. X-axes shows the log2 fold-change between un-
induced and induced samples after 24 hr (left) and 36 hr (right) of culture, and Y-axes shows log2 
adjusted p value. Data was generated with two independent replicates for each condition. Significantly 
differentially expressed VSG genes are shown in blue, and all other genes in red. Not significant genes 
including VSGs are shown in black. (Plotted by Kathryn Crouch). 
Given the severe growth phenotype and large accumulation of DNA damage in 
TbRH2A depleted cells, differential expression of many genes might have been 
anticipated. However, RNA from only 32 genes was significantly differentially 
expressed after 24 hr of RNAi knockdown and all of these RNAs showed increased 
reads compared to un-induced samples (Figure 5.14, Table 8.1).  VSGs (5) and 
ESAGs (25) accounted for nearly all of this gene set, and the remaining two genes 
were procyclin-related (Figure 5.14).  These data, indicating altered expression of 
antigenic variation-associated and RNA Pol I-transcribed genes, are explored in 
more detail in chapter 6.  In fact, after 36 hrs tet-induction these effects were 
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more marked: from a total of 113 RNAs (Figure 5.14,Table 8.2) that showed 
significantly increased reads, 18 of the 32 genes seen at 24 hrs remained up 
regulated; and, in total, 37 VSGs and 14 ESAGs were up-regulated at 36 hrs, along 
with 10 procyclin and 10 RHS-associated genes (Figure 5.14).  Amongst the 
remaining 42 genes with significantly increased RNA, 14 encode hypothetical 
proteins, 4 were listed as GRESAGs (genes relating to ESAGs), and a SLAC reverse 
transcriptase and a centrosomal spinal body protein, CEP44, was detected (Table 
8.2).  
 
Figure 5.14 Classes of genes up-regulated after TbRH2A knockdown.  
The number of genes up-regulated in tet-induced TbRH2A RNAi parasites after 24 (left) and 36 hr 
(right) of growth that are annotated at VSGs, ESAGs, procyclin, RHS-associated and other genes. 
Total number of genes up-regulated genes are shown below. For full list of genes and associated 
statistics see Table 8.1and Table 8.2.  
In contrast to the exclusive increase in RNA after 24 hrs of TbRH2A RNAi, 396 genes 
were instead found to be down-regulated after 36hr, of RNAi induction (Table 8.3). 
Using this set of genes, along with the 113 found to be up-regulated, gene ontology 
(GO term) analysis was performed to investigate the biological processes which are 
affected after 36 hrs of TbRH2A knockdown (section 2.8.5.5). GO terms were 
plotted as a network, where each node represents a GO term and connecting edges 
show hierarchical relationships. All terms over-represented in the down-regulated 
(orange) or up-regulated (green) genes were plotted, where colour intensity 
corresponds with adjusted p value (Figure 5.15). In both cases, GO terms were 
deemed significantly enriched if an adjusted p value < 0.01 was found.  Consistent 
with the predominance of VSGs and ESAGs, antigenic variation and parent GO terms 
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were enriched in the up-regulated set of genes. Down-regulated biological 
processes appeared more diverse, but small molecule biosynthetic processes were 
the most significantly down-regulated term.  Branches of this term include several 
relating to the synthesis or salvage of both nucleotides and ribonucleotides, 
particularly purines. Other terms involve the metabolic processing of other small 
molecules, including cellular carbohydrates, ketones and organic acids. Lastly, 
cytoskeleton organisation, cellular component movement and molecule transport 
were also down-regulated upon depletion of TbRH2A (Figure 5.15).
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Figure 5.15 Gene ontology analysis reveals antigenic variation is up-regulated and small molecular biosynthesis down-regulated after TbRH2A 
knockdown.  
Biological process GO terms linked to genes significantly up- or down-regulated after 36 hr induction of TbRH2A RNAi, as well as parent terms, are plotted 
as a network. Those enriched in up-regulated and down-regulated genes are coloured green and orange, respectively. Colour intensity indicates 
significance as adjusted p values.  Values > 0.01 are not significant (white).
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5.5 Discussion 
In this chapter the data provide several insights into R-loop and RNase H2 function 
in T. brucei. The first insight is the relatively rigid nature of R-loop localisation 
across the T. brucei genome. DRIP-seq mapping of RNA-DNA hybrids across the Mb 
chromosomes reveals surprisingly little change in the structures’ enrichment after 
tet-induction of TbRH2A depletion, despite the pronounced growth defects that are 
seen and the severe damage accumulation. Specifically, similar numbers of DRIP 
enriched regions located within the RNA Pol II transcribed PTUs are seen before and 
after RNAi, and inside these regions R-loops are found predominantly around PASs, 
without pronounced change after loss of TbRH2. Furthermore, the same widespread 
R-loop localisation in the flanking regions of CDSs is also observed in both WT and 
Tbrh1-/- parasites. This highly reproducible signal pattern highlights that R-loops 
consistently form across these regions and are not readily displaced, although the 
mechanism linking PASs and R-loops cannot be elucidated at the point. Although it 
is likely that RNase H2 is able to target these intergenic R-loops, along with RNase 
H1, this cannot be fully concluded from the data presented, since the R-loops 
appear to be detected in similar numbers at these regions in both TbRH2A RNAi 
induced and un-induced samples, as well as in Tbrh1-/- mutants.  
However, it should be noted that the necessary scaling of library sizes during 
normalisation of IP coverage to input coverage, means any global increases or 
decreases in R-loop formation within the sampled populations may be masked. 
Indeed, the addition of spike-in chromatin has been used elsewhere to allow 
normalisation of input and IP library sizes using the sequence depth of alignments 
to an exogenous genome instead. This additional control enabled the detection of 
globally reduced histone H3 lysine-79 di-methylation (H3K79me2) and H3K27 tri-
methylation (H3K27me3) in human cells treated with inhibitors of 
methyltransferases DOT1L and  EZH2, respectively (Orlando et al., 2014; Egan et 
al., 2016).  Since inter-CDS sequences are the major site of R-loops in the T. brucei 
genome, undetected global changes may similarly be masked here. Hence, a direct 
quantitative comparison between the WT, TbRH2A RNAi and Tbrh1-/- DRIP mapping 
cannot confidently be made without the additional of spike-in controls that would 
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allow libraries to be scaled to an unaffected factor. Masking of global changes may 
in fact explain why both tet – and tet + differ from WT mapping, presumably due to 
leaky RNAi expression, yet few differences are observed between induced and un-
induced samples. Nonetheless, it should be noted that clear and localised changes 
in deposition of γH2A can be detected by ChIP, and that these changes correlate 
with potentially altered R-loop abundance at TSSs, perhaps indicating disruption of 
transcription. 
Despite the above concerns about DRIP-seq quantification, regions that do or do not 
form R-loops in the different cells can be compared between DRIP samples via the 
presence or absence of signal peaks, irrespective of their enrichment level. In this 
case, several regions house a greater number of R-loop forming sites (DRIP enriched 
regions) in both the tet- and tet + parasites compared with WT. These regions 
include the subtelomeric VSG arrays, RNA Pol I transcribed genes and RHS-
associated genes. Interestingly, the same regions show increased DRIP enriched 
regions after null mutation of TbRH1, and so both classes of T. brucei RNase H are 
likely to target R-loops at these sites. This is most intriguing for the VSG array 
regions and RNA Pol I transcribed genes, which includes the BESs. This finding is 
investigated more thoroughly in chapter 6.  Also in common with Tbrh1-/- DRIP-seq 
analysis, is the apparent reduction of R-loop formation over RNA Pol III transcribed 
tRNA and snRNA genes. However, DRIP-qPCR analysis revealed RNA-DNA hybrids are 
more likely increased after TbRH1 loss and that normalisation of DRIP-seq library 
sizes masked such an increase. It may be the case that hybrids also increase over 
tRNA and snRNA genes after depletion of TbRH2A, but this requires investigation 
with DRIP-qPCR and spike-in controls. Importantly, as all these changes are 
observed after loss of either RNase H type, R-loop-related defects in these regions 
are unlikely to explain why TbRH2A is essential and TbRH1 is not.   
As discussed in the introduction, the evidence that RNase H2 is essential in T. 
brucei differs from the non-essential nature of the enzyme complex in yeast and is 
perhaps more comparable to mammals. However, is the basis for the importance of 
RNase H2 the same in both cases? It seems unlikely that the essentiality of TbRH2 
lies in a role in either replicating or segregating the genome. R-loops have been 
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implicated in initiation of DNA replication (Lombraña et al., 2015), but DRIP-seq 
could not distinguish patterns of R-loops in SSRs regions that act as origins in T. 
brucei compared with those that do not (Tiengwe et al., 2012). Furthermore, loss 
of TbRH2A did not appear to impede uptake of EdU, arguing for continued DNA 
replication in the absence of the RNase H enzyme. R-loops were also found 
abundantly at centromeres, perhaps arguing that they play are role in chromosome 
segregation (Kabeche et al., 2018), but potentially increased abundance was seen 
after TbRH2A RNAi and in TbRH1 null mutants, despite the differences in 
importance of the RNase H enzymes. The clearest set of data that indicates a 
potentially specific and critical role for TbRH2 is that which has linked the TbRNase 
H2 complex to R-loop dynamics specifically at RNA Pol II transcription initiation 
sites. DRIP-seq mapping revealed a loss of peaks at TSSs within divergent and head-
to-tail SSRs. Importantly, this reduction is unique to regions of transcription 
initiation, not termination, and is seen irrespective of whether or not the SSR is also 
an ORI. Upon first consideration this finding appears counterintuitive, since loss of 
the action of an RNase H protein that processes R-loops might be expected to cause 
an increase in R-loop abundance. Indeed, loss of R-loop formation at the TSSs may 
be an artefact of normalisation if global changes have occurred after tet-induced 
RNAi. However, several data argue against this concern. Firstly, the R-loop 
decrease after TbRH2 RNAi is unique to the Pol II TSSs within the SSRs; at most 
other locations in the genome DRIP-seq signal enrichment remains comparable 
between tet – and tet + samples (and in some circumstances shows an increase 
compared with WT), and the anomalous decreases seen at RNA Pol III genes is 
common to both tet -and tet + samples relative to WT.  Secondly, γH2A mapping via 
ChIP-seq reveals TSSs as highly discrete, prominent sites of putative DNA lesions 
specifically after TbRH2A knockdown. Lastly, data discussed in chapter 4 clearly 
links R-loop formation with RNA Pol II transcription initiation sites, as WT DRIP-seq 
signal correlates with epigenetic markers of transcription initiation (H2A.Z, H2B.V, 
H4K10ac and BDF3 binding; Figure 4.21).  
Taken together, the DRIP-seq and γH2A ChIP-seq data suggest a highly localised 
association between R-loops and DNA damage at TSSs. It is hard to imagine such a 
localised effect is due to increased incorporation of ribonucleotides due to TbRH2 
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loss, and instead the altered pattern of DRIP-seq signal argues for changed 
processing of R-loops leading to damage. As DRIP-seq was performed after 24 hr of 
TbRH2A knockdown, yet γH2A binding at TSSs doesn’t appear to occur until 36 hr of 
knockdown, it may be the case that DNA lesions form after R-loops have been 
disrupted in some manner at the TSSs. There are several plausible explanations for 
this, all of which assume RNase H1 is unable to efficiently target initiation-
associated R-loops. In the absence of the RNase H2 complex it may be the case that 
initiation-associated R-loops become fragile sites, vulnerable to breakage, due to 
action of other R-loop processing enzymes. For example, flap endonucleases, which 
are able to target the structures at either end of R-loops, might generate either 
single- or double-stranded DNA breaks (Sollier et al., 2014). A second possibility is 
that persistent R-loop formation behind an RNA Pol II primed for transcription could 
lead to transcriptional stalling. This structural change to the local chromatin may 
alone be sufficient to cause DNA breakage, or the stalled transcription machinery 
might pose a significant barrier to DNA replication forks. As discussed in section 
1.4.2.4, R-loops are known to accumulate at sites of transcription-replication 
clashes and such clashes have been shown to generate single- or double-stranded 
breaks (Hamperl et al., 2017; Lang et al., 2017). One reason the SSRs may be a 
pronounced site of such collisions in T. brucei is the known co-localisation of ORIs 
with SSRs (Tiengwe et al., 2012). This is complicated, however, because although 
all SSRs appear to bind at least one component of the Origin Recognition Complex, 
not all SSRs are activated as origins. Despite this, the DRIP-seq data suggests all 
TSSs accumulate damage, not simply those that are ORI-active. In addition, damage 
is not seen at convergent SSRs, and ORI activity has been described at a small 
number of these SSRs. All of these scenarios lead to destruction of the RNA-DNA 
hybrid and subsequent generation of DNA lesions, perhaps explaining the reduced 
levels of R-loops, as other activities are recruited to resolve the problems.  
γH2A mapping also reveals lower level, sporadic DNA damage across the Pol II PTUs. 
If TbRNase H2 does indeed have a role in resolving R-loops generated behind 
transcribing polymerases, it is plausible that similar events generate DNA damage 
behind RNA Pol II units that have become stalled within the PTU, like at the TSSs. 
Experiments assessing RNA Pol II movement across the PTUs in parasites depleted of 
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TbRH2A may help to investigate this further. It is also likely that ribonucleotide 
load is increased in parasites depleted of TbRH2A, as demonstrated in RNase H2-
null mice (Hiller et al., 2012; Reijns et al., 2012). Although this requires 
experimental investigation, an increased load of ribonucleotides may result in DNA 
damage across the heavily transcribed genome of T. brucei. However, a lack of a 
functional RER pathway is unlikely to explain such localised damage to the RNA Pol 
II TSSs.  
Gene expression profiling via RNA-seq revealed perhaps surprisingly few changes in 
the transcriptome of TbRH2A depleted cells. However, two observations can be 
made. Firstly, changes in VSG and ESAG expression highlight a role of R-loops in VSG 
switching; a finding explored in more detail in chapter 6 of this thesis. Secondly, 
nucleoside biosynthesis and salvage pathways are predicted to be down-regulated 
after TbRH2A depletion, in particular purines pathways. The most likely reason for 
this is a negative feed-back mechanism trigged by excess nucleotides or 
ribonucleotides in the cells (Berg et al., 2002). Indeed pyrimidine biosynthesis and 
salvage pathways are well documented in trypanosomatids (Tiwari and Dubey, 
2018), and negative feedback has been shown to operate in Crithidia fasciculata 
where UTP, UDP and CTP inhibit the first enzyme of the de novo pyrimidine 
biosynthesis pathway, carbamoyl phosphate synthetase II (CPSII) (Aoki and Oya, 
1987). In contrast, T. brucei like other trypanosomatids, lacks de novo purine 
biosynthesis pathways and relies upon purine salvage (Ceron et al., 1979; Berens, 
Krug and Marr, 1995; Boitz et al., 2012). Interestingly, excess cytosolic DNA is also 
detected in mouse cells carrying a mutation of the RNase H2A subunit (Pokatayev et 
al., 2016). In both cases, the question remains, where does the excess nucleic acid 
originate? In T. brucei, GO terms involving both nucleotide and ribonucleotide 
metabolic pathways are enriched within the genes down-regulated after TbRH2A 
depletion. Indeed, both may originate from the aberrant breakdown of R-loops in 
absence of the RNase H2 complex.  
Together, the data in this chapter highlight a potential role of RNase H2 in the 
turnover of R-loops specifically associated with RNA Pol II transcription initiation. 
Although this possibility would be an exciting avenue of investigation in the future, 
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the involvement of the RER pathway must first be investigated. It remains possible, 
if not highly probably, that ribonucleotide load into the DNA genome of T. brucei 
parasites lacking TbRH2A is increased, which would be strongly predicted to cause 
some level of disruption. Indeed, PCF T. brucei cells lacking uracil-DNA glycosylase 
(UNG), which specifically removes uracil from the DNA genome, display 
hypermutation rates due mainly to GC to AT transitions and insertions as a 
consequence of increased uracil load (Víctor M. Castillo-Acosta et al., 2012). 
Although loss of UNG alone is well tolerated, combined depletion of deoxyuridine 
5’-triphosphate pyrophosphatase (dUTPase) that is responsible for removing dUTP 
from the deoxribonucleotide pool, causes proliferation defects and higher mutation 
rates in BSF parasites (Víctor M Castillo-Acosta et al., 2012). However, embedded 
ribonucleotides are unlikely to lead to the localised DNA lesions observed in TbRH2A 
depleted T. brucei and so it remains likely that impaired R-loop processing due to 
loss of TbRH2A is the primary cause of the localised DNA damage observed here. 
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6 R-loop formation can drive VSG switching
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6.1 Introduction 
As discussed in section 1.3, VSG switching can occur via a number of routes, be they 
transcription- or recombination-based, and a number of factors have been 
implicated in the processes (reviewed by McCulloch, Morrison, and Hall 2015). 
However, the events that trigger such switching are unclear. Several studies 
support a role for DSBs in initiating VSG switching via recombination, the foremost 
of these involving the insertion of an endonuclease, ISceI, recognition sequence 
with the BESs and expression of ISceI to experimentally induce DSBs (Boothroyd et 
al., 2009).  Increased levels of switching through gene conversion were 
subsequently observed. Interestingly, the elevated levels of switching were 
dependent upon location of the ISceI recognition site to between the 70-bp repeats 
and VSG coding regions, and deletion of the 70-bp repeats abolished switching 
induction, though paradoxically a later study suggested the opposite: the loss of the 
70-bp repeats increased VSG switching (Hovel-Miner et al., 2016). Additionally, the 
use of ligation-mediated PCR in WT parasites lacking ISceI recognition sequences, 
led to the detection of DSBs within the 70-bp repeats of the actively transcribed 
BES. DSBs were less detectable within the inactive BESs and ESAGs (Boothroyd et 
al., 2009). This study therefore implied both the 70-bp repeats and active 
transcription by RNA Pol I as key factors for VSG switching via gene conversion. A 
later study by Glover and colleagues added to, and somewhat clouded this picture, 
showing by ligation-mediated PCR that DSBs are not limited to the 70-bp repeats or 
the active BES, but confirming that ISceI-mediated DSB formation leads to induction 
of VSG switching when the lesions were positioned near the 70-bp repeats, and not 
when at the BES promoter or downstream of the VSG (Glover, Alsford and Horn, 
2013). 
It is therefore considered possible that, as well as providing homologous sequence, 
the 70-bp repeats may have an active role in promoting DSBs leading to VSG 
switching. How such a pathway could operate, however, is less clear. Genetic 
manipulation of the 70-bp repeat regions in the ISceI expressing T. brucei cell line 
led to the hypothesis that 70-bp repeats even have a role in VSG selection (Hovel-
Miner et al., 2016). DSB induction in the active BES containing a shorter repeat 
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region led to recombination using other BES-housed VSGs as the donor sequences 
for gene conversion, whereas switching events in cells containing longer 70-bp 
repeat sequences occurred more frequently with VSGs associated with mini-
chromosomes or undetermined sites (Hovel-Miner et al., 2016). It is worth noting 
that these studies rely on artificially induced VSG switching and, indeed, deletion of 
the 70-bp repeats was not found to impede low levels of VSG switching observed 
during in vitro culture of unperturbed T. brucei (McCulloch, Rudenko and Borst, 
1997).  
In either case, the proposed model of 70-bp repeat induced VSG switching raises 
the question of how the repeat region may elicit formation of a DSB. One possibility 
is that an endonuclease enzyme cleaves this region (Barry, 1997), yet no such 
native endonuclease has been discovered to date. Alternatively, as active 
transcription appears to be required, is has been suggested that transcription-
associated breakage might trigger VSG switching (McCulloch, Morrison and Hall, 
2015).  Lastly, it has been proposed that the 70-bp repeats may be able to stall 
replication, leading to fork collapse and DSBs (McCulloch, Morrison and Hall, 2015). 
That replication might be a driver of such a form of initiation is consistent with the 
active BES, unlike all silent BES, being replicated early in S phase (Devlin et al., 
2016), and with the effects of RECQ2 (Devlin et al., 2016), TOP3alpha (Kim and 
Cross, 2010) and RMI1 (Kim and Cross, 2011) mutation.  
Another feature of the BESs that may promote recombination-based VSG switching 
is their proximity to the telomeric repeats (discussed in section 1.3.3.3). Indeed, 
ligation-mediated PCR suggested that all BESs are fragile, in particular in regions 
adjacent to the telomeric repeats (Glover, Alsford and Horn, 2013). In addition, 
critically short telomeres, at least in telomerase-deficient cells, are associated with 
higher rates of VSG switching (Hovel-Miner et al., 2012). Interestingly, models of 
VSG switching induced by the 70-bp repeats or the telomeric repeats are not 
necessarily mutually exclusive (McCulloch, Morrison and Hall, 2015). However, how 
each may contribute to in vivo switching, and how they may impact upon VSG donor 
sequence selection here, remains to be investigated.  
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One way in which transcription events can lead to DSBs is via the generation of R-
loop structures (reviewed by Sollier and Cimprich 2015). Elevated levels of R-loop 
formation are documented in many RNA biogenesis mutants, coinciding with 
increased DNA damage (see section 1.4.2.2). However, R-loops are also likely to 
lead to DSBs in unperturbed cells. Largely, it is thought that the R-loop structure 
alone is insufficient to generate breakage and a secondary event is required. Again, 
several pathways have been suggested to take part in such events. These include 
the involvement of ssDNA targeting enzymes, processing by flap endonucleases and 
clashes with replication machinery (Sollier and Cimprich, 2015).  
The ssDNA element of R-loops provides an ideal substrate for specific nucleases, 
including activation-induced cytidine deaminase (AID). AID promotes the conversion 
of cytosine residues to uracil specifically within ssDNA, leaving the site sensitive to 
the action of uracil DNA glycosylase, a base excision repair enzyme. Removal of the 
uracil base by the glycosylase then results in a DNA lesion. This is known to occur at 
the Ig locus of mature B lymphocytes, where an R-loop is formed. Subsequent 
processing of both the non-template and template strands of the structure, results 
in the DSB required to induce Ig class switching recombination (Basu et al., 2011).  
R-loop formation also results in nucleic acid flaps at either side of the hybrid that 
may be processed by structure-specific endonucleases (Sollier et al., 2014).  Human 
flap endonucleases XPF and XPG (xeroderma pigmentosum types F and G) actively 
process R-loops that form in RNA-processing or topoisomerase I mutant cells, into 
DSBs (Sollier et al., 2014). As these enzymes normally generate a ssDNA gap during 
the nucleotide excision repair (NER) pathway, it is possible that they act similarly 
at R-loop structures and a second event results in DSBs (Sollier and Cimprich, 2015). 
Alternatively, the enzymes may detect both DNA strands of the R-loops and directly 
generate DSBs, as supported by in vitro studies showing cleavage of both sense and 
anti-sense strands by purified XPF and XPG (Tian and Alt, 2000).  
Lastly, as discussed in section 1.4.2.4, clashes between transcription-associated R-
loops and replication machinery lead to DSBs. Replication has been found to be 
necessary for R-loop-induced DNA damage in several circumstances. This includes in 
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yeast THO mutants, where transcription during S-phase is required for the 
associated hyper-recombination phenotype (Wellinger, Prado and Aguilera, 2006), 
and in ASF or TOP1 null mutant human cells, where DSBs are dependent upon 
replication (Tuduri et al., 2009; Gan et al., 2011). Importantly, these models are 
not mutually exclusive and, in fact, could operate in succession to process an R-
loop into a DSB. Indeed, R-loop-induced DNA damage in ASF mutant human cells, 
which is dependent on replication (Gan et al., 2011), is suppressed by knockdown of 
XPG expression (Sollier et al., 2014), implying the involvement of both DNA 
replication and flap endonucleases (Sollier and Cimprich, 2015).  
6.1.1 Chapter aims 
As R-loops have been shown to induce DSBs, in some cases leading to recombination 
events, the aim of this chapter was to ask if R-loops are able to drive VSG switching 
in T. brucei. DRIP-seq mapping to each BES was used to assess R-loop formation in 
WT cells and in cells lacking either RNase H1 or RNase H2A. VSG switching was also 
assessed in these mutant cells via RT-qPCR, immunofluorescence assays and RNA-
seq. Lastly, уH2A histone binding across the BESs was investigated via ChIP-seq to 
ascertain whether R-loop formation in absence of RNase H activity could result in 
DNA damage, capable of triggering VSG recombination events.
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6.2 TbRH1 and VSG switching 
As discussed in Chapter 3, homozygous knockout Tbrh1-/- parasites propagate 
though the cell cycle at the same rate as WT parasites and so loss of the enzyme 
does not appear deleterious to BSF T. brucei.  Deletion of the gene is, however, 
associated with increased levels of R-loops, as demonstrated by DRIP-seq and DRIP-
qPCR (Chapter 4), including within the centromere repeats, rRNA loci, and 
potentially across the RNA Pol II transcribed PTUs. Classification of DRIP enriched 
regions additionally revealed an increase in R-loop formation within the VSG array 
regions of the Mb chromosomes in Tbrh1-/- parasites.  In this section, DRIP-seq 
mapping in the BESs was analysed in WT and Tbrh1-/- cells, as well as levels of VSG 
switching and BES-associated DNA damage. 
6.2.1 BES-associated R-loop formation in the absence of TbRH1 
DRIP-seq reads for WT and Tbrh1-/- cells were mapped across all 14 distinct BESs 
previously identified and sequenced by Hertz-Fowler et al. (2008). To ensure 
Illumina reads were only mapped to the correct BES, MapQ filtering was applied 
(section 2.8.4.1) as described by (Hutchinson, Glover and Horn, 2016) to remove all 
multi-mapping reads. Little WT DRIP-seq signal was observable across any BES in WT 
cells, although signal enrichment was clear at the telomere-proximal terminus of 
each BES contig (Figure 6.1). These peaks of DRIP-seq signal likely represent 
telomeric R-loops, or TERRA (Cusanelli and Chartrand, 2015; Nanavaty et al., 2017).  
In contrast, multiple DRIP-seq signal peaks were observable across all BESs in 
Tbrh1-/- cells, most notably across the 70-bp repeat regions (purple boxes, Figure 
6.1). In contrast with the predominant localisation of R-loops to inter-CDS regions in 
the RNA Pol II PTUs (Chapter 5), there was less evidence for such discrete 
localisation in the BES, whether active or silent. 
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Figure 6.1 R-loops form across the BESs after TbRH1 loss. 
Localisation of R-loops by DRIP-seq in WT and Tbrh1-/- BSF cells. DRIP-seq signal is shown mapped 
to BES1 (the predominantly active BES of WT cells) and other mainly inactive BESs. Pink and green 
tracks show normalised ratios of read-depth fold-change (1-3 fold) in IP samples relative to input in WT 
and Tbrh1-/- mutants, respectively, while the orange tracks show the ratio of IP enrichment in Tbrh1-/- 
cells compared with WT. Promoters (aqua), ESAGs (blue, numbered), 70-bp repeats (purple) and 
VSGs (red) are annotated as boxes; pseudogenes are indicated (ψ), and the end of the available ES 
sequence is denoted by a black circle.  
To validate enrichment of RNA-DNA hybrids within the BESs, DRIP-qPCR was 
performed on two independent DRIP replicates (Figure 6.2). Primers targeting 
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ESAG6, ESAG8, VSG221 and VSG121 coding regions were used to amplify sequence in 
both the input and IP samples. The percentage of each sequence contained within 
the input that was the recovered during the IP reaction was calculated to indicate 
levels of DNA-RNA hybrid formation at these regions.  In addition, a second IP 
reaction was set up in parallel, per experiment, and was treated with E. coli RNase 
HI to degrade RNA within the hybrids, and so reduce binding to the S9.6 antibody 
(section 2.6.3).  In all cases, increased input percentage was seen in Tbrh1-/- 
samples compared to WT, and the addition of E. coli RNase HI depleted this signal. 
Thus, the DRIP-qPCR validates the increased DRIP-seq mapping within the BES of 
the Tbrh1-/- mutants (Figure 1.1) and shows this signal is due to R-loops. 
 
Figure 6.2 DRIP-qPCR confirms R-loop formation after TbRH1 loss.  
DRIP-qPCR, with or without E. coli RNase HI (EcRHI) treatment, showing the percentage of PCR 
amplification in the IP sample relative to input for WT cells (pink) and Tbrh1-/- mutants (green); error 
bars display SEM for at least three technical replicates and data are shown for two biological replicates 
(1 and 2). 
To analyse patterns of DRIP signal more thoroughly, the BESs were divided into 
three regions: the ESAG containing region from the 5’ end of each BES to the 70-bp 
repeats; the 70-bp repeats and 500 bp of upstream and downstream flanking 
sequences; and the VSG, again with 500 bp of flanking sequence (Figure 6.2). In 
each case, the isolated region of each BES was scaled and DRIP-seq signal plotted 
per BES as a heatmap for both WT and Tbrh1-/- samples (Figure 6.2, upper panels). 
Additionally, K-means clustering analysis was performed to ascertain whether DRIP-
seq signal differed between the normally active BES (BES1) and the other, silent 
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BESs across each of these three regions.  K-means clustering separates samples (in 
this case each BES) into a specified number of clusters (here two) according to each 
sample’s signal distance from the mean of each cluster. Where BESs were 
successfully clustered into active (cluster 2, aqua) and silent (cluster 1, blue), the 
average signal of each cluster was plotted separately as metaplot profiles above the 
heatmap. Where clustering was unsuccessful, the average signal of all 14 BESs was 
plotted. 
In WT cells, DRIP-seq signal peaks were largely absent across the ESAG-containing 
portions of each BES (Figure 6.3, left). However, in Tbrh1-/- cells there was a broad 
increase in signal across the region. Interestingly, K-means analysis successfully 
separated active BES1 (cluster 2) from all other silent BESs (cluster 1), indicating 
signal differed between these two groups. Separate comparison of the average 
DRIP-seq signal for WT (purple) and Tbrh1-/- (green) samples in the silent and 
active BESs, indicates a slightly greater increase in RNA-DNA hybrid formation in the 
active site upon loss of TbRH1 (Figure 6.3 lower panel). However, it is notable that 
there is only one active BES and 13 silent under consideration, and so significance 
cannot be confidently assigned. K-means clustering of the 70-bp repeat regions also 
resulted in separation of the active and silent BESs (Figure 6.3, centre). Here the 
difference in signal between these groups was more clearly seen, even in the WT 
DRIP-seq sample. The signal across the silent BESs in the WT sample was notably 
depleted across the 70-bp repeats, in comparison with the surrounding regions 
(Figure 6.3, navy). Signal across the actively transcribed 70-bp repeats, however, 
displayed a slight peak in signal (Figure 6.3, aqua), suggesting low levels of R-loops 
form here in WT T. brucei. In Tbrh1-/- cells, hybrid formation clearly increased 
across the 70-bp repeats of both active and inactive BESs, although the signal 
profiles were again markedly different. DRIP-seq signal clearly increased across the 
entire length of the 70-bp repeats after TbRH1 loss in the inactive BESs. However, 
in the active site DRIP-seq signal increased mainly in the upstream portion of the 
repeats, before depleting in the downstream portions, and thus following the 
direction of transcription.
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Figure 6.3  R-loops form most distinctly across the 70-bp repeats.  
DRIP-seq signal fold-change (IP relative to input samples; y-axes) plotted as heatmaps and average signal profiles over BES regions encompassing the 
ESAGs, 70-bp repeats and VSG; for each region, 5’ and 3’ (x-axes) denote the upstream and downstream boundaries, and in some cases -/+ 0.5 kb of 
flanking sequence is shown. Upper two panels: comparison of WT and Tbrh1-/- DRIP-seq signal using K-means clustering, which separated the active (light 
green, cluster 2) and inactive (dark blue, cluster 1) BES when analysing ESAGs and 70-bp repeats, but not VSGs. Lower panels: Overlay of WT (purple) 
and Tbrh1-/- (green) DRIP-seq signals in the three BES regions, with the active and silent BES displayed separately for the ESAGs and 70-bp repeats.
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DRIP-seq signal was not significantly different between the active and inactive BES 
VSGs in either the WT or Tbrh1-/- enrichment profiles, as K-means clustering failed 
to separate the genes in each analysis (Figure 6.3, right). In all cases, DRIP-seq 
signal was slightly depleted across the VSG coding regions. In the WT samples, there 
was signal enrichment downstream of the VSG that, as discussed, is mostly likely 
due to telomeric R-loops.  Upon loss of TbRH1, this telomeric DRIP-seq signal 
increased, as did signal upstream of the VSG, perhaps due to signal enrichment 
across the 70-bp repeats (which are positioned 5’ to the VSG coding regions).  
6.2.2 Levels of VSG switching increase after TbRH1 is deleted 
To ascertain whether the increased R-loop formation in Tbrh1-/- parasites’ BESs 
compared to WT parasites could elicit VSG switching, changes in VSG expression 
were compared between populations, both at the transcript and protein level.  
6.2.2.1 Normally silent VSGs are transcribed in Tbrh1-/- parasites 
RT-qPCR targeting the constitutively active VSG221 and a selection of other, 
normally silent BES-associated VSGs, was used to ask if changes in VSG transcript 
levels occur in Tbrh1-/- parasites relative to WT. After knockout of TbRH1, RNA 
levels of VSG221 were reduced below that of the WT level (Figure 6.4). In addition, 
RNA levels of five normally silent VSGs (VSG121, VSG800, VSGT3, VSG13 and 
VSG224) were increased between ~ 1.25 and 2.25-fold-change relative to WT levels 
(Figure 6.4), indicating silent VSGs are expressed after TbRH1 loss in a small 
proportion of the population.  
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Figure 6.4 Loss of TbRH1 results in increased transcription of silent BES-associated VSGs.  
Left: Simplified diagram of BES used to generate a protective surface coat in the bloodstream T. brucei 
cells; only telomere-proximal VSGs (coloured boxes, numbered) from a selection of BES are shown, 
and the single BES being actively transcribed (encoding VSG221, pink) is denoted by an arrow 
extending from the promoter (flag). Right: Graph of VSG RNA levels (corresponding to the BES 
diagram, and determined by RT-qPCR) in Tbrh1-/- cells, plotted as fold-change relative to levels of the 
cognate VSG RNA in WT cells; * indicates VSG221 is in the active BES of wild type cells, and error 
bars show SEM for three independent experiments. 
To corroborate these findings, RNA-seq was performed using RNA extracted from 
WT and Tbrh1-/- parasites and reads where mapped, again with MapQ filtering, to 
the 14 BESs (Hertz-Fowler et al., 2008) as well as to a collection of 2470 VSG coding 
regions documented in T. brucei Lister427 (Cross, Kim and Wickstead, 2014). RNA-
seq reads are shown mapped to active BES1 and inactive BES3, as well as the VSG 
coding regions associated with the remaining 12 BESs, in Figure 6.5. Mapping to 
BES1 showed this BES is the most actively transcribed in the WT and Tbrh1-/- 
parasites, since the greatest numbers of reads, for every gene, were seen here. 
Mapping to the silent BESs revealed an increase in reads that mapped to some 
associated VSGs in the Tbrh1-/- sample compared to WT cells. This increase was 
most striking for VSG121, VSG8 and VSG11. Curiously, mapping to VSG224 (in BES7), 
which increased in expression by RT-qPCR, revealed fewer reads in the Tbrh1-/- 
sample (Figure 6.5), though it should be noted that the populations used for RT-
qPCR and RNA-seq are distinct. 
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Figure 6.5 RNA-seq reveals transcription of silent BES-housed VSGs after loss of TbRH1.  
Plots of normalised RNA-seq read depth abundance (y-axes) relative to CDS position (x-axes) are 
shown in WT and Tbrh1-/- cells for the complete BES housing VSG221 and VS121, and for just the 
VSGs housed within the remaining BES identified by (Hertz-Fowler et al., 2008); VSG identity numbers 
are from (Cross, Kim and Wickstead, 2014).  
In some cases, reads were also detected that aligned to silent, non-BES associated 
VSG coding regions (Figure 6.6). RPKM was calculated for each VSG in the collection 
and fold-change in RPKM of the Tbrh1-/- sample relative to the WT sample was 
determined in each case (section 2.8.5.4).  Of the 2470 VSG coding regions 
analysed, 65 were found to have an increased RPKM value (> 1.5 FC) in the Tbrh1-/- 
sample relative to WT. Of these, 9 are BES-associated, 2 are housed in MESs, 3 are 
located in the mini-chromosomes, and 20 within the Mb chromosome arrays. The 
remaining 31 are predicated to be pseudogenes (Figure 6.6). 
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Figure 6.6 RNA-seq reveals increased transcription of silent VSGs across the repertoire after 
loss of TbRH1.  
Above: Graph depicting the number of VSG genes that display >1.5-fold increase in RNA abundance 
(determined by RNA-seq, as RPKM values) in Tbrh1-/- cells relative to WT; the total number is sub-
categorised depending on whether the VSGs have been localised to the BESs, are intact genes in the 
subtelomeric arrays (array), are in mini-chromosomes (MC), are pseudogenes (pseudo), or are in a 
mVSG ES (MES). Below: Plots of normalised RNAseq read depth abundance (y-axes) relative to CDS 
position (x-axes) for a selection of the above VSGs; VSG identity numbers are from (Cross, Kim and 
Wickstead, 2014). 
6.2.2.2 VSG switching frequency is higher in Tbrh1-/- parasites 
To investigate the stability of (the normally dominant) VSG221 expression in the 
Tbrh1-/- cell line, parasites were cloned to give three clonal lines derived from a 
single cell (generation 0) of both the WT and Tbrh1-/- lines. Immunofluorescent 
analysis was then performed to assess expression of VSG221 protein coat after ~24 
generations (defined as a population doubling) of growth, and at further points over 
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~45 generations of growth. Cumulative growth was recorded over the time course 
and showed no difference between the WT and Tbrh1-/- parasites (Figure 6.7). 
>200 parasites for each clone, per time point, were scored for VSG221 expression 
and VSG221-negative parasites are shown as a proportion of total parasites in Figure 
6.7. After ~24 generations Tbrh1-/- clonal lines were found to have switched off 
VSG221 at a frequency of ~0.005. In contrast, a switching frequency of ~0.001 was 
found for WT parasites. After ~27 generations a higher frequency of switching was 
observed in Tbrh1-/- parasites, ~0.0125, whereas WT frequency remained similar 
(~0.0005). Switching frequency then remained similar, although switching at 
generation ~44 of Tbrh1-/- was found to be slightly lower, at ~0.007. 
 
Figure 6.7 Tbrh1-/- parasites switch off expression of VSG221 at a higher frequency than WT 
parasites.  
Three VSG221-expressing clones of each cell type were generated and serially passaged 
independently. At multiple time points the number of cells in the populations that do not express 
VSG221 was assessed by immunofluorescence with anti-VSG221 antiserum; non-VSG221 expressing 
WT (black) and Tbrh1-/- (grey) cells are shown as a proportion of the total population. >200 cells were 
counted for each clone, at each time point (data shows the average and SD of the three clones). 
Cumulative density of WT (solid line) and Tbrh1-/- cells (dotted line) over the course of the analysis is 
also shown (average density and SD is shown). 
6.2.2.3 VSG coat switching is increased in Tbrh1-/- cells 
Changes in VSG expression were next investigated at the protein level via 
immunofluorescence.  WT 1.2 (the parental line of Tbrh1-/- cells, elsewhere 
referred to as WT in this thesis) and Tbrh1-/- parasites were dual stained with 
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antibodies targeting the WT 1.2 dominant VSG, VSG221, as well as VSG121, which is 
normally silent in this cell line (Figure 6.8). Another WT T. brucei line, WT 1.6, was 
also dual stained as these parasites have been selected for impaired expression of 
VSG221 and mainly expresses VSG121 as the dominant VSG (Glover et al., 2007). 
The percentage of cells expressing one or the other VSG, both VSGs, or neither was 
calculated in WT 1.2 and Tbrh1-/- populations, revealing ~3.12% of the Tbrh1-/- 
parasites did not express either VSG on their surface, whereas parental line WT 1.2 
exclusively expressed VSG221 (Figure 6.8B). A small percentage (~0.35%) of Tbrh1-
/- cells expressed VSG121 on their surface, which was not seen in WT 1.2 cells. Of 
the Tbrh1-/- VSG121-positive parasites, ~25% also expressed VSG221 (Figure 6.8C), 
indicating either these cells are still in the process of switching VSG protein coats, 
or monoallelic control of VSG expression has been lost. Of the VSG121 expressing 
WT 1.6 cells, virtually all parasites expressed VSG121 exclusively. 
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Figure 6.8 Loss of TbRH1 induces switching of the VSG coat.   
A) Co-immunofluorescence imaging of VSG221 and VSG121 coats. In addition to WT 1.2 cells and 
Tbrh1-/- mutants, an example of a cell is shown from a T. brucei strain (WT 1.6) that predominantly 
expresses VSG121 (Glover et al., 2007) (Scale bar, 5 μm). B) Percentage of WT (WT 1.2) and Tbrh1-/- 
cells expressing VSG221 and/or VSG121 on their surface, as determined by co-immunofluorescence 
imaging with anti-VSG221 and VSG121 antiserum. The graph depicts the relative proportions of cells 
in the population in which only VSG221 (pink) or VSG121 (yellow) could be detected, as well as cell 
with both (orange) or neither (grey) of the two VSG on their surface; >200 cells were analysed for each 
cell type in each of three replicates (error bars denote SEM). C) Analysis of WT 1.6 and Tbrh1-/- 
mutant cells that express VSG121 on the cell surface, showing the percentages that simultaneously 
express VSG221 (orange) or only express VSG121 (yellow); >100 cells were analysed in each of three 
replicate experiments for each cell type. 
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6.2.3 DNA damage levels increase in Tbrh1-/- parasites 
As DNA damage within BESs is predicted to elicit VSG switching, at least by 
recombination, levels of the histone variant and DNA damage marker γH2A (Glover 
and Horn, 2012) were assessed in Tbrh1-/- parasites and compared with WT. 
Deletion of TbRH1 causes no detectible change to growth rate or cell cycle 
progression (section 3.4), but it is possible that low levels of widespread damage, 
or highly localised DNA damage may be well tolerated.  Western blot analysis of 
whole protein extracts showed limited differences in the total level of γH2A signal 
between WT and Tbrh1-/- cells (Figure 6.9A). The slight increase in average band 
intensity of three independent replicates was deemed not significant by a Wilcoxon 
rank test (Figure 6.9B).  
 
Figure 6.9 Expression levels of γH2A in Tbrh1-/- parasites do not change substantially 
compared with WT.  
A) Western blot of γ-H2A, detected by specific antiserum, in WT and Tbrh1-/- mutants; antiserum 
detecting EF1-α provides a loading control. B) Relative density of γH2A western blot signal, normalised 
to EF1-α, is compared in WT (normalised to 1.0) and Tbrh1-/- cells. 
γH2A was also detected by immunofluorescence using fixed cells. In WT cells ~7% of 
parasites displayed γH2A staining, in agreement with previous findings by Glover 
and Horn (2012) (Figure 6.10A and B). In the Tbrh1-/- population ~17% of cells 
displayed γH2A staining, indicating increased nuclear damage. Of these γH2A-
positive cells, ~50% contained a single focus of γH2A staining, in both WT and 
 
 
Tb
rh
1-
/- 
W
T 
EF1α 
γH2A 
W
T
T
b
rh
1
-/
-0 .0
0 .5
1 .0
1 .5
F
o
ld
 c
h
a
n
g
e
 in
 r
e
l. 
d
e
n
si
ty
A B 
  
218 
Tbrh1-/- samples (Figure 6.10C). The number of γH2A-positive cells possessing two 
foci increased from ~20% in the WT population to ~ 33% in the Tbrh1-/- parasites. 
Only very few cells were found to express three foci: ~1% and ~2.7% of WT and 
Tbrh1-/- γH2A–positive parasites, respectively. The remaining population of γH2A-
positive cells displayed diffuse staining across the nucleus. This reduced from ~33% 
of γH2A-positive WT cells to ~18.5% of Tbrh1-/- γH2A –positive parasites. Hence, 
DNA damage most often occurs at defined loci, rather than genome-wide, in Tbrh1-
/- cells.  
 
Figure 6.10 Loss of TbRH1 leads to increased levels of nuclear damage, mainly in replicating 
cells.   
A) Immunofluorescent imaging of anti-γH2A signal and co-localisation with DAPI staining in WT and 
Tbrh1-/- cells. These are representative images of those analysed in B, C and D. B) Percentage of WT 
and Tbrh1-/- cells (n >200 in each of three replicates) with detectable nuclear anti-γH2A signal. C) 
Distribution of intra-nuclear γH2A signal in WT and Tbrh1-/- cells (n >200 in each of three replicates). 
Of the γH2A-positive cells those with 1, 2 or 3 foci, or diffuse staining across the nucleus, are shown as 
a percentage of all positive cells. D) Percentage of γH2A-positive WT and Tbrh1-/- cells of each cell 
cycle stage discernable by DAPI staining (1N1K, 1N1elongated K (1N1eK), 1N2K and 2N2K), 
expressed as a percentage of total cells counted within each stage. n ≥50 for each cell cycle stage in 
three replicates. In all cases error bars show SD from the mean. 
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Counting of γH2A-positive cells was repeated, this time separating parasites 
according to their cell cycle stage (1N1K, 1N1elongated K (1N1eK), 1N2K and 2N2K). 
At least 50 cells in each stage were counted and the percentage displaying γH2A 
staining was calculated for both WT and Tbrh1-/- T. brucei lines (Figure 6.10D). A 
greater percentage of WT cells undergoing nuclear replication (1N1eK) or in in G2-M 
phase (1N2K) displayed γH2A signal compared to those at the end of M phase (2N2K) 
or through G1 (1N1K). Analysis of the Tbrh1-/- mutants showed that the increased 
proportion of total cells with γH2A signal (Figure 6.10B) was nearly entirely 
accounted for by greater numbers of γH2A-positive cells within the 1N1eK (~2.4-
fold increase) and 1N2K (~3.6-fold) populations. Hence, γH2A foci form most often 
in cells which are undergoing, or have recently undergone, DNA replication in the 
absence of TbRH1. Super-resolution structure-illumination microscopy imaging of 
anti-γH2A signal and DAPI staining confirmed the discrete nature of γH2A foci in 
these cells (Figure 6.11).  
 
Figure 6.11 γH2A staining forms discrete foci in WT and Tbrh1-/- DNA replication-associated 
cells.  
Super-resolution structure-illumination microscopy imaging of anti-γH2A signal and DAPI staining of 
representative replicating (1N1eK and 1N2K) cells. In the merged images of anti-γH2A (pink) and DAPI 
(aqua), colour us provided. Images were processed by Leandro Lemgruber. 
ChIP-seq mapping of γH2A was next employed to ask if the γH2A histone variant 
localised to the BESs in response to loss of TbRH1. ChIP-seq was performed with WT 
and Tbrh1-/- populations and the fold-change between input and IP sample read 
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coverage (section 2.8.4.2) was plotted across the 14 BESs (Hertz-Fowler et al., 
2008), using MapQ filtering. BES-associated γH2A signal was found almost 
exclusively in the active BES (BES1) in WT and Tbrh1-/- samples (Figure 6.12). The 
predominantly telomere-proximal signal peaks observed in the WT sample were 
clearly conserved in the Tbrh1-/- ChIP-seq sample, though the peaks were more 
widespread and also appeared to extend upstream of the 70-bp repeats and VSG. In 
contrast, only minor increases in γH2A ChIP-seq peaks were evident across the 
silent BES when comparing the Tbrh1-/- cells with WT. Elsewhere in the genome, 
γH2A ChIP-seq signal was uniformly increased relative to input samples across Pol II 
transcribed PTUs in both WT and Tbrh1-/- samples, most likely due to the antibody 
binding to non-phosphorylated H2A histone (Figure 8.6).  
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Figure 6.12 Localisation of γH2A by ChIP-seq in WT and Tbrh1-/- cells. 
ChIP-seq signal is shown mapped to the 14 BESs (Hertz-Fowler et al., 2008).  Annotations are as 
described in Figure 6.1. Pink and green tracks show normalised ratios of read-depth fold-change (1-3 
fold) in IP samples relative to input in WT and Tbrh1-/- mutants, respectively. 
6.3 RNase H2 and VSG switching 
6.3.1 TbRH2A depletion leads to R-loop formation in the BES 
To ask if the VSG effects (described above) seen after loss of TbRH1 are also seen 
after loss of TbRH2A, DRIP-seq data generated using the TbRH2ARNAi line, after 24 hr 
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of growth with or without tet-induction, was aligned to the 14 characterised BESs 
with MapQ filtering and enrichment in coverage in IP samples relative to input was 
calculated for each.  DRIP-seq signal was clearly enriched across the active and 
inactive BESs relative to WT, both in the tet-induced and un-induced samples 
(Figure 6.13A), consistent with the RNAi being slightly leaky without tet-induction 
(Chapter 3). Like DRIP-seq signal derived from Tbrh1-/- parasites, signal peaks were 
clearly seen across the 70-bp repeat regions, as well as across the ESAG containing 
regions and downstream of the VSGs. Perhaps surprisingly, the peaks observed in 
the tet-induced sample appeared to be slightly lower than was seen in the 
uninduced, though it is possible this effect is an artefact of global changes after 
TbRH2A loss that are masked by data normalisation during mapping (K. Chen et al., 
2015). 
DRIP-qPCR targeting VSG221 (active BES1), VSG121 (inactive BES3), ESAG6 and 
ESAG8 coding regions indicated increased levels of RNA-DNA hybrid formation in 
induced samples compared to un-induced after 36 hr of growth (Figure 6.13B). In all 
cases, the IP enrichment in the tet + samples was significantly reduced by 
treatment with EcRHI. However, DRIP-qPCR after 24 hr of growth showed only 
minor differences in R-loop levels between tet – and tet + samples, for reasons that 
are unclear, and only in the case of the VSGs did treatment with EcRH1 reduce the 
enrichment.   
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Figure 6.13 R-loops levels increase across the BESs in cells depleted of TbRH2A expression.  
A) Localisation of R-loops by DRIP-seq the TbRH2A RNAi line grown in the absence (tet -; blue) or 
presence (tet +; orange) of RNAi induction for 24hr. DRIP-seq mapping in WT parasites is also show 
(pink). Mapping is shown to BES1 (active site of WT parasites) and BES3 (normally transcriptionally 
silent site). Annotation of BESs are as in Figure 6.1. B) DRIP-qPCR using primers targeting the 
sequences of ESAG6, ESAG8, VSG221 (BES1) and VSG121 (BES3), with or without E.coli RNase HI 
(EcRHI) treatment, showing the percentage of amplification in the IP sample relative to input.  This is 
shown for tet induction (tet +) and non-induction (tet -) after 24 (left) and 36 hr (right) of growth. Error 
bars display SEM for three technical replicates. No VSG221 DNA could be PCR-amplified to 
detectable levels from 24 hr tet + IP sample after treatment with EcRH1.  
6.3.2 TbRH2A depletion leads VSG switching in T. brucei 
6.3.2.1 Normally silent VSGs are transcribed after TbRH2A depletion 
VSG expression changes were investigated via RT-qPCR after 24 and 36 hr tet-
induction of RNAi to deplete TbRH2A transcripts. Here, no change in VSG221 RNA 
levels were detectable in induced cells relative to un-induced, both 24 and 36 hr 
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post-induction (Figure 6.14). In contrast, levels of RNA from all the silent VSGs 
increased after tet-induction, both at 24 hrs and, even more markedly, after 36 hr 
of induction, where all silent VSGs increased over 3-fold relative to un-induced 
samples.  
 
Figure 6.14 Loss of TbRH2A results in increased transcription of silent BES-associated VSGs.  
Left: Simplified diagram of BES used to generate a protective surface coat in the BSF T. brucei cells; 
only telomere-proximal VSGs (coloured boxes, numbered) from a selection of BES are shown, and the 
single BES being actively transcribed (encoding VSG221, pink) is denoted by an arrow extending from 
the promoter (flag). Right: Graph of VSG RNA levels (corresponding to the ES diagram and 
determined by RT-qPCR) of tet-induced TbRH2ARNAi parasites, plotted as fold-change relative to levels 
of the cognate VSG RNA in un-induced cells after both 24 hr and 36 hr of culture; Error bars show SD 
for three independent experiments. 
RNA-seq data were also aligned, using MapQ filtering, to the 14 BESs (Hertz-Fowler 
et al., 2008) and VSG coding region collection (Cross, Kim and Wickstead, 2014); in 
this case total RNA was extracted from the TbRH2ARNAi parasites after 24 and 36 hr 
of growth with and without tet-induction, with two independent replicates analysed 
in each case.  Mapping to the BES-associated VSGs showed increased read mapping 
to 11 of the 13 silent VSGs after tet-induction both after 24 hr (Figure 8.7) and 36 
hr of induction (Figure 6.15). The predominantly transcribed VSG221, in contrast, 
showed reduced read coverage at both time points. Curiously, VSG17, which is 
housed within silent BES13, displayed more mapped reads before induction than 
after, in both replicates, after 36 hr of growth. In these conditions, unlike in the 
Tbrh1-/- cells, read coverage also increased over the BES coding regions after 
TbRH2A RNAi, though this effect was predominantly localised to ESAG6 and ESAG7, 
which are promoter-proximal (Figure 6.15, Figure 8.7).  
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Figure 6.15 RNA-seq reveals transcription of silent BES-housed VSGs after loss of TbRH2A.  
Normalised RNA-seq read depth abundance (y-axes) is plotted for two independent replicates (overlaid 
orange and blue) of TbRH2A RNAi parasites after 36 hr of growth, with (tet +) and without (tet -) 
induction.  Read depth is shown relative to CDS position (x-axes) for BES1 and BES3 as well as  a 
selection of the above VSG housed within BES identified by (Hertz-Fowler et al., 2008); VSG identity 
numbers are from (Cross, Kim and Wickstead, 2014). For RNA-seq depth abundance after 24 hr of 
culture see Figure 8.7 
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As discussed in chapter 5, aligning this RNA-seq data to the T. brucei 927 genome 
and performing differential expression analysis revealed 32 up-regulated genes 
after 24 hr tet-induction annotated as either VSG, ESAG or procyclin, and after 36 
hr of induction 37 VSGs and 14 ESAGs were up-regulated (Figure 5.14). To explore 
the increase in silent VSG expression further after TbRH2A depletion, differential 
expression analysis (section 2.8.5.3) was repeated using mapping to the VSG 
collection of the T. brucei Lister 427 stain (Cross, Kim and Wickstead, 2014).  20 
VSGs were found to be up-regulated after 24 hr of TbRH2A RNAi induction, and 50 
after 36 hr induction (Figure 6.16).  Of these, 40% and 60% were classified as 
pseudogenes (Cross, Kim and Wickstead, 2014) in the 24 hr and 36 hr samples, 
respectively (Figure 6.16).  Of the remaining VSGs with increased expression after 
24 hrs, 25% were classified as intact array genes, 20% as intact mini-chromosomal 
associated, 10% associated with mVSG ESs and the remaining 5% (1 VSG) was BES-
associated (Figure 6.16).  After 36 hr, a similar proportion of up-regulated VSGs 
were array-associated (26%), 10% were housed in the BESs and 2% (1 VSG) were 
mVSG ES-associated (Figure 6.16). No mini-chromosome associated VSGs were 
significantly up-regulated at this time point. Examples of reads mapping to some of 
these VSGs are shown for 36 hr post-induction (Figure 6.16).  
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Figure 6.16 RNA-seq reveals increased expression of silent VSGs across the repertoire after 
depletion of TbRH2A.  
Above: Graph depicting the number of VSG genes that display upregulation in induced samples 
relative to un-induced at both 24 hr and 36 hr time points. Upregulation was determined by differential 
expression analysis (section 2.8.5.3) using two independent RNA-seq replicates.  The total number is 
sub-categorised depending on whether the VSGs have been localised to the BES, are intact genes in 
the subtelomeric arrays (array), are in mini-chromosomes (MC), are pseudogenes (pseudo), or are in a 
mVSG ESs (MES). Below: Plots of normalised RNA-seq read depth abundance (y-axes)  relative to 
CDS position (x-axes) for a selection of the above VSGs. Two independent repeats after 36 hr of 
growth are plotted (overlaid in orange and blue). VSG identity numbers are from (Cross, Kim and 
Wickstead, 2014). 
6.3.2.2 Changes in the VSG protein coat after TbRH2A depletion 
To investigate if changes in the VSG surface occur after depletion of TbRH2A, 
immunofluorescence analysis of the VSG coat was undertaken. Anti-VSG221 and 
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anti-VSG121 dual staining of induced and un-induced parasites after 12, 24 and 36 
hr of culture was performed. An average of ~0.84% of the un-induced populations 
from each time point were found to express neither VSG221 nor VSG121 (Figure 
6.17B). This appeared to slightly increase to ~1% of cells after 12 hr of tet-
induction. After 24 hr, however, ~1.75% of parasites showed no VSG221 or VSG121 
signal and a further ~0.18% expressed both VSGs simultaneously. No cells were 
found to exclusively express VSG121 at this time point.  After 36 hr of TbRH2A 
depletion, ~4.5% of cells expressed neither VSG, ~0.24% expressed VSG121 
exclusively and ~0.73% expressed both proteins. Hence, ~1% of cells began to 
express VSG121 but of these ~75% expressed both VSGs (Figure 6.17B). 
 
Figure 6.17 Loss of TbRH2A induces switching of the VSG coat.  
A) Co-immunofluorescence imaging of VSG221 (pink) and VSG121 (yellow) surface expression. 
Example images are shown of cells which have undergone 24 hr of culture with (tet -) or without (tet +) 
RNAi induction (Scale bar, 5 μm). B) The graph displays the percentage of un-induced (tet -, all time 
points) and induced cells after 12, 24 and 36 hr of culture with tet, expressing only VSG221 (pink) or 
VSG121 (yellow) on their surface, as well as cell with both (orange) or neither (grey) of the two VSG on 
their surface, as determined by co-immunofluorescence imaging with anti-VSG221 and VSG121 
antiserum. >200 cells were analysed for each cell type in each of three replicates (error bars denote 
SEM). The table below shows the average percentage of the three replicates in each case, plotted on 
the graph above. 
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6.3.3 γH2A is enriched in the active and silent BESs after TbRH2A 
depletion 
γH2A ChIP-seq data generated after 24 and 36 hr of tet-induction of TbRH2A RNAi, 
explored previously in section 5.3, were next mapped across the 14 characterised 
BESs (Hertz-Fowler et al., 2008) using MapQ filtering.  As described previously 
(section 5.3), signal enrichment between induced and un-induced samples (each 
first normalised to the relevant input sequencing) was plotted for both 24 and 36 hr 
time points (Figure 6.18). Separate plotting of induced and un-induced samples 
relative to input, for both time points, is displayed in Figure 8.8. For comparison, 
γH2A ChIP-seq signal enrichment in WT cells is also shown (data as in Figure 1.12). 
The extent of γH2A signal increase was considerable, since even 24 hr post-
induction much greater numbers of peaks were seen than WT cells (Figure 6.18).  
Notably, signal peaks appeared in all BESs, not predominantly active BES1, and 
displayed a much wider distribution: peaks were not mainly localised around the 
70-bp-repeats but also spread across the ESAG-containing regions. Signal was also 
evident within, and flanking the VSG coding regions (Figure 6.18). Despite this 
greater accumulation of BES γH2A, some similarities can be drawn with the BES 
γH2A ChIP-seq mapping in Tbrh1-/- mutants: first, signal enrichment appeared 
greater in the active BES (BES1, VSG221) than in the silent BESs; and, second, there 
was a notably lower signal enrichment across the 70-bp repeats. After 36 hrs of 
RNAi, the γH2A ChIP-seq signal appeared slightly more extensive across active BES1 
and also appeared to increase, to a greater extent, across all the silent BESs. 
Despite this apparent increase, signal enrichment still appeared lower across the 
70-bp repeats. 
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Figure 6.18 Localisation of γH2A by ChIP-seq mapping to the BESs after depletion of TbRH2A 
expression with RNAi. 
ChIP-seq signal enrichment is shown mapped to the 14 BESs (Hertz-Fowler et al., 2008) as a ratio of 
tet-induced samples relative to un-induced (each first normalised to the cognate input sample) for both 
24 (purple) and 36 (green) hr time points. WT γH2A ChIP-seq signal (normalised to input) is shown for 
comparison (pink). Annotations are as described in Figure 6.1.  
Increased γH2A signal after 24 and 36 hr induction compared to un-induced samples 
was corroborated by γH2A ChIP-qPCR, targeting VSG221, VSG121, ESAG6 and ESAG8 
coding regions (Figure 6.19).  In all four cases, γH2A immunoprecipitated DNA 
increased significantly in tet + samples compared with tet – counterparts for both 
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time points. Also, in all four cases, 36 hr tet + IP sample recovery was greater than 
at 24 hr. Finally, VSG221 showed the highest level of γH2A immunoprecipitation 
after both 24 and 36 hr of TbRH2A knockdown (Figure 6.19), consistent with greater 
abundance of modified histone in active BES1 compared with inactive BES3.  
 
Figure 6.19 ChIP-qPCR targeting histone variant γH2A shows increased binding of the damage-
dependent modified histone after TbRH2A depletion.  
γH2A ChIP-qPCR using primers targeting the sequences of ESAG6, ESAG8, VSG221 (BES1) and 
VSG121 (BES3), is depicted as the percentage of amplification sequence in the IP sample relative to 
input.  Data is shown for tet induction (tet +) and non-induction (tet -) after 24 (left) and 36 hr (right) of 
growth. Error bars display SD for two technical replicates. 
6.4 Discussion 
Data presented in this chapter have revealed that increased R-loop formation due 
to loss of RNase H activity results in increased VSG BES-associated DNA damage and 
elicits VSG switching in T. brucei parasites. Taken together the data suggest BES 
sequence composition, active transcription and, potentially, DNA replication, 
appear to interplay and contribute to a model of R-loop driven VSG switching 
(Figure 6.20). 
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Figure 6.20 Model of R-loop driven VSG expression changes in RNase H depleted parasites. 
The topmost diagram depicts transcription (red arrow) of the active BES, starting at the promoter (flag) 
to transcribe the ESAGs (white boxes) and VSG (red box) towards the telomeric repeats (arrow 
heads). Transcription through the 70-bp repeats (lined box) is potentially perturbed in some manner, 
(indicated by a dashed red arrow) or is R-loop prone as demonstrated by the diagram below.  Here, R-
loop formation across the 70-bp repeats is depicted in WT parasites, where both RNase H1 and the 
RNase H2 complex (blue) are able to resolve RNA-DNA hybrids. In either Tbrh1-/- or induced TbRH2A 
RNAi parasites (RNase H depleted), however, R-loops persist and potentially cause the retrograde 
spreading of R-loops as RNA Pol I (red) continue to transcribe the BES. These may lead to an in situ 
switch to a previously silent BES (teal) due to a lack of VSG expression, or to the accumulation of DNA 
damage in the active BES. The newly activate BES may also suffer the same fate in the absence of 
RNase H activity and accumulate R-loops. Recombinational switching is also predicted to occur due to 
the accumulation of DNA damage. In this case, secondary events such as targeting by flap 
endonucleases, cytidine deaminases, or potentially clashes with replication machinery, may lead to 
DSB formation. Here, one DSB is depicted for simplicity, however, DSBs may occur in any location 
across the BES to allow recombination with silent array VSGs (multiple coloured boxes), VSG found in 
other BES or mVSG ES. In fact, recombination may occur with elements of pseudogenic VSG 
sequence to generate mosaic VSGs (not shown).   
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BES structure, particularly 70-bp repeat sequence composition, appears to 
encourage R-loop formation, most likely via transcription during expression of the 
active VSG. DRIP-seq mapping of RNA-DNA hybrids within the active BES of WT cells 
indicates a small enrichment in signal within the 70-bp repeat region of BES (Figure 
6.3), despite a striking paucity of BES R-loops in such cells. Extensive hybrids are 
then detected across the 70-bp repeats of all BESs after abolition of RNase H 
activity, since the same effect is seen in both Tbrh1-/- null mutants (Figure 6.1, 
Figure 6.3) and during RNAi knockdown of TbRH2A expression (Figure 6.13). 
Although DRIP-seq signal peaks are observable across the 70-bp repeats when there 
is no induction of RNAi (tet – track, Figure 6.13), this is most likely due to leaky 
RNAi expression (Figure 3.14A) resulting in slight loss of TbRH2A activity. Whether 
DRIP-seq signal is significantly higher in the RNAi-induced sample vs un-induced 
cells cannot be confidently ascertained from the DRIP-seq data presented, which is 
probably not quantitative (K. Chen et al., 2015). To allow clear quantitative 
comparison between samples, DRIP-seq would require inclusion of spike-in controls 
(K. Chen et al., 2015). Nonetheless, targeted DRIP-qPCR allied to E. coli RNase HI 
treatment in the Tbrh1-/- mutants and after 36 hrs of TbRH2A RNAi argues that R-
loops do increase in the BES, though the 70-bp repeats were not directly tested. 
Characteristics of the 70-bp repeats may make this region a favourable location 
within the BES for R-loop formation. 70-bp repeats are variable in length and 
sequence but are in part formed of AT-rich triplicate repeats (Shah et al., 1987; 
Hovel-Miner et al., 2016). AT-rich repeats are known to become non-H bonded 
(Ohshima et al., 1996) and even promote recombination (Pan et al., 2010) when 
transcribed. It is therefore plausible that transcription of these vulnerable repeats 
leads to R-loop formation and, potentially, initiates VSG switching mechanisms 
(Figure 6.20).  Indeed, it is now widely accepted that the repetitive nature of 
several fragile sites encourages R-loop formation when transcribed, underlying 
these regions’ vulnerability to breakage (Sollier and Cimprich, 2015; Freudenreich, 
2018).  
Accordingly, 70-bp repeat associated R-loops could trigger VSG switching by 
potentially two, non-mutually exclusive, routes: transcriptional in situ switching 
and recombination-based switching. The former may be explained by considering 
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the fate of the active BES after prominent R-loop formation. DRIP-seq mapping and 
DRIP-qPCR reveals RNA-DNA hybrids also form in the BES upstream of the 70-bp 
repeats, within the ESAG coding regions. This effect is seen both after knockout of 
TbRH1 (Figure 6.1 and Figure 6.3) and after RNAi knockdown of TbRH2A, most 
markedly after 36 hr of tet-induction, as demonstrated by DRIP-qPCR (Figure 6.13). 
In all cases, DRIP-seq peaks do not appear to form specifically within a particular 
sequence type, such as the predominant inter-CDS localisation seen in RNA Pol II 
PTUs (Chapter 4). Instead, DRIP-seq enrichment appears arbitrary in the BES, and 
feasibly may accumulate as a consequence of retrograde spreading of transcription 
blockage, extending from the 70-bp repeats (Figure 6.20). Indeed, transcriptional 
pausing is known to cause R-loop formation (Chen et al., 2017). Blockage to 
transcription upstream to the VSG coding region would hence result in a failure to 
express the active VSG, which is known both to be lethal to T. brucei BSF parasites 
(Sheader et al., 2005) and capable of triggering switching (Aitcheson et al., 2005). 
Thus, R-loop formation in the active BES due to loss of RNase H activity may result 
in the selection for parasites that have switched transcription to a different BES.  
Data in this thesis support the above model of R-loop driven BES transcriptional 
switching. RT-qPCR targeting BES-associated VSGs (Figure 6.4 and Figure 6.14), and 
RNA-seq analysis of RNase H deficient lines reveals increased expression of both 
BES-associated VSGs and ESAGs (Figure 6.5 and Figure 6.15). In situ switching to an 
alternative BES in RNase H-deficient cells invariably means the newly selected BES 
is also likely to accumulate R-loops and suffer transcription blockages, resulting in 
further switching. This would account for the finding that all BES, not just active 
BES1, display DRIP-seq signal after TbRH1 knockout (Figure 6.1) or TbRH2A 
knockdown (Figure 6.13).  Furthermore, the simultaneous expression of two VSGs 
(VSG221 and VSG121) after loss of TbRH1 (Figure 6.8) and TbRH2A (Figure 6.17), 
albeit in small proportions of the populations, indicates either cells in the process 
of switching, or cells in which monoallelic BES control has been undermined. 
Although an attractive model, blockage to transcription as a result of R-loop 
formation requires experimentally validation, by ChIP-seq targeting an RNA Pol I 
subunit, for example. 
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Despite the support for the above transcriptional model, the data presented here 
do not indicate that R-loops induce in situ switching alone, but may generate 
lesions capable of eliciting VSG switching via recombination. (In fact, it might be 
considered that it is lesions generated by R-loops, and not the RNA-DNA hybrids 
alone, that impede VSG transcription and cause in situ switching.) DNA breakage is 
widely acknowledged to initiate VSG gene conversion and recombination events 
(Barry and McCulloch, 2001; Horn, 2004; Boothroyd et al., 2009), but how such 
lesions are generated in the parasites is unclear. The increased abundance of 
Thr130 phosphorylated histone H2A, which is a marker of nuclear DNA damage 
(Kinner et al., 2008; Glover and Horn, 2012), in the BESs after depletion of RNase H 
activity points to R-loop structures as a potential trigger for initiating DNA lesions. 
γH2A ChIP-seq reveals predominant binding of the phosphorylated histone to sites 
close to the 70-bp repeats of the active site (BES1) in WT parasites.  In Tbrh1-/- 
parasites this relatively localised accumulation of γH2A in the active BES increases 
(Figure 6.12), as well as spreading upstream into the ESAG coding region. Little 
γH2A signal is seen in inactive BESs of Tbrh1-/- cells. More extensive γH2A 
enrichment in the BESs is observable in TbRH2A RNAi induced parasites, relative to 
un-induced samples, both 24 and 36 hr after induction (Figure 6.18 and Figure 
6.19), since increased γH2A ChIP signal is found throughout both the active and 
silent BES, and is not so clearly limited to regions around the 70-bp repeats. The 
basis for this difference in damage accumulation in the Tbrh1-/- mutants versus 
TbRH2ARNAi cells probably rests in the severity of the phenotypes, suggesting loss of 
the former RNase H is tolerated but depletion of the latter is lethal. Furthermore, 
the difference in the BES γH2A ChIP-seq data is consistent with the more limited, 
replication-associated accumulation of nuclear γH2A foci in Tbrh1-/- mutants 
relative to the much more severe accumulation of γH2A signal throughout the 
nucleus after TbRH2A RNAi. 
Further data presented in this chapter support the hypothesis that the lesions 
indicated by γH2A, which increase after loss of RNase H, induce VSG recombination 
events. Firstly, RNA-seq analyses show increased transcription of silent VSG found 
outside of the BESs, in both Tbrh1-/- (Figure 6.6) and TbRH2A RNAi induced 
parasites (Figure 6.16). Although analysis of the Tbrh1-/- cells is limited by only 
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having a single replicate, comparison of read depth between WT and Tbrh1-/- 
samples demonstrates increased transcription in Tbrh1-/- parasites of intact VSGs 
found within subtelomeric arrays, mini-chromosomes and mVSG ESs, as well as 
some pseudogenic VSGs. Differential expression analysis allowed statistically 
significant differences in VSG expression to be identified after TbRH2A depletion. 
Again, VSGs from subtelomeric arrays, mVSG ESs and mini-chromosomes, as well 
pseudo-VSG sequences, were all identified as being more highly transcribed after 
depletion of TbRH2A, most widely after 36 hr of knockdown. Though it is 
conceivable these data indicate increased transcription of the genes from their 
endogenous loci, it is more likely that expression of these non-BES VSGs is due to 
recombination into the BES. Moreover, RNA-seq mapping provided weak evidence 
for increased transcription of entire, silent BES and so the proximity of damage, at 
least in Tbrh1-/- mutants, to the 70-bp repeats and VSG may drive the 
recombination of non-BES VSG genes. One area of uncertainty is that no strong 
γH2A ChIP-seq signal was detected in the 70-bp repeats, either in the WT cells or 
the two RNase H mutants, which seems at odds with the suggestion the repeats 
might be a focus for VSG switch initiation. Nonetheless, nothing is known about 
nucleosome density in the 70-bp repeats and it is conceivable that lowering of H-
bonding limits H2A deposition, and hence limits damage-dependent formation of 
γH2A. In addition, the nature of the DNA lesion that might form to generate γH2A 
signal is unknown and may take a different form in the 70-bp repeats and elsewhere 
in the BESs. It is also conceivable that lack of γH2A ChIP of the 70-bp repeats is 
merely a technical artefact of ChIP with this antiserum or library preparation on 
such sequences. 
Taken together, the data in this chapter suggest R-loops may in fact initiate both 
transcription and recombination routes of VSG switching, and mechanistically link 
the two processes. If found to be the case, this hypothesis is in keeping with 
findings that both transcriptional switching and VSG gene conversation are impaired 
in homologous recombination mutants lacking RAD51, BRCA2 and RAD51-3 
(McCulloch and Barry, 1999; Hartley and McCulloch, 2008; Dobson et al., 2011). 
Furthermore, the formation of R-loops and lesions upstream of 70-bp repeats within 
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the ESAG coding regions is also consistent with frequent observations of intra-BES 
recombination events (McCulloch, Rudenko and Borst, 1997). 
The similarities between the TbRH1 and TbRH2A data sets in this chapter suggest an 
overlap in functions of the two enzymes during VSG expression and switching: in 
both cases, increased R-loops, γH2A abundance and VSG switching are observed 
after RNase H loss. However, differences between the phenotypes do exist and 
future exploitation of these difference could provide further insight in to switching 
mechanisms. The differences in BES-associated DNA damage levels between cells 
lacking TbRH1 and TbRH2A appears to be matched by slightly different levels in VSG 
switching; immunofluorescent staining with anti-VSG221 antisera reveals a greater 
proportion of TbRH2A depleted cells that do not express the dominant VSG 
(VSG221) than Tbrh1-/- mutant cells (Figure 6.8 andFigure 6.17), consistent with 
greater increased expression of silent VSGs after TbRH2A RNAi. The reason for 
elevated DNA damage and, importantly, damage across all BES and not 
predominantly active BES1 after TbRH2A loss relative to TbRH1 loss is currently 
unclear. Although the two enzymes presumably act, at least in part, redundantly at 
the BESs to resolve R-loops, it may be the case that the TbRH2 complex has a more 
active role than TbRH1 at the BESs. It also must be considered that the TbRH2 
complex is probably able to remove embedded ribonucleotides via initiating the 
RER pathway, a function that TbRH1 is unlikely to carry out. It is hence possible 
that higher levels of embedded ribonucleotides in the BES after TbRH2A depletion 
contributes to more DNA lesions. Indeed, increased incorporation of uracil into 
DNA, due to loss of uracil-DNA glycosylase, leads to lesions and VSG switching 
(Víctor M Castillo-Acosta et al., 2012).  
How R-loops might cause recombination in the context of VSG switching requires 
further investigation.  However, parallels can be drawn with circumstances in other 
eukaryotes where R-loops induced DNA breakage and recombination. Firstly, R-
loops and transcriptional pausing alone may cause sufficient instability to result in 
DNA lesions. However, this is somewhat unlikely, since, as discussed previously, it is 
generally accepted that a secondary event is necessary to process R-loops into DSBs 
(Sollier and Cimprich, 2015).  One possibility is that clashes between transcription-
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associated R-loops and DNA replication machinery within the BESs generate DSBs. 
This hypothesis is supported by the observation that DNA damage in Tbrh1-/- 
parasites is largely associated with DNA replication, as demonstrated by increased 
γH2A foci in 1N1eK and 1N2K stage parasites (Figure 6.11). An association between 
DNA damage and DNA replication in TbRH2A depleted cells is, however, less easily 
understood due to the severe changes to the cell cycle. Nonetheless, EdU uptake 
experiments (Figure 3.18) and flow cytometry analysis (Figure 3.16) show that 
TbRH2A depleted cells continue to synthesise DNA. Hence, it is possible that clashes 
with the DNA replication machinery occur in the actively transcribed BESs of these 
parasites with greater frequency than in Tbrh1-/- mutants. An element of this 
model may also explain the differential timing of BESs replication; the active BES 
has been found to replicate early in BSF cells but not PCFs (Devlin et al., 2016).  
Another possibility is that R-loops are the target of currently unknown enzymes or 
factors that elicit VSG switching. AID targets cytosine residues in the exposed ssDNA 
of R-loops, converting the bases to uracil and leaving the strand vulnerable to 
breakage during class switching in the IgH locus of B lymphocytes (Basu et al., 
2011). Although experimental testing would be required to test such a model, the 
localised recombination observed in Ig switching has some similarities with the 
long-range recombination events of VSG switching, though the mode of 
recombination is quite different. Processing by other enzymes, such as flap 
endonucleases, is also possible but again would require experimental investigation. 
Indeed, R-loop induced hyper-recombination of THO mutant yeast is suppressed by 
overexpression of XPG flap endonuclease (Sollier et al., 2014). 
Lastly, it remains possible that R-loops may be a response to DNA lesions rather 
than the cause. DNA nicks have been found capable of initiating R-loop formation 
(Roy et al., 2010). Furthermore, RNA-DNA hybrids can form as intermediate 
structures during HR repair of DSBs, and these require degradation by RNase H 
(Ohle et al., 2016).  Although it is clear that R-loops induce damage and 
recombination in many settings, distinguishing R-loops which cause lesions from 
those which result from them remains challenging (Sollier and Cimprich, 2015). All 
possible routes of R-loop processing into DSBs require investigation before a 
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tangible model of R-loop driven VSG switching can be established. However, if R-
loops do prove to be a key feature in VSG switching, several observations of VSG 
switching phenotypes in other T. brucei mutants may be explained. Firstly, deletion 
of RAD51 in T. brucei impairs VSG switching and so was hypothesised to catalyse 
switching reactions (McCulloch and Barry, 1999). Mutation of RAD51 in yeast leads 
to R-loop formation and rearrangements (Wahba, Gore and Koshland, 2013). 
Conversely, gene conversion events are increased in REQ2 mutant parasites (Devlin 
et al., 2016). This phenotype is also explicable, since RecQ helicase mutants of 
both yeast (SGS2) and mammalian cells (BLM) causes R-loop increases and locus-
specific instability (Chang et al., 2017). Lastly, RNase H mutant yeast display DNA 
damage at the RNA Pol I transcribed rRNA loci, which is repaired by break-induced 
replication facilitated by persistent R-loops (Amon and Koshland, 2016). 
Interestingly, break-induced replication has previously  been proposed to induce 
VSG switching (Barry and McCulloch, 2001; Kim and Cross, 2010). 
To fully understand the role of R-loops in VSG switching mechanisms, many 
questions need to be addressed. Firstly, do R-loops cause or result from DNA 
lesions?  Exactly what type are these lesions and, if R-loops are causal, what events 
process R-loops into DNA breaks? How does signalling of the resulting lesion(s) 
initiate the repair-processes that facilitate VSG switching?  Lastly, if R-loops form 
during HR-mediated repair of DNA lesions, does this result in trans formation of R-
loops in other BESs and/or silent VSG arrays? Irrespective of the detailed 
mechanism, data discussed in this chapter strongly argues that BES structure 
facilitates R-loop formation, particularly in the 70-bp repeat regions whose 
upstream position to the VSG is advantageous for HR-mediated break repair of 
lesions and whose sequence directs recombination to the large bank of 70-bp repeat 
associated silent VSGs.
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7 Perspectives and future directions
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Since the sequence-specific DNA binding capabilities of RNA were first 
demonstrated (Thomas, White and Davis, 1976; White and Hogness, 1977), 
investigation into RNA-DNA hybrids and R-loop structures has expanded extensively. 
Isolation of the hybrids using the S9.6 antibody, as well as the advent of next-
generation sequencing technologies, has more recently facilitated global analysis of 
RNA-DNA hybrid formation across multiple genomes, including that of S. cerevisiae 
(El Hage et al., 2010; Wahba, Gore and Koshland, 2013; Chan et al., 2014), S. 
pombe (Ohle et al., 2016), Arabidopsis (Xu et al., 2017), mouse (Sanz et al., 2016) 
and human (Ginno et al., 2012, 2013; Sanz et al., 2016). In this thesis DRIP-seq has 
been used to investigate RNA-DNA hybrid localisation across the unusually 
structured T. brucei genome.  Mapping of R-loops across the core of the T. brucei 
genome has revealed loci where R-loop formation appears conserved with other 
genomes, such as the centromeres and RNA Pol III transcribed tRNA and snRNA 
genes, RNA Pol II transcriptional start sites, and rRNA gene arrays.  Additionally, a 
novel association of R-loops with sites of polyadenylation and, potentially, trans-
splicing has been uncovered.  
Genetic manipulation of putative RNase H enzymes has also allowed the role of 
these enzymes in T. brucei genome maintenance to be explored. R-loop mapping 
via DRIP-seq in BSF parasites lacking either type 1 or type 2 RNase H activity 
revealed a potentially specific role of the RNase H2 complex at RNA Pol II 
transcription initiation regions, a role which RNase H1 appears unable to efficiently 
perform. Lastly, mapping of both R-loops and the DNA damage marker gH2A to the 
VSG BESs, as well as analysis of VSG switching in Tbrh1-/- and TbRH2ARNAi parasites, 
demonstrates R-loop formation may drive VSG switching in the parasite, suggesting 
a localised function with potential parallels to R-loop-induced genome instability in 
other organisms.  
7.1 The RNase H repertoire of T. brucei 
Most organisms express at least one RNase H enzyme, and more commonly possess 
two types of RNase H enzyme, broadly classified as type 1 and type 2, the latter of 
which is made up of three subunits in eukaryotes. Three putatively catalytic RNase 
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H proteins could be identified in the T. brucei genome via analysis of the predicted 
amino acid sequences, as well as two proteins that may act as the RNase H2B and 
H2C subunits. T. brucei is, however, not alone in expressing more than two 
putatively catalytic RNase H-like proteins. For example, Candida albicans possesses 
three genes which all encode a type 1 RNase H. Two of these show similarity with 
bacterial RNase HI proteins and appear to be the product of a duplication event 
(Kochiwa, Tomita and Kanai, 2007), whereas the third is more typical of eukaryote 
RNase H1 (Cerritelli and Crouch, 2009). C. elegans possess four genes encoding 
RNase H1-like proteins, in addition to a type 2 RNase H complex, yet only two are 
catalytic (Arudchandran et al., 2002). The varied combinations of RNase H proteins 
expressed by diverse organisms presumably reflects differing genome structures 
and, although all catalytic proteins resolve RNA-DNA hybrids in some manner, 
specific roles the RNase H proteins have evolved to perform in each. 
The T. brucei RNase H1 protein, TbRH1, examined in this thesis has previously been 
characterised as a type 1 RNase H  (Hesslein and Campbell, 1997). This protein 
possesses a “typical” type 1 eukaryotic RNase H structure (Cerritelli and Crouch, 
2009), containing conserved HBD and RNase H domains and a 42 amino acid 
Connecting Domain (Kobil and Campbell, 2000), and so is likely to resolve RNA-DNA 
hybrids containing a minimum of four consecutive ribonucleotide residues (Ohtani 
et al., 1999). Epitope tagging of the full length TbRH1 protein reveals nuclear 
localisation of the protein, previously shown to be dependent upon the functional 
N-terminal HBD (Kobil, 2000).  Unlike mammalian type 1 RNase H proteins, TbRH1 
lacks an MTS required for targeting to the mitochondria, consistent with a lack of 
detectable mitochondrial or kDNA localisation of the tagged protein in this study. In 
mice, and probably humans, RNase H1 is completely essential for mtDNA replication 
(Cerritelli et al., 2003) but most likely acts redundantly with the RNase H2 complex 
in the nuclear genome. In accordance with RNase H1 being non-essential for 
eukaryotic nuclear genome functions, null mutation of the protein is not lethal in 
yeast, despite resulting in genomic instability (Wahba et al., 2011; O’Connell, 
Jinks-Robertson and Petes, 2015).  It is likely that TbRH1 acts similarly to other 
eukaryotic RNase H1 proteins in the T. brucei nuclear genome, since deletion of the 
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protein causes no deleterious effects, either to growth rate or cell cycle 
progression, despite elevated levels of DNA damage.  
DRIP-seq mapping of RNA-DNA hybrids and targeted DRIP-qPCR has revealed that 
TbRH1 potentially targets R-loops genome-wide in T. brucei. Although normalisation 
of sequencing data may have masked expected increases in R-loops after TbRH1 loss 
in certain areas, increased hybrids were detected across the centromeric repeats, 
in subtelomeric regions, rRNA gene arrays, RHS-associated genes and in the BESs of 
Tbrh1-/- parasites in comparison with WT. DRIP-qPCR further demonstrated TbRH1 
is likely to target RNA-DNA hybrids that form over the RNA Pol III transcribed tRNA 
and snRNA genes, as demonstrated in yeast (El Hage et al., 2014), and potentially 
globally across RNA Pol II transcribed PTUs. The data discussed in this thesis 
therefore do not indicate any site-specific activity for TbRH1, although this would 
require further experimental investigation, for example via ChIP-seq localisation of 
the enzyme. Recently, R-loop resolution activity of RNase H1 has been shown to 
allow progression of replication forks within the human genome (Parajuli et al., 
2017). Given the widespread formation of R-loops across the T. brucei genome, it is 
very likely that these structures form barriers to replication machinery in the 
parasite, and perhaps TbRH1 resolves hybrids to allow unperturbed replication in 
this setting as well. However, none of the data presented here is able to refute or 
confirm such a suggestion and further analysis would be necessary, such as by 
testing for the accumulation of replication machinery at prominent R-loop forming 
loci in the presence and absence of TbRH1. 
In contrast to dual mitochondrial and nuclear localisation of RNase H1 in mammals, 
a distinct RNase H-like protein (TbRH3) was identified in this thesis that contains an 
MTS and can be colocalised to the kDNA. This protein shows weak homology with 
either type 1 or type 2 RNase H enzymes in most eukaryotic species but does have 
orthologs in other trypanosomatids and shows some homology with bacterial RNase 
HII monomeric proteins. Although the predicted RNase H domain of this protein is 
larger than that of bacterial type 2 proteins, all active site and catalytic residues 
have been conserved, perhaps highlighting specialisation of the domain for a role in 
kDNA replication or maintenance. These data suggest trypanosomatids have evolved 
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a dedicated mitochondrial RNase H. One reason may be that the unique structure of 
the kDNA requires a stand-alone protein. It could be assumed that TbRH3 acts, 
instead of TbRH1, in kDNA replication, as type 1 RNase H proteins have been shown 
do in mtDNA replication (Xu and Clayton, 1996) and in E. coli plasmid replication 
(Itoh and Tomizawa, 1980), by excising the RNA strand of R-loops that form at the 
organellar genome replication origin to generate a ssDNA primer for DNA 
replication. However, as TbRH3 shows best homology to type 2 bacterial RNase H 
proteins that are unable to resect tracts of RNA-DNA hybrid in a processive manner 
like type 1 RNases H, its precise activity is likely to differ somewhat. Hence it is 
unlikely that TbRH3 catalyses a reaction at kDNA replication origins identical to 
type 1 RNases H during mtDNA and plasmid replication.   
Replication origins of kDNA minicircles contain the universal minicircle sequence 
(UMS), where leading strand synthesis is initiated by binding of the UMS binding 
protein (UMSBP) (Abu-Elneel, Kapeller and Shlomai, 1999). Interestingly, the UMS 
takes on an unusual, but poorly characterised conformation to allow the UMSBP to 
bind only a single strand of template DNA (Avrahami, Tzfati and Shlomai, 1995). 
UMSBP additionally binds a distinct hexamer sequence where the first Okazaki 
fragment is synthesised, beginning lagging strand replication (Abu-Elneel, Kapeller 
and Shlomai, 1999). In contrast, here UMSBP binds the non-template DNA strand, 
which logically could be the ssDNA element of an R-loop structure, containing an 
RNA-DNA hybrid formed by the RNA primer. Interestingly, Okazaki fragment primers 
remain in replicated minicircles until they migrate to the anti-podal sites for 
removal (Ryan and Englund, 1989), where TbRH3 appears to migrate during the cell 
cycle. Here, TbRH3 may remove the RNA primers between Okazaki fragments. 
Indeed, mammalian RNase H1 is able to degrade most of the RNA primer sequence, 
although it is unable to remove the 3’-most RNA, which is instead excessed by a 
flap endonuclease (Turchi et al., 1994). Nonetheless, as noted above, TbRH3 does 
not contain a ‘typical’ RNase H type 1 or type 2 domain structure and so its 
function may be more specialised to the complex kDNA. Indeed, the inability to 
generate RNAi cells meant it was not possible to directly test for a role in either 
minicircle or maxicircle kDNA replication. 
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The RNase H2 complex is essential for mammalian development and has been shown 
here to be essential for viability of BSF T. brucei parasites. Similarities exist 
between the phenotypes of mouse cell lacking a functional RNase H2 complex and 
parasite’s depleted for TbRH2A, including accumulation at the G2/M cell cycle 
stage and increased DNA damage (Hiller et al., 2012; Reijns et al., 2012), indicating 
the protein may have a conserved function. However, the mutant phenotypes differ 
in the impact upon DNA replication, as mouse cells fail to synthesise nascent DNA to 
WT levels without RNase H2 (Reijns et al., 2012), whereas T. brucei RNAi cells 
continue to replicate the nuclear genome, causing increased nuclear genome 
content despite very high levels of damage. This difference may simply reflect 
differences in the activation of cell cycle check points after RNase H2 loss, or 
perhaps the greater use of break-induced replication in T. brucei. Interestingly, 
RNase H2 is not essential in the yeast genome, where it is proposed to both resolve 
RNA-DNA hybrids and remove embedded ribonucleotides to prevent DNA damage 
and genomic rearrangements (Conover et al., 2015; O’Connell, Jinks-Robertson and 
Petes, 2015). The lack of at least one, although more likely both, of these functions 
presumably leads to irreversible damage in the mammalian and T. brucei genomes. 
It may be the case that additional proteins act redundantly with RNase H2 in yeast, 
or that RNase H2 has assumed another role in mammals and T. brucei that other 
proteins, including RNase H1, cannot perform.  
DRIP-seq using T. brucei cells depleted of TbRH2A by RNAi revealed little difference 
in R-loop formation between the RNAi-induced and induced parasites, with the sole 
clear exception being loss in DRIP-seq signal at the RNA Pol II TSSs. This localised 
change may indicate a specialisation of RNase H2 to resolve hybrids found at 
transcription initiation sites. Further evidence for this role lies in the accumulation 
of DNA damage, as indicated by gH2A mapping, at the same regions after loss of 
TbRH2.  Presumably, the RNA-DNA hybrid is processed into a DNA break in the 
absence of adequate TbRH2A protein, and so the hybrid can no longer be detected 
with DRIP-seq. Although it remains possible that TbRH2 removes large amounts of 
embedded ribonucleotides that cannot be endured by the parasites, why this mis-
incorporation should be more pronounced at, or even specific for, transcription 
initiation sites is unclear. The intriguing possibility that RNase H2, acting on R-
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loops, might play an active role in transcription initiation deserves further 
experimental examination, as this has not yet been described for any type 2 RNase 
H protein. One route to examine this may be to use ChIP and ask if TbRH2A localises 
to transcription start sites. Moreover, analysis of TbRH2A mutants that lack 
ribonucleotide excision activity but retain R-loop resolution functions (Chon et al., 
2013), would be very illuminating. 
7.2 R-loop formation across the T. brucei genome 
Using the DRIP-seq approach, RNA-DNA hybrids have been mapped across the T. 
brucei Mb chromosomes in WT parasites, as well as those depleted of RNase H2A 
and in null mutants of TbRH1. Signal peaks were highly consistent across all the 
cells, with very pronounced enrichment between CDS regions within the RNA Pol II 
transcribed PTUs (discussed below). Of the other R-loop forming sites described in 
this work, many have also been demonstrated in other genomes. For example, RNA 
Pol III transcribed tRNA and snRNA genes are known site of R-loops (El Hage et al., 
2014), as demonstrated in T. brucei by both DRIP-seq and DRIP-qPCR.  The Pol I 
rRNA array genes are also well-known sites of hybrid formation (Thomas, White and 
Davis, 1976; El Hage et al., 2010, 2014), again as observed here in T. brucei. 
Tandem repeat sequences are also known to encourage R-loop formation (Lin et al., 
2010) and a broad increase in DRIP-seq signal observably correlates with tandem 
repeats across the Mb chromosomes in T. brucei, in particular at centromeric 
repeats, similar to that observed in S. cerevisiae (Castellano-Pozo et al., 2013). 
Interestingly, centromeric R-loops have recently been directly implicated in a 
signalling cascade: RPA coats the ssDNA of the R-loops and activates ATR, which in 
turn stimulates Aurora A, via Chk1, to ensure correct chromosome segregation 
during mitosis (Kabeche et al., 2018). The finding that T. brucei centromeres also 
form R-loops indicates that this pathway may be conserved, despite the potentially 
highly variant kinetochore complex that links the centromere with the spindle 
(Akiyoshi and Gull, 2014; D’Archivio and Wickstead, 2017). 
R-loops have been well documented at CGI-associated ORIs in the human genome 
(Ginno et al., 2013), but the data presented here found no evidence to link R-loops 
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to DNA replication in T. brucei. Although DRIP-seq does reveal hybrids at SSRs, this 
signal correlates well with transcription initiation (discussed below), rather than 
being specific to ORI-containing SSRs (Tiengwe et al., 2012). However, it may be 
the case that ORI-specific R-loops escaped detection in this study if, for example, 
they are resolved by factors other than RNase H1 and H2. Additionally, as 
essentially all SSRs display ORC binding, whether or not they are activated as an ORI 
during S phase (Tiengwe et al., 2012), it remains plausible that R-loops could play a 
part in ORC recruitment, as suggested in the human genome (Lombraña et al., 
2015).  Similarly, no evidence was found to implicate R-loops in transcription 
termination processes in T. brucei, as no significant DRIP-seq signal could be 
observed at the terminal regions of the PTUs. This is in striking contrast to the 
widespread roles of R-loops in transcription termination in the human (Skourti-
Stathaki, Kamieniarz-Gdula and Proudfoot, 2014; Sanz et al., 2016) and S. 
cerevisiae (Wahba et al., 2016) genomes. However, it again remains the case that 
factors other than RNases H1 and H2 may resolve termination-associated R-loops, 
such as a homolog of sen1/SETX, which is known to process R-loops at RNA Pol II 
termination pause sites (Skourti-Stathaki, Proudfoot and Gromak, 2011; Skourti-
Stathaki, Kamieniarz-Gdula and Proudfoot, 2014). Nonetheless, it is conceivable 
that the evolution of multigenic transcription in trypanosomatids has selected for 
abolishment of R-loop activity in transcription termination, as it would prevent 
traversal of RNA Pol II to the downstream gene. 
7.2.1 R-loops and transcription initiation  
As discussed in Chapter 4, R-loops are associated with promoters in mammals 
(Ginno et al., 2012; Boque-Sastre et al., 2015; P. B. Chen et al., 2015; Sanz et al., 
2016), A. thaliana (Xu et al., 2017) and yeast (Chan et al., 2014; El Hage et al., 
2014). In this thesis, R-loops have been detected at RNA Pol II transcription start 
sites, despite little clear similarity of these regions with conventional RNA Pol II 
promoters. At CGI promoters in the human genome R-loops provide protection from 
repressive DNA methylation, promoting active transcription (Ginno et al., 2012). 
Though a functional DNA methylation pathway has been demonstrated in T. brucei 
(Militello et al., 2008), the modification’s role in transcription has yet to be 
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established. Although DRIP-seq signal correlates well with epigenetic markers of 
transcription initiation, whether or not R-loops have a role in their deposition is still 
unknown. Similarly, at human CGI promoters R-loops are correlated with epigenetic 
markers associated with open chromatin, and increased RNA Pol accessibility (Stork 
et al., 2016; Chen et al., 2017), yet a pathway directly linking R-loops to regulation 
of these markers is to be established. Thus, despite the potential similarity to R-
loop localisation in the trypanosome genome, further work is needed to determine 
if there is a functional overlap. R-loops have also been associated with promoter 
regions in the A. thaliana genome (Xu et al., 2017), although a pathway has not 
been demonstrated to directly link R-loops and chromatin here. In the mouse 
genome, where R-loops are again found at CGI promoters, binding of the 
remodelling complex Tip60-p400 is enhanced by R-loop structures, whereas binding 
of repressive complex PRC2 is suppressed (P. B. Chen et al., 2015). To date such 
complexes have not been described in T. brucei, and so it is unclear if R-loops 
might suppress the binding of chromatin condensing factors and/or encourage the 
binding of those that regulate RNA Pol II TSS chromatin structure, such as histone 
H2A.Z or H2B.V deposition enzymes (Siegel et al., 2009; Wedel et al., 2017).   
Although DRIP-seq mapping of RNA-DNA hybrids in Tbrh1-/- cells demonstrated TSS-
associated R-loops remain present in the absence of TbRH1, mapping in parasites 
depleted of TbRH2A revealed the hybrids are lost, or at least reduced, at these 
loci. As localised DNA damage is also found at these sites after TbRH2A depletion, it 
is likely that R-loops are not correctly resolved in these conditions. These findings 
reinforce the suggestion that RNase H2 acts specifically in the regulation of TSS-
associated R-loops, which may indicate a parasite-specific adaption of their 
function. Perhaps the RNase H2 complex has binding partners that recruit it to R-
loop-prone transcription initiation regions. If so, identification of such factors 
would be revealing. It is perhaps valuable to note that in humans cells RNase H2-
specific recruitment has been demonstrated to replicating DNA and localised sites 
of DNA damage, both via PCNA binding (Kind et al., 2014). If a similar PCNA-
association exists for TbRH2, this would reinforce a link between transcription and 
DNA replication in T. brucei (Tiengwe et al., 2012; Devlin et al., 2016).  
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7.2.2 R-loop formation at sites of trans-splicing and polyadenylation 
In other genomes, R-loops are poorly associated with splicing sites and are, in fact, 
protected from RNA-DNA hybrid formation by the presence of introns, an 
observation made in both yeast (Bonnet et al., 2017) and humans (Bonnet et al., 
2017; Dumelie and Jaffrey, 2017). Thus, the data in T. brucei, where effectively 
every CDS within a PTUs is an exon and the intra-CDS sequences are introns, is 
diametrically opposed. Unlike in other eukaryotes, the DRIP-seq reveals a strong 
enrichment for R-loops across intergenic and UTR sequences, which is well 
correlated with both PASs and nucleosome depletion. RNA Pol II is likely to pause at 
the nucleosome depleted sites between CDS regions (Wedel et al., 2017), and so it 
is possible that R-loop formation promotes such pausing to facilitate the action of 
the trans splicing and polyadenylation machineries. However, R-loops may equally 
form as a consequence of such RNA Pol II pausing. As a result, the two possibilities 
require experimental investigation by, for example, assessing RNA Pol II pausing via 
ChIP-seq (Wedel et al., 2017) in RNase H deficient parasites where increased R-
loops are to be expected. Similarly, R-loop formation could be analysed using DRIP 
methods in parasites where transcriptional pausing has been induced artificially 
such as with the use of a-amanitin (Das et al., 2006). 
7.3 R-loops are able to drive VSG switching 
Another, equally specific location of R-loop formation in the T. brucei genome is 
within the BESs, particularly across the 70-bp repeats. Multigenic, protein-coding 
RNA Pol I transcription units of this sort have no counterpart in non-kinetoplastid 
eukaryotes, indicating R-loop localisation in this environment is truly unique. The 
data presented, demonstrating the accumulation of BES-associated DNA damage 
and increased levels of VSG switching in Tbrh1-/- mutants and TbRH2A depleted 
parasites strongly supports a model of R-loop-driven VSG switching, potentially by 
both transcription and recombination routes. However, several questions remain 
before a pathway of switching can be clearly drawn. Firstly, what events ensure R-
loop formation predominantly, or exclusively in the actively transcribed BES? Does 
transcription stall as a result of R-loops, causing a decrease in VSG transcript levels 
capable of causing a transcriptional switch to an alternative BES? Is the R-loop 
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directly processed to form a DNA break, and if so by what factors? Alternatively, is 
a secondary event such as collision with the DNA replication machinery required to 
generate a DNA break? Do R-loops in fact form in trans due to the highly 
homologous sequences of the BESs and within the VSG archive? Lastly, in 
unperturbed parasite populations that undergo switching during an infection, what 
events could precede R-loop formation? Data in this thesis suggest RNase H enzymes 
target these R-loops for resolution; is this also the case during infection? How are 
sufficient R-loops generated in order to induce optimum levels of switching?  
Although the high divergence of antigenic variation strategies used by different 
infective organisms means R-loop driven antigen variation is likely to be specific to 
T. brucei, this work does contribute to a growing understanding of how R-loops may 
induce recombination (Skourti-Stathaki and Proudfoot, 2014; Sollier and Cimprich, 
2015). Indeed, to date only during mammalian Ig class switching has deliberate R-
loop formation been linked to planned recombination (Basu et al., 2011). Thus, 
dissecting how R-loops effect VSG switching could have wide-reaching implications 
for the understanding of genome stability in many settings. 
7.4 Future directions 
Data presented in this thesis provide the first genome-wide account of R-loops in a 
kinetoplastid genome, as well as the first characterisation of all three RNase H 
proteins in T. brucei. To date, R-loops have only been examined in T. brucei in the 
context of telomere biology, where their abundance was shown to be reduced after 
over-expression of TbRH1 (Nanavaty et al., 2017). By examining R-loop distribution 
genome-wide a global perspective on how R-loops may contribute to genome 
stability and function is revealed. These findings offer the opportunity for several 
exciting lines of research to be explored in the future.  Firstly, what exactly is the 
role of the T. brucei RNase H2 complex, and what makes it an essential enzyme? Is 
it in fact crucial that RNase H2 removes embedded ribonucleotides through the RER 
pathway? To establish this ribonucleotide load could be investigated in TbRH2A 
depleted parasites, and phenotype rescue could be attempted with an TbRH2A 
mutant protein capable of resolve RNA-DNA hybrids alone, as performed in S. 
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cerevisiae (Chon et al., 2013).  ChIP-seq could also be performed with both TbRH1 
and TbRH2A to establish if the two enzymes target the same or different genome 
loci. Immunoprecipitation and mass spectrometry could also be enlisted to establish 
binding partners of the RNase H2 complex. 
Another intriguing avenue would be to establish if there is a functional link between 
R-loops and kinetoplastid gene expression. This would actually involve examination 
of two questions. First, do R-loops act in RNA Pol II transcription initiation, a 
correlation that is frequently observed in other genomes yet has not be functionally 
characterised. Second, do R-loops contribute to multigenic pre-mRNA processing, 
which would be very novel if correct. Mapping of RNA Pol II binding with ChIP-seq in 
parasites lacking RNase H activity, perhaps by targeting TbRH2A for depletion with 
RNAi in the Tbrh1-/- background, may uncover changes at the TSS. Additionally, 
changes in RNA Pol II movement across the PTUs would help investigation into the 
role, if any, of R-loops in trans-splicing and polyadenylation. Finally, changes in 
transcription initiation- and processing-associated epigenetic markers could be 
investigated in the RNase H deficient cells, via ChIP-qPCR or ChIP-seq targeting 
H2A.Z, H2B.V and H4K10ac (Siegel et al., 2009).  
Detailed investigation of R-loop-driven VSG switching could also be pursued. Here 
there are many possible approaches: for example, RNA Pol I movement across the 
BES could be tracked via ChIP-seq in RNase H deficient cells to establish if pausing 
occurs due to R-loop formation. The 70-bp repeat sequence could also be 
genetically manipulated to establish if characteristics of the repeats facilitate R-
loop formation. DNA replication could also be tracked with DNA combing technology 
(Calderano et al., 2015) to establish if transcription-replication clashes are 
encouraged by R-loop formation and, if so, are these co-transcriptional or head-on? 
Lastly, in order to establish the factors that interact with RNA-DNA hybrids, which 
could potentially be involved in VSG recombination reactions, the S9.6 antibody 
might be utilise in a chromatin pull-down of associated proteins that could then be 
identified via mass spectrometry (Cristini et al., 2018). In fact, this approach may 
also uncover proteins that might link R-loops to transcription initiation, trans-
splicing or polyadenylation.
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8 Appendices
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Figure 8.1 Python script to generate a list of DRIP enriched regions. 
Once DRIP-seq enrichment was found in 50 bp windows, those with enrichment of IP compared to 
input samples > 1.2 fold were combined and considered as DRIP enriched regions. 50 bp window 
coordinates were used as an input for the above script in bed format and were scanned to find those 
that are adjacent and display > 1.2 fold-change. The start coordinate of the first window to meet the 
criteria and end coordinate of last downstream window to do so were printed and exported in BED 
format of enriched regions.  
1. ## Generate enriched region coodinates from enriched bin coordinate file   
2.    
3. # from tabulate import tabulate   
4. import numpy   
5. file = open("RH2A_unind_coverage_gt1.2.bedgraph", "r") ##Reads in the file of bin c
oordinates   
6. lines = file.read().splitlines() ## Split this file by each line and read lines   
7. length = (len(lines) - 1) ## calculate how many lines in the file    
8. index = 0 ## set up an index for each line   
9. Chrom = []   
10. Start = []   
11. End = []   
12. ## Generate a for loop to go through the file line by line    
13. for line in lines:   
14.     if index == 0:              # To print first chro and start coord    
15.         line = lines[index]   
16.         splitLine = line.split("\t")   
17.         Chrom.append(splitLine[0])   
18.         Start.append(splitLine[1])         
19.     if index < length:                   ## only if the index is less then the tota
l length   
20.         line = lines[index]                            
21.         next_line = lines[index+1]   
22.         splitLine = line.split("\t")   
23.         splitNextLine = next_line.split("\t")   
24.         if splitLine[2] != splitNextLine[1]:        ## is the end coord of line and
 start coord if next line different?   
25.                 Chrom.append(splitNextLine[0])   
26.                 Start.append(splitNextLine[1])   
27.                 End.append(splitLine[2])   
28.     if index == length:         # print the last end coord   
29.         line = lines[index]   
30.         splitLine = line.split("\t")   
31.         End.append(splitLine[2])   
32.     else:   
33.         exit   
34.     index = index + 1 #This is nessecary to add the index to the next line   
35. # print chrom   
36. #` print Start   
37. # print End   
38.    
39. results = numpy.column_stack((Chrom, Start, End)) ##Create an array for chrom, star
t and end   
40. # print results   
41.    
42. file = open("RH2A_unind_enriched_region_coords.bed", "w") ##wirte out the array to 
a file   
43. numpy.savetxt(file, results, delimiter = "  ", fmt = "%s")   
44. file.close   
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Figure 8.2 Python script to find GC and AT skew of DNA sequences 
The above script was used to calculate GC or AT skew for sequences inputted in fasta format. The 
script for GC skew is shown as an example, AT skew script was identical where G was exchanged for 
A and C for T. Skew was calculated in 10 bp windows.   
1. ## This script will find the GC skew over binned regions of fasta sequence   
2. ## Input it of fasta format of as many sequences as need.    
3. ## Window can be changes to alter the size of window in bp (non-sliding window)   
4. ## Input and ouput file names can be changed as required   
5.    
6. from __future__ import print_function   
7.    
8.    
9. file = open("WT_Rloop_pos_gene_seq.fasta", "r") # Reads in the file of region coord
inates   
10. lines = file.read().splitlines() # Split this file by each line and read lines   
11. index = 0 # Set up an index for each line   
12. file = open("WT_Rloop_pos_gene_GCskew.bed", "w") # File to save GC skew data too   
13.     
14. values = []    
15. window = 10   
16. for seq in lines:   
17.     if not seq.startswith(">"):                  # Skip fasta sequence names   
18.         for i in range(0, len(seq), window):   
19.             s = seq[i: i + window]    
20.             g = s.count('G') + s.count('g')    
21.             c = s.count('C') + s.count('c')   
22.             try:   
23.                 skew = (g - c) / float(g + c)   
24.             except ZeroDivisionError:   
25.                 skew = 0.0    
26.             bins = str(skew) + "\t"   
27.             print(bins, sep = ' ', end = '', file = file) # Print skew value of eac
h bin on the same line, seperated by a tab   
28.         print("\r", end = '', file = file) # Start a new line in file of skew data 
for next fasta seq   
29.         index = index +1   
30. file.close()   
 
  
255 
 
Figure 8.3 DRIP-seq mapping for RNA-DNA hybrids to the mVSG expression sites. 
DRIP-seq signal enrichment is plotted across 5 available mVSG expression sites, for data generated in 
WT (pink), Tbrh1-/- (green), TbRH2A un-induced (blue)  and induced (orange)  (24 hr) cell lines. In all 
cases red box depicts mVSG coding regions, and circles indicate end of avaible contig sequence.  
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Figure 8.4 DRIP-seq mapping for RNA-DNA hybrid at centromeres in TbRH2A RNAi parasites. 
DRIP-seq enrichment of IP sample relative input is plotted across the 8 known centromeric regions for 
both induced (orange) and un-induced (blue) sample. In all cases red boxes depict centromeric 
repeats, thick black boxes are coding regions with transcription direction indicated with white arrows, 
and UTRs are shown as think black boxes.   
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Figure 8.5 gH2A ChIP-seq mapping to the Mb chromosomes in TbRH2A RNAi parasites. 
gH2A ChIP-seq mapping to three example Mb chromosomes (1, 5 and 11) is shown. Enrichment of IP 
mapping relative to input is shown for un-induced and induced samples taken after 24hr (pink) and 36 
hr (green) of culture. Scales, 1-5 fold-change. Coding regions are shown in the top track with black 
depicting the sense strand, and red anti-sense.   
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Figure 8.6 gH2A ChIP-seq mapping to the Mb chromosomes in WT and Tbrh1-/- parasites. 
gH2A ChIP-seq mapping to three example Mb chromosomes (1, 5 and 11) is shown. Enrichment of IP 
mapping relative to input is shown for WT (pink) and Tbrh1-/- (green) of culture. Scales, 1-5 fold-
change. Coding regions are shown in the top track with black depicting the sense strand, and red anti-
sense.   
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Figure 8.7 RNA-seq mapping to silent BES-housed VSGs after 24 hr of TbRH2A depletion.  
Normalised RNA-seq read depth abundance (y-axes) is plotted for two independent replicates (overlaid 
orange and blue) of TbRH2A RNAi parasites after 24 hr of growth, with (tet +) and without (tet -) 
induction. Read depth is shown relative to CDS position (x-axes) for BES1 and BES3 as well as  a 
selection of the above VSG housed within BES identified by (Hertz-Fowler et al., 2008); VSG identity 
numbers are from (Cross, Kim and Wickstead, 2014).  
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Figure 8.8 γH2A ChIP-seq mapping to the BESs after 24hr of TbRH2A depletion. 
ChIP-seq signal enrichment is shown mapped to the active BES, BES1, and an inactive BES, BES3, 
(Hertz-Fowler et al., 2008) as a ratio of IP to input signal for un-induced (lighter) and induced (darker) 
samples taken at  both 24 (purple) and 36 (green) hr time points. Annotations are as described in 
Figure 6.1. 
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Gene ID Base Mean Log2 FC p value Gene description 
Tb427.BES98.4 80.91446371 4.854500301 4.76E-14 expression site-associated gene 3 (ESAG3, pseudogene), putative 
Tb427.BES134.3 196.4132048 4.632872805 3.40E-17 transferrin-binding protein, putative 
Tb427.BES134.6 1317.875299 4.16131121 4.38E-34 variant surface glycoprotein (VSG) 
Tb427.BES134.2 915.4331785 4.040173088 4.90E-20 transferrin-binding protein, putative 
Tb427.BES98.2 1719.674636 3.675707873 6.12E-18 transferrin-binding protein, putative 
Tb427.BES129.6 41.67769308 3.636744051 1.33E-07 expression site-associated gene 3 (ESAG3, pseudogene), putative 
Tb427.BES134.5 39.19467042 3.610256624 6.18E-05 expression site-associated gene 3 (ESAG3, pseudogene), putative 
Tb427.BES129.3 142.5747758 3.58134443 0.000000006 transferrin-binding protein, putative 
Tb427.BES98.1 803.919418 3.564188717 3.56E-16 transferrin-binding protein, putative 
Tb427.BES153.1 64.8268814 3.491335833 1.12E-10 folate transporter, putative 
Tb427.BES122.1 1848.159365 3.316942889 0.000116136 transferrin-binding protein, putative 
Tb427.BES15.1 63.08762692 3.209696259 1.04E-07 folate transporter, putative 
Tb427.BES28.1 147.0893493 3.187391215 3.15E-07 transferrin-binding protein, putative 
Tb427.BES98.3 167.5221562 3.134199178 1.28E-18 expression site-associated gene 5 (ESAG5) protein, putative 
Tb427.BES56.3 1015.486523 2.947401705 1.72E-10 transferrin-binding protein, putative 
Tb427.BES29.8 74.77286568 2.935857152 8.58E-08 expression site-associated gene 1 (ESAG1) protein, putative 
Tb427.BES56.1 58.9491296 2.917904869 1.99E-06 folate transporter, putative 
Tb427.BES98.4 38.26632636 2.869435937 1.59E-05 expression site-associated gene 3 (ESAG3, pseudogene), putative 
Tb427.BES29.5 104.4553261 2.74888531 2.35E-09 expression site-associated gene 3 (ESAG3, pseudogene), putative 
Tb427.BES29.6 144.1569569 2.741079309 2.24E-07 expression site-associated gene 2 (ESAG2) protein, putative 
Tb427.BES56.5 113.9970646 2.628604888 2.27E-11 expression site-associated gene 3 (ESAG3, pseudogene), putative 
Tb427.BES29.1 37.23482713 2.501653448 0.000159181 folate transporter, putative 
Tb927.10.10210 626.8045138 2.344035412 1.38E-06 procyclin-associated gene 4 (PAG4) protein 
Tb427.BES126.5 468.6077199 2.261115845 1.12E-06 expression site-associated gene 3 (ESAG3, pseudogene), putative 
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Tb427.BES126.9 51.38611308 2.113184858 0.000139011 expression site-associated gene 3 (ESAG3) protein, putative 
Tb427.BES10.2 673.9775699 1.949775237 1.53E-05 transferrin-binding protein, putative 
Tb427.BES29.3 1423.189122 1.874848581 7.59E-06 transferrin-binding protein, putative 
Tb927.11.17440 948.8572373 1.801535235 1.85E-09 variant surface glycoprotein (VSG), degenerate 
Tb427.BES29.9 7767.543212 1.652226649 2.02E-12 variant surface glycoprotein (VSG) 
Tb427.BES56.13 857.6695129 1.562144419 4.78E-07 variant surfave glycoprotein (VSG) 
Tb927.6.510 742.2088554 1.333807798 1.19E-05 GPEET procyclin 
Tb427.BES98.12 624.7495503 1.204289916 9.61E-07 variant surface glycoprotein (VSG) 
Table 8.1 Antigenic variation associated genes are upregulated after 24hr of TbRH2A RNAi 
List of genes found to be statistically up regulated after 24 hr TbRH2A knockdown with RNAi. The log2 fold-change (FC) of normalisaed read counts in tet-
induced samples relative to un-induced is shown for each gene, as well as p value of significance and gene description.   
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Gene ID Base Mean Log2 FC p value Gene description 
Tb927.7.6540 52.11121318 6.925801127 3.96E-07 variant surface glycoprotein (VSG, atypical), putative 
Tb927.11.19410 9.82459566 6.732055091 0.000654909 variant surface glycoprotein (VSG), putative 
Tb927.9.16130 9.650666209 6.705819231 0.000776044 variant surface glycoprotein (VSG, pseudogene), putative 
Tb927.9.17970 9.611356636 6.702508309 0.00055714 variant surface glycoprotein (VSG, pseudogene), putative 
Tb927.9.16130 8.528470356 6.529239771 0.001068167 variant surface glycoprotein (VSG, pseudogene), putative 
Tb927.11.18870 14.71649152 5.797281008 0.000552866 variant surface protein (VSG), putative (pseudogene) 
Tb927.9.16100 10.15205259 5.223211467 0.003040099 variant surface glycoprotein (VSG, pseudogene), putative 
Tb427.BES153.1 50.46346806 5.064435689 6.70E-09 folate transporter, putative 
Tb927.9.400 13.4299292 4.987509649 0.00198716 variant surface glycoprotein (VSG, pseudogene), putative 
Tb927.7.6530 181.2744897 4.958744655 0.00012341 variant surface glycoprotein, degenerate 
Tb427.BES134.6 1557.938318 4.908508218 0.000103825 variant surface glycoprotein (VSG) 
Tb927.9.17430 14.35338573 4.824059228 0.001091433 variant surface glycoprotein (VSG, pseudogene), putative 
Tb427.BES134.3 137.3508479 4.754244349 0.00123756 transferrin-binding protein, putative 
Tb927.7.1980 19.3064374 4.7504538 8.44E-05 retrotransposon hot spot protein 7 (RHS7), putative 
Tb927.7.1960 52.957613 4.541740671 2.87E-09 retrotransposon hot spot protein 7 (RHS7), putative 
Tb427.BES134.2 622.0362066 4.50528691 0.001880094 transferrin-binding protein, putative 
Tb927.9.16350 28.16973622 4.495286261 4.03E-05 variant surface glycoprotein (VSG, pseudogene), putative 
Tb927.7.6520 174.0741508 4.439723679 8.34E-12 variant surface glycoprotein, frameshift 
Tb927.9.400 17.79488162 4.424338667 0.000530527 variant surface glycoprotein (VSG, pseudogene), putative 
Tb927.9.16130 40.31895526 4.235957117 6.18E-06 variant surface glycoprotein (VSG, pseudogene), putative 
Tb927.9.16060 13.60311146 4.208796447 0.002128565 hypothetical protein 
Tb927.3.2550 53.73419138 4.108403155 0.000006747 hypothetical protein, conserved 
Tb927.9.18130 17.97321897 4.080665434 0.000739989 variant surface glycoprotein (VSG, pseudogene), putative 
Tb927.9.16170 98.41075253 4.011319195 8.12E-08 variant surface glycoprotein (VSG, pseudogene), putative 
Tb927.11.17440 1689.413382 3.915725633 1.66E-06 variant surface glycoprotein (VSG), degenerate 
Tb427.BES56.1 33.9857857 3.897738906 0.000012517 folate transporter, putative 
Tb427.BES64.2 2360.214434 3.857551673 4.79E-06 variant surface glycoprotein (VSG) 
Tb927.9.16370 39.47922286 3.848001048 2.32E-05 variant surface glycoprotein (VSG, pseudogene), putative 
Tb927.9.16160 13.56820979 3.823669368 0.003125917 variant surface glycoprotein (VSG, pseudogene), putative 
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Tb927.9.350 32.42208327 3.806051867 1.26E-05 variant surface glycoprotein (VSG, pseudogene), putative 
Tb427.BES134.5 16.24052381 3.79930773 0.001260451 expression site-associated gene 3 (ESAG3, pseudogene), putative 
Tb927.3.2540 27.88594666 3.769763367 8.76E-05 variant surface glycoprotein (VSG)-related, putative 
Tb927.3.2500 39.6974236 3.536648275 0.000265094 Trypanosomal VSG domain containing protein, putative 
Tb427.BES15.1 43.21821073 3.510988205 1.24E-06 folate transporter, putative 
Tb927.9.16640 46.71814216 3.453973341 7.25E-06 variant surface glycoprotein (VSG), putative 
Tb927.3.2580 48.73238532 3.417205899 1.18E-05 hypothetical protein, conserved 
Tb927.7.6510 117.2153427 3.362454632 1.25E-06 variant surface glycoprotein, degenerate 
Tb427.BES129.6 22.19878306 3.344558174 0.002564161 expression site-associated gene 3 (ESAG3, pseudogene), putative 
Tb427.BES29.1 33.72605882 3.326101763 3.50E-05 folate transporter, putative 
Tb427.BES129.3 92.45314016 3.325156116 4.51E-05 transferrin-binding protein, putative 
Tb927.9.16070 31.49144846 3.313301532 0.000207691 hypothetical protein 
Tb427.BES98.4 38.95353032 3.287313173 7.01E-05 expression site-associated gene 3 (ESAG3, pseudogene), putative 
Tb927.6.510 2743.247315 2.888428876 3.13E-27 GPEET procyclin 
Tb927.9.13160 34.81573771 2.861135188 0.000300634 hypothetical protein 
Tb927.9.760 34.64970861 2.788927427 0.001229052 hypothetical protein 
Tb927.3.2520 25.86796758 2.768736243 0.000677067 expression site-associated gene 1 (ESAG1) protein, putative 
Tb927.3.2530 44.31005596 2.732369665 0.000106956 expression site-associated gene 11 (ESAG11), degenerate 
Tb427.BES98.4 26.62190256 2.654005325 0.001033015 expression site-associated gene 3 (ESAG3, pseudogene), putative 
Tb11.v5.0353 42.78081849 2.599420192 8.65E-05 retrotransposon hot spot (RHS) protein, putative 
Tb927.9.14660 224.0843812 2.539511815 0.000000015 SLACS reverse transcriptase, putative (pseudogene) 
Tb927.6.810 125.5648416 2.527923271 4.94E-06 hypothetical protein 
Tb427.BES56.5 74.55858437 2.520131727 2.85E-05 expression site-associated gene 3 (ESAG3, pseudogene), putative 
Tb927.7.1990 54.39904771 2.446660193 6.77E-05 retrotransposon hot spot protein 7 (RHS7), point mutation 
Tb427.BES98.3 109.3919206 2.365870381 8.64E-08 expression site-associated gene 5 (ESAG5) protein, putative 
Tb11.v5.0797 114.1711689 2.327838541 4.21E-06 flagellar calcium-binding protein 
Tb927.10.13060 48.39581998 2.274925451 0.00197326 hypothetical protein 
Tb927.7.7560 443.7862501 2.268750814 0.000000532 hypothetical protein 
Tb927.7.6500 371.4551197 2.209533977 5.38E-06 variant surface glycoprotein (VSG), putative 
Tb927.9.210 46.92075342 2.193052773 0.000171584 variant surface glycoprotein (VSG, pseudogene), putative 
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Tb927.9.4840 114.122153 2.1298012 0.001279235 glucose transporter (pseudogene), putative 
Tb927.2.680 345.4546485 2.111870366 1.62E-05 Protein of unknown function (DUF1181), putative 
Tb927.6.470 485.0195869 2.017178561 8.74E-06 gene related to expression site-associated gene 2 (GRESAG2), putative 
Tb11.v5.0702 114.8166629 1.938027666 0.000548371 calpain-like cysteine peptidase, putative 
Tb927.6.110 192.7403593 1.904900892 1.61E-05 hypothetical protein 
Tb927.8.7300 302.5703561 1.858756115 2.62E-12 variant surface glycoprotein (VSG)-related, putative 
Tb927.11.4080 426.878734 1.852426671 0.000000001 variant surface glycoprotein (VSG)-related, putative 
Tb427.BES126.5 218.1031774 1.843028523 0.000354384 expression site-associated gene 3 (ESAG3, pseudogene), putative 
Tb927.2.6310 60.93971409 1.800364433 0.002121981 iron/ascorbate oxidoreductase family protein, putative 
Tb927.10.10210 489.4000215 1.761289861 2.73E-12 procyclin-associated gene 4 (PAG4) protein 
Tb927.10.10230 820.7554285 1.758441501 2.08E-14 procyclin-associated gene 5 (PAG5) protein 
Tb927.6.480 67.64540321 1.739061382 0.000383447 surface protein EP3-2 procyclin precursor 
Tb927.8.270 101.5036729 1.731211535 8.77E-05 variant surface glycoprotein, degenerate 
Tb927.1.3360 446.0502814 1.682070187 8.09E-05 hypothetical protein 
Tb927.1.280 51.20720474 1.663429373 0.002921437 Protein of unknown function (DUF1181), putative 
Tb927.10.10240 770.0499371 1.656041053 4.02E-12 procyclin-associated gene 1 (PAG1) protein 
Tb927.8.7320 221.5496491 1.652145682 9.62E-09 variant surface glycoprotein (VSG)-related, putative 
Tb927.4.130 416.2726939 1.595604064 3.23E-07 receptor-type adenylate cyclase GRESAG 4, pseudogene, putative 
Tb927.7.150 207.3910624 1.568650168 0.001413761 variant surface glycoprotein, degenerate 
Tb927.4.190 278.3005905 1.541229888 0.000516936 retrotransposon hot spot protein (RHS, pseudogene), putative 
Tb927.10.10220 962.6179284 1.509791474 1.17E-07 procyclin-associated gene 2 (PAG2) protein 
Tb927.10.10270 174.210351 1.499458754 0.001479878 hypothetical protein 
Tb927.5.280 63.04040369 1.49209763 0.001821499 retrotransposon hot spot protein 3 (RHS3), interrupted, degenerate 
Tb927.2.720 345.8331458 1.490494453 4.40E-05 retrotransposon hot spot protein 5 (RHS5), degenerate 
Tb927.6.520 1082.406497 1.464066503 6.88E-06 EP3-2 procyclin 
Tb927.2.910 436.5109616 1.464036617 2.97E-06 expression site-associated gene 4 (ESAG4), degenerate 
Tb927.4.240 300.5563346 1.452479593 0.00140124 retrotransposon hot spot protein 4 (RHS4), degenerate 
Tb927.10.10260 2008.912194 1.442501305 3.94E-06 EP1 procyclin 
Tb927.6.100 105.8013248 1.426997378 0.002129678 receptor-type adenylate cyclase GRESAG 4, pseudogene, putative 
Tb927.9.18140 11383.24334 1.418870436 7.13E-06 variant surface glycoprotein (VSG, pseudogene), putative 
  266 
Tb927.10.10250 621.1927578 1.349448564 4.45E-06 EP2 procyclin 
Tb927.6.210 367.075393 1.337717246 0.001514039 leucine-rich repeat protein (LRRP, pseudogene), putative 
Tb927.5.4020 414.3249901 1.334263638 0.000379904 hypothetical protein 
Tb927.1.275 195.0247213 1.327932369 0.00017662 expression site-associated gene 4 (ESAG4), pseudogene 
Tb927.3.2590 1759.247304 1.309063016 1.62E-06 hypothetical protein 
Tb927.3.1500 1585.561051 1.272159875 2.37E-06 variant surface glycoprotein (VSG)-related, putative 
Tb927.1.70 1268.318947 1.265998034 0.000134422 retrotransposon hot spot protein 4 (RHS4), putative 
Tb927.7.6490 4323.283585 1.250545624 1.48E-05 hypothetical protein, conserved 
Tb927.3.1510 387.2309373 1.238675074 9.90E-06 variant surface glycoprotein (VSG)-related, putative 
Tb927.5.5530 1227.091308 1.222801364 2.39E-06 Variant Surface Glycoprotein, putative 
Tb927.6.530 156.8191787 1.214100699 0.000697794 procyclin associated gene 3 (PAG3) protein 
Tb927.2.3330 151.7381566 1.192337209 0.002112579 hypothetical protein 
Tb927.6.340 319.062522 1.16057376 0.000561548 receptor-type adenylate cyclase GRESAG 4, pseudogene, putative 
Tb927.2.660 1369.101818 1.155089376 0.000597791 expression site-associated gene 4 (ESAG4), degenerate 
Tb07.30D13.60 320.1801847 1.145649936 5.40E-05 hypothetical protein, conserved (pseudogene) 
Tb927.7.6570 1149.455028 1.128136503 5.46E-05 Enriched in surface-labeled proteome protein 17 
Tb927.2.1260 660.570418 1.116307126 0.000201577 expression site-associated gene 4 (ESAG4), degenerate 
Tb927.7.6840 751.799654 1.113600086 0.002743568 Centrosomal spindle body, CEP44, putative 
Tb927.6.140 2162.058647 1.10856309 9.84E-05 retrotransposon hot spot protein 5 (RHS5), putative 
Tb927.6.690 490.3490536 1.106868329 9.41E-05 hypothetical protein, conserved 
Tb927.3.5690 1919.948201 1.034801434 7.06E-06 hypothetical protein, conserved 
Tb11.v5.0226 155.7227032 1.029097031 0.003270251 invariant surface glycoprotein, putative 
Tb927.5.2260 167.3798552 1.00679401 0.002141654 conserved protein 
Tb927.11.12710 1242.658229 1.005622583 0.000785991 variant surface glycoprotein (VSG)-related, putative 
Table 8.2 Mainly antigenic variation associated genes are upregulated after 36 hr of TbRH2A RNAi 
List of genes found to be statistically up regulated after 36 hr TbRH2A knockdown with RNAi. The log2 fold-change (FC) of normalisaed read counts in tet-
induced samples relative to un-induced is shown for each gene, as well as p value of significance and gene description.  
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Gene ID Base Mean Log2 FC p value Gene description 
Tb927.9.12550 419.475039 -1.803595591 2.80E-07 glycerol kinase, glycosomal 
Tb927.10.14140 9414.531185 -1.674005926 1.03E-24 pyruvate kinase 1 
Tb927.11.11980 621.2182858 -1.665807523 7.62E-06 cytoskeleton-associated protein 15 
Tb427.BES40.20 8821.839598 -1.567112409 4.38E-12 expression site-associated gene 1 (ESAG1) protein, putative 
Tb927.10.8230 5464.790321 -1.519769327 1.81E-18 protein disulfide isomerase 2 
Tb927.6.4300 434.1677737 -1.512632505 0.000341599 glyceraldehyde 3-phosphate dehydrogenase, glycosomal 
Tb427.BES40.22 3610039.441 -1.512092644 0.000000137 variant surface glycoprotein (VSG) 
Tb927.9.12610 760.8971767 -1.480026204 6.75E-05 glycerol kinase, glycosomal 
Tb11.v5.0531 290.2426473 -1.414328275 0.000164914 fructose-bisphosphate aldolase, glycosomal, putative 
Tb927.10.2890 92.23681948 -1.410642832 0.001201291 enolase 
Tb11.v5.0668 534.7367365 -1.402773873 2.69E-10 protein disulfide isomerase 
Tb927.9.12630 798.5237588 -1.381058966 0.0003749 glycerol kinase, glycosomal 
Tb927.1.2390 2256.684615 -1.350381971 1.48E-07 beta tubulin 
Tb927.11.715 370.6775856 -1.348965155 0.000005261 dynein light chain LC8, putative 
Tb427.BES40.7 2240.75733 -1.341675389 3.11E-05 receptor-type adenylate cyclase, putative 
Tb927.1.700 5749.735276 -1.339352437 2.86E-06 phosphoglycerate kinase 
Tb927.4.4860 350.8721809 -1.330997659 2.33E-08 amino acid transporter 8, putative 
Tb427.BES40.16 15582.84102 -1.271857462 1.40E-10 expression site-associated gene 3 (ESAG3) protein, putative 
Tb927.10.6880 209.7609699 -1.24521761 9.72E-05 glyceraldehyde 3-phosphate dehydrogenase, cytosolic 
Tb927.3.1470 186.061793 -1.242631355 6.22E-05 variant surface glycoprotein (VSG)-related, putative 
Tb927.11.880 31003.87333 -1.210523996 2.22E-07 cyclophilin a 
Tb927.11.1090 307.1177856 -1.203734963 9.75E-06 calpain-like protein, putative 
Tb927.11.18680 1094.614237 -1.197770312 1.39E-08 dynein light chain LC8, putative 
Tb11.v5.0540 691.345731 -1.192342859 3.32E-08 amino acid transporter 8, putative 
Tb927.7.1780 1760.175306 -1.185127344 3.78E-07 Adenine phosphoribosyltransferase, putative 
Tb927.4.4840 302.4570039 -1.184088841 1.68E-05 amino acid transporter 7, putative 
Tb927.2.4590 2454.867917 -1.162772126 3.80E-07 branched-chain amino acid aminotransferase, putative 
Tb927.11.7380 6439.120443 -1.161239686 2.35E-13 glycerol-3-phosphate dehydrogenase (FAD-dependent), mitochondrial 
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Tb427.BES40.10 17893.51703 -1.153481308 5.62E-07 expression site-associated gene 3 (ESAG3) protein, putative 
Tb927.3.4070 10489.68528 -1.152675423 1.69E-05 Pyruvate transporter, putative 
Tb927.10.11300 682.3798256 -1.139914534 6.19E-08 paraflagellar rod component, putative 
Tb927.8.5120 3302.43861 -1.137615658 4.57E-07 cytochrome c 
Tb927.3.2960 10857.00718 -1.136727203 4.03E-11 inosine-adenosine-guanosine-nucleosidehydrolase 
Tb11.v5.0516 425.7969728 -1.135311815 1.13E-06 glyceraldehyde 3-phosphate dehydrogenase, cytosolic, putative 
Tb927.10.4560 2090.744141 -1.132742929 1.39E-10 elongation factor 2 
Tb927.9.12110 3011.7123 -1.125345273 6.00E-13 6-phosphogluconate dehydrogenase, decarboxylating 
Tb927.3.3270 40034.84321 -1.113142024 6.10E-05 ATP-dependent 6-phosphofructokinase, glycosomal 
Tb927.5.4530 1068.250128 -1.093810961 3.59E-07 Long chain fatty acyl elongase 
Tb927.11.16350 738.3691773 -1.093564168 0.000552014 hypothetical protein, conserved 
Tb927.2.6150 278.5767622 -1.085138987 0.000215295 adenosine transporter 2 
Tb927.9.10310 2413.384703 -1.08115305 0.000000091 mitochondrial carrier protein 11 
Tb927.11.16760 5407.474251 -1.071429426 2.58E-08 T-complex protein 1, alpha subunit, putative 
Tb927.1.2360 218.0001538 -1.067127513 0.000660849 alpha tubulin 
Tb927.3.1520 229.1075979 -1.065007102 9.52E-05 variant surface glycoprotein (VSG)-related, putative 
Tb927.11.12120 1057.604948 -1.059029585 0.00023701 RNA-binding protein, putative 
Tb927.10.11700 1206.434069 -1.055943595 2.29E-05 guanylate kinase, putative 
Tb927.9.6210 4910.126175 -1.05526352 3.28E-13 arginine kinase 
Tb427.BES40.17 628.3313574 -1.04754019 0.000939984 hypothetical protein 
Tb927.11.14090 4710.993038 -1.046230144 1.02E-08 Double RNA binding domain protein 18 
Tb927.11.5520 6890.768777 -1.042013426 2.81E-10 triosephosphate isomerase 
Tb927.8.8330 7398.56821 -1.038676453 3.18E-08 cysteine peptidase, putative 
Tb927.11.13500 10235.89331 -1.029364307 4.84E-13 par1 
Tb927.4.4870 251.9304803 -1.027673114 0.000911145 amino acid transporter, putative 
Tb927.11.9590 32030.66425 -1.025530683 3.78E-07 S-adenosylhomocysteine hydrolase, putative 
Tb927.6.3840 13071.99154 -1.018677696 4.54E-12 reticulon domain protein 
Tb927.9.10230 9873.811841 -1.017246088 4.42E-11 Co-chaperone protein P23 
Tb927.9.10400 2536.600137 -1.016564649 0.000004435 hypothetical protein, conserved 
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Tb927.11.7460 1799.190188 -1.007372253 0.000002871 luminal binding protein 1 (BiP), putative 
Tb927.7.2240 4649.670772 -0.99714677 8.67E-09 hypothetical protein, conserved 
Tb927.10.4570 15523.37547 -0.992707051 1.10E-07 elongation factor 2 
Tb927.10.10920 463.921429 -0.991885845 1.89E-05 heat shock protein, putative 
Tb927.10.14170 1935.180161 -0.990737218 8.98E-10 aquaglyceroporin 2 
Tb927.10.15760 3414.968275 -0.989259681 5.43E-09 hypothetical protein, conserved 
Tb927.5.3810 1667.711073 -0.979245139 0.000586268 
orotidine-5-phosphate decarboxylase/orotate 
phosphoribosyltransferase, putative 
Tb927.4.2530 7285.637991 -0.977468582 3.48E-10 hypothetical protein, conserved 
Tb927.10.3640 183.9941052 -0.976193235 0.000932917 nuclear transmembrane protein, putative 
Tb927.10.1390 2877.29184 -0.970794792 0.003158761 hypoxanthine-guanine phosphoribosyltransferase, putative 
Tb927.11.16400 3362.795615 -0.969582914 2.33E-09 kinetoplast-associated protein 3, putative 
Tb927.10.12820 3987.230204 -0.969090137 3.54E-08 hypothetical protein, conserved 
Tb927.1.2400 402.1086263 -0.960923446 0.000211812 alpha tubulin 
Tb927.4.1300 5497.119056 -0.957169605 1.01E-07 amidinotransferase, putative 
Tb927.9.4680 8166.964166 -0.955930435 2.99E-11 Eukaryotic initiation factor 4A-1 
Tb927.9.8950 7372.783409 -0.953330821 1.32E-10 metallo- peptidase, Clan M- Family M48 
Tb927.11.1900 8820.546413 -0.951284005 0.000001095 T-complex protein 1, beta subunit, putative 
Tb927.11.3240 7565.151696 -0.948018576 1.86E-08 T-complex protein 1, zeta subunit, putative 
Tb927.11.2400 1358.051051 -0.944933316 4.35E-07 Flabarin-like protein 
Tb927.8.7410 8859.500739 -0.944741761 3.05E-07 calreticulin, putative 
Tb927.8.5460 818.7350987 -0.941870284 0.000272996 Flagellar calcium-binding 44 kDa protein 
Tb927.5.3400 5619.667734 -0.941606433 3.15E-08 calcium-translocating P-type ATPase 
Tb927.10.2190 2292.796451 -0.939270382 5.99E-08 Protein of unknown function (DUF667), putative 
Tb927.7.5790 4694.063269 -0.938964022 4.45E-09 protein disulfide isomerase, putative 
Tb927.11.15910 3706.934352 -0.935981401 7.55E-09 iron superoxide dismutase 
Tb927.10.830 2570.191047 -0.932895213 3.53E-07 adenylate kinase, putative 
Tb927.11.16130 10195.10265 -0.926740296 2.53E-10 nucleoside diphosphate kinase 
Tb11.v5.0838 2825.059887 -0.92241439 1.10E-07 leucine-rich repeat protein (LRRP), putative 
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Tb927.7.4160 3030.046525 -0.920726322 0.000000003 Fatty acid elongase 
Tb11.v5.0538 1221.266373 -0.918603105 0.000025941 69 kDa paraflagellar rod protein, putative 
Tb927.6.3750 3590.288892 -0.91525592 2.38E-08 heat shock 70 kDa protein, mitochondrial precursor, putative 
Tb927.8.6390 4442.273589 -0.911574639 0.000126627 lysophospholipase, putative 
Tb927.9.12700 2929.855727 -0.90958146 1.74E-05 phospholipase A1, putative 
Tb927.10.10140 4575.533482 -0.908684554 8.68E-10 paraflagellar rod component, putative 
Tb927.10.1060 5062.358733 -0.908296115 2.17E-06 T-complex protein 1, delta subunit, putative 
Tb927.11.4180 2571.802431 -0.896759972 0.000000083 PSP1 C-terminal conserved region, putative 
Tb927.4.2310 6087.385189 -0.896683584 3.52E-07 asparaginyl-tRNA synthetase, putative 
Tb927.10.14150 6099.71452 -0.895496101 2.75E-05 nuclear segregation protein, putative 
Tb927.10.5840 10560.03362 -0.894073627 3.40E-07 translation elongation factor 1-beta, putative 
Tb927.11.3250 15223.20427 -0.893883352 1.09E-07 dynein heavy chain, putative 
Tb927.10.8900 714.8880949 -0.890196988 5.19E-06 choline/ethanolamine phosphotransferase (CEPT) 
Tb927.11.15100 4917.393522 -0.882412403 2.41E-08 Tb5.20 
Tb927.11.2650 7151.344863 -0.881838792 4.91E-07 heat shock protein 84, putative 
Tb927.2.4710 7427.054425 -0.881574334 5.70E-10 RNA-binding protein, putative 
Tb927.8.730 5186.090853 -0.876169021 3.09E-05 nucleolar RNA-binding protein, putative 
Tb927.7.1300 12530.48916 -0.876076512 1.24E-06 protein disulfide isomerase, putative 
Tb927.10.11710 1088.015232 -0.875296849 2.33E-05 hypothetical protein 
Tb927.9.2470 12702.74154 -0.874079236 0.000000017 nucleolar protein 
Tb927.7.2650 12067.57219 -0.873311284 7.95E-10 hypothetical protein, conserved 
Tb927.10.8190 6560.146812 -0.872024334 0.000000009 T-complex protein 1, theta subunit, putative 
Tb927.11.18700 179.4465319 -0.871901873 0.003342113 hypothetical protein, conserved 
Tb927.10.9570 5334.357615 -0.865080828 3.98E-08 paraflagellar rod component, putative 
Tb927.11.5370 2173.403409 -0.864688689 2.68E-07 hypothetical protein, conserved 
Tb927.11.6230 5593.38036 -0.862654833 4.12E-07 protein transport protein SEC61 subunit alpha, putative 
Tb927.11.1430 5911.948489 -0.86105537 3.27E-09 Component of motile flagella 2 
Tb927.8.2460 2471.84321 -0.860473491 3.56E-07 hypothetical protein, conserved 
Tb11.v5.0414 834.3044404 -0.856703292 4.07E-06 ATP-dependent DEAD/H RNA helicase, putative 
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Tb927.11.13050 268.931369 -0.856082864 0.00211502 calmodulin 
Tb927.6.2360 406.456844 -0.85579691 0.00045849 adenosine kinase, putative 
Tb927.3.930 16862.19739 -0.850230763 1.96E-07 dynein heavy chain, putative 
Tb927.3.1840 4820.130574 -0.84864077 4.24E-08 3-oxo-5-alpha-steroid 4-dehydrogenase, putative 
Tb927.9.11270 9864.619752 -0.847988091 1.33E-06 t- complex protein 1 (eta subunit), putative 
Tb927.11.16360 676.0004779 -0.847280011 0.002146365 hypothetical protein, conserved 
Tb927.9.6290 6348.935551 -0.844375256 0.002886301 arginine kinase 
Tb11.v5.0171 353.275894 -0.842532031 0.001252249 5'-3' exonuclease XRNA, putative 
Tb927.4.5010 12101.22174 -0.841583991 3.92E-06 calreticulin, putative 
Tb927.1.3830 12671.48689 -0.839553499 0.000771345 glucose-6-phosphate isomerase, glycosomal 
Tb927.11.7510 12407.25617 -0.839420266 0.000319258 luminal binding protein 1 (BiP), putative 
Tb927.11.11520 4748.720447 -0.838783151 5.18E-08 glycosomal membrane protein 
Tb927.9.13785 1416.537587 -0.837740553 0.000934346 kinetoplastid membrane protein 11-5 
Tb927.7.2400 547.5891448 -0.83758287 0.000213052 tyrosyl-tRNA synthetase, putative 
Tb11.v5.1046 12850.99314 -0.832219859 3.47E-08 elongation factor 1-alpha, putative 
Tb927.11.1070 3738.042377 -0.826335724 5.34E-08 glycosomal transporter (GAT3), putative 
Tb927.10.6400 5350.929418 -0.824964243 0.00000004 chaperonin HSP60, mitochondrial precursor 
Tb927.8.2070 627.341065 -0.821710164 6.16E-05 Present in the outer mitochondrial membrane proteome 39-1 
Tb10.NT.148 604.3611845 -0.820436552 7.79E-05 Noncoding RNA, putative 
Tb927.7.1110 3586.745938 -0.817221501 0.001994057 asparagine synthetase a, putative 
Tb927.11.13020 2053.279768 -0.817183338 0.000459508 calmodulin 
Tb927.11.7560 4709.471953 -0.816560157 4.03E-07 Component of motile flagella 15 
Tb927.6.3940 2649.190638 -0.815478592 2.99E-05 Autophagy-related protein 27, putative 
Tb927.11.3030 2450.860262 -0.814057215 0.000165459 phosphoribosylpyrophosphate synthetase, putative 
Tb927.10.8940 26390.36718 -0.813726115 7.79E-08 flagellum targeting protein kharon1, putative 
Tb927.9.5860 2334.883567 -0.807933895 4.99E-07 tryparedoxin peroxidase 
Tb927.7.4470 1716.835184 -0.80587591 7.67E-07 hypothetical protein, conserved 
Tb927.11.5440 3348.834161 -0.805166612 1.32E-05 NADP-dependent malic enzyme, cytosolic 
Tb927.11.10940 837.503866 -0.80098237 0.000109131 hypothetical protein, conserved 
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Tb927.11.13190 1982.843303 -0.800003482 6.53E-07 elongation factor 1 gamma, putative 
Tb927.7.710 5940.138912 -0.799555675 0.000004652 heat shock 70 kDa protein, putative 
Tb927.8.4430 10160.82582 -0.794747262 0.003300383 uridine phosphorylase 
Tb927.11.14880 7643.144736 -0.794742456 2.41E-08 Paraflagellar Rod Proteome Component 9, putative 
Tb927.10.12330 778.5875352 -0.791999756 0.000275023 zinc finger protein family member, putative 
Tb927.10.540 6619.630867 -0.790642274 0.000000392 ATP-dependent RNA helicase SUB2, putative 
Tb927.10.14890 9861.283852 -0.79047051 5.69E-07 C-terminal motor kinesin, putative 
Tb927.11.16630 1960.453787 -0.790006023 0.000121889 major facilitator superfamily, putative 
Tb927.9.4210 1917.679487 -0.789390712 6.39E-07 fatty acyl CoA synthetase 3 
Tb927.5.2570 1625.232207 -0.788241343 1.17E-05 eukaryotic translation initiation factor 3 subunit b 
Tb927.10.14500 2590.212382 -0.787971867 2.54E-06 hypothetical protein, conserved 
Tb927.8.4330 2887.143111 -0.787756132 0.00023079 small GTP-binding protein Rab11 
Tb927.11.760 11200.07093 -0.787226985 2.41E-06 protein phosphatase 2C, putative 
Tb927.11.13090 1144.602005 -0.786986755 0.000074046 elongation factor 1 gamma, putative 
Tb927.9.4750 5200.99029 -0.786901342 7.04E-07 hypothetical protein 
Tb927.11.17000 6182.683058 -0.785467003 6.79E-06 AIR9-like protein 
Tb927.9.4200 3195.577923 -0.783519636 5.21E-06 fatty acyl CoA synthetase 2 
Tb927.8.1550 3728.80798 -0.777944341 1.74E-06 paraflagellar rod component, putative 
Tb927.11.720 4891.01396 -0.776803883 2.30E-07 hypothetical protein, conserved 
Tb927.2.6000 4022.680949 -0.775445124 0.000636964 glycosylphosphatidylinositol-specific phospholipase C 
Tb927.5.1210 12493.64589 -0.773157455 2.87E-08 short-chain dehydrogenase, putative 
Tb927.3.4100 5914.761264 -0.772636032 0.000136155 Pyruvate transporter, putative 
Tb927.10.6510 922.3024971 -0.771940143 3.67E-05 chaperonin HSP60, mitochondrial precursor 
Tb927.5.3220 3546.687722 -0.770505076 1.61E-06 signal peptidase type I, putative 
Tb927.11.1990 2742.415818 -0.768961753 0.000330096 arginyl-tRNA synthetase, putative 
Tb927.5.3800 3417.696804 -0.768940679 0.000491452 
glutamine hydrolysing (not ammonia-dependent) carbomoyl phosphate 
synthase, putative 
Tb927.1.4490 1567.233241 -0.765882679 0.000101802 acetyltransferase, putative 
Tb927.11.6870 1772.347747 -0.764561238 1.49E-05 14-3-3 protein 2 
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Tb11.v5.0671 506.4260477 -0.758123731 0.00130034 protein kinase A catalytic subunit, putative 
Tb927.6.4000 5281.098596 -0.757764492 0.000235423 small glutamine-rich tetratricopeptide repeat protein, putative 
Tb927.11.1980 4575.549232 -0.754010598 3.77E-06 zinc finger protein family member, putative 
Tb927.10.15320 923.5530731 -0.752367069 3.26E-05 hypothetical protein, conserved 
Tb927.7.470 1766.883651 -0.752351823 2.46E-05 Enriched in surface-labeled proteome protein 14 
Tb927.10.12890 5349.309811 -0.751588497 3.15E-06 bifunctional aminoacyl-tRNA synthetase, putative 
Tb927.10.7680 3475.570192 -0.750609595 7.27E-06 GTPase activating protein, putative 
Tb927.10.16120 5495.020397 -0.750471427 7.86E-05 inosine-5'-monophosphate dehydrogenase 
Tb927.2.4210 4461.099174 -0.750081302 5.79E-07 Phosphoenolpyruvate carboxykinase [ATP], glycosomal 
Tb927.11.14620 5145.975341 -0.749904086 0.000403727 expression site-associated gene 2 (ESAG2) protein, putative 
Tb927.10.2530 1413.598342 -0.749738348 0.000141402 adenylate kinase, putative 
Tb927.9.10770 31861.98876 -0.749223513 9.85E-07 polyadenylate-binding protein 2 
Tb927.11.15420 467.9747692 -0.745810374 0.000543131 eukaryotic translation initiation factor 3 subunit k 
Tb927.11.6860 1769.523263 -0.745537237 5.67E-05 hypothetical protein 
Tb927.4.4040 3706.486064 -0.744831211 6.61E-06 hypothetical protein, conserved 
Tb927.8.6660 7424.204041 -0.744315234 1.76E-07 paraflagellar rod component, putative 
Tb927.9.11100 1127.979006 -0.744206736 6.12E-05 cAMP-dependent protein kinase catalytic subunit 1 
Tb927.5.4500 2065.183116 -0.742638816 3.77E-05 ras-like small GTPase, putative 
Tb927.7.3550 20003.02941 -0.741243994 8.26E-08 cytoskeleton associated protein, putative 
Tb927.9.5770 3539.85029 -0.739708 1.77E-06 tryparedoxin peroxidase 
Tb927.5.4420 3378.378891 -0.736336992 2.89E-06 nucleolar RNA helicase II, putative 
Tb927.11.2300 1780.441926 -0.735959989 0.002121054 eukaryotic peptide chain release factor subunit 1, putative 
Tb927.9.9940 2761.148498 -0.735704383 7.68E-06 PACRGB 
Tb927.7.3760 3468.107835 -0.734279909 1.22E-05 phosphatidylserine synthase, putative 
Tb927.10.7930 8928.061917 -0.730427015 2.31E-07 2,3-bisphosphoglycerate-independent phosphoglycerate mutase 
Tb927.10.1040 2404.534284 -0.729253654 0.00003754 serine peptidase, Clan SC, Family S10 
Tb927.6.4500 9729.203503 -0.726585563 3.22E-07 conserved repeat domain containing protein, putative 
Tb927.10.200 5182.214995 -0.725986093 3.65E-06 vacuolar ATP synthase, putative 
Tb927.11.3730 3080.33511 -0.720466791 0.000415832 leucyl-tRNA synthetase, putative 
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Tb927.10.14790 7442.066215 -0.717009904 0.002779163 metallo-peptidase, Clan MG, Family M24 
Tb927.8.650 6087.590423 -0.714684521 9.63E-06 cation-transporting ATPase, putative 
Tb927.10.13780 3641.950217 -0.712674232 0.000145753 glycogen synthase kinase 3 
Tb927.11.14250 6874.962822 -0.712519947 2.70E-06 T-complex protein 1, epsilon subunit, putative 
Tb927.11.11010 11163.12045 -0.710564573 1.64E-05 hypothetical protein, conserved 
Tb927.11.1110 5934.934901 -0.708940305 1.33E-05 calpain, putative 
Tb927.3.5370 4151.160645 -0.708936 1.83E-05 hypothetical protein, conserved 
Tb927.9.5320 4095.503061 -0.700844443 0.001206321 nucleolar RNA binding protein, putative 
Tb927.10.13630 9715.081017 -0.700162457 4.38E-05 glucosidase, putative 
Tb927.10.14700 4976.171304 -0.699286654 1.28E-05 hypothetical protein, conserved 
Tb927.9.12650 13135.2986 -0.698934509 4.17E-06 ubiquitin-activating enzyme E1, putative 
Tb927.6.5070 7672.412136 -0.698487454 0.000041344 hypothetical protein, conserved 
Tb927.11.8970 6892.274619 -0.697200975 0.000520844 ribose 5-phosphate isomerase, putative 
Tb927.4.2740 4085.120321 -0.696981065 0.001236883 p25-alpha, putative 
Tb927.11.14950 7460.211993 -0.696766526 2.38E-06 zinc finger protein 2 
Tb927.9.14130 1740.285574 -0.696748382 0.003413531 hypothetical protein, conserved 
Tb927.10.8830 3531.744794 -0.695837941 0.000117181 Flagellum attachment zone protein 5 
Tb927.8.6110 7393.848792 -0.695392274 0.000879283 3-hydroxy-3-methylglutaryl-CoA synthase, putative 
Tb927.8.760 2813.80376 -0.693792773 0.001836736 nucleolar RNA-binding protein 
Tb927.10.4760 2748.89117 -0.69211295 0.000008787 Integral membrane protein DUF106, putative 
Tb927.9.9290 5920.605776 -0.691124039 0.001878827 polyadenylate-binding protein 1 
Tb927.10.5810 12275.754 -0.690543672 0.000230966 The ARF-like 2 binding protein BART, putative 
Tb927.10.9430 3235.589583 -0.690296172 0.000533671 phosphoribosylpyrophosphate synthetase, putative 
Tb927.11.2610 23809.25442 -0.690260343 2.68E-06 hypothetical protein, conserved 
Tb927.7.1130 1852.951366 -0.689516116 0.000110072 trypanothione/tryparedoxin dependent peroxidase 2 
Tb927.10.13290 2427.547374 -0.688813782 0.001158452 ethanolamine phosphotransferase (EPT) 
Tb927.7.190 4011.789559 -0.68705547 0.001124911 thimet oligopeptidase, putative 
Tb927.9.4190 3263.844066 -0.686995059 0.000978855 fatty acyl CoA syntetase 1 
Tb927.5.1360 3268.335541 -0.683130341 3.14E-05 nucleoside 2-deoxyribosyltransferase 
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Tb927.11.15200 667.4741549 -0.67977659 0.001815135 hypothetical protein, conserved 
Tb927.9.9550 5341.743968 -0.677202996 2.56E-05 conserved protein, unknown function 
Tb927.7.3330 2354.785873 -0.676531471 1.99E-05 Flagellar attachment zone protein 10 
Tb927.11.5820 2453.675234 -0.676079378 4.12E-05 Inhibitor of apoptosis-promoting Bax1, putative 
Tb927.9.9810 3777.762197 -0.675329414 0.000106974 hypothetical protein, conserved 
Tb927.10.7090 4987.959551 -0.672022429 1.82E-05 Alternative oxidase, mitochondrial 
Tb927.7.1470 2406.849151 -0.671712456 0.001037493 Mitochondrial ATP synthase subunit c-3 
Tb927.8.3150 6052.221477 -0.670613071 0.000265362 T-complex protein 1, gamma subunit, putative 
Tb927.10.14780 4022.420363 -0.670016153 0.000505851 Canertinib-binding protein kinase 1 
Tb927.9.8880 2873.066485 -0.66954361 3.44E-05 actin B 
Tb927.11.11250 4937.56218 -0.664988169 2.03E-05 cytosolic malate dehydrogenase 
Tb927.10.12010 1737.166152 -0.664814339 0.000961398 hypothetical protein, conserved 
Tb927.8.1990 7222.198204 -0.663549298 0.000544874 peroxidoxin 
Tb927.10.2370 2370.563624 -0.662950372 0.002432723 Lupus La protein homolog, putative 
Tb927.10.1630 1746.341423 -0.66189842 0.000371762 atp-binding cassette sub-family e member 1 
Tb927.8.6240 4042.817898 -0.660343511 5.19E-05 STOP axonemal protein 
Tb927.6.4480 4737.533062 -0.659113818 1.33E-05 valyl-tRNA synthetase, putative 
Tb927.7.4260 3690.014914 -0.656691169 2.98E-05 Enriched in surface-labeled proteome protein 13 
Tb927.9.6250 655.4390898 -0.656015448 0.000976164 arginine kinase 
Tb927.11.6440 8469.652534 -0.655100438 2.28E-05 hypothetical protein, conserved 
Tb927.3.5340 4894.881557 -0.652816307 2.88E-05 Hsc70-interacting protein (Hip), putative 
Tb927.11.7170 3577.21945 -0.64962454 7.29E-05 seryl-tRNA synthetase 
Tb927.10.2240 5095.367187 -0.646103631 1.82E-05 RNA binding protein 
Tb927.11.14370 2260.413925 -0.645466282 4.19E-05 Microtubule-associated protein 103???kDa 
Tb927.11.9530 16345.36347 -0.645348987 6.57E-06 14-3-3 protein 1 
Tb927.7.940 3883.875344 -0.643152046 0.000193892 protein kinase C substrate protein, heavy chain, putative 
Tb927.10.5770 1912.828205 -0.643127017 7.96E-05 Valosin-containing protein 
Tb927.6.4320 3427.036138 -0.641993951 0.000181458 Protein of unknown function (DUF2817), putative 
Tb927.4.2040 9879.95908 -0.641990327 0.000908813 DNA/RNA-binding protein Alba 3 
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Tb927.11.1150 1777.924837 -0.641603721 0.00015664 radial spoke protein 3 
Tb927.10.12670 2035.93561 -0.641346983 4.87E-05 hypothetical protein, conserved 
Tb927.9.8990 1490.821453 -0.639868972 0.000101932 Ankyrin repeats (3 copies), putative 
Tb927.7.4180 6038.614291 -0.639052837 0.000046176 Fatty acid elongase 
Tb927.8.6760 6643.116096 -0.637615717 0.000317122 translationally-controlled tumor protein homolog, putative 
Tb927.5.4390 1602.879124 -0.6374048 0.000190575 hypothetical protein, conserved 
Tb927.7.4290 1954.585128 -0.637230915 8.99E-05 Nuclear distribution protein C homolog 
Tb927.5.3830 2296.119081 -0.636001247 0.00022806 dihydroorotate dehydrogenase (fumarate) 
Tb927.11.740 9080.836753 -0.635457293 3.04E-05 eukaryotic translation initiation factor 5A 
Tb927.9.10560 1377.697868 -0.631312943 0.000735028 Archaic Translocase of outer membrane 19 kDa subunit 
Tb927.10.13580 1183.578725 -0.629968851 0.000936651 major facilitator superfamily protein (MFS), putative 
Tb927.2.4440 751.0335192 -0.629707486 0.001010453 hypothetical protein 
Tb927.10.15180 6765.25061 -0.627773169 9.47E-05 nucleosome assembly protein, putative 
Tb927.9.12510 2767.022841 -0.62728473 8.21E-05 ATP-dependent DEAD/H RNA helicase, putative 
Tb927.11.4910 2202.702 -0.626253737 0.0002334 predicted ankyrin repeat family protein 
Tb927.10.13670 2017.058615 -0.625540266 0.003096723 serine/threonine protein phosphatase 5 
Tb927.11.2700 1344.203977 -0.622445486 0.001997121 Basal body protein 
Tb927.5.1260 1167.984231 -0.622075499 0.000419251 
Sulfate transporter N-terminal domain with GLY motif/Sulfate transporter 
family, putative 
Tb927.9.8000 6479.502252 -0.6220709 0.000329646 ubiquitin-protein ligase, putative 
Tb927.10.3990 7296.227197 -0.618963922 6.53E-05 DHH1 
Tb927.11.1330 969.1144962 -0.614117928 0.000517378 Stress responsive A/B Barrel Domain, putative 
Tb927.2.5060 3695.528124 -0.613984687 0.000676444 GTP binding protein, putative 
Tb927.10.2900 4004.380459 -0.613254263 3.37E-05 importin beta-1 subunit, putative 
Tb927.10.12710 15908.62432 -0.613113248 0.002849952 heat shock protein 110, putative 
Tb927.11.550 5905.182303 -0.612017602 0.001207535 hypothetical protein SCD6.10 
Tb927.11.13230 2865.760491 -0.610763151 0.000658763 VAMP-associated protein, putative 
Tb927.9.1750 5274.501925 -0.610325976 4.60E-05 Fibronectin type III domain containing protein, putative 
Tb927.6.4370 3196.606925 -0.607981964 0.00280883 eukaryotic translation initiation factor 3 subunit d 
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Tb927.11.800 3579.648431 -0.607439367 0.000336474 prefoldin subunit, putative 
Tb927.6.4440 8550.830584 -0.605392289 0.001154272 RNA-binding protein 42 (RNA-binding motif protein 42) 
Tb927.11.950 3559.365348 -0.603720977 5.06E-05 RNA-binding protein, putative 
Tb927.3.1900 893.4207317 -0.603107239 0.001634962 conserved protein, unknown function 
Tb927.5.4180 7069.544345 -0.602189874 0.002746364 histone H4, putative 
Tb927.11.9640 4290.050426 -0.599138516 0.000304971 glycyl-tRNA synthetase, putative 
Tb927.9.4420 2970.672373 -0.598329 0.000129565 hypothetical protein, conserved 
Tb927.11.3980 2337.837761 -0.598301398 0.001589118 metallo-peptidase, Clan ME, Family M16 
Tb927.11.7350 3516.663712 -0.598121171 0.000475914 Histone H2B variant V 
Tb927.11.1420 830.9338361 -0.597607896 0.002124447 hypothetical protein, conserved 
Tb927.3.960 1380.021671 -0.594844201 0.000507813 protein transport protein Sec61 gamma subunit, putative 
Tb927.8.7970 2458.204136 -0.591767242 0.000415885 hypothetical protein 
Tb927.10.10280 1293.330848 -0.591112887 0.00063382 microtubule-associated protein, putative 
Tb927.10.8980 1252.450132 -0.590321516 0.001139261 hypothetical protein, conserved 
Tb927.7.2510 3001.979555 -0.590098038 0.001808278 endoplasmatic reticulum retrieval protein, putative 
Tb927.3.2050 2567.54636 -0.589798365 0.000373327 Minicircle replication factor 172 
Tb927.8.1460 1189.852446 -0.58592677 0.000909099 EamA-like transporter family, putative 
Tb927.11.7780 1878.364315 -0.584736068 0.002772 Mitochondrial import receptor subunit ATOM46 
Tb11.v5.0463 820.4250395 -0.583900872 0.002453244 expression site-associated gene (ESAG) protein, putative 
Tb927.7.5840 1812.166084 -0.582455744 0.001880707 hypothetical protein, conserved 
Tb927.6.4140 3482.508744 -0.579784064 0.00075765 paraflagellar rod component, putative 
Tb927.11.10800 1631.791288 -0.578633049 0.00076608 Domain of unknown function (DUF4496), putative 
Tb927.6.4180 1553.860847 -0.577214252 0.000426252 FUN14 family, putative 
Tb927.9.9100 2451.654976 -0.575407644 0.000449894 hypothetical protein, conserved 
Tb927.5.3170 2033.221852 -0.573464529 0.001086622 ribose-phosphate pyrophosphokinase, putative 
Tb927.10.14980 4095.441603 -0.573009537 0.000564264 intraflagellar transport protein 52 
Tb927.4.590 5603.370138 -0.572944693 8.14E-05 PQQ-like domain/Protein of unknown function (DUF1620), putative 
Tb927.8.2320 1236.732262 -0.572292605 0.000792531 hypothetical protein 
Tb927.10.170 3634.440867 -0.571463555 0.001318979 pseudouridine synthase, Cbf5p 
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Tb927.11.11590 5038.184144 -0.570237236 0.003207507 Eukaryotic translation initiation factor 3 subunit E 
Tb927.11.1020 5539.095699 -0.570054081 0.001990888 ribokinase, putative 
Tb927.11.260 3843.773896 -0.569847538 0.00018555 Putative intraflagellar transport protein F6 
Tb927.10.13280 4122.133928 -0.5684295 0.000116312 hypothetical protein, conserved 
Tb927.5.1160 5800.990307 -0.566973939 0.001815165 Degradation arginine-rich protein for mis-folding, putative 
Tb927.3.1590 1419.827744 -0.566632459 0.001054365 mitochondrial RNA binding complex 1 subunit 
Tb927.11.15370 5772.559169 -0.566547545 0.000145872 Importin subunit beta-4, putative 
Tb927.8.2540 7231.409674 -0.566478033 0.000345741 3-ketoacyl-CoA thiolase, putative 
Tb927.9.5190 1906.749257 -0.566256141 0.000574193 proliferative cell nuclear antigen (PCNA), putative 
Tb927.9.1440 6405.778807 -0.565014492 0.000755334 Paraquat-inducible protein A, putative 
Tb927.11.14300 5378.023054 -0.56426515 0.000105345 Dynein intermediate chain, axonemal 
Tb927.6.4630 3304.136116 -0.563429267 0.000269605 kinetoplastid-specific phospho-protein phosphatase, putative 
Tb927.6.3650 4833.943644 -0.5630773 0.00011479 ADP-ribosylation factor, putative 
Tb927.10.10050 3593.081501 -0.560788343 0.00072761 hypothetical protein, conserved 
Tb927.11.15130 1270.805999 -0.56037142 0.001008246 DnaJ homolog, putative 
Tb927.10.13720 5550.334358 -0.55866066 0.000169486 RNA-binding protein 29, putative 
Tb927.11.2430 8958.134103 -0.558449955 0.00038053 Cytoplasmic dynein 2 heavy chain (DYNC2H2), putative 
Tb927.5.4480 7822.444037 -0.557114353 0.000220809 paraflagellar rod component par4, putative 
Tb927.10.14760 8948.870998 -0.557091313 0.001159511 clathrin light chain, putative 
Tb927.10.7140 5414.22425 -0.556258979 0.00014021 membrane-bound acid phosphatase 2 
Tb927.11.2540 2596.761637 -0.556083656 0.000401816 hypothetical protein, conserved 
Tb927.6.5050 1861.418321 -0.555068951 0.000787403 V-type ATPase, C subunit, putative 
Tb927.9.11480 5106.744673 -0.553691346 0.000249083 Enriched in surface-labeled proteome protein 9 
Tb927.7.2190 4980.92797 -0.553249191 0.002273385 translocon-associated protein (TRAP), alpha subunit, putative 
Tb927.8.1870 15649.21438 -0.551905249 0.001934585 Golgi/lysosome glycoprotein 1 
Tb927.9.6560 2980.467002 -0.549792153 0.002486407 NAK family pseudokinase, putative 
Tb11.v5.0863 1335.720298 -0.549343641 0.001238422 hypothetical protein, conserved 
Tb927.11.5840 2278.069619 -0.549228657 0.001777706 Protein translation factor SUI1 homolog, putative 
Tb927.9.2590 2621.252802 -0.549051287 0.000529711 hypothetical protein, conserved 
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Tb927.7.1120 1486.459929 -0.547876549 0.00339555 trypanothione/tryparedoxin dependent peroxidase 1, cytosolic 
Tb927.7.2170 3891.991111 -0.547816876 0.001601383 hypothetical protein, conserved 
Tb927.10.1230 2910.09764 -0.547140356 0.0003076 Enriched in surface-labeled proteome protein 23 
Tb927.8.3790 1416.484585 -0.542014729 0.001040868 paraflagellar rod component, putative 
Tb927.7.1330 866.57155 -0.540141461 0.00330241 hypothetical protein, conserved 
Tb927.8.3250 7907.303357 -0.539746588 0.000294192 dynein heavy chain, putative 
Tb11.v5.0364 1255.00935 -0.539434613 0.001543269 hypothetical protein, conserved 
Tb927.10.840 2923.919308 -0.538946865 0.000733241 Flagellum attachment zone protein 6 
Tb927.11.4450 3045.17466 -0.535162938 0.002738864 ALBA-Domain Protein 
Tb927.10.290 2586.452852 -0.53473888 0.0006195 proteasome alpha 2 subunit, putative 
Tb927.11.15140 3641.055743 -0.534313258 0.000577158 bilobe region protein, putative 
Tb927.6.4460 2977.267203 -0.53098429 0.001877408 S-adenosylmethionine decarboxylase 
Tb927.9.13070 15923.28306 -0.530061325 0.003245095 Heat shock factor binding 1 domain-containing protein 
Tb927.11.9860 10628.91411 -0.530025708 0.001517248 EF-hand domain pair, putative 
Tb927.11.8140 1411.373758 -0.529873645 0.002781086 ER lumen retaining receptor protein, putative 
Tb927.2.3780 3656.171074 -0.529483275 0.001852787 translation initiation factor IF-2, putative 
Tb927.11.4290 5578.025859 -0.528866155 0.000363895 40S ribosomal protein S12 
Tb927.11.10990 1469.961875 -0.528708449 0.001951443 methylthioribose-1-phosphate isomerase, putative 
Tb927.10.3970 4296.657657 -0.527461633 0.0006745 hypothetical protein, conserved 
Tb927.10.14030 6637.264614 -0.526798765 0.002378443 hypothetical protein, conserved 
Tb927.9.15890 1906.336624 -0.526279569 0.000990718 expression site-associated gene 5 (ESAG5) protein, putative 
Tb927.3.5060 3183.584813 -0.52550554 0.001403243 Ankyrin repeats (many copies)/Ankyrin repeats (3 copies), putative 
Tb927.9.9060 3023.240129 -0.525423942 0.000878961 Lsm12 protein, putative 
Tb927.11.6460 3177.628858 -0.524873393 0.000713521 hypothetical protein, conserved 
Tb927.10.3790 3547.985992 -0.52475147 0.001018297 hypothetical protein, conserved 
Tb927.3.1680 3226.641322 -0.523335324 0.002378908 Eukaryotic translation initiation factor 3 subunit F 
Tb927.10.8930 3318.635644 -0.521943736 0.001400273 paraflagellar rod component, putative 
Tb927.11.500 13947.00393 -0.52179048 0.000614144 RNA-binding protein, UBP1 
Tb927.4.1270 3224.436274 -0.519573364 0.00247714 ruvB-like DNA helicase, putative 
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Tb927.11.5850 6317.992429 -0.516168228 0.000632155 RNA-binding protein 38, putative 
Tb927.11.3380 2713.066194 -0.515285579 0.001789019 Ran-binding protein 1, putative 
Tb927.11.1080 2280.462007 -0.514951526 0.00097302 hypothetical protein, conserved 
Tb927.11.3490 4638.232328 -0.514930099 0.000456469 hypothetical protein, conserved 
Tb927.7.1920 1895.539547 -0.514747294 0.001304447 paraflagellar rod component, putative 
Tb927.10.14330 2761.213642 -0.513861006 0.00317349 Utp14 protein, putative 
Tb927.6.4770 1098.783899 -0.511272904 0.003283857 protein mkt1, putative 
Tb927.11.16340 3076.40169 -0.503942526 0.00165277 Importin-beta N-terminal domain/HEAT-like repeat, putative 
Tb927.9.12980 3329.47373 -0.499534534 0.002515118 Alpha/beta hydrolase family, putative 
Tb927.9.7770 2751.168475 -0.498754399 0.001252842 spermidine synthase 
Tb927.2.4410 3204.994786 -0.496531809 0.001753379 Eukaryotic protein of unknown function (DUF846), putative 
Tb927.6.4970 3645.348818 -0.494963175 0.003170023 serine/arginine-rich protein specific kinase SRPK, putative 
Tb927.11.6790 1962.82959 -0.491821989 0.002779326 predicted WD40 repeat protein 
Tb927.11.14840 5410.191681 -0.490727637 0.002014638 chromosomal passenger complex 2 
Tb927.10.13710 3789.744984 -0.488486945 0.001699873 
Activator of Hsp90 ATPase, N-terminal/Activator of Hsp90 ATPase 
homolog 1-like protein, putative 
Tb927.10.6800 2525.334565 -0.483097639 0.001771955 developmentally regulated GTP-binding protein, putative 
Tb927.3.720 4988.861346 -0.47973977 0.001863358 zinc finger protein 3 
Tb927.11.630 3244.023653 -0.474902713 0.003032184 RNA polymerase I second largest subunit 
Tb927.11.2360 4067.066921 -0.461982987 0.001887451 phenylalanyl-tRNA synthetase (beta subunit), putative 
Tb927.8.5450 4885.204973 -0.459366078 0.001701591 amino acid permease 24 
Tb927.8.1940 2869.968511 -0.453133135 0.003310826 endosomal integral membrane protein, putative 
Tb927.5.1000 18735.89493 -0.45016784 0.001429049 ubiquitin-conjugating enzyme E2, putative 
Tb927.10.14470 5196.753709 -0.445541559 0.003074318 intraflagellar transport protein 140 
Table 8.3 List of downregulated genes after 36hr of TbRH2A RNAi 
List of genes found to be statistically down regulated after 36 hr TbRH2A knockdown with RNAi. The log2 fold-change (FC) of normalisaed read counts in 
tet-induced samples relative to un-induced is shown for each gene, as well as p value of significance and gene description
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Gene ID Base Mean Log2 FC p value Gene description 
Tb427VSG-621 147.73983 4.103694 0.0002079 array 
Tb427VSG-15 1235.56385 3.892097 0 BES 
Tb427VSG-2096 11.76122 3.382387 0.0024056 Pseudogene 
Tb427VSG-1299 15.86982 3.290564 0.0007291 Pseudogene 
Tb427VSG-631 326.97103 2.867043 0 array 
Tb427VSG-775 235.98108 2.796116 0 array 
Tb427VSG-582 93.64212 2.584657 0.0000016 MES 
Tb427VSG-3591 140.76899 2.328949 0.0000006 Pseudogene 
Tb427VSG-5 103.85178 2.246091 0.0000009 BES 
Tb427VSG-514 53.30968 2.083303 0.0017956 MC 
Tb427VSG-322 1720.99756 1.716163 0.0000028 array 
Tb427VSG-636 114.55927 1.686899 0.0004664 array 
Tb427VSG-3709 192.04112 1.682074 0.0000412 Pseudogene 
Tb427VSG-6 546.80796 1.630817 0.0000417 BES 
Tb427VSG-3064 448.01582 1.555355 0.0000221 Pseudogene 
Tb427VSG-1954 539.42207 1.534786 0.000236 MES 
Tb427VSG-397 408.14157 1.521798 0.0004783 Pseudogene 
Tb427VSG-8 5879.58614 1.412936 0.0001566 BES 
Tb427VSG-1316 2272.83319 1.150647 0.0012714 Pseudogene 
Tb427VSG-1559 1098.06947 1.093385 0.0031419 Pseudogene 
Table 8.4 List of expressed VSGs after 24 hr of TbRH2A RNAi 
VSG genes found to be significantly (p < 0.005) upregulated after 24 hr of TbRH2A RNAi in induced 
samples relative to un-induced, expressed as Log2 fold-change (FC) in read counts. Whether each 
VSG is predicted to be found intact within silent arrays (array), a BES or an mVSG ES, or be 
pseudogenic is also shown.  
  
282 
Gene ID Base Mean Log2 FC p value Gene description 
Tb427VSG-1206 1.63E+01 4.548474 0.0005312 pseudogene 
Tb427VSG-423 3.77E+01 4.483429 0.0000051 array 
Tb427VSG-3238 9.43E+00 3.752305 0.009258 pseudogene 
Tb427VSG-3623 9.27E+00 3.716557 0.0080107 pseudogene 
Tb427VSG-3768 2.95E+01 3.681719 0.0000915 pseudogene 
Tb427VSG-596 1.01E+01 3.654775 0.0071546 array 
Tb427VSG-1614 6.35E+01 3.635489 0.0000008 pseudogene 
Tb427VSG-1641 1.08E+01 3.577864 0.0067922 pseudogene 
Tb427VSG-3709 3.75E+02 3.438951 0 pseudogene 
Tb427VSG-3064 8.58E+02 3.258154 0 pseudogene 
Tb427VSG-5 1.72E+02 3.144822 0.0000001 BES 
Tb427VSG-3037 1.20E+02 3.124865 0.0000037 pseudogene 
Tb427VSG-15 7.42E+02 3.088941 0.0000022 BES 
Tb427VSG-2096 2.04E+01 2.968342 0.0013374 pseudogene 
Tb427VSG-1387 1.58E+01 2.930711 0.0081921 pseudogene 
Tb427VSG-312 5.34E+01 2.846268 0.000176 array 
Tb427VSG-570 3.44E+01 2.804362 0.0013071 array 
Tb427VSG-1579 2.76E+01 2.63234 0.0013355 pseudogene 
Tb427VSG-1022 2.34E+01 2.575163 0.0025979 pseudogene 
Tb427VSG-1157 1.45E+02 2.569905 0.0000327 pseudogene 
Tb427VSG-1316 2.27E+03 2.561984 0.0000298 pseudogene 
Tb427VSG-3139 9.45E+01 2.560946 0.0001056 pseudogene 
Tb427VSG-2272 3.90E+01 2.501443 0.0009362 array 
Tb427VSG-3386 2.73E+01 2.427168 0.002898 pseudogene 
Tb427VSG-322 1.73E+03 2.411786 0.0000117 array 
Tb427VSG-621 6.59E+01 2.328027 0.0035334 array 
Tb427VSG-1559 1.00E+03 2.301547 0.0000547 pseudogene 
Tb427VSG-3449 3.71E+02 2.178837 0.0002387 pseudogene 
Tb427VSG-13 1.90E+02 2.159051 0.0003525 BES 
Tb427VSG-14 1.07E+03 2.147594 0.0000755 BES 
Tb427VSG-636 1.62E+02 2.137291 0.0008439 array 
Tb427VSG-775 1.42E+02 2.121092 0.0015607 array 
Tb427VSG-11 8.33E+02 1.913511 0.0018668 BES 
Tb427VSG-3577 6.52E+01 1.899652 0.0039648 pseudogene 
Tb427VSG-3719 2.73E+02 1.896749 0.0035249 pseudogene 
Tb427VSG-1394 1.89E+03 1.860581 0.0012079 pseudogene 
Tb427VSG-3221 3.63E+02 1.844018 0.0016085 pseudogene 
Tb427VSG-1042 9.57E+01 1.816259 0.0022194 pseudogene 
Tb427VSG-1241 8.87E+01 1.752897 0.005665 pseudogene 
Tb427VSG-761 1.14E+02 1.734486 0.0037029 array 
Tb427VSG-502 4.97E+01 1.733352 0.0105722 array 
Tb427VSG-676 1.89E+02 1.726471 0.0079513 array 
Tb427VSG-1073 6.03E+01 1.721688 0.0075532 pseudogene 
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Tb427VSG-531 1.18E+03 1.69994 0.0016698 mVSG ES 
Tb427VSG-3303 4.86E+03 1.614583 0.0055186 pseudogene 
Tb427VSG-3104 4.56E+03 1.599405 0.005474 pseudogene 
Tb427VSG-1347 2.47E+02 1.572806 0.0044442 pseudogene 
Tb427VSG-1521 2.09E+02 1.487125 0.0106162 pseudogene 
Tb427VSG-350 1.11E+02 1.481647 0.0101408 array 
Tb427VSG-1267 7.01E+02 1.416988 0.0100395 pseudogene 
Tb427VSG-2 4.64E+06 -2.990698 0 BES active 
Table 8.5 List of expressed VSGs after 36 hr of TbRH2A RNAi 
VSG genes found to be significantly (p < 0.005) differential expressed after 36 hr of TbRH2A RNAi in 
induced samples relative to un-induced expressed as Log2 fold-change (FC) in read counts.  The final 
VSG, Tb427VSG-2 (also named VSG221 in this thesis), is housed in the dominant BES and is down-
regulated in comparison to all others found to be upregulated. Whether each VSG is predicted to be 
found intact within silent arrays (array), a BES or an mVSG ES, or be pseudogenic is also show.
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